id	sid	tid	token	lemma	pos
dpc-5733	1	1	dermatology	dermatology	NOUN
dpc-5733	1	2	:	:	PUNCT
dpc-5733	1	3	practical	practical	ADJ
dpc-5733	1	4	and	and	CCONJ
dpc-5733	1	5	conceptual	conceptual	ADJ
dpc-5733	1	6	original	original	ADJ
dpc-5733	1	7	article	article	NOUN
dpc-5733	1	8	|	|	ADV
dpc-5733	1	9	dermatol	dermatol	ADJ
dpc-5733	1	10	pract	pract	NOUN
dpc-5733	1	11	concept	concept	NOUN
dpc-5733	1	12	.	.	PUNCT
dpc-5733	2	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	2	2	1	1	NUM
dpc-5733	2	3	therapeutic	therapeutic	ADJ
dpc-5733	2	4	modulation	modulation	NOUN
dpc-5733	2	5	of	of	ADP
dpc-5733	2	6	peripheral	peripheral	ADJ
dpc-5733	2	7	blood	blood	NOUN
dpc-5733	2	8	cells	cell	NOUN
dpc-5733	2	9	and	and	CCONJ
dpc-5733	2	10	inflammatory	inflammatory	ADJ
dpc-5733	2	11	indices	index	NOUN
dpc-5733	2	12	during	during	ADP
dpc-5733	2	13	52	52	NUM
dpc-5733	2	14	weeks	week	NOUN
dpc-5733	2	15	of	of	ADP
dpc-5733	2	16	risankizumab	risankizumab	NOUN
dpc-5733	2	17	in	in	ADP
dpc-5733	2	18	responder	responder	NOUN
dpc-5733	2	19	patients	patient	NOUN
dpc-5733	2	20	with	with	ADP
dpc-5733	2	21	moderate	moderate	ADJ
dpc-5733	2	22	-	-	PUNCT
dpc-5733	2	23	to	to	ADP
dpc-5733	2	24	-	-	PUNCT
dpc-5733	2	25	severe	severe	ADJ
dpc-5733	2	26	psoriasis	psoriasis	NOUN
dpc-5733	2	27	:	:	PUNCT
dpc-5733	2	28	results	result	VERB
dpc-5733	2	29	from	from	ADP
dpc-5733	2	30	a	a	DET
dpc-5733	2	31	multicenter	multicenter	ADJ
dpc-5733	2	32	prospective	prospective	ADJ
dpc-5733	2	33	study	study	NOUN
dpc-5733	2	34	antonella	antonella	PROPN
dpc-5733	2	35	di	di	PROPN
dpc-5733	2	36	cesare1	cesare1	PROPN
dpc-5733	2	37	,	,	PUNCT
dpc-5733	2	38	elia	elia	PROPN
dpc-5733	2	39	rosi1	rosi1	PROPN
dpc-5733	2	40	,	,	PUNCT
dpc-5733	2	41	emanuele	emanuele	PROPN
dpc-5733	2	42	trovato2	trovato2	PROPN
dpc-5733	2	43	,	,	PUNCT
dpc-5733	2	44	leonardo	leonardo	PROPN
dpc-5733	2	45	pescitelli3	pescitelli3	PROPN
dpc-5733	2	46	,	,	PUNCT
dpc-5733	2	47	salvatore	salvatore	PROPN
dpc-5733	2	48	panduri4	panduri4	PROPN
dpc-5733	2	49	,	,	PUNCT
dpc-5733	2	50	flavia	flavia	PROPN
dpc-5733	2	51	manzo	manzo	PROPN
dpc-5733	2	52	margiotta4,5	margiotta4,5	PROPN
dpc-5733	2	53	,	,	PUNCT
dpc-5733	2	54	alessandra	alessandra	PROPN
dpc-5733	2	55	michelucci4,5	michelucci4,5	PROPN
dpc-5733	2	56	,	,	PUNCT
dpc-5733	2	57	eugenio	eugenio	PROPN
dpc-5733	2	58	capalbo2	capalbo2	PROPN
dpc-5733	2	59	,	,	PUNCT
dpc-5733	2	60	martina	martina	PROPN
dpc-5733	2	61	dragotto2	dragotto2	PROPN
dpc-5733	2	62	,	,	PUNCT
dpc-5733	2	63	michela	michela	PROPN
dpc-5733	2	64	magnano6	magnano6	PROPN
dpc-5733	2	65	,	,	PUNCT
dpc-5733	2	66	susanna	susanna	PROPN
dpc-5733	2	67	rossari6	rossari6	PROPN
dpc-5733	2	68	,	,	PUNCT
dpc-5733	2	69	imma	imma	PROPN
dpc-5733	2	70	savarese7	savarese7	PROPN
dpc-5733	2	71	,	,	PUNCT
dpc-5733	2	72	gionata	gionata	PROPN
dpc-5733	2	73	buggiani3	buggiani3	PROPN
dpc-5733	2	74	,	,	PUNCT
dpc-5733	2	75	nicola	nicola	PROPN
dpc-5733	2	76	milanesi7	milanesi7	PROPN
dpc-5733	2	77	,	,	PUNCT
dpc-5733	2	78	elisa	elisa	PROPN
dpc-5733	2	79	lorenzoni8	lorenzoni8	PROPN
dpc-5733	2	80	,	,	PUNCT
dpc-5733	2	81	federica	federica	PROPN
dpc-5733	2	82	ricceri9	ricceri9	PROPN
dpc-5733	2	83	,	,	PUNCT
dpc-5733	2	84	marco	marco	PROPN
dpc-5733	2	85	romanelli4	romanelli4	PROPN
dpc-5733	2	86	,	,	PUNCT
dpc-5733	2	87	pietro	pietro	PROPN
dpc-5733	2	88	rubegni2	rubegni2	PROPN
dpc-5733	2	89	,	,	PUNCT
dpc-5733	2	90	nicola	nicola	PROPN
dpc-5733	2	91	pimpinelli1	pimpinelli1	PROPN
dpc-5733	2	92	,	,	PUNCT
dpc-5733	2	93	francesca	francesca	PROPN
dpc-5733	2	94	prignano1	prignano1	PROPN
dpc-5733	2	95	1	1	NUM
dpc-5733	2	96	section	section	NOUN
dpc-5733	2	97	of	of	ADP
dpc-5733	2	98	dermatology	dermatology	NOUN
dpc-5733	2	99	,	,	PUNCT
dpc-5733	2	100	department	department	NOUN
dpc-5733	2	101	of	of	ADP
dpc-5733	2	102	health	health	PROPN
dpc-5733	2	103	sciences	sciences	PROPN
dpc-5733	2	104	,	,	PUNCT
dpc-5733	2	105	university	university	NOUN
dpc-5733	2	106	of	of	ADP
dpc-5733	2	107	florence	florence	NOUN
dpc-5733	2	108	,	,	PUNCT
dpc-5733	2	109	florence	florence	NOUN
dpc-5733	2	110	,	,	PUNCT
dpc-5733	2	111	italy	italy	PROPN
dpc-5733	2	112	2	2	NUM
dpc-5733	2	113	dermatology	dermatology	NOUN
dpc-5733	2	114	section	section	NOUN
dpc-5733	2	115	,	,	PUNCT
dpc-5733	2	116	department	department	NOUN
dpc-5733	2	117	of	of	ADP
dpc-5733	2	118	medical	medical	ADJ
dpc-5733	2	119	,	,	PUNCT
dpc-5733	2	120	surgical	surgical	ADJ
dpc-5733	2	121	and	and	CCONJ
dpc-5733	2	122	neurological	neurological	ADJ
dpc-5733	2	123	science	science	NOUN
dpc-5733	2	124	,	,	PUNCT
dpc-5733	2	125	university	university	PROPN
dpc-5733	2	126	of	of	ADP
dpc-5733	2	127	siena	siena	PROPN
dpc-5733	2	128	,	,	PUNCT
dpc-5733	2	129	siena	siena	PROPN
dpc-5733	2	130	,	,	PUNCT
dpc-5733	2	131	italy	italy	PROPN
dpc-5733	2	132	3	3	NUM
dpc-5733	2	133	unit	unit	NOUN
dpc-5733	2	134	of	of	ADP
dpc-5733	2	135	dermatology	dermatology	NOUN
dpc-5733	2	136	,	,	PUNCT
dpc-5733	2	137	san	san	PROPN
dpc-5733	2	138	giuseppe	giuseppe	PROPN
dpc-5733	2	139	hospital	hospital	PROPN
dpc-5733	2	140	,	,	PUNCT
dpc-5733	2	141	empoli	empoli	NOUN
dpc-5733	2	142	,	,	PUNCT
dpc-5733	2	143	florence	florence	NOUN
dpc-5733	2	144	,	,	PUNCT
dpc-5733	2	145	italy	italy	PROPN
dpc-5733	2	146	4	4	NUM
dpc-5733	2	147	department	department	PROPN
dpc-5733	2	148	of	of	ADP
dpc-5733	2	149	dermatology	dermatology	NOUN
dpc-5733	2	150	,	,	PUNCT
dpc-5733	2	151	university	university	NOUN
dpc-5733	2	152	of	of	ADP
dpc-5733	2	153	pisa	pisa	PROPN
dpc-5733	2	154	,	,	PUNCT
dpc-5733	2	155	pisa	pisa	PROPN
dpc-5733	2	156	,	,	PUNCT
dpc-5733	2	157	italy	italy	PROPN
dpc-5733	2	158	5	5	NUM
dpc-5733	2	159	interdisciplinary	interdisciplinary	ADJ
dpc-5733	2	160	center	center	NOUN
dpc-5733	2	161	of	of	ADP
dpc-5733	2	162	health	health	NOUN
dpc-5733	2	163	science	science	NOUN
dpc-5733	2	164	,	,	PUNCT
dpc-5733	2	165	sant'anna	sant'anna	PROPN
dpc-5733	2	166	school	school	NOUN
dpc-5733	2	167	of	of	ADP
dpc-5733	2	168	advanced	advanced	ADJ
dpc-5733	2	169	studies	study	NOUN
dpc-5733	2	170	of	of	ADP
dpc-5733	2	171	pisa	pisa	PROPN
dpc-5733	2	172	,	,	PUNCT
dpc-5733	2	173	pisa	pisa	PROPN
dpc-5733	2	174	,	,	PUNCT
dpc-5733	2	175	italy	italy	PROPN
dpc-5733	2	176	6	6	NUM
dpc-5733	2	177	unit	unit	NOUN
dpc-5733	2	178	of	of	ADP
dpc-5733	2	179	dermatology	dermatology	NOUN
dpc-5733	2	180	,	,	PUNCT
dpc-5733	2	181	versilia	versilia	NOUN
dpc-5733	2	182	hospital	hospital	NOUN
dpc-5733	2	183	,	,	PUNCT
dpc-5733	2	184	lido	lido	NOUN
dpc-5733	2	185	di	di	PROPN
dpc-5733	2	186	camaiore	camaiore	PROPN
dpc-5733	2	187	,	,	PUNCT
dpc-5733	2	188	lucca	lucca	PROPN
dpc-5733	2	189	,	,	PUNCT
dpc-5733	2	190	italy	italy	PROPN
dpc-5733	2	191	7	7	NUM
dpc-5733	2	192	department	department	PROPN
dpc-5733	2	193	of	of	ADP
dpc-5733	2	194	dermatology	dermatology	NOUN
dpc-5733	2	195	,	,	PUNCT
dpc-5733	2	196	san	san	PROPN
dpc-5733	2	197	jacopo	jacopo	PROPN
dpc-5733	2	198	hospital	hospital	PROPN
dpc-5733	2	199	,	,	PUNCT
dpc-5733	2	200	pistoia	pistoia	PROPN
dpc-5733	2	201	,	,	PUNCT
dpc-5733	2	202	italy	italy	PROPN
dpc-5733	2	203	8	8	NUM
dpc-5733	2	204	unit	unit	NOUN
dpc-5733	2	205	of	of	ADP
dpc-5733	2	206	dermatology	dermatology	NOUN
dpc-5733	2	207	,	,	PUNCT
dpc-5733	2	208	hospital	hospital	NOUN
dpc-5733	2	209	of	of	ADP
dpc-5733	2	210	campo	campo	PROPN
dpc-5733	2	211	di	di	PROPN
dpc-5733	2	212	marte	marte	PROPN
dpc-5733	2	213	,	,	PUNCT
dpc-5733	2	214	lucca	lucca	PROPN
dpc-5733	2	215	,	,	PUNCT
dpc-5733	2	216	italy	italy	PROPN
dpc-5733	2	217	9	9	NUM
dpc-5733	2	218	unit	unit	NOUN
dpc-5733	2	219	of	of	ADP
dpc-5733	2	220	dermatology	dermatology	NOUN
dpc-5733	2	221	,	,	PUNCT
dpc-5733	2	222	san	san	PROPN
dpc-5733	2	223	donato	donato	PROPN
dpc-5733	2	224	hospital	hospital	PROPN
dpc-5733	2	225	,	,	PUNCT
dpc-5733	2	226	arezzo	arezzo	PROPN
dpc-5733	2	227	,	,	PUNCT
dpc-5733	2	228	italy	italy	PROPN
dpc-5733	2	229	key	key	PROPN
dpc-5733	2	230	message	message	NOUN
dpc-5733	2	231	:	:	PUNCT
dpc-5733	2	232	biologic	biologic	NOUN
dpc-5733	2	233	therapies	therapy	NOUN
dpc-5733	2	234	act	act	VERB
dpc-5733	2	235	on	on	ADP
dpc-5733	2	236	specific	specific	ADJ
dpc-5733	2	237	immune	immune	NOUN
dpc-5733	2	238	-	-	PUNCT
dpc-5733	2	239	pathogenic	pathogenic	ADJ
dpc-5733	2	240	pathways	pathway	NOUN
dpc-5733	2	241	and	and	CCONJ
dpc-5733	2	242	potentially	potentially	ADV
dpc-5733	2	243	on	on	ADP
dpc-5733	2	244	systemic	systemic	ADJ
dpc-5733	2	245	inflammation	inflammation	NOUN
dpc-5733	2	246	as	as	ADV
dpc-5733	2	247	well	well	ADV
dpc-5733	2	248	.	.	PUNCT
dpc-5733	3	1	risankizumab	risankizumab	PROPN
dpc-5733	3	2	modulates	modulate	NOUN
dpc-5733	3	3	relevant	relevant	ADJ
dpc-5733	3	4	peripheral	peripheral	ADJ
dpc-5733	3	5	inflammatory	inflammatory	ADJ
dpc-5733	3	6	indices	index	NOUN
dpc-5733	3	7	such	such	ADJ
dpc-5733	3	8	as	as	ADP
dpc-5733	3	9	neutrophils	neutrophil	NOUN
dpc-5733	3	10	-	-	PUNCT
dpc-5733	3	11	to	to	ADP
dpc-5733	3	12	-	-	PUNCT
dpc-5733	3	13	lymphocyte	lymphocyte	NOUN
dpc-5733	3	14	-	-	PUNCT
dpc-5733	3	15	ratio	ratio	NOUN
dpc-5733	3	16	,	,	PUNCT
dpc-5733	3	17	pan	pan	ADJ
dpc-5733	3	18	-	-	ADJ
dpc-5733	3	19	immune	immune	ADJ
dpc-5733	3	20	-	-	PUNCT
dpc-5733	3	21	inflammationvalue	inflammationvalue	NOUN
dpc-5733	3	22	,	,	PUNCT
dpc-5733	3	23	systemic	systemic	ADJ
dpc-5733	3	24	-	-	PUNCT
dpc-5733	3	25	immune	immune	ADJ
dpc-5733	3	26	-	-	PUNCT
dpc-5733	3	27	inflammation	inflammation	NOUN
dpc-5733	3	28	-	-	PUNCT
dpc-5733	3	29	index	index	NOUN
dpc-5733	3	30	,	,	PUNCT
dpc-5733	3	31	and	and	CCONJ
dpc-5733	3	32	systemic	systemic	ADJ
dpc-5733	3	33	-	-	PUNCT
dpc-5733	3	34	immune	immune	ADJ
dpc-5733	3	35	-	-	PUNCT
dpc-5733	3	36	response	response	NOUN
dpc-5733	3	37	-	-	PUNCT
dpc-5733	3	38	index	index	NOUN
dpc-5733	3	39	,	,	PUNCT
dpc-5733	3	40	especially	especially	ADV
dpc-5733	3	41	in	in	ADP
dpc-5733	3	42	super	super	ADJ
dpc-5733	3	43	-	-	ADJ
dpc-5733	3	44	responder	responder	ADJ
dpc-5733	3	45	patients	patient	NOUN
dpc-5733	3	46	,	,	PUNCT
dpc-5733	3	47	with	with	ADP
dpc-5733	3	48	potential	potential	ADJ
dpc-5733	3	49	impact	impact	NOUN
dpc-5733	3	50	on	on	ADP
dpc-5733	3	51	long	long	ADJ
dpc-5733	3	52	-	-	PUNCT
dpc-5733	3	53	term	term	NOUN
dpc-5733	3	54	psoriatic	psoriatic	ADJ
dpc-5733	3	55	patients	patient	NOUN
dpc-5733	3	56	’	'	PUNCT
dpc-5733	3	57	prognosis	prognosis	NOUN
dpc-5733	3	58	.	.	PUNCT
dpc-5733	4	1	key	key	ADJ
dpc-5733	4	2	words	word	NOUN
dpc-5733	4	3	:	:	PUNCT
dpc-5733	4	4	psoriasis	psoriasis	NOUN
dpc-5733	4	5	,	,	PUNCT
dpc-5733	4	6	risankizumab	risankizumab	NOUN
dpc-5733	4	7	,	,	PUNCT
dpc-5733	4	8	sii	sii	PROPN
dpc-5733	4	9	,	,	PUNCT
dpc-5733	4	10	siri	siri	NOUN
dpc-5733	4	11	,	,	PUNCT
dpc-5733	4	12	nlr	nlr	PROPN
dpc-5733	4	13	citation	citation	NOUN
dpc-5733	4	14	:	:	PUNCT
dpc-5733	4	15	di	di	PROPN
dpc-5733	4	16	cesare	cesare	PROPN
dpc-5733	4	17	a	a	PROPN
dpc-5733	4	18	,	,	PUNCT
dpc-5733	4	19	rosi	rosi	PROPN
dpc-5733	4	20	e	e	PROPN
dpc-5733	4	21	,	,	PUNCT
dpc-5733	4	22	trovato	trovato	PROPN
dpc-5733	4	23	e	e	PROPN
dpc-5733	4	24	,	,	PUNCT
dpc-5733	4	25	et	et	PROPN
dpc-5733	4	26	al	al	PROPN
dpc-5733	4	27	.	.	PUNCT
dpc-5733	5	1	therapeutic	therapeutic	ADJ
dpc-5733	5	2	modulation	modulation	NOUN
dpc-5733	5	3	of	of	ADP
dpc-5733	5	4	peripheral	peripheral	ADJ
dpc-5733	5	5	blood	blood	NOUN
dpc-5733	5	6	cells	cell	NOUN
dpc-5733	5	7	and	and	CCONJ
dpc-5733	5	8	inflammatory	inflammatory	ADJ
dpc-5733	5	9	indices	index	NOUN
dpc-5733	5	10	during	during	ADP
dpc-5733	5	11	52	52	NUM
dpc-5733	5	12	weeks	week	NOUN
dpc-5733	5	13	of	of	ADP
dpc-5733	5	14	risankizumab	risankizumab	NOUN
dpc-5733	5	15	in	in	ADP
dpc-5733	5	16	responder	responder	NOUN
dpc-5733	5	17	patients	patient	NOUN
dpc-5733	5	18	with	with	ADP
dpc-5733	5	19	moderate	moderate	ADJ
dpc-5733	5	20	-	-	PUNCT
dpc-5733	5	21	to	to	ADP
dpc-5733	5	22	-	-	PUNCT
dpc-5733	5	23	severe	severe	ADJ
dpc-5733	5	24	psoriasis	psoriasis	NOUN
dpc-5733	5	25	:	:	PUNCT
dpc-5733	5	26	results	result	VERB
dpc-5733	5	27	from	from	ADP
dpc-5733	5	28	a	a	DET
dpc-5733	5	29	multicenter	multicenter	ADJ
dpc-5733	5	30	prospective	prospective	ADJ
dpc-5733	5	31	study	study	NOUN
dpc-5733	5	32	.	.	PUNCT
dpc-5733	6	1	dermatol	dermatol	NOUN
dpc-5733	6	2	pract	pract	PROPN
dpc-5733	6	3	concept	concept	NOUN
dpc-5733	6	4	.	.	PUNCT
dpc-5733	7	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	7	2	.	.	PUNCT
dpc-5733	8	1	doi	doi	NOUN
dpc-5733	8	2	:	:	PUNCT
dpc-5733	8	3	https://doi.org/10.5826/dpc.1504a5733	https://doi.org/10.5826/dpc.1504a5733	PUNCT
dpc-5733	8	4	accepted	accept	VERB
dpc-5733	8	5	:	:	PUNCT
dpc-5733	8	6	august	august	PROPN
dpc-5733	8	7	31	31	NUM
dpc-5733	8	8	,	,	PUNCT
dpc-5733	8	9	2025	2025	NUM
dpc-5733	8	10	;	;	PUNCT
dpc-5733	8	11	published	publish	VERB
dpc-5733	8	12	:	:	PUNCT
dpc-5733	9	1	october	october	PROPN
dpc-5733	9	2	2025	2025	NUM
dpc-5733	9	3	copyright	copyright	NOUN
dpc-5733	9	4	:	:	PUNCT
dpc-5733	9	5	©	©	PROPN
dpc-5733	9	6	2025	2025	NUM
dpc-5733	9	7	di	di	NOUN
dpc-5733	9	8	cesare	cesare	PROPN
dpc-5733	9	9	et	et	PROPN
dpc-5733	9	10	al	al	PROPN
dpc-5733	9	11	.	.	PUNCT
dpc-5733	10	1	this	this	PRON
dpc-5733	10	2	is	be	AUX
dpc-5733	10	3	an	an	DET
dpc-5733	10	4	open	open	ADJ
dpc-5733	10	5	-	-	PUNCT
dpc-5733	10	6	access	access	NOUN
dpc-5733	10	7	article	article	NOUN
dpc-5733	10	8	distributed	distribute	VERB
dpc-5733	10	9	under	under	ADP
dpc-5733	10	10	the	the	DET
dpc-5733	10	11	terms	term	NOUN
dpc-5733	10	12	of	of	ADP
dpc-5733	10	13	the	the	DET
dpc-5733	10	14	creative	creative	ADJ
dpc-5733	10	15	commons	common	NOUN
dpc-5733	10	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5733	10	17	license	license	NOUN
dpc-5733	10	18	(	(	PUNCT
dpc-5733	10	19	by	by	ADP
dpc-5733	10	20	-	-	PUNCT
dpc-5733	10	21	nc-4.0	nc-4.0	NOUN
dpc-5733	10	22	)	)	PUNCT
dpc-5733	10	23	,	,	PUNCT
dpc-5733	10	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5733	10	25	,	,	PUNCT
dpc-5733	10	26	which	which	PRON
dpc-5733	10	27	permits	permit	VERB
dpc-5733	10	28	unrestricted	unrestricted	ADJ
dpc-5733	10	29	noncommercial	noncommercial	ADJ
dpc-5733	10	30	use	use	NOUN
dpc-5733	10	31	,	,	PUNCT
dpc-5733	10	32	distribution	distribution	NOUN
dpc-5733	10	33	,	,	PUNCT
dpc-5733	10	34	and	and	CCONJ
dpc-5733	10	35	reproduction	reproduction	NOUN
dpc-5733	10	36	in	in	ADP
dpc-5733	10	37	any	any	DET
dpc-5733	10	38	medium	medium	NOUN
dpc-5733	10	39	,	,	PUNCT
dpc-5733	10	40	provided	provide	VERB
dpc-5733	10	41	the	the	DET
dpc-5733	10	42	original	original	ADJ
dpc-5733	10	43	authors	author	NOUN
dpc-5733	10	44	and	and	CCONJ
dpc-5733	10	45	source	source	NOUN
dpc-5733	10	46	are	be	AUX
dpc-5733	10	47	credited	credit	VERB
dpc-5733	10	48	.	.	PUNCT
dpc-5733	11	1	funding	funding	NOUN
dpc-5733	11	2	:	:	PUNCT
dpc-5733	11	3	none	none	NOUN
dpc-5733	11	4	.	.	PUNCT
dpc-5733	12	1	competing	compete	VERB
dpc-5733	12	2	interests	interest	NOUN
dpc-5733	12	3	:	:	PUNCT
dpc-5733	12	4	none	none	NOUN
dpc-5733	12	5	.	.	PUNCT
dpc-5733	13	1	authorship	authorship	NOUN
dpc-5733	13	2	:	:	PUNCT
dpc-5733	13	3	all	all	DET
dpc-5733	13	4	authors	author	NOUN
dpc-5733	13	5	have	have	AUX
dpc-5733	13	6	contributed	contribute	VERB
dpc-5733	13	7	significantly	significantly	ADV
dpc-5733	13	8	to	to	ADP
dpc-5733	13	9	this	this	DET
dpc-5733	13	10	publication	publication	NOUN
dpc-5733	13	11	.	.	PUNCT
dpc-5733	14	1	corresponding	correspond	VERB
dpc-5733	14	2	author	author	NOUN
dpc-5733	14	3	:	:	PUNCT
dpc-5733	14	4	antonella	antonella	PROPN
dpc-5733	14	5	di	di	PROPN
dpc-5733	14	6	cesare	cesare	PROPN
dpc-5733	14	7	,	,	PUNCT
dpc-5733	14	8	md	md	PROPN
dpc-5733	14	9	,	,	PUNCT
dpc-5733	14	10	section	section	NOUN
dpc-5733	14	11	of	of	ADP
dpc-5733	14	12	dermatology	dermatology	NOUN
dpc-5733	14	13	,	,	PUNCT
dpc-5733	14	14	ospedale	ospedale	PROPN
dpc-5733	14	15	p.	p.	PROPN
dpc-5733	14	16	palagi	palagi	PROPN
dpc-5733	14	17	,	,	PUNCT
dpc-5733	14	18	viale	viale	NOUN
dpc-5733	14	19	michelangelo	michelangelo	NOUN
dpc-5733	14	20	,	,	PUNCT
dpc-5733	14	21	41	41	NUM
dpc-5733	14	22	,	,	PUNCT
dpc-5733	14	23	50125	50125	NUM
dpc-5733	14	24	florence	florence	NOUN
dpc-5733	14	25	,	,	PUNCT
dpc-5733	14	26	italy	italy	PROPN
dpc-5733	14	27	.	.	PUNCT
dpc-5733	15	1	email	email	NOUN
dpc-5733	15	2	:	:	PUNCT
dpc-5733	15	3	antonelladicesare@yahoo.it	antonelladicesare@yahoo.it	PROPN
dpc-5733	15	4	2	2	NUM
dpc-5733	15	5	original	original	ADJ
dpc-5733	15	6	article	article	NOUN
dpc-5733	15	7	|	|	ADV
dpc-5733	15	8	dermatol	dermatol	ADJ
dpc-5733	15	9	pract	pract	NOUN
dpc-5733	15	10	concept	concept	NOUN
dpc-5733	15	11	.	.	PUNCT
dpc-5733	16	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	16	2	introduction	introduction	NOUN
dpc-5733	16	3	despite	despite	SCONJ
dpc-5733	16	4	consistent	consistent	ADJ
dpc-5733	16	5	data	datum	NOUN
dpc-5733	16	6	on	on	ADP
dpc-5733	16	7	disease	disease	NOUN
dpc-5733	16	8	pathogenesis	pathogenesis	NOUN
dpc-5733	16	9	and	and	CCONJ
dpc-5733	16	10	on	on	ADP
dpc-5733	16	11	the	the	DET
dpc-5733	16	12	efficacy	efficacy	NOUN
dpc-5733	16	13	of	of	ADP
dpc-5733	16	14	different	different	ADJ
dpc-5733	16	15	biologic	biologic	NOUN
dpc-5733	16	16	therapies	therapy	NOUN
dpc-5733	16	17	,	,	PUNCT
dpc-5733	16	18	there	there	PRON
dpc-5733	16	19	is	be	VERB
dpc-5733	16	20	still	still	ADV
dpc-5733	16	21	a	a	DET
dpc-5733	16	22	need	need	NOUN
dpc-5733	16	23	for	for	ADP
dpc-5733	16	24	manageable	manageable	ADJ
dpc-5733	16	25	and	and	CCONJ
dpc-5733	16	26	accessible	accessible	ADJ
dpc-5733	16	27	tools	tool	NOUN
dpc-5733	16	28	to	to	PART
dpc-5733	16	29	optimize	optimize	VERB
dpc-5733	16	30	psoriasis	psoriasis	NOUN
dpc-5733	16	31	treatment	treatment	NOUN
dpc-5733	16	32	.	.	PUNCT
dpc-5733	17	1	innate	innate	ADJ
dpc-5733	17	2	and	and	CCONJ
dpc-5733	17	3	acquired	acquire	VERB
dpc-5733	17	4	immune	immune	ADJ
dpc-5733	17	5	cells	cell	NOUN
dpc-5733	17	6	such	such	ADJ
dpc-5733	17	7	as	as	ADP
dpc-5733	17	8	lymphocytes	lymphocyte	NOUN
dpc-5733	17	9	and	and	CCONJ
dpc-5733	17	10	neutrophils	neutrophil	NOUN
dpc-5733	17	11	are	be	AUX
dpc-5733	17	12	key	key	ADJ
dpc-5733	17	13	drivers	driver	NOUN
dpc-5733	17	14	in	in	ADP
dpc-5733	17	15	psoriasis	psoriasis	NOUN
dpc-5733	17	16	onset	onset	NOUN
dpc-5733	17	17	and	and	CCONJ
dpc-5733	17	18	maintenance	maintenance	NOUN
dpc-5733	17	19	,	,	PUNCT
dpc-5733	17	20	and	and	CCONJ
dpc-5733	17	21	their	their	PRON
dpc-5733	17	22	ratio	ratio	NOUN
dpc-5733	17	23	(	(	PUNCT
dpc-5733	17	24	nlr	nlr	PROPN
dpc-5733	17	25	)	)	PUNCT
dpc-5733	17	26	is	be	AUX
dpc-5733	17	27	a	a	DET
dpc-5733	17	28	recognized	recognize	VERB
dpc-5733	17	29	marker	marker	NOUN
dpc-5733	17	30	of	of	ADP
dpc-5733	17	31	systemic	systemic	ADJ
dpc-5733	17	32	inflammation	inflammation	NOUN
dpc-5733	17	33	[	[	X
dpc-5733	17	34	1–4	1–4	NOUN
dpc-5733	17	35	]	]	X
dpc-5733	17	36	.	.	PUNCT
dpc-5733	18	1	other	other	ADJ
dpc-5733	18	2	blood	blood	NOUN
dpc-5733	18	3	-	-	PUNCT
dpc-5733	18	4	derived	derive	VERB
dpc-5733	18	5	indices	index	NOUN
dpc-5733	18	6	,	,	PUNCT
dpc-5733	18	7	such	such	ADJ
dpc-5733	18	8	as	as	ADP
dpc-5733	18	9	pan	pan	ADJ
dpc-5733	18	10	-	-	ADJ
dpc-5733	18	11	immune	immune	ADJ
dpc-5733	18	12	inflammation	inflammation	NOUN
dpc-5733	18	13	value	value	NOUN
dpc-5733	18	14	(	(	PUNCT
dpc-5733	18	15	piv	piv	NOUN
dpc-5733	18	16	)	)	PUNCT
dpc-5733	18	17	and	and	CCONJ
dpc-5733	18	18	systemic	systemic	ADJ
dpc-5733	18	19	immune	immune	ADJ
dpc-5733	18	20	inflammation	inflammation	NOUN
dpc-5733	18	21	index	index	NOUN
dpc-5733	18	22	(	(	PUNCT
dpc-5733	18	23	sii	sii	PROPN
dpc-5733	18	24	)	)	PUNCT
dpc-5733	18	25	,	,	PUNCT
dpc-5733	18	26	have	have	AUX
dpc-5733	18	27	been	be	AUX
dpc-5733	18	28	evaluated	evaluate	VERB
dpc-5733	18	29	as	as	ADP
dpc-5733	18	30	risk	risk	NOUN
dpc-5733	18	31	factors	factor	NOUN
dpc-5733	18	32	for	for	ADP
dpc-5733	18	33	disease	disease	NOUN
dpc-5733	18	34	development	development	NOUN
dpc-5733	18	35	,	,	PUNCT
dpc-5733	18	36	prognostic	prognostic	ADJ
dpc-5733	18	37	markers	marker	NOUN
dpc-5733	18	38	of	of	ADP
dpc-5733	18	39	evolution	evolution	NOUN
dpc-5733	18	40	,	,	PUNCT
dpc-5733	18	41	or	or	CCONJ
dpc-5733	18	42	of	of	ADP
dpc-5733	18	43	treatment	treatment	NOUN
dpc-5733	18	44	response	response	NOUN
dpc-5733	18	45	in	in	ADP
dpc-5733	18	46	human	human	ADJ
dpc-5733	18	47	diseases	disease	NOUN
dpc-5733	18	48	and	and	CCONJ
dpc-5733	18	49	inflammation	inflammation	NOUN
dpc-5733	18	50	[	[	X
dpc-5733	18	51	5–10	5–10	ADJ
dpc-5733	18	52	]	]	X
dpc-5733	18	53	.	.	PUNCT
dpc-5733	19	1	recently	recently	ADV
dpc-5733	19	2	,	,	PUNCT
dpc-5733	19	3	two	two	NUM
dpc-5733	19	4	metanalyses	metanalyse	NOUN
dpc-5733	19	5	summarized	summarize	VERB
dpc-5733	19	6	the	the	DET
dpc-5733	19	7	potential	potential	ADJ
dpc-5733	19	8	application	application	NOUN
dpc-5733	19	9	of	of	ADP
dpc-5733	19	10	systemic	systemic	ADJ
dpc-5733	19	11	inflammatory	inflammatory	ADJ
dpc-5733	19	12	indices	index	NOUN
dpc-5733	19	13	in	in	ADP
dpc-5733	19	14	psoriasis	psoriasis	NOUN
dpc-5733	19	15	compared	compare	VERB
dpc-5733	19	16	to	to	ADP
dpc-5733	19	17	the	the	DET
dpc-5733	19	18	general	general	ADJ
dpc-5733	19	19	population	population	NOUN
dpc-5733	19	20	,	,	PUNCT
dpc-5733	19	21	with	with	ADP
dpc-5733	19	22	special	special	ADJ
dpc-5733	19	23	regard	regard	NOUN
dpc-5733	19	24	to	to	ADP
dpc-5733	19	25	nlr	nlr	PROPN
dpc-5733	19	26	(	(	PUNCT
dpc-5733	19	27	neutrophil	neutrophil	PROPN
dpc-5733	19	28	-	-	PUNCT
dpc-5733	19	29	to	to	ADP
dpc-5733	19	30	-	-	PUNCT
dpc-5733	19	31	lymphocyte	lymphocyte	NOUN
dpc-5733	19	32	ratio	ratio	NOUN
dpc-5733	19	33	)	)	PUNCT
dpc-5733	19	34	and	and	CCONJ
dpc-5733	19	35	plr	plr	NOUN
dpc-5733	19	36	(	(	PUNCT
dpc-5733	19	37	platelet	platelet	NOUN
dpc-5733	19	38	-	-	PUNCT
dpc-5733	19	39	to	to	ADP
dpc-5733	19	40	-	-	PUNCT
dpc-5733	19	41	lymphocyte	lymphocyte	NOUN
dpc-5733	19	42	ratio	ratio	NOUN
dpc-5733	19	43	)	)	PUNCT
dpc-5733	19	44	and	and	CCONJ
dpc-5733	19	45	their	their	PRON
dpc-5733	19	46	possible	possible	ADJ
dpc-5733	19	47	correlation	correlation	NOUN
dpc-5733	19	48	to	to	ADP
dpc-5733	19	49	disease	disease	NOUN
dpc-5733	19	50	severity	severity	NOUN
dpc-5733	19	51	.	.	PUNCT
dpc-5733	20	1	some	some	DET
dpc-5733	20	2	studies	study	NOUN
dpc-5733	20	3	retrospectively	retrospectively	ADV
dpc-5733	20	4	investigated	investigate	VERB
dpc-5733	20	5	the	the	DET
dpc-5733	20	6	effect	effect	NOUN
dpc-5733	20	7	of	of	ADP
dpc-5733	20	8	systemic	systemic	ADJ
dpc-5733	20	9	treatment	treatment	NOUN
dpc-5733	20	10	on	on	ADP
dpc-5733	20	11	peripheral	peripheral	ADJ
dpc-5733	20	12	blood	blood	NOUN
dpc-5733	20	13	cells	cell	NOUN
dpc-5733	20	14	and	and	CCONJ
dpc-5733	20	15	their	their	PRON
dpc-5733	20	16	derived	derived	ADJ
dpc-5733	20	17	parameters	parameter	NOUN
dpc-5733	20	18	,	,	PUNCT
dpc-5733	20	19	including	include	VERB
dpc-5733	20	20	sii	sii	PROPN
dpc-5733	20	21	and	and	CCONJ
dpc-5733	20	22	siri	siri	NOUN
dpc-5733	20	23	(	(	PUNCT
dpc-5733	20	24	systemic	systemic	ADJ
dpc-5733	20	25	immune	immune	ADJ
dpc-5733	20	26	response	response	NOUN
dpc-5733	20	27	index	index	NOUN
dpc-5733	20	28	)	)	PUNCT
dpc-5733	21	1	[	[	X
dpc-5733	21	2	11–14	11–14	NUM
dpc-5733	21	3	]	]	PUNCT
dpc-5733	21	4	.	.	PUNCT
dpc-5733	22	1	for	for	ADP
dpc-5733	22	2	these	these	DET
dpc-5733	22	3	reasons	reason	NOUN
dpc-5733	22	4	,	,	PUNCT
dpc-5733	22	5	we	we	PRON
dpc-5733	22	6	performed	perform	VERB
dpc-5733	22	7	a	a	DET
dpc-5733	22	8	prospective	prospective	ADJ
dpc-5733	22	9	observational	observational	ADJ
dpc-5733	22	10	study	study	NOUN
dpc-5733	22	11	on	on	ADP
dpc-5733	22	12	patients	patient	NOUN
dpc-5733	22	13	with	with	ADP
dpc-5733	22	14	moderate	moderate	ADJ
dpc-5733	22	15	-	-	PUNCT
dpc-5733	22	16	to	to	ADP
dpc-5733	22	17	-	-	PUNCT
dpc-5733	22	18	severe	severe	ADJ
dpc-5733	22	19	cutaneous	cutaneous	ADJ
dpc-5733	22	20	psoriasis	psoriasis	NOUN
dpc-5733	22	21	treated	treat	VERB
dpc-5733	22	22	with	with	ADP
dpc-5733	22	23	risankizumab	risankizumab	NOUN
dpc-5733	22	24	in	in	ADP
dpc-5733	22	25	order	order	NOUN
dpc-5733	22	26	to	to	PART
dpc-5733	22	27	assess	assess	VERB
dpc-5733	22	28	therapeutic	therapeutic	ADJ
dpc-5733	22	29	effect	effect	NOUN
dpc-5733	22	30	overtime	overtime	NOUN
dpc-5733	22	31	on	on	ADP
dpc-5733	22	32	whole	whole	ADJ
dpc-5733	22	33	blood	blood	NOUN
dpc-5733	22	34	cell	cell	NOUN
dpc-5733	22	35	count	count	NOUN
dpc-5733	22	36	and	and	CCONJ
dpc-5733	22	37	derived	derive	VERB
dpc-5733	22	38	indices	index	NOUN
dpc-5733	22	39	with	with	ADP
dpc-5733	22	40	regard	regard	NOUN
dpc-5733	22	41	to	to	ADP
dpc-5733	22	42	clinical	clinical	ADJ
dpc-5733	22	43	efficacy	efficacy	NOUN
dpc-5733	22	44	of	of	ADP
dpc-5733	22	45	the	the	DET
dpc-5733	22	46	drug	drug	NOUN
dpc-5733	22	47	.	.	PUNCT
dpc-5733	23	1	materials	material	NOUN
dpc-5733	23	2	and	and	CCONJ
dpc-5733	23	3	methods	method	NOUN
dpc-5733	23	4	patients	patient	NOUN
dpc-5733	23	5	with	with	ADP
dpc-5733	23	6	moderate	moderate	ADJ
dpc-5733	23	7	-	-	PUNCT
dpc-5733	23	8	to	to	ADP
dpc-5733	23	9	-	-	PUNCT
dpc-5733	23	10	severe	severe	ADJ
dpc-5733	23	11	psoriasis	psoriasis	NOUN
dpc-5733	23	12	,	,	PUNCT
dpc-5733	23	13	defined	define	VERB
dpc-5733	23	14	as	as	ADP
dpc-5733	23	15	pasi	pasi	NOUN
dpc-5733	23	16	≥10	≥10	ADJ
dpc-5733	23	17	or	or	CCONJ
dpc-5733	23	18	pasi	pasi	VERB
dpc-5733	23	19	<	<	X
dpc-5733	23	20	10	10	NUM
dpc-5733	23	21	but	but	CCONJ
dpc-5733	23	22	bsa	bsa	PROPN
dpc-5733	23	23	>	>	X
dpc-5733	23	24	10	10	NUM
dpc-5733	23	25	and	and	CCONJ
dpc-5733	23	26	involvement	involvement	NOUN
dpc-5733	23	27	of	of	ADP
dpc-5733	23	28	special	special	ADJ
dpc-5733	23	29	sites	site	NOUN
dpc-5733	23	30	/	/	SYM
dpc-5733	23	31	difficult	difficult	ADJ
dpc-5733	23	32	-	-	PUNCT
dpc-5733	23	33	to	to	ADP
dpc-5733	23	34	-	-	PUNCT
dpc-5733	23	35	treat	treat	NOUN
dpc-5733	23	36	areas	area	NOUN
dpc-5733	23	37	(	(	PUNCT
dpc-5733	23	38	i.e.	i.e.	X
dpc-5733	23	39	,	,	PUNCT
dpc-5733	23	40	scalp	scalp	NOUN
dpc-5733	23	41	,	,	PUNCT
dpc-5733	23	42	genitals	genital	NOUN
dpc-5733	23	43	,	,	PUNCT
dpc-5733	23	44	face	face	NOUN
dpc-5733	23	45	,	,	PUNCT
dpc-5733	23	46	and	and	CCONJ
dpc-5733	23	47	palmoplantar	palmoplantar	NOUN
dpc-5733	23	48	regions	region	NOUN
dpc-5733	23	49	)	)	PUNCT
dpc-5733	23	50	,	,	PUNCT
dpc-5733	23	51	eligible	eligible	ADJ
dpc-5733	23	52	to	to	ADP
dpc-5733	23	53	therapy	therapy	NOUN
dpc-5733	23	54	with	with	ADP
dpc-5733	23	55	risankizumab	risankizumab	NOUN
dpc-5733	23	56	were	be	AUX
dpc-5733	23	57	prospectively	prospectively	ADV
dpc-5733	23	58	enrolled	enrol	VERB
dpc-5733	23	59	in	in	ADP
dpc-5733	23	60	the	the	DET
dpc-5733	23	61	study	study	NOUN
dpc-5733	23	62	.	.	PUNCT
dpc-5733	24	1	patients	patient	NOUN
dpc-5733	24	2	were	be	AUX
dpc-5733	24	3	prescribed	prescribe	VERB
dpc-5733	24	4	risankizumab	risankizumab	NOUN
dpc-5733	24	5	sc	sc	PROPN
dpc-5733	24	6	150	150	NUM
dpc-5733	24	7	mg	mg	NOUN
dpc-5733	24	8	at	at	ADP
dpc-5733	24	9	t0	t0	PROPN
dpc-5733	24	10	,	,	PUNCT
dpc-5733	24	11	week	week	NOUN
dpc-5733	24	12	4	4	NUM
dpc-5733	24	13	,	,	PUNCT
dpc-5733	24	14	and	and	CCONJ
dpc-5733	24	15	every	every	DET
dpc-5733	24	16	12	12	NUM
dpc-5733	24	17	weeks	week	NOUN
dpc-5733	24	18	thereafter	thereafter	ADV
dpc-5733	24	19	.	.	PUNCT
dpc-5733	25	1	baseline	baseline	VERB
dpc-5733	25	2	demographic	demographic	ADJ
dpc-5733	25	3	and	and	CCONJ
dpc-5733	25	4	clinical	clinical	ADJ
dpc-5733	25	5	features	feature	NOUN
dpc-5733	25	6	as	as	ADV
dpc-5733	25	7	well	well	ADV
dpc-5733	25	8	as	as	ADP
dpc-5733	25	9	complete	complete	ADJ
dpc-5733	25	10	hematologic	hematologic	NOUN
dpc-5733	25	11	data	datum	NOUN
dpc-5733	25	12	,	,	PUNCT
dpc-5733	25	13	including	include	VERB
dpc-5733	25	14	whole	whole	ADJ
dpc-5733	25	15	blood	blood	NOUN
dpc-5733	25	16	cell	cell	NOUN
dpc-5733	25	17	count	count	NOUN
dpc-5733	25	18	,	,	PUNCT
dpc-5733	25	19	c	c	NOUN
dpc-5733	25	20	-	-	PUNCT
dpc-5733	25	21	reactive	reactive	ADJ
dpc-5733	25	22	protein	protein	NOUN
dpc-5733	25	23	(	(	PUNCT
dpc-5733	25	24	crp	crp	PROPN
dpc-5733	25	25	)	)	PUNCT
dpc-5733	25	26	,	,	PUNCT
dpc-5733	25	27	and	and	CCONJ
dpc-5733	25	28	erythrocyte	erythrocyte	PROPN
dpc-5733	25	29	-	-	PUNCT
dpc-5733	25	30	sedimentation	sedimentation	NOUN
dpc-5733	25	31	rate	rate	NOUN
dpc-5733	25	32	(	(	PUNCT
dpc-5733	25	33	esr	esr	PROPN
dpc-5733	25	34	)	)	PUNCT
dpc-5733	25	35	,	,	PUNCT
dpc-5733	25	36	were	be	AUX
dpc-5733	25	37	recorded	record	VERB
dpc-5733	25	38	at	at	ADP
dpc-5733	25	39	baseline	baseline	NOUN
dpc-5733	25	40	and	and	CCONJ
dpc-5733	25	41	during	during	ADP
dpc-5733	25	42	risankizumab	risankizumab	NOUN
dpc-5733	25	43	treatment	treatment	NOUN
dpc-5733	25	44	at	at	ADP
dpc-5733	25	45	weeks	week	NOUN
dpc-5733	25	46	12	12	NUM
dpc-5733	25	47	,	,	PUNCT
dpc-5733	25	48	24	24	NUM
dpc-5733	25	49	,	,	PUNCT
dpc-5733	25	50	and	and	CCONJ
dpc-5733	25	51	52	52	NUM
dpc-5733	25	52	.	.	PUNCT
dpc-5733	26	1	patients	patient	NOUN
dpc-5733	26	2	were	be	AUX
dpc-5733	26	3	considered	consider	VERB
dpc-5733	26	4	responders	responder	NOUN
dpc-5733	26	5	to	to	PART
dpc-5733	26	6	risankizumab	risankizumab	VERB
dpc-5733	26	7	if	if	SCONJ
dpc-5733	26	8	they	they	PRON
dpc-5733	26	9	reached	reach	VERB
dpc-5733	26	10	at	at	ADP
dpc-5733	26	11	least	least	ADJ
dpc-5733	26	12	pasi	pasi	VERB
dpc-5733	26	13	75	75	NUM
dpc-5733	26	14	within	within	ADP
dpc-5733	26	15	three	three	NUM
dpc-5733	26	16	risankizumab	risankizumab	NOUN
dpc-5733	26	17	injections	injection	NOUN
dpc-5733	26	18	,	,	PUNCT
dpc-5733	26	19	with	with	ADP
dpc-5733	26	20	clinical	clinical	ADJ
dpc-5733	26	21	evaluation	evaluation	NOUN
dpc-5733	26	22	at	at	ADP
dpc-5733	26	23	week	week	NOUN
dpc-5733	26	24	24	24	NUM
dpc-5733	26	25	.	.	PUNCT
dpc-5733	27	1	patients	patient	NOUN
dpc-5733	27	2	with	with	ADP
dpc-5733	27	3	incomplete	incomplete	ADJ
dpc-5733	27	4	data	datum	NOUN
dpc-5733	27	5	or	or	CCONJ
dpc-5733	27	6	who	who	PRON
dpc-5733	27	7	did	do	AUX
dpc-5733	27	8	not	not	PART
dpc-5733	27	9	reach	reach	VERB
dpc-5733	27	10	week	week	NOUN
dpc-5733	27	11	52	52	NUM
dpc-5733	27	12	and	and	CCONJ
dpc-5733	27	13	discontinued	discontinued	ADJ
dpc-5733	27	14	risankizumab	risankizumab	NOUN
dpc-5733	27	15	,	,	PUNCT
dpc-5733	27	16	either	either	CCONJ
dpc-5733	27	17	due	due	ADJ
dpc-5733	27	18	to	to	ADP
dpc-5733	27	19	primary	primary	ADJ
dpc-5733	27	20	failure	failure	NOUN
dpc-5733	27	21	(	(	PUNCT
dpc-5733	27	22	one	one	NUM
dpc-5733	27	23	patient	patient	NOUN
dpc-5733	27	24	)	)	PUNCT
dpc-5733	27	25	or	or	CCONJ
dpc-5733	27	26	to	to	ADP
dpc-5733	27	27	adverse	adverse	ADJ
dpc-5733	27	28	events	event	NOUN
dpc-5733	27	29	or	or	CCONJ
dpc-5733	27	30	for	for	ADP
dpc-5733	27	31	personal	personal	ADJ
dpc-5733	27	32	reasons	reason	NOUN
dpc-5733	27	33	(	(	PUNCT
dpc-5733	27	34	i.e.	i.e.	X
dpc-5733	27	35	,	,	PUNCT
dpc-5733	27	36	moved	move	VERB
dpc-5733	27	37	to	to	ADP
dpc-5733	27	38	another	another	DET
dpc-5733	27	39	town	town	NOUN
dpc-5733	27	40	,	,	PUNCT
dpc-5733	27	41	three	three	NUM
dpc-5733	27	42	patients	patient	NOUN
dpc-5733	27	43	)	)	PUNCT
dpc-5733	27	44	were	be	AUX
dpc-5733	27	45	excluded	exclude	VERB
dpc-5733	27	46	from	from	ADP
dpc-5733	27	47	the	the	DET
dpc-5733	27	48	analysis	analysis	NOUN
dpc-5733	27	49	(	(	PUNCT
dpc-5733	27	50	figure	figure	NOUN
dpc-5733	27	51	1	1	NUM
dpc-5733	27	52	)	)	PUNCT
dpc-5733	27	53	.	.	PUNCT
dpc-5733	28	1	at	at	ADP
dpc-5733	28	2	each	each	DET
dpc-5733	28	3	time	time	NOUN
dpc-5733	28	4	point	point	NOUN
dpc-5733	28	5	,	,	PUNCT
dpc-5733	28	6	calculation	calculation	NOUN
dpc-5733	28	7	of	of	ADP
dpc-5733	28	8	nlr	nlr	PROPN
dpc-5733	28	9	,	,	PUNCT
dpc-5733	28	10	plr	plr	NOUN
dpc-5733	28	11	,	,	PUNCT
dpc-5733	28	12	mlr	mlr	NOUN
dpc-5733	28	13	(	(	PUNCT
dpc-5733	28	14	monocyte	monocyte	NOUN
dpc-5733	28	15	-	-	PUNCT
dpc-5733	28	16	to	to	ADP
dpc-5733	28	17	-	-	PUNCT
dpc-5733	28	18	lymphocyte	lymphocyte	NOUN
dpc-5733	28	19	ratio	ratio	NOUN
dpc-5733	28	20	)	)	PUNCT
dpc-5733	28	21	,	,	PUNCT
dpc-5733	28	22	piv	piv	NOUN
dpc-5733	28	23	,	,	PUNCT
dpc-5733	28	24	sii	sii	PROPN
dpc-5733	28	25	,	,	PUNCT
dpc-5733	28	26	and	and	CCONJ
dpc-5733	28	27	siri	siri	NOUN
dpc-5733	28	28	was	be	AUX
dpc-5733	28	29	performed	perform	VERB
dpc-5733	28	30	.	.	PUNCT
dpc-5733	29	1	the	the	DET
dpc-5733	29	2	formula	formula	NOUN
dpc-5733	29	3	for	for	ADP
dpc-5733	29	4	sii	sii	PROPN
dpc-5733	29	5	,	,	PUNCT
dpc-5733	29	6	piv	piv	NOUN
dpc-5733	29	7	,	,	PUNCT
dpc-5733	29	8	and	and	CCONJ
dpc-5733	29	9	siri	siri	NOUN
dpc-5733	29	10	were	be	AUX
dpc-5733	29	11	,	,	PUNCT
dpc-5733	29	12	respectively	respectively	ADV
dpc-5733	29	13	:	:	PUNCT
dpc-5733	29	14	i	i	X
dpc-5733	29	15	)	)	PUNCT
dpc-5733	30	1	[	[	X
dpc-5733	30	2	neutrophil	neutrophil	ADJ
dpc-5733	30	3	(	(	PUNCT
dpc-5733	30	4	103	103	NUM
dpc-5733	30	5	/	/	SYM
dpc-5733	30	6	mmc	mmc	NOUN
dpc-5733	30	7	)	)	PUNCT
dpc-5733	30	8	  	  	SPACE
dpc-5733	30	9	×	×	NOUN
dpc-5733	30	10	  	  	SPACE
dpc-5733	30	11	platelet	platelet	NOUN
dpc-5733	30	12	(	(	PUNCT
dpc-5733	30	13	103	103	NUM
dpc-5733	30	14	/	/	SYM
dpc-5733	30	15	mmc)]/lymphocyte	mmc)]/lymphocyte	PROPN
dpc-5733	30	16	(	(	PUNCT
dpc-5733	30	17	103	103	NUM
dpc-5733	30	18	/	/	SYM
dpc-5733	30	19	mmc	mmc	PROPN
dpc-5733	30	20	)	)	PUNCT
dpc-5733	30	21	;	;	PUNCT
dpc-5733	30	22	ii	ii	X
dpc-5733	30	23	)	)	PUNCT
dpc-5733	31	1	[	[	X
dpc-5733	31	2	neutrophil	neutrophil	NOUN
dpc-5733	31	3	(	(	PUNCT
dpc-5733	31	4	103	103	NUM
dpc-5733	31	5	/	/	SYM
dpc-5733	31	6	mmc	mmc	NOUN
dpc-5733	31	7	)	)	PUNCT
dpc-5733	31	8	 	 	SPACE
dpc-5733	31	9	×	×	NOUN
dpc-5733	31	10	 	 	SPACE
dpc-5733	31	11	platelet	platelet	NOUN
dpc-5733	31	12	(	(	PUNCT
dpc-5733	31	13	103/	103/	NOUN
dpc-5733	31	14	mmc	mmc	X
dpc-5733	31	15	)	)	PUNCT
dpc-5733	31	16	  	  	SPACE
dpc-5733	31	17	×	×	NOUN
dpc-5733	31	18	  	  	SPACE
dpc-5733	31	19	monocyte	monocyte	NOUN
dpc-5733	31	20	(	(	PUNCT
dpc-5733	31	21	103	103	NUM
dpc-5733	31	22	/	/	SYM
dpc-5733	31	23	mmc)]/lymphocyte	mmc)]/lymphocyte	PROPN
dpc-5733	31	24	(	(	PUNCT
dpc-5733	31	25	103	103	NUM
dpc-5733	31	26	/	/	SYM
dpc-5733	31	27	mmc	mmc	PROPN
dpc-5733	31	28	)	)	PUNCT
dpc-5733	31	29	count	count	NOUN
dpc-5733	31	30	;	;	PUNCT
dpc-5733	31	31	iii	iii	X
dpc-5733	31	32	)	)	PUNCT
dpc-5733	31	33	neutrophil	neutrophil	NOUN
dpc-5733	31	34	(	(	PUNCT
dpc-5733	31	35	103	103	NUM
dpc-5733	31	36	/	/	SYM
dpc-5733	31	37	mmc	mmc	NOUN
dpc-5733	31	38	)	)	PUNCT
dpc-5733	31	39	 	 	SPACE
dpc-5733	31	40	×	×	NOUN
dpc-5733	31	41	 	 	SPACE
dpc-5733	31	42	monocytes	monocyte	VERB
dpc-5733	31	43	(	(	PUNCT
dpc-5733	31	44	103	103	NUM
dpc-5733	31	45	/	/	SYM
dpc-5733	31	46	mmc)]/	mmc)]/	NOUN
dpc-5733	31	47	lymphocyte	lymphocyte	NOUN
dpc-5733	31	48	(	(	PUNCT
dpc-5733	31	49	103	103	NUM
dpc-5733	31	50	/	/	SYM
dpc-5733	31	51	mmc	mmc	PROPN
dpc-5733	31	52	)	)	PUNCT
dpc-5733	31	53	count	count	NOUN
dpc-5733	31	54	.	.	PUNCT
dpc-5733	32	1	introduction	introduction	NOUN
dpc-5733	32	2	:	:	PUNCT
dpc-5733	32	3	whole	whole	ADJ
dpc-5733	32	4	blood	blood	NOUN
dpc-5733	32	5	cells	cell	NOUN
dpc-5733	32	6	and	and	CCONJ
dpc-5733	32	7	derived	derived	ADJ
dpc-5733	32	8	indices	index	NOUN
dpc-5733	32	9	can	can	AUX
dpc-5733	32	10	be	be	AUX
dpc-5733	32	11	used	use	VERB
dpc-5733	32	12	as	as	ADP
dpc-5733	32	13	a	a	DET
dpc-5733	32	14	read	read	NOUN
dpc-5733	32	15	-	-	PUNCT
dpc-5733	32	16	out	out	NOUN
dpc-5733	32	17	of	of	ADP
dpc-5733	32	18	the	the	DET
dpc-5733	32	19	inflammatory	inflammatory	ADJ
dpc-5733	32	20	pathogenic	pathogenic	ADJ
dpc-5733	32	21	processes	process	NOUN
dpc-5733	32	22	in	in	ADP
dpc-5733	32	23	many	many	ADJ
dpc-5733	32	24	human	human	ADJ
dpc-5733	32	25	diseases	disease	NOUN
dpc-5733	32	26	,	,	PUNCT
dpc-5733	32	27	including	include	VERB
dpc-5733	32	28	psoriasis	psoriasis	NOUN
dpc-5733	32	29	.	.	PUNCT
dpc-5733	33	1	indeed	indeed	ADV
dpc-5733	33	2	,	,	PUNCT
dpc-5733	33	3	systemic	systemic	ADJ
dpc-5733	33	4	treatments	treatment	NOUN
dpc-5733	33	5	with	with	ADP
dpc-5733	33	6	special	special	ADJ
dpc-5733	33	7	regard	regard	NOUN
dpc-5733	33	8	to	to	ADP
dpc-5733	33	9	anti	anti	ADJ
dpc-5733	33	10	-	-	ADJ
dpc-5733	33	11	il-23	il-23	ADJ
dpc-5733	33	12	agents	agent	NOUN
dpc-5733	33	13	could	could	AUX
dpc-5733	33	14	exert	exert	VERB
dpc-5733	33	15	anti	anti	ADJ
dpc-5733	33	16	-	-	ADJ
dpc-5733	33	17	inflammatory	inflammatory	ADJ
dpc-5733	33	18	and	and	CCONJ
dpc-5733	33	19	disease	disease	NOUN
dpc-5733	33	20	modifying	modify	VERB
dpc-5733	33	21	effects	effect	NOUN
dpc-5733	33	22	;	;	PUNCT
dpc-5733	33	23	however	however	ADV
dpc-5733	33	24	,	,	PUNCT
dpc-5733	33	25	there	there	PRON
dpc-5733	33	26	is	be	VERB
dpc-5733	33	27	still	still	ADV
dpc-5733	33	28	a	a	DET
dpc-5733	33	29	lack	lack	NOUN
dpc-5733	33	30	of	of	ADP
dpc-5733	33	31	conclusive	conclusive	ADJ
dpc-5733	33	32	data	datum	NOUN
dpc-5733	33	33	.	.	PUNCT
dpc-5733	34	1	objectives	objective	NOUN
dpc-5733	34	2	:	:	PUNCT
dpc-5733	34	3	we	we	PRON
dpc-5733	34	4	aimed	aim	VERB
dpc-5733	34	5	to	to	PART
dpc-5733	34	6	assess	assess	VERB
dpc-5733	34	7	the	the	DET
dpc-5733	34	8	therapeutic	therapeutic	ADJ
dpc-5733	34	9	effect	effect	NOUN
dpc-5733	34	10	of	of	ADP
dpc-5733	34	11	risankizumab	risankizumab	NOUN
dpc-5733	34	12	on	on	ADP
dpc-5733	34	13	whole	whole	ADJ
dpc-5733	34	14	blood	blood	NOUN
dpc-5733	34	15	cells	cell	NOUN
dpc-5733	34	16	and	and	CCONJ
dpc-5733	34	17	inflammatory	inflammatory	ADJ
dpc-5733	34	18	indices	index	NOUN
dpc-5733	34	19	in	in	ADP
dpc-5733	34	20	psoriatic	psoriatic	ADJ
dpc-5733	34	21	patients	patient	NOUN
dpc-5733	34	22	.	.	PUNCT
dpc-5733	35	1	methods	method	NOUN
dpc-5733	35	2	:	:	PUNCT
dpc-5733	35	3	we	we	PRON
dpc-5733	35	4	performed	perform	VERB
dpc-5733	35	5	a	a	DET
dpc-5733	35	6	prospective	prospective	ADJ
dpc-5733	35	7	multicenter	multicenter	ADJ
dpc-5733	35	8	observational	observational	ADJ
dpc-5733	35	9	study	study	NOUN
dpc-5733	35	10	on	on	ADP
dpc-5733	35	11	adult	adult	NOUN
dpc-5733	35	12	patients	patient	NOUN
dpc-5733	35	13	with	with	ADP
dpc-5733	35	14	moderate	moderate	ADJ
dpc-5733	35	15	-	-	PUNCT
dpc-5733	35	16	to	to	ADP
dpc-5733	35	17	-	-	PUNCT
dpc-5733	35	18	severe	severe	ADJ
dpc-5733	35	19	psoriasis	psoriasis	NOUN
dpc-5733	35	20	who	who	PRON
dpc-5733	35	21	underwent	undergo	VERB
dpc-5733	35	22	risankizumab	risankizumab	NOUN
dpc-5733	35	23	therapy	therapy	NOUN
dpc-5733	35	24	for	for	ADP
dpc-5733	35	25	at	at	ADV
dpc-5733	35	26	least	least	ADV
dpc-5733	35	27	52	52	NUM
dpc-5733	35	28	weeks	week	NOUN
dpc-5733	35	29	.	.	PUNCT
dpc-5733	36	1	blood	blood	NOUN
dpc-5733	36	2	cell	cell	NOUN
dpc-5733	36	3	count	count	NOUN
dpc-5733	36	4	,	,	PUNCT
dpc-5733	36	5	crp	crp	PROPN
dpc-5733	36	6	,	,	PUNCT
dpc-5733	36	7	and	and	CCONJ
dpc-5733	36	8	esr	esr	PROPN
dpc-5733	36	9	were	be	AUX
dpc-5733	36	10	prospectively	prospectively	ADV
dpc-5733	36	11	recorded	record	VERB
dpc-5733	36	12	for	for	ADP
dpc-5733	36	13	each	each	DET
dpc-5733	36	14	patient	patient	NOUN
dpc-5733	36	15	included	include	VERB
dpc-5733	36	16	in	in	ADP
dpc-5733	36	17	the	the	DET
dpc-5733	36	18	study	study	NOUN
dpc-5733	36	19	,	,	PUNCT
dpc-5733	36	20	at	at	ADP
dpc-5733	36	21	routine	routine	ADJ
dpc-5733	36	22	visits	visit	NOUN
dpc-5733	36	23	up	up	ADP
dpc-5733	36	24	to	to	ADP
dpc-5733	36	25	week	week	NOUN
dpc-5733	36	26	52	52	NUM
dpc-5733	36	27	.	.	PUNCT
dpc-5733	37	1	the	the	DET
dpc-5733	37	2	ratio	ratio	NOUN
dpc-5733	37	3	between	between	ADP
dpc-5733	37	4	peripheral	peripheral	ADJ
dpc-5733	37	5	cells	cell	NOUN
dpc-5733	37	6	,	,	PUNCT
dpc-5733	37	7	namely	namely	ADV
dpc-5733	37	8	nlr	nlr	PROPN
dpc-5733	37	9	,	,	PUNCT
dpc-5733	37	10	plr	plr	NOUN
dpc-5733	37	11	,	,	PUNCT
dpc-5733	37	12	mlr	mlr	NOUN
dpc-5733	37	13	,	,	PUNCT
dpc-5733	37	14	sii	sii	PROPN
dpc-5733	37	15	,	,	PUNCT
dpc-5733	37	16	and	and	CCONJ
dpc-5733	37	17	piv	piv	NOUN
dpc-5733	37	18	,	,	PUNCT
dpc-5733	37	19	were	be	AUX
dpc-5733	37	20	calculated	calculate	VERB
dpc-5733	37	21	and	and	CCONJ
dpc-5733	37	22	compared	compare	VERB
dpc-5733	37	23	at	at	ADP
dpc-5733	37	24	time	time	NOUN
dpc-5733	37	25	0	0	NUM
dpc-5733	37	26	and	and	CCONJ
dpc-5733	37	27	at	at	ADP
dpc-5733	37	28	weeks	week	NOUN
dpc-5733	37	29	12	12	NUM
dpc-5733	37	30	,	,	PUNCT
dpc-5733	37	31	24	24	NUM
dpc-5733	37	32	,	,	PUNCT
dpc-5733	37	33	and	and	CCONJ
dpc-5733	37	34	52	52	NUM
dpc-5733	37	35	of	of	ADP
dpc-5733	37	36	treatment	treatment	NOUN
dpc-5733	37	37	.	.	PUNCT
dpc-5733	38	1	at	at	ADP
dpc-5733	38	2	different	different	ADJ
dpc-5733	38	3	timepoints	timepoint	NOUN
dpc-5733	38	4	,	,	PUNCT
dpc-5733	38	5	modulation	modulation	NOUN
dpc-5733	38	6	of	of	ADP
dpc-5733	38	7	laboratory	laboratory	NOUN
dpc-5733	38	8	values	value	NOUN
dpc-5733	38	9	and	and	CCONJ
dpc-5733	38	10	derived	derived	ADJ
dpc-5733	38	11	indices	index	NOUN
dpc-5733	38	12	and	and	CCONJ
dpc-5733	38	13	their	their	PRON
dpc-5733	38	14	correlation	correlation	NOUN
dpc-5733	38	15	with	with	ADP
dpc-5733	38	16	disease	disease	NOUN
dpc-5733	38	17	severity	severity	NOUN
dpc-5733	38	18	and	and	CCONJ
dpc-5733	38	19	response	response	NOUN
dpc-5733	38	20	to	to	ADP
dpc-5733	38	21	treatment	treatment	NOUN
dpc-5733	38	22	were	be	AUX
dpc-5733	38	23	analyzed	analyze	VERB
dpc-5733	38	24	.	.	PUNCT
dpc-5733	39	1	subanalysis	subanalysis	NOUN
dpc-5733	39	2	of	of	ADP
dpc-5733	39	3	very	very	ADV
dpc-5733	39	4	early	early	ADJ
dpc-5733	39	5	responders	responder	NOUN
dpc-5733	39	6	and	and	CCONJ
dpc-5733	39	7	late	late	ADJ
dpc-5733	39	8	responders	responder	NOUN
dpc-5733	39	9	was	be	AUX
dpc-5733	39	10	performed	perform	VERB
dpc-5733	39	11	as	as	ADV
dpc-5733	39	12	well	well	ADV
dpc-5733	39	13	.	.	PUNCT
dpc-5733	40	1	results	result	NOUN
dpc-5733	40	2	:	:	PUNCT
dpc-5733	40	3	we	we	PRON
dpc-5733	40	4	observed	observe	VERB
dpc-5733	40	5	a	a	DET
dpc-5733	40	6	progressive	progressive	ADJ
dpc-5733	40	7	reduction	reduction	NOUN
dpc-5733	40	8	in	in	ADP
dpc-5733	40	9	inflammatory	inflammatory	ADJ
dpc-5733	40	10	indices	index	NOUN
dpc-5733	40	11	such	such	ADJ
dpc-5733	40	12	as	as	ADP
dpc-5733	40	13	crp	crp	PROPN
dpc-5733	40	14	,	,	PUNCT
dpc-5733	40	15	esr	esr	PROPN
dpc-5733	40	16	,	,	PUNCT
dpc-5733	40	17	nlr	nlr	PROPN
dpc-5733	40	18	,	,	PUNCT
dpc-5733	40	19	and	and	CCONJ
dpc-5733	40	20	sii	sii	ADV
dpc-5733	40	21	during	during	ADP
dpc-5733	40	22	treatment	treatment	NOUN
dpc-5733	40	23	,	,	PUNCT
dpc-5733	40	24	with	with	ADP
dpc-5733	40	25	prominent	prominent	ADJ
dpc-5733	40	26	modification	modification	NOUN
dpc-5733	40	27	involving	involve	VERB
dpc-5733	40	28	siri	siri	NOUN
dpc-5733	40	29	as	as	ADV
dpc-5733	40	30	well	well	ADV
dpc-5733	40	31	,	,	PUNCT
dpc-5733	40	32	in	in	ADP
dpc-5733	40	33	patients	patient	NOUN
dpc-5733	40	34	who	who	PRON
dpc-5733	40	35	had	have	VERB
dpc-5733	40	36	a	a	DET
dpc-5733	40	37	very	very	ADV
dpc-5733	40	38	early	early	ADJ
dpc-5733	40	39	and	and	CCONJ
dpc-5733	40	40	almost	almost	ADV
dpc-5733	40	41	complete	complete	ADJ
dpc-5733	40	42	response	response	NOUN
dpc-5733	40	43	to	to	PART
dpc-5733	40	44	risankizumab	risankizumab	VERB
dpc-5733	40	45	.	.	PUNCT
dpc-5733	41	1	reduction	reduction	NOUN
dpc-5733	41	2	in	in	ADP
dpc-5733	41	3	neutrophils	neutrophil	NOUN
dpc-5733	41	4	and	and	CCONJ
dpc-5733	41	5	mpv	mpv	PROPN
dpc-5733	41	6	,	,	PUNCT
dpc-5733	41	7	a	a	DET
dpc-5733	41	8	transient	transient	ADJ
dpc-5733	41	9	increase	increase	NOUN
dpc-5733	41	10	in	in	ADP
dpc-5733	41	11	eosinophils	eosinophil	NOUN
dpc-5733	41	12	at	at	ADP
dpc-5733	41	13	week	week	NOUN
dpc-5733	41	14	12	12	NUM
dpc-5733	41	15	,	,	PUNCT
dpc-5733	41	16	and	and	CCONJ
dpc-5733	41	17	a	a	DET
dpc-5733	41	18	progressive	progressive	ADJ
dpc-5733	41	19	increase	increase	NOUN
dpc-5733	41	20	in	in	ADP
dpc-5733	41	21	peripheral	peripheral	ADJ
dpc-5733	41	22	basophils	basophil	NOUN
dpc-5733	41	23	were	be	AUX
dpc-5733	41	24	associated	associate	VERB
dpc-5733	41	25	with	with	ADP
dpc-5733	41	26	therapeutic	therapeutic	ADJ
dpc-5733	41	27	response	response	NOUN
dpc-5733	41	28	.	.	PUNCT
dpc-5733	42	1	conclusion	conclusion	NOUN
dpc-5733	42	2	:	:	PUNCT
dpc-5733	42	3	risankizumab	risankizumab	NOUN
dpc-5733	42	4	promotes	promote	VERB
dpc-5733	42	5	a	a	DET
dpc-5733	42	6	progressive	progressive	ADJ
dpc-5733	42	7	anti	anti	ADJ
dpc-5733	42	8	-	-	ADJ
dpc-5733	42	9	inflammatory	inflammatory	ADJ
dpc-5733	42	10	effect	effect	NOUN
dpc-5733	42	11	,	,	PUNCT
dpc-5733	42	12	more	more	ADV
dpc-5733	42	13	prominent	prominent	ADJ
dpc-5733	42	14	in	in	ADP
dpc-5733	42	15	patients	patient	NOUN
dpc-5733	42	16	with	with	ADP
dpc-5733	42	17	a	a	DET
dpc-5733	42	18	faster	fast	ADJ
dpc-5733	42	19	response	response	NOUN
dpc-5733	42	20	in	in	ADP
dpc-5733	42	21	the	the	DET
dpc-5733	42	22	early	early	ADJ
dpc-5733	42	23	phases	phase	NOUN
dpc-5733	42	24	of	of	ADP
dpc-5733	42	25	treatment	treatment	NOUN
dpc-5733	42	26	.	.	PUNCT
dpc-5733	43	1	abstract	abstract	ADJ
dpc-5733	43	2	original	original	ADJ
dpc-5733	43	3	article	article	NOUN
dpc-5733	43	4	|	|	ADV
dpc-5733	43	5	dermatol	dermatol	ADJ
dpc-5733	43	6	pract	pract	NOUN
dpc-5733	43	7	concept	concept	NOUN
dpc-5733	43	8	.	.	PUNCT
dpc-5733	44	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	44	2	3	3	NUM
dpc-5733	44	3	the	the	DET
dpc-5733	44	4	primary	primary	ADJ
dpc-5733	44	5	aims	aim	NOUN
dpc-5733	44	6	of	of	ADP
dpc-5733	44	7	the	the	DET
dpc-5733	44	8	study	study	NOUN
dpc-5733	44	9	were	be	AUX
dpc-5733	44	10	to	to	PART
dpc-5733	44	11	analyze	analyze	VERB
dpc-5733	44	12	the	the	DET
dpc-5733	44	13	modulation	modulation	NOUN
dpc-5733	44	14	of	of	ADP
dpc-5733	44	15	laboratory	laboratory	NOUN
dpc-5733	44	16	values	value	NOUN
dpc-5733	44	17	and	and	CCONJ
dpc-5733	44	18	derived	derived	ADJ
dpc-5733	44	19	indices	index	NOUN
dpc-5733	44	20	at	at	ADP
dpc-5733	44	21	different	different	ADJ
dpc-5733	44	22	time	time	NOUN
dpc-5733	44	23	points	point	NOUN
dpc-5733	44	24	,	,	PUNCT
dpc-5733	44	25	and	and	CCONJ
dpc-5733	44	26	their	their	PRON
dpc-5733	44	27	correlation	correlation	NOUN
dpc-5733	44	28	with	with	ADP
dpc-5733	44	29	disease	disease	NOUN
dpc-5733	44	30	severity	severity	NOUN
dpc-5733	44	31	.	.	PUNCT
dpc-5733	45	1	the	the	DET
dpc-5733	45	2	co	co	ADJ
dpc-5733	45	3	-	-	ADJ
dpc-5733	45	4	primary	primary	ADJ
dpc-5733	45	5	endpoint	endpoint	NOUN
dpc-5733	45	6	was	be	AUX
dpc-5733	45	7	the	the	DET
dpc-5733	45	8	assessment	assessment	NOUN
dpc-5733	45	9	of	of	ADP
dpc-5733	45	10	differences	difference	NOUN
dpc-5733	45	11	between	between	ADP
dpc-5733	45	12	patients	patient	NOUN
dpc-5733	45	13	who	who	PRON
dpc-5733	45	14	reached	reach	VERB
dpc-5733	45	15	pasi	pasi	NOUN
dpc-5733	45	16	≥90	≥90	PROPN
dpc-5733	45	17	as	as	ADV
dpc-5733	45	18	early	early	ADV
dpc-5733	45	19	as	as	ADP
dpc-5733	45	20	week	week	NOUN
dpc-5733	45	21	12	12	NUM
dpc-5733	45	22	(	(	PUNCT
dpc-5733	45	23	super	super	NOUN
dpc-5733	45	24	-	-	NOUN
dpc-5733	45	25	responders	responder	NOUN
dpc-5733	45	26	,	,	PUNCT
dpc-5733	45	27	sr	sr	PROPN
dpc-5733	45	28	)	)	PUNCT
dpc-5733	45	29	versus	versus	ADP
dpc-5733	45	30	patients	patient	NOUN
dpc-5733	45	31	who	who	PRON
dpc-5733	45	32	reached	reach	VERB
dpc-5733	45	33	pasi	pasi	NOUN
dpc-5733	45	34	≥75	≥75	PROPN
dpc-5733	45	35	from	from	ADP
dpc-5733	45	36	week	week	NOUN
dpc-5733	45	37	24	24	NUM
dpc-5733	45	38	(	(	PUNCT
dpc-5733	45	39	late	late	ADJ
dpc-5733	45	40	responders	responder	NOUN
dpc-5733	45	41	,	,	PUNCT
dpc-5733	45	42	lr	lr	NOUN
dpc-5733	45	43	)	)	PUNCT
dpc-5733	45	44	.	.	PUNCT
dpc-5733	46	1	statistical	statistical	ADJ
dpc-5733	46	2	analysis	analysis	NOUN
dpc-5733	46	3	descriptive	descriptive	ADJ
dpc-5733	46	4	statistics	statistic	NOUN
dpc-5733	46	5	were	be	AUX
dpc-5733	46	6	used	use	VERB
dpc-5733	46	7	to	to	PART
dpc-5733	46	8	summarize	summarize	VERB
dpc-5733	46	9	the	the	DET
dpc-5733	46	10	characteristics	characteristic	NOUN
dpc-5733	46	11	of	of	ADP
dpc-5733	46	12	the	the	DET
dpc-5733	46	13	study	study	NOUN
dpc-5733	46	14	population	population	NOUN
dpc-5733	46	15	.	.	PUNCT
dpc-5733	47	1	normal	normal	ADJ
dpc-5733	47	2	distribution	distribution	NOUN
dpc-5733	47	3	was	be	AUX
dpc-5733	47	4	tested	test	VERB
dpc-5733	47	5	for	for	ADP
dpc-5733	47	6	all	all	DET
dpc-5733	47	7	samples	sample	NOUN
dpc-5733	47	8	and	and	CCONJ
dpc-5733	47	9	not	not	PART
dpc-5733	47	10	parametric	parametric	ADJ
dpc-5733	47	11	tests	test	NOUN
dpc-5733	47	12	were	be	AUX
dpc-5733	47	13	used	use	VERB
dpc-5733	47	14	where	where	SCONJ
dpc-5733	47	15	appropriate	appropriate	ADJ
dpc-5733	47	16	.	.	PUNCT
dpc-5733	48	1	for	for	ADP
dpc-5733	48	2	continuous	continuous	ADJ
dpc-5733	48	3	variables	variable	NOUN
dpc-5733	48	4	,	,	PUNCT
dpc-5733	48	5	the	the	DET
dpc-5733	48	6	significance	significance	NOUN
dpc-5733	48	7	of	of	ADP
dpc-5733	48	8	the	the	DET
dpc-5733	48	9	difference	difference	NOUN
dpc-5733	48	10	between	between	ADP
dpc-5733	48	11	medians	median	NOUN
dpc-5733	48	12	of	of	ADP
dpc-5733	48	13	the	the	DET
dpc-5733	48	14	groups	group	NOUN
dpc-5733	48	15	was	be	AUX
dpc-5733	48	16	investigated	investigate	VERB
dpc-5733	48	17	by	by	ADP
dpc-5733	48	18	using	use	VERB
dpc-5733	48	19	mann	mann	PROPN
dpc-5733	48	20	-	-	PUNCT
dpc-5733	48	21	whitney	whitney	PROPN
dpc-5733	48	22	test	test	NOUN
dpc-5733	48	23	.	.	PUNCT
dpc-5733	49	1	one	one	NUM
dpc-5733	49	2	-	-	PUNCT
dpc-5733	49	3	way	way	NOUN
dpc-5733	49	4	anova	anova	PROPN
dpc-5733	49	5	test	test	NOUN
dpc-5733	49	6	for	for	ADP
dpc-5733	49	7	independent	independent	ADJ
dpc-5733	49	8	measures	measure	NOUN
dpc-5733	49	9	(	(	PUNCT
dpc-5733	49	10	kruskal	kruskal	PROPN
dpc-5733	49	11	wallis	wallis	PROPN
dpc-5733	49	12	test	test	NOUN
dpc-5733	49	13	,	,	PUNCT
dpc-5733	49	14	plus	plus	CCONJ
dpc-5733	49	15	dunn	dunn	PROPN
dpc-5733	49	16	’s	’s	PART
dpc-5733	49	17	correction	correction	NOUN
dpc-5733	49	18	)	)	PUNCT
dpc-5733	49	19	was	be	AUX
dpc-5733	49	20	used	use	VERB
dpc-5733	49	21	to	to	PART
dpc-5733	49	22	compare	compare	VERB
dpc-5733	49	23	the	the	DET
dpc-5733	49	24	means	mean	NOUN
dpc-5733	49	25	of	of	ADP
dpc-5733	49	26	≥3	≥3	NOUN
dpc-5733	49	27	independent	independent	ADJ
dpc-5733	49	28	samples	sample	NOUN
dpc-5733	49	29	simultaneously	simultaneously	ADV
dpc-5733	49	30	.	.	PUNCT
dpc-5733	50	1	treatment	treatment	NOUN
dpc-5733	50	2	effect	effect	NOUN
dpc-5733	50	3	was	be	AUX
dpc-5733	50	4	studied	study	VERB
dpc-5733	50	5	by	by	ADP
dpc-5733	50	6	comparing	compare	VERB
dpc-5733	50	7	medians	median	NOUN
dpc-5733	50	8	of	of	ADP
dpc-5733	50	9	values	value	NOUN
dpc-5733	50	10	at	at	ADP
dpc-5733	50	11	different	different	ADJ
dpc-5733	50	12	time	time	NOUN
dpc-5733	50	13	points	point	NOUN
dpc-5733	50	14	either	either	CCONJ
dpc-5733	50	15	with	with	ADP
dpc-5733	50	16	wilcoxon	wilcoxon	ADJ
dpc-5733	50	17	matched	match	VERB
dpc-5733	50	18	-	-	PUNCT
dpc-5733	50	19	pairs	pair	NOUN
dpc-5733	50	20	signed	sign	VERB
dpc-5733	50	21	-	-	PUNCT
dpc-5733	50	22	rank	rank	NOUN
dpc-5733	50	23	test	test	NOUN
dpc-5733	50	24	or	or	CCONJ
dpc-5733	50	25	with	with	ADP
dpc-5733	50	26	matched	match	VERB
dpc-5733	50	27	friedman	friedman	PROPN
dpc-5733	50	28	anova	anova	PROPN
dpc-5733	50	29	test	test	PROPN
dpc-5733	50	30	with	with	ADP
dpc-5733	50	31	dunn	dunn	PROPN
dpc-5733	50	32	’s	’s	PART
dpc-5733	50	33	post	post	NOUN
dpc-5733	50	34	-	-	NOUN
dpc-5733	50	35	test	test	NOUN
dpc-5733	50	36	for	for	ADP
dpc-5733	50	37	≥3	≥3	PROPN
dpc-5733	50	38	samples	sample	NOUN
dpc-5733	50	39	simultaneously	simultaneously	ADV
dpc-5733	50	40	.	.	PUNCT
dpc-5733	51	1	categorical	categorical	ADJ
dpc-5733	51	2	variables	variable	NOUN
dpc-5733	51	3	were	be	AUX
dpc-5733	51	4	analyzed	analyze	VERB
dpc-5733	51	5	with	with	ADP
dpc-5733	51	6	pearson	pearson	PROPN
dpc-5733	51	7	’s	’s	PART
dpc-5733	51	8	chi	chi	ADJ
dpc-5733	51	9	-	-	PUNCT
dpc-5733	51	10	square	square	ADJ
dpc-5733	51	11	test	test	NOUN
dpc-5733	51	12	.	.	PUNCT
dpc-5733	52	1	fisher	fisher	PROPN
dpc-5733	52	2	exact	exact	PROPN
dpc-5733	52	3	test	test	NOUN
dpc-5733	52	4	was	be	AUX
dpc-5733	52	5	also	also	ADV
dpc-5733	52	6	used	use	VERB
dpc-5733	52	7	when	when	SCONJ
dpc-5733	52	8	appropriate	appropriate	ADJ
dpc-5733	52	9	.	.	PUNCT
dpc-5733	53	1	correlation	correlation	NOUN
dpc-5733	53	2	between	between	ADP
dpc-5733	53	3	variables	variable	NOUN
dpc-5733	53	4	was	be	AUX
dpc-5733	53	5	assessed	assess	VERB
dpc-5733	53	6	with	with	ADP
dpc-5733	53	7	non	non	ADJ
dpc-5733	53	8	-	-	ADJ
dpc-5733	53	9	parametric	parametric	ADJ
dpc-5733	53	10	spearman	spearman	NOUN
dpc-5733	53	11	rank	rank	PROPN
dpc-5733	53	12	coefficient	coefficient	PROPN
dpc-5733	53	13	test	test	NOUN
dpc-5733	53	14	.	.	PUNCT
dpc-5733	54	1	all	all	DET
dpc-5733	54	2	p	p	NOUN
dpc-5733	54	3	-	-	PUNCT
dpc-5733	54	4	values	value	NOUN
dpc-5733	54	5	cited	cite	VERB
dpc-5733	54	6	are	be	AUX
dpc-5733	54	7	two	two	NUM
dpc-5733	54	8	-	-	PUNCT
dpc-5733	54	9	sided	sided	ADJ
dpc-5733	54	10	,	,	PUNCT
dpc-5733	54	11	and	and	CCONJ
dpc-5733	54	12	values	value	NOUN
dpc-5733	54	13	of	of	ADP
dpc-5733	54	14	p	p	NOUN
dpc-5733	54	15	less	less	ADJ
dpc-5733	54	16	than	than	ADP
dpc-5733	54	17	.05	.05	NUM
dpc-5733	54	18	were	be	AUX
dpc-5733	54	19	considered	consider	VERB
dpc-5733	54	20	statistically	statistically	ADV
dpc-5733	54	21	significant	significant	ADJ
dpc-5733	54	22	.	.	PUNCT
dpc-5733	55	1	results	result	VERB
dpc-5733	55	2	total	total	ADJ
dpc-5733	55	3	population	population	NOUN
dpc-5733	55	4	and	and	CCONJ
dpc-5733	55	5	baseline	baseline	VERB
dpc-5733	55	6	clinical	clinical	ADJ
dpc-5733	55	7	features	feature	NOUN
dpc-5733	55	8	in	in	ADP
dpc-5733	55	9	total	total	ADJ
dpc-5733	55	10	,	,	PUNCT
dpc-5733	55	11	103	103	NUM
dpc-5733	55	12	patients	patient	NOUN
dpc-5733	55	13	(	(	PUNCT
dpc-5733	55	14	70	70	NUM
dpc-5733	55	15	m	m	NOUN
dpc-5733	55	16	,	,	PUNCT
dpc-5733	55	17	43	43	NUM
dpc-5733	55	18	f	f	NOUN
dpc-5733	55	19	;	;	PUNCT
dpc-5733	55	20	median	median	ADJ
dpc-5733	55	21	age	age	NOUN
dpc-5733	55	22	:	:	PUNCT
dpc-5733	55	23	54	54	NUM
dpc-5733	55	24	,	,	PUNCT
dpc-5733	55	25	iqr	iqr	NOUN
dpc-5733	55	26	:	:	PUNCT
dpc-5733	55	27	45–67	45–67	NUM
dpc-5733	55	28	)	)	PUNCT
dpc-5733	55	29	were	be	AUX
dpc-5733	55	30	included	include	VERB
dpc-5733	55	31	in	in	ADP
dpc-5733	55	32	the	the	DET
dpc-5733	55	33	study	study	NOUN
dpc-5733	55	34	(	(	PUNCT
dpc-5733	55	35	figure	figure	NOUN
dpc-5733	55	36	1	1	NUM
dpc-5733	55	37	)	)	PUNCT
dpc-5733	55	38	.	.	PUNCT
dpc-5733	56	1	patients	patient	NOUN
dpc-5733	56	2	were	be	AUX
dpc-5733	56	3	all	all	PRON
dpc-5733	56	4	affected	affect	VERB
dpc-5733	56	5	with	with	ADP
dpc-5733	56	6	cutaneous	cutaneous	ADJ
dpc-5733	56	7	plaque	plaque	NOUN
dpc-5733	56	8	psoriasis	psoriasis	NOUN
dpc-5733	56	9	(	(	PUNCT
dpc-5733	56	10	median	median	NOUN
dpc-5733	56	11	pasi	pasi	NOUN
dpc-5733	56	12	13.7	13.7	NUM
dpc-5733	56	13	,	,	PUNCT
dpc-5733	56	14	iqr	iqr	NOUN
dpc-5733	56	15	9.7–16.8	9.7–16.8	NUM
dpc-5733	56	16	)	)	PUNCT
dpc-5733	56	17	,	,	PUNCT
dpc-5733	56	18	and	and	CCONJ
dpc-5733	56	19	18.4	18.4	NUM
dpc-5733	56	20	%	%	NOUN
dpc-5733	56	21	(	(	PUNCT
dpc-5733	56	22	19/103	19/103	NUM
dpc-5733	56	23	)	)	PUNCT
dpc-5733	56	24	had	have	VERB
dpc-5733	56	25	concomitant	concomitant	ADJ
dpc-5733	56	26	arthritis	arthritis	NOUN
dpc-5733	56	27	(	(	PUNCT
dpc-5733	56	28	psa	psa	NOUN
dpc-5733	56	29	)	)	PUNCT
dpc-5733	56	30	.	.	PUNCT
dpc-5733	57	1	special	special	ADJ
dpc-5733	57	2	areas	area	NOUN
dpc-5733	57	3	including	include	VERB
dpc-5733	57	4	scalp	scalp	NOUN
dpc-5733	57	5	,	,	PUNCT
dpc-5733	57	6	nail	nail	NOUN
dpc-5733	57	7	,	,	PUNCT
dpc-5733	57	8	palmoplantar	palmoplantar	NOUN
dpc-5733	57	9	,	,	PUNCT
dpc-5733	57	10	genital	genital	ADJ
dpc-5733	57	11	,	,	PUNCT
dpc-5733	57	12	and	and	CCONJ
dpc-5733	57	13	face	face	NOUN
dpc-5733	57	14	regions	region	NOUN
dpc-5733	57	15	were	be	AUX
dpc-5733	57	16	involved	involve	VERB
dpc-5733	57	17	in	in	ADP
dpc-5733	57	18	55.3	55.3	NUM
dpc-5733	57	19	%	%	NOUN
dpc-5733	57	20	(	(	PUNCT
dpc-5733	57	21	57/103	57/103	NUM
dpc-5733	57	22	)	)	PUNCT
dpc-5733	57	23	,	,	PUNCT
dpc-5733	57	24	35.9	35.9	NUM
dpc-5733	57	25	%	%	NOUN
dpc-5733	57	26	(	(	PUNCT
dpc-5733	57	27	37/103	37/103	NUM
dpc-5733	57	28	)	)	PUNCT
dpc-5733	57	29	,	,	PUNCT
dpc-5733	57	30	33.98	33.98	NUM
dpc-5733	57	31	%	%	NOUN
dpc-5733	57	32	(	(	PUNCT
dpc-5733	57	33	35/103	35/103	NUM
dpc-5733	57	34	)	)	PUNCT
dpc-5733	57	35	,	,	PUNCT
dpc-5733	57	36	25.2	25.2	NUM
dpc-5733	57	37	%	%	NOUN
dpc-5733	57	38	(	(	PUNCT
dpc-5733	57	39	26/103	26/103	NUM
dpc-5733	57	40	)	)	PUNCT
dpc-5733	57	41	,	,	PUNCT
dpc-5733	57	42	and	and	CCONJ
dpc-5733	57	43	6.8	6.8	NUM
dpc-5733	57	44	%	%	NOUN
dpc-5733	57	45	(	(	PUNCT
dpc-5733	57	46	7/103	7/103	NOUN
dpc-5733	57	47	)	)	PUNCT
dpc-5733	57	48	of	of	ADP
dpc-5733	57	49	patients	patient	NOUN
dpc-5733	57	50	,	,	PUNCT
dpc-5733	57	51	respectively	respectively	ADV
dpc-5733	57	52	.	.	PUNCT
dpc-5733	58	1	patients	patient	NOUN
dpc-5733	58	2	had	have	AUX
dpc-5733	58	3	all	all	PRON
dpc-5733	58	4	been	be	AUX
dpc-5733	58	5	previously	previously	ADV
dpc-5733	58	6	treated	treat	VERB
dpc-5733	58	7	with	with	ADP
dpc-5733	58	8	conventional	conventional	ADJ
dpc-5733	58	9	systemic	systemic	ADJ
dpc-5733	58	10	agents	agent	NOUN
dpc-5733	58	11	:	:	PUNCT
dpc-5733	58	12	(	(	PUNCT
dpc-5733	58	13	69/103	69/103	NOUN
dpc-5733	58	14	;	;	PUNCT
dpc-5733	58	15	66.9	66.9	NUM
dpc-5733	58	16	%	%	NOUN
dpc-5733	58	17	)	)	PUNCT
dpc-5733	58	18	cyclosporin	cyclosporin	NOUN
dpc-5733	58	19	a	a	NOUN
dpc-5733	58	20	,	,	PUNCT
dpc-5733	58	21	41/103	41/103	NUM
dpc-5733	58	22	(	(	PUNCT
dpc-5733	58	23	39.8	39.8	NUM
dpc-5733	58	24	%	%	NOUN
dpc-5733	58	25	)	)	PUNCT
dpc-5733	58	26	methotrexate	methotrexate	NOUN
dpc-5733	58	27	,	,	PUNCT
dpc-5733	58	28	27/103	27/103	NUM
dpc-5733	58	29	(	(	PUNCT
dpc-5733	58	30	26.21	26.21	NUM
dpc-5733	58	31	%	%	NOUN
dpc-5733	58	32	)	)	PUNCT
dpc-5733	58	33	acitretin	acitretin	NOUN
dpc-5733	58	34	,	,	PUNCT
dpc-5733	58	35	and	and	CCONJ
dpc-5733	58	36	1/103	1/103	NUM
dpc-5733	58	37	(	(	PUNCT
dpc-5733	58	38	0.97	0.97	NUM
dpc-5733	58	39	%	%	NOUN
dpc-5733	58	40	)	)	PUNCT
dpc-5733	58	41	dimethyl	dimethyl	NOUN
dpc-5733	58	42	-	-	PUNCT
dpc-5733	58	43	fumarate	fumarate	NOUN
dpc-5733	58	44	or	or	CCONJ
dpc-5733	58	45	phototherapy	phototherapy	NOUN
dpc-5733	58	46	(	(	PUNCT
dpc-5733	58	47	44/103	44/103	NUM
dpc-5733	58	48	;	;	PUNCT
dpc-5733	58	49	42.7	42.7	NUM
dpc-5733	58	50	%	%	NOUN
dpc-5733	58	51	)	)	PUNCT
dpc-5733	58	52	,	,	PUNCT
dpc-5733	58	53	nbuvb	nbuvb	NOUN
dpc-5733	58	54	and/or	and/or	CCONJ
dpc-5733	58	55	puva	puva	PROPN
dpc-5733	58	56	;	;	PUNCT
dpc-5733	58	57	16/103	16/103	NUM
dpc-5733	58	58	(	(	PUNCT
dpc-5733	58	59	15.5	15.5	NUM
dpc-5733	58	60	%	%	NOUN
dpc-5733	58	61	)	)	PUNCT
dpc-5733	58	62	were	be	AUX
dpc-5733	58	63	naïve	naïve	ADJ
dpc-5733	58	64	to	to	ADP
dpc-5733	58	65	biologics	biologic	NOUN
dpc-5733	58	66	.	.	PUNCT
dpc-5733	59	1	among	among	ADP
dpc-5733	59	2	bio	bio	ADJ
dpc-5733	59	3	-	-	ADJ
dpc-5733	59	4	experienced	experienced	ADJ
dpc-5733	59	5	patients	patient	NOUN
dpc-5733	59	6	,	,	PUNCT
dpc-5733	59	7	37/103	37/103	NUM
dpc-5733	59	8	(	(	PUNCT
dpc-5733	59	9	35.9	35.9	NUM
dpc-5733	59	10	%	%	NOUN
dpc-5733	59	11	)	)	PUNCT
dpc-5733	59	12	had	have	AUX
dpc-5733	59	13	failed	fail	VERB
dpc-5733	59	14	one	one	NUM
dpc-5733	59	15	,	,	PUNCT
dpc-5733	59	16	34/103	34/103	NUM
dpc-5733	59	17	(	(	PUNCT
dpc-5733	59	18	33	33	NUM
dpc-5733	59	19	%	%	NOUN
dpc-5733	59	20	)	)	PUNCT
dpc-5733	59	21	two	two	NUM
dpc-5733	59	22	,	,	PUNCT
dpc-5733	59	23	7/103	7/103	NUM
dpc-5733	59	24	(	(	PUNCT
dpc-5733	59	25	6.8	6.8	NUM
dpc-5733	59	26	%	%	NOUN
dpc-5733	59	27	)	)	PUNCT
dpc-5733	59	28	three	three	NUM
dpc-5733	59	29	,	,	PUNCT
dpc-5733	59	30	6/103	6/103	NUM
dpc-5733	59	31	four	four	NUM
dpc-5733	59	32	(	(	PUNCT
dpc-5733	59	33	5.85	5.85	NUM
dpc-5733	59	34	)	)	PUNCT
dpc-5733	59	35	,	,	PUNCT
dpc-5733	59	36	2/103	2/103	NUM
dpc-5733	59	37	five	five	NUM
dpc-5733	59	38	(	(	PUNCT
dpc-5733	59	39	1.9	1.9	NUM
dpc-5733	59	40	%	%	NOUN
dpc-5733	59	41	)	)	PUNCT
dpc-5733	59	42	,	,	PUNCT
dpc-5733	59	43	and	and	CCONJ
dpc-5733	59	44	1/103	1/103	NUM
dpc-5733	59	45	(	(	PUNCT
dpc-5733	59	46	0.97	0.97	NUM
dpc-5733	59	47	%	%	NOUN
dpc-5733	59	48	)	)	PUNCT
dpc-5733	59	49	six	six	NUM
dpc-5733	59	50	biologic	biologic	NOUN
dpc-5733	59	51	agents	agent	NOUN
dpc-5733	59	52	,	,	PUNCT
dpc-5733	59	53	with	with	ADP
dpc-5733	59	54	a	a	DET
dpc-5733	59	55	median	median	ADJ
dpc-5733	59	56	number	number	NOUN
dpc-5733	59	57	of	of	ADP
dpc-5733	59	58	one	one	NUM
dpc-5733	59	59	biologic	biologic	NOUN
dpc-5733	59	60	agent	agent	NOUN
dpc-5733	59	61	(	(	PUNCT
dpc-5733	59	62	iqr	iqr	NOUN
dpc-5733	59	63	1–2	1–2	NUM
dpc-5733	59	64	/	/	SYM
dpc-5733	59	65	patient	patient	NOUN
dpc-5733	59	66	)	)	PUNCT
dpc-5733	59	67	.	.	PUNCT
dpc-5733	60	1	patients	patient	NOUN
dpc-5733	60	2	had	have	VERB
dpc-5733	60	3	a	a	DET
dpc-5733	60	4	median	median	ADJ
dpc-5733	60	5	body	body	NOUN
dpc-5733	60	6	mass	mass	NOUN
dpc-5733	60	7	index	index	NOUN
dpc-5733	60	8	(	(	PUNCT
dpc-5733	60	9	bmi	bmi	PROPN
dpc-5733	60	10	)	)	PUNCT
dpc-5733	60	11	of	of	ADP
dpc-5733	60	12	26.54	26.54	NUM
dpc-5733	60	13	(	(	PUNCT
dpc-5733	60	14	iqr	iqr	NOUN
dpc-5733	60	15	:	:	PUNCT
dpc-5733	60	16	24.14–29.41	24.14–29.41	NUM
dpc-5733	60	17	)	)	PUNCT
dpc-5733	60	18	,	,	PUNCT
dpc-5733	60	19	and	and	CCONJ
dpc-5733	60	20	21/103	21/103	NUM
dpc-5733	60	21	(	(	PUNCT
dpc-5733	60	22	20.4	20.4	NUM
dpc-5733	60	23	%	%	NOUN
dpc-5733	60	24	)	)	PUNCT
dpc-5733	60	25	patients	patient	NOUN
dpc-5733	60	26	were	be	AUX
dpc-5733	60	27	obese	obese	ADJ
dpc-5733	60	28	(	(	PUNCT
dpc-5733	60	29	bmi	bmi	PROPN
dpc-5733	60	30	≥30	≥30	PROPN
dpc-5733	60	31	)	)	PUNCT
dpc-5733	60	32	.	.	PUNCT
dpc-5733	61	1	comorbidities	comorbiditie	NOUN
dpc-5733	61	2	were	be	AUX
dpc-5733	61	3	reported	report	VERB
dpc-5733	61	4	for	for	ADP
dpc-5733	61	5	65/103	65/103	NUM
dpc-5733	61	6	(	(	PUNCT
dpc-5733	61	7	63	63	NUM
dpc-5733	61	8	%	%	NOUN
dpc-5733	61	9	)	)	PUNCT
dpc-5733	61	10	patients	patient	NOUN
dpc-5733	61	11	,	,	PUNCT
dpc-5733	61	12	the	the	DET
dpc-5733	61	13	most	most	ADV
dpc-5733	61	14	common	common	ADJ
dpc-5733	61	15	being	be	AUX
dpc-5733	61	16	systemic	systemic	ADJ
dpc-5733	61	17	hypertension	hypertension	NOUN
dpc-5733	61	18	(	(	PUNCT
dpc-5733	61	19	35/103	35/103	NUM
dpc-5733	61	20	;	;	PUNCT
dpc-5733	61	21	33.98	33.98	NUM
dpc-5733	61	22	%	%	NOUN
dpc-5733	61	23	)	)	PUNCT
dpc-5733	61	24	,	,	PUNCT
dpc-5733	61	25	dyslipidemia	dyslipidemia	NOUN
dpc-5733	61	26	(	(	PUNCT
dpc-5733	61	27	24/103	24/103	NUM
dpc-5733	61	28	;	;	PUNCT
dpc-5733	61	29	23.3	23.3	NUM
dpc-5733	61	30	%	%	NOUN
dpc-5733	61	31	)	)	PUNCT
dpc-5733	61	32	,	,	PUNCT
dpc-5733	61	33	and	and	CCONJ
dpc-5733	61	34	type	type	NOUN
dpc-5733	61	35	2	2	NUM
dpc-5733	61	36	diabetes	diabetes	NOUN
dpc-5733	61	37	(	(	PUNCT
dpc-5733	61	38	9/103	9/103	NUM
dpc-5733	61	39	;	;	PUNCT
dpc-5733	61	40	8.74	8.74	NUM
dpc-5733	61	41	%	%	NOUN
dpc-5733	61	42	)	)	PUNCT
dpc-5733	61	43	.	.	PUNCT
dpc-5733	62	1	latent	latent	PROPN
dpc-5733	62	2	tb	tb	PROPN
dpc-5733	62	3	,	,	PUNCT
dpc-5733	62	4	previous	previous	ADJ
dpc-5733	62	5	hcv	hcv	NOUN
dpc-5733	62	6	infection	infection	NOUN
dpc-5733	62	7	,	,	PUNCT
dpc-5733	62	8	and	and	CCONJ
dpc-5733	62	9	inactive	inactive	ADJ
dpc-5733	62	10	hbv	hbv	NOUN
dpc-5733	62	11	infection	infection	NOUN
dpc-5733	62	12	were	be	AUX
dpc-5733	62	13	recorded	record	VERB
dpc-5733	62	14	in	in	ADP
dpc-5733	62	15	13/103	13/103	NUM
dpc-5733	62	16	(	(	PUNCT
dpc-5733	62	17	12.6	12.6	NUM
dpc-5733	62	18	%	%	NOUN
dpc-5733	62	19	)	)	PUNCT
dpc-5733	62	20	,	,	PUNCT
dpc-5733	62	21	3/103	3/103	NUM
dpc-5733	62	22	(	(	PUNCT
dpc-5733	62	23	2.9	2.9	NUM
dpc-5733	62	24	%	%	NOUN
dpc-5733	62	25	)	)	PUNCT
dpc-5733	62	26	and	and	CCONJ
dpc-5733	62	27	8/103	8/103	NUM
dpc-5733	62	28	(	(	PUNCT
dpc-5733	62	29	7.7	7.7	NUM
dpc-5733	62	30	%	%	NOUN
dpc-5733	62	31	)	)	PUNCT
dpc-5733	62	32	patients	patient	NOUN
dpc-5733	62	33	,	,	PUNCT
dpc-5733	62	34	respectively	respectively	ADV
dpc-5733	62	35	.	.	PUNCT
dpc-5733	63	1	baseline	baseline	PROPN
dpc-5733	63	2	laboratory	laboratory	NOUN
dpc-5733	63	3	values	value	NOUN
dpc-5733	63	4	of	of	ADP
dpc-5733	63	5	the	the	DET
dpc-5733	63	6	overall	overall	ADJ
dpc-5733	63	7	population	population	NOUN
dpc-5733	63	8	and	and	CCONJ
dpc-5733	63	9	derived	derived	ADJ
dpc-5733	63	10	indices	index	NOUN
dpc-5733	63	11	are	be	AUX
dpc-5733	63	12	reported	report	VERB
dpc-5733	63	13	in	in	ADP
dpc-5733	63	14	table	table	NOUN
dpc-5733	63	15	1	1	NUM
dpc-5733	63	16	.	.	PUNCT
dpc-5733	64	1	a	a	DET
dpc-5733	64	2	significant	significant	ADJ
dpc-5733	64	3	correlation	correlation	NOUN
dpc-5733	64	4	between	between	ADP
dpc-5733	64	5	age	age	NOUN
dpc-5733	64	6	and	and	CCONJ
dpc-5733	64	7	bmi	bmi	NOUN
dpc-5733	64	8	was	be	AUX
dpc-5733	64	9	found	find	VERB
dpc-5733	64	10	(	(	PUNCT
dpc-5733	64	11	p=0.015	p=0.015	NOUN
dpc-5733	64	12	;	;	PUNCT
dpc-5733	64	13	r=	r=	ADJ
dpc-5733	64	14	0.2391	0.2391	NUM
dpc-5733	64	15	)	)	PUNCT
dpc-5733	64	16	,	,	PUNCT
dpc-5733	64	17	mainly	mainly	ADV
dpc-5733	64	18	linked	link	VERB
dpc-5733	64	19	to	to	ADP
dpc-5733	64	20	lower	low	ADJ
dpc-5733	64	21	bmi	bmi	NOUN
dpc-5733	64	22	in	in	ADP
dpc-5733	64	23	females	female	NOUN
dpc-5733	64	24	(	(	PUNCT
dpc-5733	64	25	m	m	NOUN
dpc-5733	64	26	:	:	PUNCT
dpc-5733	64	27	p=0.24	p=0.24	NOUN
dpc-5733	64	28	r=0.142	r=0.142	NOUN
dpc-5733	64	29	;	;	PUNCT
dpc-5733	64	30	f	f	X
dpc-5733	64	31	:	:	PUNCT
dpc-5733	64	32	p=	p=	PROPN
dpc-5733	64	33	0.014	0.014	NUM
dpc-5733	64	34	,	,	PUNCT
dpc-5733	64	35	r=0.424	r=0.424	X
dpc-5733	64	36	)	)	PUNCT
dpc-5733	64	37	.	.	PUNCT
dpc-5733	65	1	actually	actually	ADV
dpc-5733	65	2	,	,	PUNCT
dpc-5733	65	3	male	male	ADJ
dpc-5733	65	4	patients	patient	NOUN
dpc-5733	65	5	(	(	PUNCT
dpc-5733	65	6	bmi	bmi	PROPN
dpc-5733	65	7	:	:	PUNCT
dpc-5733	65	8	27.28	27.28	NUM
dpc-5733	65	9	;	;	PUNCT
dpc-5733	65	10	iqr	iqr	NOUN
dpc-5733	65	11	:	:	PUNCT
dpc-5733	65	12	25.36–29.76	25.36–29.76	NUM
dpc-5733	65	13	)	)	PUNCT
dpc-5733	65	14	were	be	AUX
dpc-5733	65	15	significantly	significantly	ADV
dpc-5733	65	16	overweight	overweight	ADJ
dpc-5733	65	17	compared	compare	VERB
dpc-5733	65	18	to	to	ADP
dpc-5733	65	19	females	female	NOUN
dpc-5733	65	20	(	(	PUNCT
dpc-5733	65	21	bmi	bmi	PROPN
dpc-5733	65	22	:	:	PUNCT
dpc-5733	65	23	24.14	24.14	NUM
dpc-5733	65	24	,	,	PUNCT
dpc-5733	65	25	iqr	iqr	NOUN
dpc-5733	65	26	:	:	PUNCT
dpc-5733	65	27	21.14–28.19	21.14–28.19	NUM
dpc-5733	65	28	)	)	PUNCT
dpc-5733	65	29	(	(	PUNCT
dpc-5733	65	30	p=0.0015	p=0.0015	PROPN
dpc-5733	65	31	)	)	PUNCT
dpc-5733	65	32	,	,	PUNCT
dpc-5733	65	33	while	while	SCONJ
dpc-5733	65	34	no	no	DET
dpc-5733	65	35	gender	gender	NOUN
dpc-5733	65	36	difference	difference	NOUN
dpc-5733	65	37	in	in	ADP
dpc-5733	65	38	disease	disease	NOUN
dpc-5733	65	39	severity	severity	NOUN
dpc-5733	65	40	(	(	PUNCT
dpc-5733	65	41	pasi	pasi	NOUN
dpc-5733	65	42	m=	m=	X
dpc-5733	65	43	13.75	13.75	NUM
dpc-5733	65	44	;	;	PUNCT
dpc-5733	65	45	iqr	iqr	NOUN
dpc-5733	65	46	:	:	PUNCT
dpc-5733	65	47	9.7–16.23	9.7–16.23	NUM
dpc-5733	65	48	;	;	PUNCT
dpc-5733	65	49	pasi	pasi	VERB
dpc-5733	65	50	f=	f=	NOUN
dpc-5733	65	51	13.9	13.9	NUM
dpc-5733	65	52	;	;	PUNCT
dpc-5733	65	53	iqr	iqr	PROPN
dpc-5733	65	54	10.8–17.4	10.8–17.4	NUM
dpc-5733	65	55	;	;	PUNCT
dpc-5733	65	56	p=0.9089	p=0.9089	PROPN
dpc-5733	65	57	)	)	PUNCT
dpc-5733	65	58	or	or	CCONJ
dpc-5733	65	59	age	age	NOUN
dpc-5733	65	60	at	at	ADP
dpc-5733	65	61	observation	observation	NOUN
dpc-5733	65	62	(	(	PUNCT
dpc-5733	65	63	age	age	NOUN
dpc-5733	65	64	m=53	m=53	PROPN
dpc-5733	65	65	;	;	PUNCT
dpc-5733	65	66	iqr	iqr	NOUN
dpc-5733	65	67	:	:	PUNCT
dpc-5733	65	68	45.75–64.25	45.75–64.25	NUM
dpc-5733	65	69	)	)	PUNCT
dpc-5733	65	70	;	;	PUNCT
dpc-5733	65	71	age	age	NOUN
dpc-5733	65	72	f=57	f=57	PROPN
dpc-5733	65	73	;	;	PUNCT
dpc-5733	65	74	iqr	iqr	PROPN
dpc-5733	65	75	41–71	41–71	PROPN
dpc-5733	65	76	;	;	PUNCT
dpc-5733	65	77	p=0.9089	p=0.9089	PROPN
dpc-5733	65	78	)	)	PUNCT
dpc-5733	65	79	was	be	AUX
dpc-5733	65	80	found	find	VERB
dpc-5733	65	81	.	.	PUNCT
dpc-5733	66	1	figure	figure	VERB
dpc-5733	66	2	1	1	NUM
dpc-5733	66	3	.	.	PUNCT
dpc-5733	67	1	flow	flow	NOUN
dpc-5733	67	2	diagram	diagram	NOUN
dpc-5733	67	3	depicting	depict	VERB
dpc-5733	67	4	the	the	DET
dpc-5733	67	5	number	number	NOUN
dpc-5733	67	6	of	of	ADP
dpc-5733	67	7	patients	patient	NOUN
dpc-5733	67	8	(	(	PUNCT
dpc-5733	67	9	pts	pt	NOUN
dpc-5733	67	10	)	)	PUNCT
dpc-5733	67	11	who	who	PRON
dpc-5733	67	12	were	be	AUX
dpc-5733	67	13	screened	screen	VERB
dpc-5733	67	14	and	and	CCONJ
dpc-5733	67	15	started	start	VERB
dpc-5733	67	16	on	on	ADP
dpc-5733	67	17	risankizumab	risankizumab	NOUN
dpc-5733	67	18	and	and	CCONJ
dpc-5733	67	19	therefore	therefore	ADV
dpc-5733	67	20	enrolled	enrol	VERB
dpc-5733	67	21	in	in	ADP
dpc-5733	67	22	the	the	DET
dpc-5733	67	23	prospective	prospective	ADJ
dpc-5733	67	24	study	study	NOUN
dpc-5733	67	25	at	at	ADP
dpc-5733	67	26	baseline	baseline	PROPN
dpc-5733	67	27	(	(	PUNCT
dpc-5733	67	28	t0	t0	NOUN
dpc-5733	67	29	)	)	PUNCT
dpc-5733	67	30	,	,	PUNCT
dpc-5733	67	31	and	and	CCONJ
dpc-5733	67	32	the	the	DET
dpc-5733	67	33	number	number	NOUN
dpc-5733	67	34	of	of	ADP
dpc-5733	67	35	patients	patient	NOUN
dpc-5733	67	36	who	who	PRON
dpc-5733	67	37	completed	complete	VERB
dpc-5733	67	38	each	each	DET
dpc-5733	67	39	follow	follow	VERB
dpc-5733	67	40	-	-	PUNCT
dpc-5733	67	41	up	up	NOUN
dpc-5733	67	42	time	time	NOUN
dpc-5733	67	43	point	point	NOUN
dpc-5733	67	44	(	(	PUNCT
dpc-5733	67	45	t12	t12	PROPN
dpc-5733	67	46	,	,	PUNCT
dpc-5733	67	47	t24	t24	NOUN
dpc-5733	67	48	,	,	PUNCT
dpc-5733	67	49	and	and	CCONJ
dpc-5733	67	50	t52	t52	NOUN
dpc-5733	67	51	)	)	PUNCT
dpc-5733	67	52	.	.	PUNCT
dpc-5733	68	1	only	only	ADV
dpc-5733	68	2	patients	patient	NOUN
dpc-5733	68	3	who	who	PRON
dpc-5733	68	4	reached	reach	VERB
dpc-5733	68	5	week	week	NOUN
dpc-5733	68	6	52	52	NUM
dpc-5733	68	7	(	(	PUNCT
dpc-5733	68	8	n=103	n=103	NOUN
dpc-5733	68	9	)	)	PUNCT
dpc-5733	68	10	of	of	ADP
dpc-5733	68	11	continuous	continuous	ADJ
dpc-5733	68	12	risankizumab	risankizumab	NOUN
dpc-5733	68	13	therapy	therapy	NOUN
dpc-5733	68	14	with	with	ADP
dpc-5733	68	15	complete	complete	ADJ
dpc-5733	68	16	hematologic	hematologic	NOUN
dpc-5733	68	17	data	datum	NOUN
dpc-5733	68	18	were	be	AUX
dpc-5733	68	19	included	include	VERB
dpc-5733	68	20	in	in	ADP
dpc-5733	68	21	the	the	DET
dpc-5733	68	22	analysis	analysis	NOUN
dpc-5733	68	23	.	.	PUNCT
dpc-5733	69	1	4	4	NUM
dpc-5733	69	2	original	original	ADJ
dpc-5733	69	3	article	article	NOUN
dpc-5733	69	4	|	|	ADV
dpc-5733	69	5	dermatol	dermatol	ADJ
dpc-5733	69	6	pract	pract	NOUN
dpc-5733	69	7	concept	concept	NOUN
dpc-5733	69	8	.	.	PUNCT
dpc-5733	70	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	70	2	table	table	NOUN
dpc-5733	70	3	1	1	NUM
dpc-5733	70	4	.	.	X
dpc-5733	71	1	whole	whole	ADJ
dpc-5733	71	2	blood	blood	NOUN
dpc-5733	71	3	cells	cell	NOUN
dpc-5733	71	4	and	and	CCONJ
dpc-5733	71	5	derived	derived	ADJ
dpc-5733	71	6	indices	index	NOUN
dpc-5733	71	7	at	at	ADP
dpc-5733	71	8	baseline	baseline	NOUN
dpc-5733	71	9	and	and	CCONJ
dpc-5733	71	10	their	their	PRON
dpc-5733	71	11	therapeutic	therapeutic	ADJ
dpc-5733	71	12	modulation	modulation	NOUN
dpc-5733	71	13	during	during	ADP
dpc-5733	71	14	risankizumab	risankizumab	NOUN
dpc-5733	71	15	treatment	treatment	NOUN
dpc-5733	71	16	.	.	PUNCT
dpc-5733	72	1	t0	t0	NOUN
dpc-5733	72	2	week	week	NOUN
dpc-5733	72	3	12	12	NUM
dpc-5733	72	4	week	week	NOUN
dpc-5733	72	5	24	24	NUM
dpc-5733	72	6	week	week	NOUN
dpc-5733	72	7	52	52	NUM
dpc-5733	73	1	p	p	NOUN
dpc-5733	73	2	wbc	wbc	PROPN
dpc-5733	73	3	mmc/103	mmc/103	NOUN
dpc-5733	73	4	6.95	6.95	NUM
dpc-5733	73	5	(	(	PUNCT
dpc-5733	73	6	3.58	3.58	NUM
dpc-5733	73	7	-	-	SYM
dpc-5733	73	8	8.91	8.91	NUM
dpc-5733	73	9	)	)	PUNCT
dpc-5733	73	10	7.18	7.18	NUM
dpc-5733	73	11	(	(	PUNCT
dpc-5733	73	12	5.86	5.86	NUM
dpc-5733	73	13	-	-	SYM
dpc-5733	73	14	8.41	8.41	NUM
dpc-5733	73	15	)	)	PUNCT
dpc-5733	73	16	7.18	7.18	NUM
dpc-5733	73	17	(	(	PUNCT
dpc-5733	73	18	5.67	5.67	NUM
dpc-5733	73	19	-	-	PUNCT
dpc-5733	73	20	8.690	8.690	NUM
dpc-5733	73	21	)	)	PUNCT
dpc-5733	73	22	6.91	6.91	NUM
dpc-5733	73	23	(	(	PUNCT
dpc-5733	73	24	5.72	5.72	NUM
dpc-5733	73	25	-	-	SYM
dpc-5733	73	26	8.17	8.17	NUM
dpc-5733	73	27	)	)	PUNCT
dpc-5733	73	28	0.3746	0.3746	NUM
dpc-5733	73	29	°	°	PROPN
dpc-5733	73	30	0.0869@	0.0869@	PROPN
dpc-5733	73	31	rbc	rbc	PROPN
dpc-5733	73	32	mmc/106	mmc/106	PROPN
dpc-5733	73	33	5.120	5.120	NUM
dpc-5733	73	34	(	(	PUNCT
dpc-5733	73	35	4.82	4.82	NUM
dpc-5733	73	36	-	-	SYM
dpc-5733	73	37	5.4	5.4	NUM
dpc-5733	73	38	)	)	PUNCT
dpc-5733	73	39	5.11	5.11	NUM
dpc-5733	73	40	(	(	PUNCT
dpc-5733	73	41	4.76	4.76	NUM
dpc-5733	73	42	-	-	SYM
dpc-5733	73	43	5.38	5.38	NUM
dpc-5733	73	44	)	)	PUNCT
dpc-5733	73	45	5.13	5.13	NUM
dpc-5733	73	46	(	(	PUNCT
dpc-5733	73	47	4.77	4.77	NUM
dpc-5733	73	48	-	-	SYM
dpc-5733	73	49	5.37	5.37	NUM
dpc-5733	73	50	)	)	PUNCT
dpc-5733	73	51	5.11	5.11	NUM
dpc-5733	73	52	(	(	PUNCT
dpc-5733	73	53	4.66	4.66	NUM
dpc-5733	73	54	-	-	SYM
dpc-5733	73	55	5.39	5.39	NUM
dpc-5733	73	56	)	)	PUNCT
dpc-5733	73	57	0.6545	0.6545	NUM
dpc-5733	73	58	0.9586@	0.9586@	NOUN
dpc-5733	73	59	plt	plt	NOUN
dpc-5733	73	60	mmc/103	mmc/103	NOUN
dpc-5733	73	61	261	261	NUM
dpc-5733	73	62	(	(	PUNCT
dpc-5733	73	63	228	228	NUM
dpc-5733	73	64	-	-	SYM
dpc-5733	73	65	306	306	NUM
dpc-5733	73	66	)	)	PUNCT
dpc-5733	73	67	253	253	NUM
dpc-5733	73	68	(	(	PUNCT
dpc-5733	73	69	219	219	NUM
dpc-5733	73	70	-	-	SYM
dpc-5733	73	71	316	316	NUM
dpc-5733	73	72	)	)	PUNCT
dpc-5733	73	73	269	269	NUM
dpc-5733	73	74	(	(	PUNCT
dpc-5733	73	75	215	215	NUM
dpc-5733	73	76	-	-	NUM
dpc-5733	73	77	319	319	NUM
dpc-5733	73	78	)	)	PUNCT
dpc-5733	73	79	265	265	NUM
dpc-5733	73	80	(	(	PUNCT
dpc-5733	73	81	217	217	NUM
dpc-5733	73	82	-	-	SYM
dpc-5733	73	83	318	318	NUM
dpc-5733	73	84	)	)	PUNCT
dpc-5733	73	85	0.3588	0.3588	NUM
dpc-5733	74	1	°	°	ADP
dpc-5733	74	2	0.2444@	0.2444@	NOUN
dpc-5733	74	3	mpv	mpv	PROPN
dpc-5733	74	4	fl	fl	PROPN
dpc-5733	74	5	10	10	NUM
dpc-5733	74	6	*	*	PUNCT
dpc-5733	74	7	*	*	PUNCT
dpc-5733	74	8	(	(	PUNCT
dpc-5733	74	9	8.45	8.45	NUM
dpc-5733	74	10	-	-	SYM
dpc-5733	74	11	10.75	10.75	NUM
dpc-5733	74	12	)	)	PUNCT
dpc-5733	74	13	10.03	10.03	NUM
dpc-5733	74	14	*	*	PUNCT
dpc-5733	74	15	*	*	PUNCT
dpc-5733	74	16	(	(	PUNCT
dpc-5733	74	17	8.5	8.5	NUM
dpc-5733	74	18	-	-	SYM
dpc-5733	74	19	10.7	10.7	NUM
dpc-5733	74	20	)	)	PUNCT
dpc-5733	74	21	10.13	10.13	NUM
dpc-5733	74	22	(	(	PUNCT
dpc-5733	74	23	9.02	9.02	NUM
dpc-5733	74	24	-	-	SYM
dpc-5733	74	25	11.1	11.1	NUM
dpc-5733	74	26	)	)	PUNCT
dpc-5733	74	27	10.13	10.13	NUM
dpc-5733	74	28	*	*	PUNCT
dpc-5733	74	29	*	*	PUNCT
dpc-5733	74	30	(	(	PUNCT
dpc-5733	74	31	9.11	9.11	NUM
dpc-5733	74	32	-	-	SYM
dpc-5733	74	33	11.07	11.07	NUM
dpc-5733	74	34	)	)	PUNCT
dpc-5733	74	35	0.0016	0.0016	NUM
dpc-5733	74	36	°	°	NOUN
dpc-5733	75	1	0.0004@	0.0004@	NOUN
dpc-5733	75	2	*	*	PUNCT
dpc-5733	75	3	*	*	PUNCT
dpc-5733	75	4	t0	t0	NOUN
dpc-5733	75	5	-	-	PUNCT
dpc-5733	75	6	w52	w52	NOUN
dpc-5733	75	7	,	,	PUNCT
dpc-5733	75	8	w12	w12	NOUN
dpc-5733	75	9	-	-	PUNCT
dpc-5733	75	10	w52	w52	ADJ
dpc-5733	75	11	neutrophils	neutrophil	NOUN
dpc-5733	75	12	mmc/103	mmc/103	VERB
dpc-5733	75	13	5.2	5.2	NUM
dpc-5733	75	14	(	(	PUNCT
dpc-5733	75	15	3.98	3.98	NUM
dpc-5733	75	16	-	-	SYM
dpc-5733	75	17	6.15	6.15	NUM
dpc-5733	75	18	)	)	PUNCT
dpc-5733	75	19	5.01	5.01	NUM
dpc-5733	75	20	(	(	PUNCT
dpc-5733	75	21	3.98	3.98	NUM
dpc-5733	75	22	-	-	SYM
dpc-5733	75	23	6.05	6.05	NUM
dpc-5733	75	24	)	)	PUNCT
dpc-5733	75	25	5.07	5.07	NUM
dpc-5733	75	26	(	(	PUNCT
dpc-5733	75	27	3.73	3.73	NUM
dpc-5733	75	28	-	-	SYM
dpc-5733	75	29	6.11	6.11	NUM
dpc-5733	75	30	)	)	PUNCT
dpc-5733	75	31	4.61	4.61	NUM
dpc-5733	75	32	(	(	PUNCT
dpc-5733	75	33	3.59	3.59	NUM
dpc-5733	75	34	-	-	SYM
dpc-5733	75	35	6	6	NUM
dpc-5733	75	36	)	)	PUNCT
dpc-5733	75	37	0.0364	0.0364	NUM
dpc-5733	76	1	°	°	NOUN
dpc-5733	76	2	0.0562@	0.0562@	NOUN
dpc-5733	76	3	lymphocytes	lymphocyte	VERB
dpc-5733	76	4	mmc/103	mmc/103	NOUN
dpc-5733	76	5	2.1	2.1	NUM
dpc-5733	76	6	(	(	PUNCT
dpc-5733	76	7	1.53	1.53	NUM
dpc-5733	76	8	-	-	SYM
dpc-5733	76	9	2.41	2.41	NUM
dpc-5733	76	10	)	)	PUNCT
dpc-5733	76	11	2.15	2.15	NUM
dpc-5733	76	12	(	(	PUNCT
dpc-5733	76	13	1.7	1.7	NUM
dpc-5733	76	14	-	-	SYM
dpc-5733	76	15	2.39	2.39	NUM
dpc-5733	76	16	)	)	PUNCT
dpc-5733	76	17	2.14	2.14	NUM
dpc-5733	76	18	(	(	PUNCT
dpc-5733	76	19	1.73	1.73	NUM
dpc-5733	76	20	-	-	SYM
dpc-5733	76	21	2.36	2.36	NUM
dpc-5733	76	22	)	)	PUNCT
dpc-5733	76	23	2.15	2.15	NUM
dpc-5733	76	24	(	(	PUNCT
dpc-5733	76	25	1.76	1.76	NUM
dpc-5733	76	26	-	-	SYM
dpc-5733	76	27	2.34	2.34	NUM
dpc-5733	76	28	)	)	PUNCT
dpc-5733	76	29	0.9821	0.9821	NUM
dpc-5733	76	30	°	°	NOUN
dpc-5733	77	1	0.6090@	0.6090@	NOUN
dpc-5733	77	2	monocytes	monocyte	VERB
dpc-5733	77	3	mmc/103	mmc/103	NOUN
dpc-5733	77	4	0.58	0.58	NUM
dpc-5733	77	5	(	(	PUNCT
dpc-5733	77	6	0.39	0.39	NUM
dpc-5733	77	7	-	-	SYM
dpc-5733	77	8	0.86	0.86	NUM
dpc-5733	77	9	)	)	PUNCT
dpc-5733	77	10	0.58	0.58	NUM
dpc-5733	77	11	(	(	PUNCT
dpc-5733	77	12	0.41	0.41	NUM
dpc-5733	77	13	-	-	PUNCT
dpc-5733	77	14	0.85	0.85	NUM
dpc-5733	77	15	)	)	PUNCT
dpc-5733	77	16	0.56	0.56	NUM
dpc-5733	77	17	(	(	PUNCT
dpc-5733	77	18	0.39	0.39	NUM
dpc-5733	77	19	-	-	SYM
dpc-5733	77	20	0.8	0.8	NUM
dpc-5733	77	21	)	)	PUNCT
dpc-5733	77	22	0.57	0.57	NUM
dpc-5733	77	23	(	(	PUNCT
dpc-5733	77	24	0.4	0.4	NUM
dpc-5733	77	25	-	-	SYM
dpc-5733	77	26	0.77	0.77	NUM
dpc-5733	77	27	)	)	PUNCT
dpc-5733	77	28	0.4397	0.4397	NUM
dpc-5733	77	29	°	°	NOUN
dpc-5733	77	30	0.1156@	0.1156@	ADP
dpc-5733	77	31	eosinophils	eosinophil	NOUN
dpc-5733	77	32	mmc/103	mmc/103	NOUN
dpc-5733	77	33	0.23	0.23	NUM
dpc-5733	77	34	*	*	SYM
dpc-5733	77	35	*	*	PUNCT
dpc-5733	77	36	(	(	PUNCT
dpc-5733	77	37	0.16	0.16	NUM
dpc-5733	77	38	-	-	SYM
dpc-5733	77	39	0.41	0.41	NUM
dpc-5733	77	40	)	)	PUNCT
dpc-5733	77	41	0.27	0.27	NUM
dpc-5733	77	42	*	*	PUNCT
dpc-5733	78	1	*	*	PUNCT
dpc-5733	79	1	(	(	PUNCT
dpc-5733	79	2	0.18	0.18	NUM
dpc-5733	79	3	-	-	SYM
dpc-5733	79	4	0.45	0.45	NUM
dpc-5733	79	5	)	)	PUNCT
dpc-5733	79	6	0.24	0.24	NUM
dpc-5733	79	7	*	*	PUNCT
dpc-5733	79	8	(	(	PUNCT
dpc-5733	79	9	0.15	0.15	NUM
dpc-5733	79	10	-	-	SYM
dpc-5733	79	11	0.35	0.35	NUM
dpc-5733	79	12	)	)	PUNCT
dpc-5733	79	13	0.24	0.24	NUM
dpc-5733	79	14	*	*	PUNCT
dpc-5733	79	15	(	(	PUNCT
dpc-5733	79	16	0.15	0.15	NUM
dpc-5733	79	17	-	-	PUNCT
dpc-5733	79	18	0.34	0.34	NUM
dpc-5733	79	19	)	)	PUNCT
dpc-5733	79	20	0.3751	0.3751	NUM
dpc-5733	79	21	°	°	NOUN
dpc-5733	79	22	0.0007@	0.0007@	NOUN
dpc-5733	79	23	*	*	PUNCT
dpc-5733	79	24	t0	t0	PROPN
dpc-5733	79	25	-	-	PUNCT
dpc-5733	79	26	w12,**w12w24nd	w12,**w12w24nd	PROPN
dpc-5733	79	27	52	52	NUM
dpc-5733	79	28	basophils	basophil	NOUN
dpc-5733	79	29	mmc/103	mmc/103	NOUN
dpc-5733	79	30	0.07	0.07	NUM
dpc-5733	79	31	(	(	PUNCT
dpc-5733	79	32	0.03	0.03	NUM
dpc-5733	79	33	-	-	SYM
dpc-5733	79	34	0.11	0.11	NUM
dpc-5733	79	35	)	)	PUNCT
dpc-5733	79	36	0.08	0.08	NUM
dpc-5733	79	37	*	*	SYM
dpc-5733	79	38	(	(	PUNCT
dpc-5733	79	39	0.04	0.04	NUM
dpc-5733	79	40	-	-	SYM
dpc-5733	79	41	0.14	0.14	NUM
dpc-5733	79	42	)	)	PUNCT
dpc-5733	79	43	0.08	0.08	NUM
dpc-5733	79	44	*	*	SYM
dpc-5733	79	45	(	(	PUNCT
dpc-5733	79	46	0.04	0.04	NUM
dpc-5733	79	47	-	-	SYM
dpc-5733	79	48	0.13	0.13	NUM
dpc-5733	79	49	)	)	PUNCT
dpc-5733	79	50	0.08	0.08	NUM
dpc-5733	79	51	*	*	SYM
dpc-5733	79	52	(	(	PUNCT
dpc-5733	79	53	0.04	0.04	NUM
dpc-5733	79	54	-	-	SYM
dpc-5733	79	55	0.14	0.14	NUM
dpc-5733	79	56	)	)	PUNCT
dpc-5733	79	57	0.0439	0.0439	NUM
dpc-5733	79	58	°	°	NOUN
dpc-5733	79	59	0.0008@*w12	0.0008@*w12	NOUN
dpc-5733	79	60	-	-	PUNCT
dpc-5733	79	61	24	24	NUM
dpc-5733	79	62	;	;	PUNCT
dpc-5733	79	63	*	*	PUNCT
dpc-5733	79	64	w24	w24	NUM
dpc-5733	79	65	-	-	PUNCT
dpc-5733	79	66	52	52	NUM
dpc-5733	79	67	esr	esr	PROPN
dpc-5733	79	68	mm	mm	PROPN
dpc-5733	79	69	/	/	SYM
dpc-5733	79	70	h	h	NOUN
dpc-5733	79	71	27.0	27.0	NUM
dpc-5733	79	72	*	*	PUNCT
dpc-5733	79	73	*	*	PUNCT
dpc-5733	79	74	*	*	PUNCT
dpc-5733	79	75	*	*	PUNCT
dpc-5733	79	76	(	(	PUNCT
dpc-5733	79	77	15.25	15.25	NUM
dpc-5733	79	78	-	-	SYM
dpc-5733	79	79	38	38	NUM
dpc-5733	79	80	)	)	PUNCT
dpc-5733	79	81	22	22	NUM
dpc-5733	79	82	(	(	PUNCT
dpc-5733	79	83	13.25	13.25	NUM
dpc-5733	79	84	-	-	SYM
dpc-5733	79	85	29.75	29.75	NUM
dpc-5733	79	86	)	)	PUNCT
dpc-5733	79	87	25	25	NUM
dpc-5733	79	88	*	*	PUNCT
dpc-5733	79	89	(	(	PUNCT
dpc-5733	79	90	13.25	13.25	NUM
dpc-5733	79	91	-	-	SYM
dpc-5733	79	92	29	29	NUM
dpc-5733	79	93	)	)	PUNCT
dpc-5733	79	94	19	19	NUM
dpc-5733	79	95	*	*	PUNCT
dpc-5733	79	96	*	*	PUNCT
dpc-5733	79	97	*	*	PUNCT
dpc-5733	79	98	*	*	PUNCT
dpc-5733	79	99	,	,	PUNCT
dpc-5733	79	100	*	*	PUNCT
dpc-5733	79	101	(	(	PUNCT
dpc-5733	79	102	13	13	NUM
dpc-5733	79	103	-	-	SYM
dpc-5733	79	104	23	23	NUM
dpc-5733	79	105	)	)	PUNCT
dpc-5733	79	106	<	<	X
dpc-5733	79	107	0.0001	0.0001	NUM
dpc-5733	79	108	°	°	NOUN
dpc-5733	79	109	<	<	X
dpc-5733	79	110	0.0001@	0.0001@	NOUN
dpc-5733	79	111	*	*	PUNCT
dpc-5733	79	112	*	*	PUNCT
dpc-5733	79	113	*	*	PUNCT
dpc-5733	79	114	*	*	PUNCT
dpc-5733	79	115	t0	t0	NOUN
dpc-5733	79	116	-	-	NOUN
dpc-5733	79	117	w52	w52	NOUN
dpc-5733	79	118	;	;	PUNCT
dpc-5733	79	119	*	*	PUNCT
dpc-5733	79	120	w24	w24	NUM
dpc-5733	79	121	-	-	PUNCT
dpc-5733	79	122	w52	w52	PROPN
dpc-5733	79	123	crp	crp	PROPN
dpc-5733	79	124	mg	mg	PROPN
dpc-5733	79	125	/	/	SYM
dpc-5733	79	126	dl	dl	PROPN
dpc-5733	79	127	0.47	0.47	NUM
dpc-5733	79	128	*	*	PUNCT
dpc-5733	79	129	*	*	PUNCT
dpc-5733	79	130	*	*	PUNCT
dpc-5733	79	131	,	,	PUNCT
dpc-5733	79	132	*	*	PUNCT
dpc-5733	79	133	*	*	PUNCT
dpc-5733	79	134	*	*	PUNCT
dpc-5733	79	135	*	*	PUNCT
dpc-5733	79	136	(	(	PUNCT
dpc-5733	79	137	0.34	0.34	NUM
dpc-5733	79	138	-	-	PUNCT
dpc-5733	79	139	0.53	0.53	NUM
dpc-5733	79	140	)	)	PUNCT
dpc-5733	79	141	0.36	0.36	NUM
dpc-5733	79	142	*	*	PUNCT
dpc-5733	79	143	*	*	PUNCT
dpc-5733	79	144	*	*	PUNCT
dpc-5733	79	145	,	,	PUNCT
dpc-5733	79	146	*	*	PUNCT
dpc-5733	79	147	*	*	PUNCT
dpc-5733	79	148	(	(	PUNCT
dpc-5733	79	149	0.27	0.27	NUM
dpc-5733	79	150	-	-	SYM
dpc-5733	79	151	0.45	0.45	NUM
dpc-5733	79	152	)	)	PUNCT
dpc-5733	79	153	0.31	0.31	NUM
dpc-5733	79	154	*	*	PUNCT
dpc-5733	79	155	*	*	PUNCT
dpc-5733	79	156	*	*	PUNCT
dpc-5733	79	157	*	*	PUNCT
dpc-5733	79	158	,	,	PUNCT
dpc-5733	79	159	*	*	PUNCT
dpc-5733	79	160	*	*	PUNCT
dpc-5733	79	161	(	(	PUNCT
dpc-5733	79	162	0.21	0.21	NUM
dpc-5733	79	163	-	-	SYM
dpc-5733	79	164	0.39	0.39	NUM
dpc-5733	79	165	)	)	PUNCT
dpc-5733	79	166	0.26	0.26	NUM
dpc-5733	79	167	*	*	PUNCT
dpc-5733	79	168	*	*	PUNCT
dpc-5733	79	169	*	*	PUNCT
dpc-5733	79	170	*	*	PUNCT
dpc-5733	79	171	,	,	PUNCT
dpc-5733	79	172	*	*	PUNCT
dpc-5733	79	173	*	*	PUNCT
dpc-5733	79	174	*	*	PUNCT
dpc-5733	79	175	(	(	PUNCT
dpc-5733	79	176	0.2	0.2	NUM
dpc-5733	79	177	-	-	PUNCT
dpc-5733	79	178	0.33	0.33	NUM
dpc-5733	79	179	)	)	PUNCT
dpc-5733	79	180	<	<	X
dpc-5733	79	181	0.0001	0.0001	NUM
dpc-5733	79	182	°	°	NOUN
dpc-5733	79	183	<	<	X
dpc-5733	79	184	0.0001@	0.0001@	NOUN
dpc-5733	79	185	*	*	NOUN
dpc-5733	79	186	*	*	PUNCT
dpc-5733	79	187	*	*	PUNCT
dpc-5733	79	188	t0w12	t0w12	NOUN
dpc-5733	79	189	,	,	PUNCT
dpc-5733	79	190	w12	w12	NOUN
dpc-5733	79	191	-	-	PUNCT
dpc-5733	79	192	w52	w52	NOUN
dpc-5733	79	193	,	,	PUNCT
dpc-5733	79	194	*	*	PUNCT
dpc-5733	79	195	*	*	NOUN
dpc-5733	79	196	w12	w12	PROPN
dpc-5733	79	197	-	-	PUNCT
dpc-5733	79	198	w24	w24	PROPN
dpc-5733	79	199	,	,	PUNCT
dpc-5733	79	200	*	*	PUNCT
dpc-5733	79	201	*	*	PUNCT
dpc-5733	79	202	*	*	PUNCT
dpc-5733	79	203	*	*	PUNCT
dpc-5733	79	204	t0	t0	PROPN
dpc-5733	79	205	-	-	PUNCT
dpc-5733	79	206	w24	w24	PROPN
dpc-5733	79	207	and	and	CCONJ
dpc-5733	79	208	52	52	NUM
dpc-5733	79	209	nlr	nlr	PROPN
dpc-5733	79	210	2.44	2.44	NUM
dpc-5733	79	211	(	(	PUNCT
dpc-5733	79	212	1.81	1.81	NUM
dpc-5733	79	213	-	-	SYM
dpc-5733	79	214	3.18	3.18	NUM
dpc-5733	79	215	)	)	PUNCT
dpc-5733	79	216	2.42	2.42	NUM
dpc-5733	79	217	(	(	PUNCT
dpc-5733	79	218	1.79	1.79	NUM
dpc-5733	79	219	-	-	SYM
dpc-5733	79	220	2.82	2.82	NUM
dpc-5733	79	221	)	)	PUNCT
dpc-5733	79	222	2.35	2.35	NUM
dpc-5733	79	223	(	(	PUNCT
dpc-5733	79	224	1.74	1.74	NUM
dpc-5733	79	225	-	-	NUM
dpc-5733	79	226	2.89	2.89	NUM
dpc-5733	79	227	)	)	PUNCT
dpc-5733	79	228	2.31	2.31	NUM
dpc-5733	79	229	(	(	PUNCT
dpc-5733	79	230	1.79	1.79	NUM
dpc-5733	79	231	-	-	SYM
dpc-5733	79	232	2.67	2.67	NUM
dpc-5733	79	233	)	)	PUNCT
dpc-5733	79	234	0.0063	0.0063	NUM
dpc-5733	79	235	°	°	NOUN
dpc-5733	79	236	0.2394@	0.2394@	ADJ
dpc-5733	79	237	plr	plr	NOUN
dpc-5733	79	238	123.2	123.2	NUM
dpc-5733	79	239	(	(	PUNCT
dpc-5733	79	240	100.9	100.9	NUM
dpc-5733	79	241	-	-	SYM
dpc-5733	79	242	61.6	61.6	NUM
dpc-5733	79	243	)	)	PUNCT
dpc-5733	79	244	129.5	129.5	NUM
dpc-5733	79	245	(	(	PUNCT
dpc-5733	79	246	101.-162.3	101.-162.3	NUM
dpc-5733	79	247	)	)	PUNCT
dpc-5733	79	248	127.8	127.8	NUM
dpc-5733	79	249	(	(	PUNCT
dpc-5733	79	250	102.6	102.6	NUM
dpc-5733	79	251	-	-	SYM
dpc-5733	79	252	61.4	61.4	NUM
dpc-5733	79	253	)	)	PUNCT
dpc-5733	79	254	126.3	126.3	NUM
dpc-5733	79	255	(	(	PUNCT
dpc-5733	79	256	100	100	NUM
dpc-5733	79	257	-	-	SYM
dpc-5733	79	258	159.6	159.6	NUM
dpc-5733	79	259	)	)	PUNCT
dpc-5733	79	260	0.3840	0.3840	NUM
dpc-5733	79	261	°	°	PART
dpc-5733	79	262	0.4252@	0.4252@	NOUN
dpc-5733	79	263	mlr	mlr	NOUN
dpc-5733	79	264	0.29	0.29	NUM
dpc-5733	79	265	(	(	PUNCT
dpc-5733	79	266	0.196	0.196	NUM
dpc-5733	79	267	-	-	SYM
dpc-5733	79	268	0.43	0.43	NUM
dpc-5733	79	269	)	)	PUNCT
dpc-5733	79	270	0.29	0.29	NUM
dpc-5733	79	271	(	(	PUNCT
dpc-5733	79	272	0.21	0.21	NUM
dpc-5733	79	273	-	-	SYM
dpc-5733	79	274	0.41	0.41	NUM
dpc-5733	79	275	)	)	PUNCT
dpc-5733	79	276	0.28	0.28	NUM
dpc-5733	79	277	(	(	PUNCT
dpc-5733	79	278	0.19	0.19	NUM
dpc-5733	79	279	-	-	SYM
dpc-5733	79	280	0.38	0.38	NUM
dpc-5733	79	281	)	)	PUNCT
dpc-5733	79	282	0.27	0.27	NUM
dpc-5733	79	283	(	(	PUNCT
dpc-5733	79	284	0.2	0.2	NUM
dpc-5733	79	285	-	-	PUNCT
dpc-5733	79	286	0.38	0.38	NUM
dpc-5733	79	287	)	)	PUNCT
dpc-5733	79	288	0.4093	0.4093	NUM
dpc-5733	79	289	°	°	PART
dpc-5733	79	290	0.6665@	0.6665@	VERB
dpc-5733	79	291	piv	piv	NOUN
dpc-5733	79	292	340.9	340.9	NUM
dpc-5733	79	293	(	(	PUNCT
dpc-5733	79	294	175	175	NUM
dpc-5733	79	295	-	-	SYM
dpc-5733	79	296	710.5	710.5	NUM
dpc-5733	79	297	)	)	PUNCT
dpc-5733	79	298	325.6	325.6	NUM
dpc-5733	79	299	(	(	PUNCT
dpc-5733	79	300	175	175	NUM
dpc-5733	79	301	-	-	SYM
dpc-5733	79	302	568.1	568.1	NUM
dpc-5733	79	303	)	)	PUNCT
dpc-5733	79	304	329.7	329.7	NUM
dpc-5733	79	305	(	(	PUNCT
dpc-5733	79	306	179.4	179.4	NUM
dpc-5733	79	307	-	-	SYM
dpc-5733	79	308	497.5	497.5	NUM
dpc-5733	79	309	)	)	PUNCT
dpc-5733	79	310	274.9	274.9	NUM
dpc-5733	79	311	(	(	PUNCT
dpc-5733	79	312	178.2	178.2	NUM
dpc-5733	79	313	-	-	SYM
dpc-5733	79	314	439.5	439.5	NUM
dpc-5733	79	315	)	)	PUNCT
dpc-5733	79	316	0.0971	0.0971	NUM
dpc-5733	79	317	°	°	NUM
dpc-5733	79	318	0.0719@	0.0719@	NOUN
dpc-5733	79	319	sii	sii	NOUN
dpc-5733	79	320	626.2	626.2	NUM
dpc-5733	79	321	(	(	PUNCT
dpc-5733	79	322	447.3	447.3	NUM
dpc-5733	79	323	-	-	SYM
dpc-5733	79	324	69.4	69.4	NUM
dpc-5733	79	325	)	)	PUNCT
dpc-5733	79	326	592.7	592.7	NUM
dpc-5733	79	327	(	(	PUNCT
dpc-5733	79	328	390.0	390.0	NUM
dpc-5733	79	329	-	-	SYM
dpc-5733	79	330	804.2	804.2	NUM
dpc-5733	79	331	)	)	PUNCT
dpc-5733	79	332	603.1	603.1	NUM
dpc-5733	79	333	(	(	PUNCT
dpc-5733	79	334	444.3	444.3	NUM
dpc-5733	79	335	-	-	SYM
dpc-5733	79	336	823.7	823.7	NUM
dpc-5733	79	337	)	)	PUNCT
dpc-5733	79	338	578.2	578.2	NUM
dpc-5733	79	339	(	(	PUNCT
dpc-5733	79	340	392.3	392.3	NUM
dpc-5733	79	341	-	-	SYM
dpc-5733	79	342	822.4	822.4	NUM
dpc-5733	79	343	)	)	PUNCT
dpc-5733	79	344	0.038	0.038	NUM
dpc-5733	79	345	°	°	PROPN
dpc-5733	80	1	0.0889@	0.0889@	PROPN
dpc-5733	80	2	siri	siri	NOUN
dpc-5733	80	3	1.35	1.35	NUM
dpc-5733	80	4	(	(	PUNCT
dpc-5733	80	5	0.75	0.75	NUM
dpc-5733	80	6	-	-	SYM
dpc-5733	80	7	2.28	2.28	NUM
dpc-5733	80	8	)	)	PUNCT
dpc-5733	80	9	1.26	1.26	NUM
dpc-5733	80	10	(	(	PUNCT
dpc-5733	80	11	0.84	0.84	NUM
dpc-5733	80	12	-	-	SYM
dpc-5733	80	13	2.3	2.3	NUM
dpc-5733	80	14	)	)	PUNCT
dpc-5733	80	15	1.15	1.15	NUM
dpc-5733	80	16	(	(	PUNCT
dpc-5733	80	17	0.74	0.74	NUM
dpc-5733	80	18	-	-	SYM
dpc-5733	80	19	2	2	NUM
dpc-5733	80	20	)	)	PUNCT
dpc-5733	80	21	1.13	1.13	NUM
dpc-5733	80	22	(	(	PUNCT
dpc-5733	80	23	0.80	0.80	NUM
dpc-5733	80	24	-	-	SYM
dpc-5733	80	25	1.74	1.74	NUM
dpc-5733	80	26	)	)	PUNCT
dpc-5733	80	27	0.0698	0.0698	NUM
dpc-5733	80	28	°	°	NOUN
dpc-5733	80	29	0.3421@	0.3421@	PROPN
dpc-5733	80	30	results	result	NOUN
dpc-5733	80	31	are	be	AUX
dpc-5733	80	32	shown	show	VERB
dpc-5733	80	33	as	as	ADP
dpc-5733	80	34	median	median	NOUN
dpc-5733	80	35	with	with	ADP
dpc-5733	80	36	iqr	iqr	PROPN
dpc-5733	80	37	;	;	PUNCT
dpc-5733	80	38	°	°	PRON
dpc-5733	80	39	wilcoxon	wilcoxon	VERB
dpc-5733	80	40	matched	match	VERB
dpc-5733	80	41	-	-	PUNCT
dpc-5733	80	42	pairs	pair	NOUN
dpc-5733	80	43	signed	sign	VERB
dpc-5733	80	44	rank	rank	NOUN
dpc-5733	80	45	test	test	NOUN
dpc-5733	80	46	;	;	PUNCT
dpc-5733	80	47	@	@	NUM
dpc-5733	80	48	anova	anova	PROPN
dpc-5733	80	49	matched	match	VERB
dpc-5733	80	50	friedman	friedman	PROPN
dpc-5733	80	51	test	test	NOUN
dpc-5733	80	52	with	with	ADP
dpc-5733	80	53	dunn	dunn	PROPN
dpc-5733	80	54	’s	’s	PART
dpc-5733	80	55	post	post	NOUN
dpc-5733	80	56	-	-	NOUN
dpc-5733	80	57	test	test	NOUN
dpc-5733	80	58	.	.	PUNCT
dpc-5733	81	1	however	however	ADV
dpc-5733	81	2	,	,	PUNCT
dpc-5733	81	3	neither	neither	DET
dpc-5733	81	4	disease	disease	NOUN
dpc-5733	81	5	severity	severity	NOUN
dpc-5733	81	6	measured	measure	VERB
dpc-5733	81	7	as	as	ADP
dpc-5733	81	8	pasi	pasi	NOUN
dpc-5733	81	9	score	score	NOUN
dpc-5733	81	10	nor	nor	CCONJ
dpc-5733	81	11	bmi	bmi	NOUN
dpc-5733	81	12	,	,	PUNCT
dpc-5733	81	13	age	age	NOUN
dpc-5733	81	14	,	,	PUNCT
dpc-5733	81	15	presence	presence	NOUN
dpc-5733	81	16	of	of	ADP
dpc-5733	81	17	psa	psa	NOUN
dpc-5733	81	18	,	,	PUNCT
dpc-5733	81	19	special	special	ADJ
dpc-5733	81	20	sites	site	NOUN
dpc-5733	81	21	involvement	involvement	NOUN
dpc-5733	81	22	,	,	PUNCT
dpc-5733	81	23	previous	previous	ADJ
dpc-5733	81	24	exposure	exposure	NOUN
dpc-5733	81	25	to	to	ADP
dpc-5733	81	26	biologics	biologic	NOUN
dpc-5733	81	27	,	,	PUNCT
dpc-5733	81	28	or	or	CCONJ
dpc-5733	81	29	concomitant	concomitant	ADJ
dpc-5733	81	30	comorbidities	comorbiditie	NOUN
dpc-5733	81	31	affected	affect	VERB
dpc-5733	81	32	results	result	NOUN
dpc-5733	81	33	in	in	ADP
dpc-5733	81	34	terms	term	NOUN
dpc-5733	81	35	of	of	ADP
dpc-5733	81	36	median	median	ADJ
dpc-5733	81	37	values	value	NOUN
dpc-5733	81	38	or	or	CCONJ
dpc-5733	81	39	correlation	correlation	NOUN
dpc-5733	81	40	to	to	ADP
dpc-5733	81	41	disease	disease	NOUN
dpc-5733	81	42	severity	severity	NOUN
dpc-5733	81	43	(	(	PUNCT
dpc-5733	81	44	correlation	correlation	NOUN
dpc-5733	81	45	matrix	matrix	NOUN
dpc-5733	81	46	,	,	PUNCT
dpc-5733	81	47	spearman	spearman	NOUN
dpc-5733	81	48	rank	rank	NOUN
dpc-5733	81	49	test	test	NOUN
dpc-5733	81	50	for	for	ADP
dpc-5733	81	51	each	each	DET
dpc-5733	81	52	marker	marker	NOUN
dpc-5733	81	53	and	and	CCONJ
dpc-5733	81	54	subgroup	subgroup	NOUN
dpc-5733	81	55	with	with	ADP
dpc-5733	81	56	p>0.05	p>0.05	PROPN
dpc-5733	81	57	,	,	PUNCT
dpc-5733	81	58	data	datum	NOUN
dpc-5733	81	59	not	not	PART
dpc-5733	81	60	shown	show	VERB
dpc-5733	81	61	)	)	PUNCT
dpc-5733	81	62	.	.	PUNCT
dpc-5733	82	1	esr	esr	PROPN
dpc-5733	82	2	positively	positively	ADV
dpc-5733	82	3	correlated	correlate	VERB
dpc-5733	82	4	with	with	ADP
dpc-5733	82	5	crp	crp	PROPN
dpc-5733	82	6	(	(	PUNCT
dpc-5733	82	7	p=0.006	p=0.006	X
dpc-5733	82	8	;	;	PUNCT
dpc-5733	82	9	r=0.29	r=0.29	NOUN
dpc-5733	82	10	)	)	PUNCT
dpc-5733	82	11	,	,	PUNCT
dpc-5733	82	12	and	and	CCONJ
dpc-5733	82	13	both	both	DET
dpc-5733	82	14	values	value	NOUN
dpc-5733	82	15	were	be	AUX
dpc-5733	82	16	positively	positively	ADV
dpc-5733	82	17	correlated	correlate	VERB
dpc-5733	82	18	to	to	ADP
dpc-5733	82	19	neutrophils	neutrophil	NOUN
dpc-5733	82	20	(	(	PUNCT
dpc-5733	82	21	esr	esr	PROPN
dpc-5733	82	22	p=0.004	p=0.004	PROPN
dpc-5733	82	23	,	,	PUNCT
dpc-5733	82	24	r=0.29	r=0.29	NOUN
dpc-5733	82	25	;	;	PUNCT
dpc-5733	82	26	crp	crp	PROPN
dpc-5733	82	27	p=0.001	p=0.001	PROPN
dpc-5733	82	28	,	,	PUNCT
dpc-5733	82	29	r=0.33	r=0.33	PROPN
dpc-5733	82	30	)	)	PUNCT
dpc-5733	82	31	,	,	PUNCT
dpc-5733	82	32	nlr	nlr	PROPN
dpc-5733	82	33	(	(	PUNCT
dpc-5733	82	34	esr	esr	PROPN
dpc-5733	82	35	p=0.001	p=0.001	PROPN
dpc-5733	82	36	,	,	PUNCT
dpc-5733	82	37	r=0.29	r=0.29	NOUN
dpc-5733	82	38	;	;	PUNCT
dpc-5733	82	39	crp	crp	PROPN
dpc-5733	82	40	p=0.001	p=0.001	PROPN
dpc-5733	82	41	,	,	PUNCT
dpc-5733	82	42	r=0.32	r=0.32	PROPN
dpc-5733	82	43	)	)	PUNCT
dpc-5733	82	44	,	,	PUNCT
dpc-5733	82	45	piv	piv	NOUN
dpc-5733	82	46	(	(	PUNCT
dpc-5733	82	47	esr	esr	PROPN
dpc-5733	82	48	p=0.002	p=0.002	PROPN
dpc-5733	82	49	,	,	PUNCT
dpc-5733	82	50	r=0.31	r=0.31	PROPN
dpc-5733	82	51	;	;	PUNCT
dpc-5733	82	52	crp	crp	PROPN
dpc-5733	82	53	p=0.005	p=0.005	PROPN
dpc-5733	82	54	,	,	PUNCT
dpc-5733	82	55	r=0.29	r=0.29	NOUN
dpc-5733	82	56	)	)	PUNCT
dpc-5733	82	57	,	,	PUNCT
dpc-5733	82	58	sii	sii	PROPN
dpc-5733	82	59	(	(	PUNCT
dpc-5733	82	60	esr	esr	PROPN
dpc-5733	82	61	p<0.001	p<0.001	PROPN
dpc-5733	82	62	,	,	PUNCT
dpc-5733	82	63	r=0.40	r=0.40	NOUN
dpc-5733	82	64	;	;	PUNCT
dpc-5733	82	65	crp	crp	PROPN
dpc-5733	82	66	p=0.001	p=0.001	PROPN
dpc-5733	82	67	,	,	PUNCT
dpc-5733	82	68	r=0.32	r=0.32	PROPN
dpc-5733	82	69	)	)	PUNCT
dpc-5733	82	70	,	,	PUNCT
dpc-5733	82	71	and	and	CCONJ
dpc-5733	82	72	siri	siri	NOUN
dpc-5733	82	73	(	(	PUNCT
dpc-5733	82	74	esr	esr	PROPN
dpc-5733	82	75	p=0.012	p=0.012	PROPN
dpc-5733	82	76	,	,	PUNCT
dpc-5733	82	77	r=0.252	r=0.252	NUM
dpc-5733	82	78	;	;	PUNCT
dpc-5733	82	79	crp	crp	PROPN
dpc-5733	82	80	original	original	ADJ
dpc-5733	82	81	article	article	NOUN
dpc-5733	82	82	|	|	ADV
dpc-5733	82	83	dermatol	dermatol	ADJ
dpc-5733	82	84	pract	pract	NOUN
dpc-5733	82	85	concept	concept	NOUN
dpc-5733	82	86	.	.	PUNCT
dpc-5733	83	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	83	2	5	5	NUM
dpc-5733	83	3	super	super	ADJ
dpc-5733	83	4	responders	responder	NOUN
dpc-5733	83	5	(	(	PUNCT
dpc-5733	83	6	sr	sr	PROPN
dpc-5733	83	7	)	)	PUNCT
dpc-5733	83	8	versus	versus	ADP
dpc-5733	83	9	late	late	ADJ
dpc-5733	83	10	responders	responder	NOUN
dpc-5733	83	11	(	(	PUNCT
dpc-5733	83	12	lr	lr	NOUN
dpc-5733	83	13	)	)	PUNCT
dpc-5733	83	14	overall	overall	ADJ
dpc-5733	83	15	,	,	PUNCT
dpc-5733	83	16	64	64	NUM
dpc-5733	83	17	patients	patient	NOUN
dpc-5733	83	18	were	be	AUX
dpc-5733	83	19	defined	define	VERB
dpc-5733	83	20	as	as	ADP
dpc-5733	83	21	sr	sr	PROPN
dpc-5733	83	22	(	(	PUNCT
dpc-5733	83	23	45	45	NUM
dpc-5733	83	24	m	m	PROPN
dpc-5733	83	25	,	,	PUNCT
dpc-5733	83	26	19	19	NUM
dpc-5733	83	27	f	f	NOUN
dpc-5733	83	28	)	)	PUNCT
dpc-5733	83	29	,	,	PUNCT
dpc-5733	83	30	while	while	SCONJ
dpc-5733	83	31	39	39	NUM
dpc-5733	83	32	(	(	PUNCT
dpc-5733	83	33	25	25	NUM
dpc-5733	83	34	m	m	PROPN
dpc-5733	83	35	,	,	PUNCT
dpc-5733	83	36	14	14	NUM
dpc-5733	83	37	f	f	X
dpc-5733	83	38	)	)	PUNCT
dpc-5733	83	39	patients	patient	NOUN
dpc-5733	83	40	were	be	AUX
dpc-5733	83	41	lr	lr	X
dpc-5733	83	42	(	(	PUNCT
dpc-5733	83	43	table	table	NOUN
dpc-5733	83	44	2	2	NUM
dpc-5733	83	45	)	)	PUNCT
dpc-5733	83	46	.	.	PUNCT
dpc-5733	84	1	baseline	baseline	PROPN
dpc-5733	84	2	median	median	ADJ
dpc-5733	84	3	differences	difference	NOUN
dpc-5733	84	4	were	be	AUX
dpc-5733	84	5	observed	observe	VERB
dpc-5733	84	6	only	only	ADV
dpc-5733	84	7	for	for	ADP
dpc-5733	84	8	neutrophils	neutrophil	NOUN
dpc-5733	84	9	levels	level	NOUN
dpc-5733	84	10	(	(	PUNCT
dpc-5733	84	11	sr	sr	PROPN
dpc-5733	84	12	:	:	PUNCT
dpc-5733	84	13	4.52	4.52	NUM
dpc-5733	84	14	;	;	PUNCT
dpc-5733	84	15	iqr	iqr	NOUN
dpc-5733	84	16	:	:	PUNCT
dpc-5733	84	17	3.96–5.69	3.96–5.69	NUM
dpc-5733	84	18	versus	versus	X
dpc-5733	84	19	lr	lr	NOUN
dpc-5733	84	20	:	:	PUNCT
dpc-5733	84	21	5.65	5.65	NUM
dpc-5733	84	22	;	;	PUNCT
dpc-5733	84	23	iqr	iqr	NOUN
dpc-5733	84	24	:	:	PUNCT
dpc-5733	84	25	4.01–6.35	4.01–6.35	NOUN
dpc-5733	84	26	;	;	PUNCT
dpc-5733	84	27	p=0.0482	p=0.0482	X
dpc-5733	84	28	)	)	PUNCT
dpc-5733	84	29	and	and	CCONJ
dpc-5733	84	30	bmi	bmi	PROPN
dpc-5733	84	31	(	(	PUNCT
dpc-5733	84	32	sr	sr	PROPN
dpc-5733	84	33	:	:	PUNCT
dpc-5733	84	34	26.09	26.09	NUM
dpc-5733	84	35	;	;	PUNCT
dpc-5733	84	36	iqr	iqr	NOUN
dpc-5733	84	37	:	:	PUNCT
dpc-5733	84	38	23.68–28.97	23.68–28.97	NUM
dpc-5733	84	39	versus	versus	ADP
dpc-5733	84	40	lr	lr	PROPN
dpc-5733	84	41	:	:	PUNCT
dpc-5733	84	42	27.77	27.77	NUM
dpc-5733	84	43	;	;	PUNCT
dpc-5733	84	44	iqr	iqr	NOUN
dpc-5733	84	45	:	:	PUNCT
dpc-5733	84	46	24.98–31.64	24.98–31.64	NUM
dpc-5733	84	47	;	;	PUNCT
dpc-5733	84	48	p=0.0497	p=0.0497	NOUN
dpc-5733	84	49	,	,	PUNCT
dpc-5733	84	50	which	which	PRON
dpc-5733	84	51	were	be	AUX
dpc-5733	84	52	higher	high	ADJ
dpc-5733	84	53	in	in	ADP
dpc-5733	84	54	lr	lr	NOUN
dpc-5733	84	55	patients	patient	NOUN
dpc-5733	84	56	.	.	PUNCT
dpc-5733	85	1	normal	normal	ADJ
dpc-5733	85	2	weight	weight	NOUN
dpc-5733	85	3	patients	patient	NOUN
dpc-5733	85	4	did	do	AUX
dpc-5733	85	5	not	not	PART
dpc-5733	85	6	display	display	VERB
dpc-5733	85	7	any	any	DET
dpc-5733	85	8	baseline	baseline	NOUN
dpc-5733	85	9	or	or	CCONJ
dpc-5733	85	10	over	over	ADP
dpc-5733	85	11	-	-	PUNCT
dpc-5733	85	12	time	time	NOUN
dpc-5733	85	13	difference	difference	NOUN
dpc-5733	85	14	in	in	ADP
dpc-5733	85	15	blood	blood	NOUN
dpc-5733	85	16	-	-	PUNCT
dpc-5733	85	17	derived	derive	VERB
dpc-5733	85	18	indices	index	NOUN
dpc-5733	85	19	compared	compare	VERB
dpc-5733	85	20	to	to	ADP
dpc-5733	85	21	patients	patient	NOUN
dpc-5733	85	22	with	with	ADP
dpc-5733	85	23	bmi	bmi	PROPN
dpc-5733	85	24	>	>	X
dpc-5733	85	25	25	25	NUM
dpc-5733	85	26	(	(	PUNCT
dpc-5733	85	27	data	datum	NOUN
dpc-5733	85	28	not	not	PART
dpc-5733	85	29	shown	show	VERB
dpc-5733	85	30	)	)	PUNCT
dpc-5733	85	31	.	.	PUNCT
dpc-5733	86	1	moreover	moreover	ADV
dpc-5733	86	2	,	,	PUNCT
dpc-5733	86	3	bmi	bmi	PROPN
dpc-5733	86	4	did	do	AUX
dpc-5733	86	5	not	not	PART
dpc-5733	86	6	impact	impact	VERB
dpc-5733	86	7	baseline	baseline	NOUN
dpc-5733	86	8	disease	disease	NOUN
dpc-5733	86	9	severity	severity	NOUN
dpc-5733	86	10	or	or	CCONJ
dpc-5733	86	11	the	the	DET
dpc-5733	86	12	overall	overall	ADJ
dpc-5733	86	13	response	response	NOUN
dpc-5733	86	14	to	to	PART
dpc-5733	86	15	risankizumab	risankizumab	VERB
dpc-5733	86	16	since	since	SCONJ
dpc-5733	86	17	all	all	DET
dpc-5733	86	18	the	the	DET
dpc-5733	86	19	patients	patient	NOUN
dpc-5733	86	20	reached	reach	VERB
dpc-5733	86	21	pasi	pasi	NOUN
dpc-5733	86	22	75	75	NUM
dpc-5733	86	23	at	at	ADP
dpc-5733	86	24	week	week	NOUN
dpc-5733	86	25	24	24	NUM
dpc-5733	86	26	,	,	PUNCT
dpc-5733	86	27	and	and	CCONJ
dpc-5733	86	28	no	no	DET
dpc-5733	86	29	difference	difference	NOUN
dpc-5733	86	30	in	in	ADP
dpc-5733	86	31	pasi	pasi	NOUN
dpc-5733	86	32	score	score	NOUN
dpc-5733	86	33	at	at	ADP
dpc-5733	86	34	week	week	NOUN
dpc-5733	86	35	52	52	NUM
dpc-5733	86	36	was	be	AUX
dpc-5733	86	37	found	find	VERB
dpc-5733	86	38	between	between	ADP
dpc-5733	86	39	lr	lr	PROPN
dpc-5733	86	40	and	and	CCONJ
dpc-5733	86	41	sr	sr	PROPN
dpc-5733	86	42	(	(	PUNCT
dpc-5733	86	43	figure	figure	NOUN
dpc-5733	86	44	2	2	NUM
dpc-5733	86	45	)	)	PUNCT
dpc-5733	86	46	.	.	PUNCT
dpc-5733	87	1	in	in	ADP
dpc-5733	87	2	lr	lr	NOUN
dpc-5733	87	3	patients	patient	NOUN
dpc-5733	87	4	,	,	PUNCT
dpc-5733	87	5	pasi	pasi	VERB
dpc-5733	87	6	score	score	NOUN
dpc-5733	87	7	inversely	inversely	ADV
dpc-5733	87	8	correlated	correlate	VERB
dpc-5733	87	9	to	to	ADP
dpc-5733	87	10	lymphocytes	lymphocytes	PROPN
dpc-5733	87	11	(	(	PUNCT
dpc-5733	87	12	p=0.02	p=0.02	NOUN
dpc-5733	87	13	;	;	PUNCT
dpc-5733	87	14	r=	r=	ADJ
dpc-5733	87	15	-0.372	-0.372	PUNCT
dpc-5733	87	16	)	)	PUNCT
dpc-5733	87	17	and	and	CCONJ
dpc-5733	87	18	directly	directly	ADV
dpc-5733	87	19	correlated	correlate	VERB
dpc-5733	87	20	to	to	ADP
dpc-5733	87	21	p=0.008	p=0.008	NOUN
dpc-5733	87	22	,	,	PUNCT
dpc-5733	87	23	r=0.27	r=0.27	PROPN
dpc-5733	87	24	)	)	PUNCT
dpc-5733	87	25	.	.	PUNCT
dpc-5733	88	1	esr	esr	PROPN
dpc-5733	88	2	was	be	AUX
dpc-5733	88	3	also	also	ADV
dpc-5733	88	4	related	relate	VERB
dpc-5733	88	5	to	to	ADP
dpc-5733	88	6	rbc	rbc	PROPN
dpc-5733	88	7	(	(	PUNCT
dpc-5733	88	8	p=0.001	p=0.001	PROPN
dpc-5733	88	9	,	,	PUNCT
dpc-5733	88	10	r=0.32	r=0.32	NOUN
dpc-5733	88	11	)	)	PUNCT
dpc-5733	88	12	,	,	PUNCT
dpc-5733	88	13	plt	plt	NOUN
dpc-5733	88	14	(	(	PUNCT
dpc-5733	88	15	p=0.009	p=0.009	NOUN
dpc-5733	88	16	,	,	PUNCT
dpc-5733	88	17	r=0.26	r=0.26	ADJ
dpc-5733	88	18	)	)	PUNCT
dpc-5733	88	19	,	,	PUNCT
dpc-5733	88	20	eosinophils	eosinophil	NOUN
dpc-5733	88	21	(	(	PUNCT
dpc-5733	88	22	p=0.004	p=0.004	NOUN
dpc-5733	88	23	,	,	PUNCT
dpc-5733	88	24	r=0.29	r=0.29	NOUN
dpc-5733	88	25	)	)	PUNCT
dpc-5733	88	26	,	,	PUNCT
dpc-5733	88	27	basophils	basophil	NOUN
dpc-5733	88	28	(	(	PUNCT
dpc-5733	88	29	p=0.013	p=0.013	NOUN
dpc-5733	88	30	,	,	PUNCT
dpc-5733	88	31	r=0.25	r=0.25	NOUN
dpc-5733	88	32	)	)	PUNCT
dpc-5733	88	33	,	,	PUNCT
dpc-5733	88	34	and	and	CCONJ
dpc-5733	88	35	plr	plr	NOUN
dpc-5733	88	36	(	(	PUNCT
dpc-5733	88	37	p=0.01	p=0.01	NOUN
dpc-5733	88	38	,	,	PUNCT
dpc-5733	88	39	r=0.26	r=0.26	ADJ
dpc-5733	88	40	)	)	PUNCT
dpc-5733	88	41	,	,	PUNCT
dpc-5733	88	42	with	with	ADP
dpc-5733	88	43	a	a	DET
dpc-5733	88	44	negative	negative	ADJ
dpc-5733	88	45	correlation	correlation	NOUN
dpc-5733	88	46	only	only	ADV
dpc-5733	88	47	with	with	ADP
dpc-5733	88	48	mpv	mpv	PROPN
dpc-5733	88	49	(	(	PUNCT
dpc-5733	88	50	p=0.012	p=0.012	PROPN
dpc-5733	88	51	,	,	PUNCT
dpc-5733	88	52	r=-0.28	r=-0.28	NOUN
dpc-5733	88	53	)	)	PUNCT
dpc-5733	88	54	.	.	PUNCT
dpc-5733	89	1	therapeutic	therapeutic	ADJ
dpc-5733	89	2	modulation	modulation	NOUN
dpc-5733	89	3	of	of	ADP
dpc-5733	89	4	whole	whole	ADJ
dpc-5733	89	5	blood	blood	NOUN
dpc-5733	89	6	cells	cell	NOUN
dpc-5733	89	7	and	and	CCONJ
dpc-5733	89	8	derived	derive	VERB
dpc-5733	89	9	indices	index	NOUN
dpc-5733	89	10	total	total	ADJ
dpc-5733	89	11	population	population	NOUN
dpc-5733	89	12	from	from	ADP
dpc-5733	89	13	t0	t0	PROPN
dpc-5733	89	14	to	to	ADP
dpc-5733	89	15	week	week	NOUN
dpc-5733	89	16	52	52	NUM
dpc-5733	89	17	,	,	PUNCT
dpc-5733	89	18	risankizumab	risankizumab	NOUN
dpc-5733	89	19	modulated	modulate	VERB
dpc-5733	89	20	different	different	ADJ
dpc-5733	89	21	parameters	parameter	NOUN
dpc-5733	89	22	,	,	PUNCT
dpc-5733	89	23	with	with	ADP
dpc-5733	89	24	an	an	DET
dpc-5733	89	25	increase	increase	NOUN
dpc-5733	89	26	in	in	ADP
dpc-5733	89	27	mpv	mpv	PROPN
dpc-5733	89	28	(	(	PUNCT
dpc-5733	89	29	p=0.0016	p=0.0016	PROPN
dpc-5733	89	30	)	)	PUNCT
dpc-5733	89	31	and	and	CCONJ
dpc-5733	89	32	basophils	basophils	PROPN
dpc-5733	89	33	(	(	PUNCT
dpc-5733	89	34	p=0.0439	p=0.0439	ADJ
dpc-5733	89	35	)	)	PUNCT
dpc-5733	89	36	and	and	CCONJ
dpc-5733	89	37	a	a	DET
dpc-5733	89	38	decrease	decrease	NOUN
dpc-5733	89	39	in	in	ADP
dpc-5733	89	40	neutrophils	neutrophil	NOUN
dpc-5733	89	41	(	(	PUNCT
dpc-5733	89	42	p=0.0364	p=0.0364	PROPN
dpc-5733	89	43	)	)	PUNCT
dpc-5733	89	44	,	,	PUNCT
dpc-5733	89	45	esr	esr	PROPN
dpc-5733	89	46	(	(	PUNCT
dpc-5733	89	47	p<0.0001	p<0.0001	NOUN
dpc-5733	89	48	)	)	PUNCT
dpc-5733	89	49	,	,	PUNCT
dpc-5733	89	50	crp	crp	PROPN
dpc-5733	89	51	(	(	PUNCT
dpc-5733	89	52	p<0.0001	p<0.0001	NOUN
dpc-5733	89	53	)	)	PUNCT
dpc-5733	89	54	,	,	PUNCT
dpc-5733	89	55	and	and	CCONJ
dpc-5733	89	56	sii	sii	PROPN
dpc-5733	89	57	(	(	PUNCT
dpc-5733	89	58	p=0.038	p=0.038	NOUN
dpc-5733	89	59	)	)	PUNCT
dpc-5733	89	60	(	(	PUNCT
dpc-5733	89	61	table	table	NOUN
dpc-5733	89	62	1	1	NUM
dpc-5733	89	63	)	)	PUNCT
dpc-5733	89	64	.	.	PUNCT
dpc-5733	90	1	a	a	DET
dpc-5733	90	2	dynamic	dynamic	ADJ
dpc-5733	90	3	increase	increase	NOUN
dpc-5733	90	4	in	in	ADP
dpc-5733	90	5	mpv	mpv	PROPN
dpc-5733	90	6	and	and	CCONJ
dpc-5733	90	7	basophils	basophils	PROPN
dpc-5733	90	8	and	and	CCONJ
dpc-5733	90	9	a	a	DET
dpc-5733	90	10	transient	transient	ADJ
dpc-5733	90	11	increase	increase	NOUN
dpc-5733	90	12	in	in	ADP
dpc-5733	90	13	eosinophils	eosinophil	NOUN
dpc-5733	90	14	were	be	AUX
dpc-5733	90	15	detected	detect	VERB
dpc-5733	90	16	(	(	PUNCT
dpc-5733	90	17	table	table	NOUN
dpc-5733	90	18	1	1	NUM
dpc-5733	90	19	)	)	PUNCT
dpc-5733	90	20	.	.	PUNCT
dpc-5733	91	1	a	a	DET
dpc-5733	91	2	positive	positive	ADJ
dpc-5733	91	3	correlation	correlation	NOUN
dpc-5733	91	4	was	be	AUX
dpc-5733	91	5	found	find	VERB
dpc-5733	91	6	between	between	ADP
dpc-5733	91	7	changes	change	NOUN
dpc-5733	91	8	in	in	ADP
dpc-5733	91	9	pasi	pasi	NOUN
dpc-5733	91	10	and	and	CCONJ
dpc-5733	91	11	nlr	nlr	PROPN
dpc-5733	91	12	(	(	PUNCT
dpc-5733	91	13	δpasi	δpasi	NOUN
dpc-5733	91	14	versus	versus	ADP
dpc-5733	91	15	δnlr	δnlr	PROPN
dpc-5733	91	16	,	,	PUNCT
dpc-5733	91	17	from	from	ADP
dpc-5733	91	18	t0	t0	PROPN
dpc-5733	91	19	to	to	ADP
dpc-5733	91	20	week	week	NOUN
dpc-5733	91	21	52	52	NUM
dpc-5733	91	22	;	;	PUNCT
dpc-5733	91	23	p=0.02	p=0.02	NOUN
dpc-5733	91	24	,	,	PUNCT
dpc-5733	91	25	r=0.23	r=0.23	NOUN
dpc-5733	91	26	)	)	PUNCT
dpc-5733	91	27	.	.	PUNCT
dpc-5733	92	1	table	table	NOUN
dpc-5733	92	2	2	2	NUM
dpc-5733	92	3	.	.	PUNCT
dpc-5733	92	4	baseline	baseline	PROPN
dpc-5733	92	5	demographic	demographic	ADJ
dpc-5733	92	6	,	,	PUNCT
dpc-5733	92	7	clinical	clinical	ADJ
dpc-5733	92	8	,	,	PUNCT
dpc-5733	92	9	and	and	CCONJ
dpc-5733	92	10	hematologic	hematologic	NOUN
dpc-5733	92	11	features	feature	NOUN
dpc-5733	92	12	in	in	ADP
dpc-5733	92	13	sr	sr	PROPN
dpc-5733	92	14	versus	versus	ADP
dpc-5733	92	15	lr	lr	NOUN
dpc-5733	92	16	patients	patient	NOUN
dpc-5733	92	17	.	.	PUNCT
dpc-5733	93	1	sr	sr	PROPN
dpc-5733	93	2	n=64	n=64	PROPN
dpc-5733	93	3	lr	lr	VERB
dpc-5733	93	4	n=39	n=39	ADP
dpc-5733	93	5	p	p	NOUN
dpc-5733	93	6	sex	sex	NOUN
dpc-5733	93	7	(	(	PUNCT
dpc-5733	93	8	male	male	NOUN
dpc-5733	93	9	,	,	PUNCT
dpc-5733	93	10	n	n	CCONJ
dpc-5733	93	11	)	)	PUNCT
dpc-5733	93	12	45	45	NUM
dpc-5733	93	13	25	25	NUM
dpc-5733	93	14	0.5223§	0.5223§	NUM
dpc-5733	93	15	age	age	NOUN
dpc-5733	93	16	(	(	PUNCT
dpc-5733	93	17	years	year	NOUN
dpc-5733	93	18	)	)	PUNCT
dpc-5733	93	19	median	median	NOUN
dpc-5733	93	20	(	(	PUNCT
dpc-5733	93	21	iqr	iqr	NOUN
dpc-5733	93	22	)	)	PUNCT
dpc-5733	93	23	52	52	NUM
dpc-5733	93	24	(	(	PUNCT
dpc-5733	93	25	42.5	42.5	NUM
dpc-5733	93	26	-	-	SYM
dpc-5733	93	27	63.75	63.75	NUM
dpc-5733	93	28	)	)	PUNCT
dpc-5733	93	29	57	57	NUM
dpc-5733	93	30	(	(	PUNCT
dpc-5733	93	31	49	49	NUM
dpc-5733	93	32	-	-	SYM
dpc-5733	93	33	71	71	NUM
dpc-5733	93	34	)	)	PUNCT
dpc-5733	93	35	0.1038	0.1038	NUM
dpc-5733	93	36	*	*	SYM
dpc-5733	93	37	bmi	bmi	PROPN
dpc-5733	93	38	median	median	PROPN
dpc-5733	93	39	(	(	PUNCT
dpc-5733	93	40	iqr	iqr	PROPN
dpc-5733	93	41	)	)	PUNCT
dpc-5733	93	42	26.09	26.09	NUM
dpc-5733	93	43	(	(	PUNCT
dpc-5733	93	44	23.68	23.68	NUM
dpc-5733	93	45	-	-	SYM
dpc-5733	93	46	28.97	28.97	NUM
dpc-5733	93	47	)	)	PUNCT
dpc-5733	93	48	27.77	27.77	NUM
dpc-5733	93	49	(	(	PUNCT
dpc-5733	93	50	24.98	24.98	NUM
dpc-5733	93	51	-	-	SYM
dpc-5733	93	52	31.64	31.64	NUM
dpc-5733	93	53	)	)	PUNCT
dpc-5733	94	1	0.0497	0.0497	NUM
dpc-5733	94	2	*	*	PUNCT
dpc-5733	94	3	pasi	pasi	PROPN
dpc-5733	94	4	median	median	PROPN
dpc-5733	94	5	(	(	PUNCT
dpc-5733	94	6	iqr	iqr	PROPN
dpc-5733	94	7	)	)	PUNCT
dpc-5733	94	8	14	14	NUM
dpc-5733	94	9	(	(	PUNCT
dpc-5733	94	10	10.8	10.8	NUM
dpc-5733	94	11	-	-	SYM
dpc-5733	94	12	15.95	15.95	NUM
dpc-5733	94	13	)	)	PUNCT
dpc-5733	94	14	12.30	12.30	NUM
dpc-5733	94	15	(	(	PUNCT
dpc-5733	94	16	7	7	NUM
dpc-5733	94	17	-	-	SYM
dpc-5733	94	18	17.4	17.4	NUM
dpc-5733	94	19	)	)	PUNCT
dpc-5733	94	20	0.2925	0.2925	NUM
dpc-5733	94	21	*	*	PUNCT
dpc-5733	94	22	special	special	ADJ
dpc-5733	94	23	sites	site	NOUN
dpc-5733	94	24	involvement	involvement	NOUN
dpc-5733	94	25	,	,	PUNCT
dpc-5733	94	26	n	n	PRON
dpc-5733	94	27	scalp	scalp	NOUN
dpc-5733	94	28	nail	nail	NOUN
dpc-5733	94	29	pp	pp	ADP
dpc-5733	94	30	genital	genital	ADJ
dpc-5733	94	31	face	face	NOUN
dpc-5733	94	32	37	37	NUM
dpc-5733	94	33	25	25	NUM
dpc-5733	94	34	16	16	NUM
dpc-5733	94	35	13	13	NUM
dpc-5733	94	36	3	3	NUM
dpc-5733	94	37	20	20	NUM
dpc-5733	94	38	12	12	NUM
dpc-5733	94	39	19	19	NUM
dpc-5733	94	40	13	13	NUM
dpc-5733	94	41	2	2	NUM
dpc-5733	94	42	>	>	PUNCT
dpc-5733	94	43	0.9999§	0.9999§	ADJ
dpc-5733	94	44	0.5257§	0.5257§	ADJ
dpc-5733	94	45	0.5457§	0.5457§	NUM
dpc-5733	94	46	0.1645§	0.1645§	NOUN
dpc-5733	94	47	0.7069§	0.7069§	ADJ
dpc-5733	94	48	psa	psa	NOUN
dpc-5733	94	49	,	,	PUNCT
dpc-5733	94	50	n	n	PRON
dpc-5733	94	51	11	11	NUM
dpc-5733	94	52	8	8	NUM
dpc-5733	94	53	0.7943§	0.7943§	NOUN
dpc-5733	94	54	comorbidities	comorbiditie	NOUN
dpc-5733	94	55	,	,	PUNCT
dpc-5733	94	56	n	n	PRON
dpc-5733	94	57	hpt	hpt	NOUN
dpc-5733	94	58	diabetes	diabetes	NOUN
dpc-5733	94	59	dyslipidemia	dyslipidemia	VERB
dpc-5733	94	60	39	39	NUM
dpc-5733	94	61	12	12	NUM
dpc-5733	94	62	4	4	NUM
dpc-5733	94	63	11	11	NUM
dpc-5733	94	64	27	27	NUM
dpc-5733	94	65	10	10	NUM
dpc-5733	94	66	5	5	NUM
dpc-5733	94	67	9	9	NUM
dpc-5733	94	68	0.5257§	0.5257§	NUM
dpc-5733	94	69	0.4686§	0.4686§	NOUN
dpc-5733	94	70	0.2937§	0.2937§	NOUN
dpc-5733	94	71	0.6083§	0.6083§	NOUN
dpc-5733	94	72	previous	previous	ADJ
dpc-5733	94	73	systemic	systemic	ADJ
dpc-5733	94	74	therapies	therapy	NOUN
dpc-5733	94	75	,	,	PUNCT
dpc-5733	94	76	n	n	DET
dpc-5733	94	77	cyclosporin	cyclosporin	NOUN
dpc-5733	94	78	a	a	DET
dpc-5733	94	79	methotrexate	methotrexate	NOUN
dpc-5733	94	80	uv	uv	NOUN
dpc-5733	94	81	(	(	PUNCT
dpc-5733	94	82	nbuvb	nbuvb	NOUN
dpc-5733	94	83	-	-	PUNCT
dpc-5733	94	84	puva	puva	NOUN
dpc-5733	94	85	)	)	PUNCT
dpc-5733	94	86	acitretin	acitretin	VERB
dpc-5733	94	87	43	43	NUM
dpc-5733	94	88	25	25	NUM
dpc-5733	94	89	29	29	NUM
dpc-5733	94	90	11	11	NUM
dpc-5733	94	91	26	26	NUM
dpc-5733	94	92	16	16	NUM
dpc-5733	94	93	15	15	NUM
dpc-5733	94	94	16	16	NUM
dpc-5733	94	95	>	>	PUNCT
dpc-5733	94	96	0.9999§	0.9999§	PUNCT
dpc-5733	94	97	>	>	PROPN
dpc-5733	94	98	0.9999§	0.9999§	ADJ
dpc-5733	94	99	0.5425§	0.5425§	NOUN
dpc-5733	94	100	0.0109§	0.0109§	NOUN
dpc-5733	94	101	number	number	NOUN
dpc-5733	94	102	of	of	ADP
dpc-5733	94	103	previous	previous	ADJ
dpc-5733	94	104	biologics	biologic	NOUN
dpc-5733	94	105	median	median	ADJ
dpc-5733	94	106	number	number	NOUN
dpc-5733	94	107	(	(	PUNCT
dpc-5733	94	108	iqr	iqr	NOUN
dpc-5733	94	109	)	)	PUNCT
dpc-5733	94	110	0	0	NUM
dpc-5733	95	1	(	(	PUNCT
dpc-5733	95	2	n	n	CCONJ
dpc-5733	95	3	)	)	PUNCT
dpc-5733	95	4	1	1	NUM
dpc-5733	95	5	(	(	PUNCT
dpc-5733	95	6	n	n	CCONJ
dpc-5733	95	7	)	)	PUNCT
dpc-5733	95	8	2	2	NUM
dpc-5733	95	9	(	(	PUNCT
dpc-5733	95	10	n	n	CCONJ
dpc-5733	95	11	)	)	PUNCT
dpc-5733	95	12	3	3	NUM
dpc-5733	95	13	(	(	PUNCT
dpc-5733	95	14	n	n	CCONJ
dpc-5733	95	15	)	)	PUNCT
dpc-5733	95	16	4	4	NUM
dpc-5733	95	17	(	(	PUNCT
dpc-5733	95	18	n	n	CCONJ
dpc-5733	95	19	)	)	PUNCT
dpc-5733	95	20	5	5	NUM
dpc-5733	95	21	(	(	PUNCT
dpc-5733	95	22	n	n	CCONJ
dpc-5733	95	23	)	)	PUNCT
dpc-5733	95	24	6	6	NUM
dpc-5733	95	25	(	(	PUNCT
dpc-5733	95	26	n	n	CCONJ
dpc-5733	95	27	)	)	PUNCT
dpc-5733	95	28	1	1	NUM
dpc-5733	95	29	(	(	PUNCT
dpc-5733	95	30	1	1	NUM
dpc-5733	95	31	-	-	SYM
dpc-5733	95	32	2	2	NUM
dpc-5733	95	33	)	)	PUNCT
dpc-5733	95	34	8	8	NUM
dpc-5733	95	35	26	26	NUM
dpc-5733	95	36	23	23	NUM
dpc-5733	95	37	4	4	NUM
dpc-5733	95	38	2	2	NUM
dpc-5733	95	39	0	0	NUM
dpc-5733	95	40	1	1	NUM
dpc-5733	95	41	2	2	NUM
dpc-5733	95	42	(	(	PUNCT
dpc-5733	95	43	1	1	NUM
dpc-5733	95	44	-	-	SYM
dpc-5733	95	45	2	2	NUM
dpc-5733	95	46	)	)	PUNCT
dpc-5733	95	47	8	8	NUM
dpc-5733	95	48	11	11	NUM
dpc-5733	95	49	11	11	NUM
dpc-5733	95	50	3	3	NUM
dpc-5733	95	51	4	4	NUM
dpc-5733	95	52	2	2	NUM
dpc-5733	95	53	0	0	NUM
dpc-5733	95	54	0.6390	0.6390	NUM
dpc-5733	95	55	*	*	PUNCT
dpc-5733	95	56	0.4006§	0.4006§	PROPN
dpc-5733	95	57	0.2898§	0.2898§	VERB
dpc-5733	96	1	0.5184§	0.5184§	NUM
dpc-5733	96	2	>	>	PUNCT
dpc-5733	96	3	0.9999§	0.9999§	VERB
dpc-5733	96	4	0.1965§	0.1965§	NUM
dpc-5733	96	5	--§fisher	--§fisher	DET
dpc-5733	96	6	exact	exact	ADJ
dpc-5733	96	7	test	test	NOUN
dpc-5733	96	8	*	*	PUNCT
dpc-5733	96	9	mann	mann	PROPN
dpc-5733	96	10	whitney	whitney	PROPN
dpc-5733	96	11	t	t	PROPN
dpc-5733	96	12	-	-	PUNCT
dpc-5733	96	13	test	test	NOUN
dpc-5733	96	14	,	,	PUNCT
dpc-5733	96	15	n	n	CCONJ
dpc-5733	96	16	=	=	SYM
dpc-5733	96	17	number	number	NOUN
dpc-5733	96	18	of	of	ADP
dpc-5733	96	19	patients	patient	NOUN
dpc-5733	96	20	6	6	NUM
dpc-5733	96	21	original	original	ADJ
dpc-5733	96	22	article	article	NOUN
dpc-5733	96	23	|	|	ADV
dpc-5733	96	24	dermatol	dermatol	ADJ
dpc-5733	96	25	pract	pract	NOUN
dpc-5733	96	26	concept	concept	NOUN
dpc-5733	96	27	.	.	PUNCT
dpc-5733	97	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	97	2	52	52	NUM
dpc-5733	97	3	:	:	PUNCT
dpc-5733	97	4	568.4	568.4	NUM
dpc-5733	97	5	;	;	PUNCT
dpc-5733	97	6	iqr	iqr	NOUN
dpc-5733	97	7	:	:	PUNCT
dpc-5733	97	8	388–815.5	388–815.5	NUM
dpc-5733	97	9	)	)	PUNCT
dpc-5733	97	10	;	;	PUNCT
dpc-5733	97	11	p=0.0477	p=0.0477	PROPN
dpc-5733	97	12	)	)	PUNCT
dpc-5733	97	13	,	,	PUNCT
dpc-5733	97	14	and	and	CCONJ
dpc-5733	97	15	siri	siri	NOUN
dpc-5733	97	16	(	(	PUNCT
dpc-5733	97	17	t0	t0	NOUN
dpc-5733	97	18	:	:	PUNCT
dpc-5733	97	19	1.32	1.32	NUM
dpc-5733	97	20	;	;	PUNCT
dpc-5733	97	21	iqr	iqr	NOUN
dpc-5733	97	22	:	:	PUNCT
dpc-5733	97	23	0.76–2.36	0.76–2.36	NUM
dpc-5733	97	24	versus	versus	ADP
dpc-5733	97	25	week	week	NOUN
dpc-5733	97	26	52	52	NUM
dpc-5733	97	27	:	:	SYM
dpc-5733	97	28	0.99	0.99	NUM
dpc-5733	97	29	;	;	PUNCT
dpc-5733	97	30	iqr	iqr	NOUN
dpc-5733	97	31	:	:	PUNCT
dpc-5733	97	32	0.76	0.76	NUM
dpc-5733	97	33	–	–	PUNCT
dpc-5733	97	34	1.62	1.62	NUM
dpc-5733	97	35	;	;	PUNCT
dpc-5733	97	36	p=0.0462	p=0.0462	PROPN
dpc-5733	97	37	)	)	PUNCT
dpc-5733	97	38	.	.	PUNCT
dpc-5733	98	1	piv	piv	NOUN
dpc-5733	98	2	slightly	slightly	ADV
dpc-5733	98	3	reduced	reduce	VERB
dpc-5733	98	4	over	over	ADP
dpc-5733	98	5	time	time	NOUN
dpc-5733	98	6	(	(	PUNCT
dpc-5733	98	7	t0	t0	NOUN
dpc-5733	98	8	:	:	PUNCT
dpc-5733	98	9	327.1	327.1	NUM
dpc-5733	98	10	;	;	PUNCT
dpc-5733	98	11	iqr	iqr	NOUN
dpc-5733	98	12	:	:	PUNCT
dpc-5733	98	13	192.3–700.1	192.3–700.1	NUM
dpc-5733	98	14	versus	versus	ADP
dpc-5733	98	15	week	week	NOUN
dpc-5733	98	16	52	52	NUM
dpc-5733	98	17	:	:	PUNCT
dpc-5733	98	18	269.3	269.3	NUM
dpc-5733	98	19	;	;	PUNCT
dpc-5733	98	20	iqr	iqr	NOUN
dpc-5733	98	21	:	:	PUNCT
dpc-5733	98	22	178.6	178.6	NUM
dpc-5733	98	23	–	–	PUNCT
dpc-5733	98	24	408.8	408.8	NUM
dpc-5733	98	25	;	;	PUNCT
dpc-5733	98	26	p=0.0768	p=0.0768	NOUN
dpc-5733	98	27	)	)	PUNCT
dpc-5733	98	28	.	.	PUNCT
dpc-5733	99	1	furthermore	furthermore	ADV
dpc-5733	99	2	,	,	PUNCT
dpc-5733	99	3	at	at	ADP
dpc-5733	99	4	week	week	NOUN
dpc-5733	99	5	52	52	NUM
dpc-5733	99	6	,	,	PUNCT
dpc-5733	99	7	nlr	nlr	PROPN
dpc-5733	99	8	was	be	AUX
dpc-5733	99	9	significantly	significantly	ADV
dpc-5733	99	10	lower	low	ADJ
dpc-5733	99	11	in	in	ADP
dpc-5733	99	12	sr	sr	PROPN
dpc-5733	99	13	patients	patient	NOUN
dpc-5733	99	14	(	(	PUNCT
dpc-5733	99	15	sr	sr	PROPN
dpc-5733	99	16	:	:	PUNCT
dpc-5733	99	17	2.2	2.2	NUM
dpc-5733	99	18	;	;	PUNCT
dpc-5733	99	19	iqr	iqr	NOUN
dpc-5733	99	20	:	:	PUNCT
dpc-5733	99	21	1.78–2.53	1.78–2.53	NUM
dpc-5733	99	22	versus	versus	X
dpc-5733	99	23	lr	lr	NOUN
dpc-5733	99	24	:	:	PUNCT
dpc-5733	99	25	2.48	2.48	NUM
dpc-5733	99	26	;	;	PUNCT
dpc-5733	99	27	iqr	iqr	NOUN
dpc-5733	99	28	:	:	PUNCT
dpc-5733	99	29	1.79–2.91	1.79–2.91	NUM
dpc-5733	99	30	;	;	PUNCT
dpc-5733	99	31	p=0.0495	p=0.0495	ADJ
dpc-5733	99	32	)	)	PUNCT
dpc-5733	99	33	,	,	PUNCT
dpc-5733	99	34	despite	despite	SCONJ
dpc-5733	99	35	the	the	DET
dpc-5733	99	36	fact	fact	NOUN
dpc-5733	99	37	that	that	SCONJ
dpc-5733	99	38	δnlr	δnlr	PROPN
dpc-5733	99	39	was	be	AUX
dpc-5733	99	40	positively	positively	ADV
dpc-5733	99	41	correlated	correlate	VERB
dpc-5733	99	42	to	to	ADP
dpc-5733	99	43	δpasi	δpasi	NOUN
dpc-5733	99	44	only	only	ADV
dpc-5733	99	45	in	in	ADP
dpc-5733	99	46	lr	lr	NOUN
dpc-5733	99	47	patients	patient	NOUN
dpc-5733	99	48	(	(	PUNCT
dpc-5733	99	49	p=0.022	p=0.022	NOUN
dpc-5733	99	50	,	,	PUNCT
dpc-5733	99	51	r=0.37	r=0.37	PROPN
dpc-5733	99	52	)	)	PUNCT
dpc-5733	99	53	.	.	PUNCT
dpc-5733	100	1	the	the	DET
dpc-5733	100	2	effect	effect	NOUN
dpc-5733	100	3	on	on	ADP
dpc-5733	100	4	transient	transient	ADJ
dpc-5733	100	5	increase	increase	NOUN
dpc-5733	100	6	in	in	ADP
dpc-5733	100	7	eosinophils	eosinophil	NOUN
dpc-5733	100	8	was	be	AUX
dpc-5733	100	9	maintained	maintain	VERB
dpc-5733	100	10	in	in	ADP
dpc-5733	100	11	both	both	DET
dpc-5733	100	12	lr	lr	NOUN
dpc-5733	100	13	and	and	CCONJ
dpc-5733	100	14	sr	sr	PROPN
dpc-5733	100	15	patients	patient	NOUN
dpc-5733	100	16	:	:	PUNCT
dpc-5733	100	17	for	for	ADP
dpc-5733	100	18	lr	lr	PROPN
dpc-5733	100	19	,	,	PUNCT
dpc-5733	100	20	t0	t0	PROPN
dpc-5733	100	21	:	:	PUNCT
dpc-5733	100	22	0.26	0.26	NUM
dpc-5733	100	23	;	;	PUNCT
dpc-5733	100	24	iqr	iqr	NOUN
dpc-5733	100	25	:	:	PUNCT
dpc-5733	100	26	0.15–0.43	0.15–0.43	NOUN
dpc-5733	100	27	;	;	PUNCT
dpc-5733	100	28	week	week	NOUN
dpc-5733	100	29	12	12	NUM
dpc-5733	100	30	*	*	PUNCT
dpc-5733	100	31	:	:	PUNCT
dpc-5733	100	32	0.32	0.32	NUM
dpc-5733	100	33	;	;	PUNCT
dpc-5733	100	34	iqr	iqr	NOUN
dpc-5733	100	35	:	:	PUNCT
dpc-5733	100	36	0.16–0.47	0.16–0.47	NOUN
dpc-5733	100	37	;	;	PUNCT
dpc-5733	100	38	week	week	NOUN
dpc-5733	100	39	24	24	NUM
dpc-5733	100	40	:	:	PUNCT
dpc-5733	100	41	0.28	0.28	NUM
dpc-5733	100	42	;	;	PUNCT
dpc-5733	100	43	iqr	iqr	NOUN
dpc-5733	100	44	:	:	PUNCT
dpc-5733	100	45	0.16–0.40	0.16–0.40	NUM
dpc-5733	100	46	;	;	PUNCT
dpc-5733	100	47	week	week	NOUN
dpc-5733	100	48	52	52	NUM
dpc-5733	100	49	:	:	PUNCT
dpc-5733	100	50	0.26	0.26	NUM
dpc-5733	100	51	;	;	PUNCT
dpc-5733	100	52	iqr	iqr	NOUN
dpc-5733	100	53	:	:	PUNCT
dpc-5733	100	54	0.14	0.14	NUM
dpc-5733	100	55	–	–	PUNCT
dpc-5733	100	56	0.38	0.38	NUM
dpc-5733	100	57	;	;	PUNCT
dpc-5733	100	58	p=	p=	PROPN
dpc-5733	100	59	0.0099	0.0099	NUM
dpc-5733	100	60	.	.	PUNCT
dpc-5733	101	1	for	for	ADP
dpc-5733	101	2	sr	sr	PROPN
dpc-5733	101	3	,	,	PUNCT
dpc-5733	101	4	t0	t0	PROPN
dpc-5733	101	5	:	:	PUNCT
dpc-5733	101	6	0.22	0.22	NUM
dpc-5733	101	7	;	;	PUNCT
dpc-5733	101	8	iqr	iqr	NOUN
dpc-5733	101	9	:	:	PUNCT
dpc-5733	101	10	0.16–0.4	0.16–0.4	NUM
dpc-5733	101	11	;	;	PUNCT
dpc-5733	101	12	week	week	NOUN
dpc-5733	101	13	12	12	NUM
dpc-5733	101	14	*	*	PUNCT
dpc-5733	101	15	:	:	PUNCT
dpc-5733	101	16	0.25	0.25	NUM
dpc-5733	101	17	;	;	PUNCT
dpc-5733	101	18	iqr	iqr	NOUN
dpc-5733	101	19	:	:	PUNCT
dpc-5733	101	20	0.18–0.42	0.18–0.42	NUM
dpc-5733	101	21	;	;	PUNCT
dpc-5733	101	22	week	week	NOUN
dpc-5733	101	23	24	24	NUM
dpc-5733	101	24	:	:	SYM
dpc-5733	101	25	0.22	0.22	NUM
dpc-5733	101	26	;	;	PUNCT
dpc-5733	101	27	iqr	iqr	NOUN
dpc-5733	101	28	:	:	PUNCT
dpc-5733	101	29	0.14	0.14	NUM
dpc-5733	101	30	–	–	PUNCT
dpc-5733	101	31	0.33	0.33	NUM
dpc-5733	101	32	;	;	PUNCT
dpc-5733	101	33	week	week	NOUN
dpc-5733	101	34	52	52	NUM
dpc-5733	101	35	:	:	SYM
dpc-5733	101	36	0.24	0.24	NUM
dpc-5733	101	37	;	;	PUNCT
dpc-5733	101	38	iqr	iqr	NOUN
dpc-5733	101	39	:	:	PUNCT
dpc-5733	101	40	0.16–0.32	0.16–0.32	PROPN
dpc-5733	101	41	;	;	PUNCT
dpc-5733	101	42	p=0.0262	p=0.0262	NOUN
dpc-5733	101	43	)	)	PUNCT
dpc-5733	101	44	,	,	PUNCT
dpc-5733	101	45	while	while	SCONJ
dpc-5733	101	46	in	in	ADP
dpc-5733	101	47	sr	sr	PROPN
dpc-5733	101	48	patients	patient	NOUN
dpc-5733	101	49	,	,	PUNCT
dpc-5733	101	50	only	only	ADV
dpc-5733	101	51	basophils	basophils	PROPN
dpc-5733	101	52	(	(	PUNCT
dpc-5733	101	53	t0	t0	NOUN
dpc-5733	101	54	:	:	PUNCT
dpc-5733	101	55	0.06	0.06	NUM
dpc-5733	101	56	;	;	PUNCT
dpc-5733	101	57	iqr	iqr	NOUN
dpc-5733	101	58	:	:	PUNCT
dpc-5733	101	59	0.03–0.10	0.03–0.10	NUM
dpc-5733	101	60	;	;	PUNCT
dpc-5733	101	61	week	week	NOUN
dpc-5733	101	62	12	12	NUM
dpc-5733	101	63	:	:	PUNCT
dpc-5733	101	64	0.10	0.10	NUM
dpc-5733	101	65	;	;	PUNCT
dpc-5733	101	66	iqr	iqr	NOUN
dpc-5733	101	67	:	:	PUNCT
dpc-5733	101	68	0.05–0.15	0.05–0.15	NUM
dpc-5733	101	69	;	;	PUNCT
dpc-5733	101	70	week	week	NOUN
dpc-5733	101	71	24	24	NUM
dpc-5733	101	72	:	:	SYM
dpc-5733	101	73	0.09	0.09	NUM
dpc-5733	101	74	;	;	PUNCT
dpc-5733	101	75	iqr	iqr	NOUN
dpc-5733	101	76	:	:	PUNCT
dpc-5733	101	77	0.04–0.14	0.04–0.14	NUM
dpc-5733	101	78	)	)	PUNCT
dpc-5733	101	79	;	;	PUNCT
dpc-5733	101	80	week	week	NOUN
dpc-5733	101	81	52	52	NUM
dpc-5733	101	82	:	:	SYM
dpc-5733	101	83	0.09	0.09	NUM
dpc-5733	101	84	;	;	PUNCT
dpc-5733	101	85	iqr	iqr	NOUN
dpc-5733	101	86	:	:	PUNCT
dpc-5733	101	87	0.04–0.14	0.04–0.14	NUM
dpc-5733	101	88	;	;	PUNCT
dpc-5733	101	89	p=0.0001	p=0.0001	NOUN
dpc-5733	101	90	,	,	PUNCT
dpc-5733	101	91	increase	increase	NOUN
dpc-5733	101	92	)	)	PUNCT
dpc-5733	101	93	and	and	CCONJ
dpc-5733	101	94	mpv	mpv	PROPN
dpc-5733	101	95	(	(	PUNCT
dpc-5733	101	96	t0	t0	PROPN
dpc-5733	101	97	:	:	PUNCT
dpc-5733	101	98	9.8	9.8	NUM
dpc-5733	101	99	;	;	PUNCT
dpc-5733	101	100	iqr	iqr	NOUN
dpc-5733	101	101	:	:	PUNCT
dpc-5733	101	102	8.3–10.6	8.3–10.6	NUM
dpc-5733	101	103	;	;	PUNCT
dpc-5733	101	104	week	week	NOUN
dpc-5733	101	105	12	12	NUM
dpc-5733	101	106	:	:	SYM
dpc-5733	101	107	10	10	NUM
dpc-5733	101	108	;	;	PUNCT
dpc-5733	101	109	iqr	iqr	NOUN
dpc-5733	101	110	:	:	PUNCT
dpc-5733	101	111	8.3–10.6	8.3–10.6	NUM
dpc-5733	101	112	;	;	PUNCT
dpc-5733	101	113	week	week	NOUN
dpc-5733	101	114	24	24	NUM
dpc-5733	101	115	:	:	PUNCT
dpc-5733	101	116	10.11	10.11	NUM
dpc-5733	101	117	;	;	PUNCT
dpc-5733	101	118	iqr	iqr	NOUN
dpc-5733	101	119	:	:	PUNCT
dpc-5733	101	120	8.4–11.20	8.4–11.20	NUM
dpc-5733	101	121	;	;	PUNCT
dpc-5733	101	122	week	week	NOUN
dpc-5733	101	123	nlr	nlr	PROPN
dpc-5733	101	124	(	(	PUNCT
dpc-5733	101	125	p=0.016	p=0.016	PROPN
dpc-5733	101	126	,	,	PUNCT
dpc-5733	101	127	r=0.383	r=0.383	NOUN
dpc-5733	101	128	)	)	PUNCT
dpc-5733	101	129	,	,	PUNCT
dpc-5733	101	130	plr	plr	NOUN
dpc-5733	101	131	(	(	PUNCT
dpc-5733	101	132	p=0.032	p=0.032	NUM
dpc-5733	101	133	,	,	PUNCT
dpc-5733	101	134	r=0.343	r=0.343	ADV
dpc-5733	101	135	)	)	PUNCT
dpc-5733	101	136	,	,	PUNCT
dpc-5733	101	137	and	and	CCONJ
dpc-5733	101	138	sii	sii	PROPN
dpc-5733	101	139	(	(	PUNCT
dpc-5733	101	140	p=0.047	p=0.047	NOUN
dpc-5733	101	141	;	;	PUNCT
dpc-5733	101	142	r=0.320	r=0.320	NOUN
dpc-5733	101	143	)	)	PUNCT
dpc-5733	101	144	at	at	ADP
dpc-5733	101	145	baseline	baseline	NOUN
dpc-5733	101	146	.	.	PUNCT
dpc-5733	102	1	during	during	ADP
dpc-5733	102	2	treatment	treatment	NOUN
dpc-5733	102	3	,	,	PUNCT
dpc-5733	102	4	the	the	DET
dpc-5733	102	5	median	median	ADJ
dpc-5733	102	6	number	number	NOUN
dpc-5733	102	7	of	of	ADP
dpc-5733	102	8	neutrophils	neutrophil	NOUN
dpc-5733	102	9	normalized	normalize	VERB
dpc-5733	102	10	as	as	ADV
dpc-5733	102	11	early	early	ADV
dpc-5733	102	12	as	as	ADP
dpc-5733	102	13	week	week	NOUN
dpc-5733	102	14	12	12	NUM
dpc-5733	102	15	(	(	PUNCT
dpc-5733	102	16	sr	sr	NOUN
dpc-5733	102	17	:	:	PUNCT
dpc-5733	102	18	4.625	4.625	NUM
dpc-5733	102	19	;	;	PUNCT
dpc-5733	102	20	iqr	iqr	PROPN
dpc-5733	102	21	:	:	PUNCT
dpc-5733	102	22	3.98–5.47	3.98–5.47	NUM
dpc-5733	102	23	versus	versus	X
dpc-5733	102	24	lr	lr	NOUN
dpc-5733	102	25	:	:	PUNCT
dpc-5733	102	26	5.18	5.18	NUM
dpc-5733	102	27	;	;	PUNCT
dpc-5733	102	28	iqr	iqr	NOUN
dpc-5733	102	29	:	:	PUNCT
dpc-5733	102	30	3.98–6.32	3.98–6.32	NUM
dpc-5733	102	31	;	;	PUNCT
dpc-5733	102	32	p=0.1525	p=0.1525	PROPN
dpc-5733	102	33	)	)	PUNCT
dpc-5733	102	34	.	.	PUNCT
dpc-5733	103	1	in	in	ADP
dpc-5733	103	2	lr	lr	NOUN
dpc-5733	103	3	there	there	PRON
dpc-5733	103	4	was	be	VERB
dpc-5733	103	5	only	only	ADV
dpc-5733	103	6	a	a	DET
dpc-5733	103	7	slight	slight	ADJ
dpc-5733	103	8	reduction	reduction	NOUN
dpc-5733	103	9	in	in	ADP
dpc-5733	103	10	the	the	DET
dpc-5733	103	11	inflammatory	inflammatory	ADJ
dpc-5733	103	12	indices	index	NOUN
dpc-5733	103	13	such	such	ADJ
dpc-5733	103	14	as	as	ADP
dpc-5733	103	15	esr	esr	PROPN
dpc-5733	103	16	(	(	PUNCT
dpc-5733	103	17	mm	mm	PROPN
dpc-5733	103	18	/	/	SYM
dpc-5733	103	19	h	h	NOUN
dpc-5733	103	20	)	)	PUNCT
dpc-5733	103	21	(	(	PUNCT
dpc-5733	103	22	t0	t0	NOUN
dpc-5733	103	23	:	:	PUNCT
dpc-5733	103	24	23	23	NUM
dpc-5733	103	25	;	;	PUNCT
dpc-5733	103	26	iqr	iqr	NOUN
dpc-5733	103	27	:	:	PUNCT
dpc-5733	103	28	15.5–36.5	15.5–36.5	NUM
dpc-5733	103	29	versus	versus	ADP
dpc-5733	103	30	week	week	NOUN
dpc-5733	103	31	52	52	NUM
dpc-5733	103	32	:	:	SYM
dpc-5733	103	33	18	18	NUM
dpc-5733	103	34	;	;	PUNCT
dpc-5733	103	35	iqr	iqr	NOUN
dpc-5733	103	36	:	:	PUNCT
dpc-5733	103	37	13.5–22.5	13.5–22.5	NUM
dpc-5733	103	38	;	;	PUNCT
dpc-5733	103	39	p=	p=	NOUN
dpc-5733	103	40	0.0398	0.0398	NUM
dpc-5733	103	41	)	)	PUNCT
dpc-5733	103	42	,	,	PUNCT
dpc-5733	103	43	crp	crp	PROPN
dpc-5733	103	44	(	(	PUNCT
dpc-5733	103	45	mg/	mg/	PROPN
dpc-5733	103	46	dl	dl	PROPN
dpc-5733	103	47	)	)	PUNCT
dpc-5733	103	48	(	(	PUNCT
dpc-5733	103	49	t0	t0	NOUN
dpc-5733	103	50	:	:	PUNCT
dpc-5733	103	51	0.45	0.45	NUM
dpc-5733	103	52	;	;	PUNCT
dpc-5733	103	53	iqr	iqr	NOUN
dpc-5733	103	54	:	:	PUNCT
dpc-5733	103	55	0.41–0.58	0.41–0.58	NUM
dpc-5733	103	56	versus	versus	ADP
dpc-5733	103	57	week	week	NOUN
dpc-5733	103	58	52	52	NUM
dpc-5733	103	59	:	:	PUNCT
dpc-5733	103	60	0.25	0.25	NUM
dpc-5733	103	61	;	;	PUNCT
dpc-5733	103	62	iqr	iqr	NOUN
dpc-5733	103	63	:	:	PUNCT
dpc-5733	103	64	0.22–0.35	0.22–0.35	NOUN
dpc-5733	103	65	;	;	PUNCT
dpc-5733	103	66	p=0.0021	p=0.0021	PROPN
dpc-5733	103	67	)	)	PUNCT
dpc-5733	103	68	,	,	PUNCT
dpc-5733	103	69	nlr	nlr	PROPN
dpc-5733	103	70	(	(	PUNCT
dpc-5733	103	71	t0	t0	NOUN
dpc-5733	103	72	:	:	PUNCT
dpc-5733	103	73	2.59	2.59	NUM
dpc-5733	103	74	;	;	PUNCT
dpc-5733	103	75	iqr	iqr	NOUN
dpc-5733	103	76	:	:	PUNCT
dpc-5733	103	77	1.81–3.61	1.81–3.61	NUM
dpc-5733	103	78	versus	versus	ADP
dpc-5733	103	79	week	week	NOUN
dpc-5733	103	80	52	52	NUM
dpc-5733	103	81	:	:	PUNCT
dpc-5733	103	82	2.48	2.48	NUM
dpc-5733	103	83	;	;	PUNCT
dpc-5733	103	84	iqr	iqr	NOUN
dpc-5733	103	85	:	:	PUNCT
dpc-5733	103	86	1.79–2.9	1.79–2.9	NUM
dpc-5733	103	87	;	;	PUNCT
dpc-5733	103	88	p=0.2491	p=0.2491	NOUN
dpc-5733	103	89	)	)	PUNCT
dpc-5733	103	90	,	,	PUNCT
dpc-5733	103	91	sii	sii	PROPN
dpc-5733	103	92	(	(	PUNCT
dpc-5733	103	93	t0	t0	NOUN
dpc-5733	103	94	:	:	PUNCT
dpc-5733	103	95	653.3	653.3	NUM
dpc-5733	103	96	;	;	PUNCT
dpc-5733	103	97	iqr	iqr	NOUN
dpc-5733	103	98	:	:	PUNCT
dpc-5733	103	99	348.4–822.1	348.4–822.1	NUM
dpc-5733	103	100	versus	versus	ADP
dpc-5733	103	101	week	week	NOUN
dpc-5733	103	102	52	52	NUM
dpc-5733	103	103	:	:	PUNCT
dpc-5733	103	104	611.5	611.5	NUM
dpc-5733	103	105	;	;	PUNCT
dpc-5733	103	106	iqr	iqr	NOUN
dpc-5733	103	107	:	:	PUNCT
dpc-5733	103	108	392.3–859.9	392.3–859.9	NUM
dpc-5733	103	109	;	;	PUNCT
dpc-5733	103	110	p=0.3872	p=0.3872	PROPN
dpc-5733	103	111	,	,	PUNCT
dpc-5733	103	112	piv	piv	PROPN
dpc-5733	103	113	(	(	PUNCT
dpc-5733	103	114	t0	t0	NOUN
dpc-5733	103	115	:	:	PUNCT
dpc-5733	103	116	359.3	359.3	NUM
dpc-5733	103	117	;	;	PUNCT
dpc-5733	103	118	iqr	iqr	PROPN
dpc-5733	103	119	:	:	PUNCT
dpc-5733	103	120	147.4–830.7	147.4–830.7	NUM
dpc-5733	103	121	versus	versus	ADP
dpc-5733	103	122	week	week	NOUN
dpc-5733	103	123	52	52	NUM
dpc-5733	103	124	:	:	PUNCT
dpc-5733	103	125	284.9	284.9	NUM
dpc-5733	103	126	;	;	PUNCT
dpc-5733	103	127	iqr	iqr	NOUN
dpc-5733	103	128	:	:	PUNCT
dpc-5733	103	129	178.2–575.3	178.2–575.3	NUM
dpc-5733	103	130	;	;	PUNCT
dpc-5733	103	131	p=0.6240	p=0.6240	PROPN
dpc-5733	103	132	)	)	PUNCT
dpc-5733	103	133	and	and	CCONJ
dpc-5733	103	134	siri	siri	NOUN
dpc-5733	103	135	(	(	PUNCT
dpc-5733	103	136	t0	t0	NOUN
dpc-5733	103	137	:	:	PUNCT
dpc-5733	103	138	1.58	1.58	NUM
dpc-5733	103	139	;	;	PUNCT
dpc-5733	103	140	iqr	iqr	NOUN
dpc-5733	103	141	:	:	PUNCT
dpc-5733	103	142	0.67–2.24	0.67–2.24	NUM
dpc-5733	103	143	versus	versus	ADP
dpc-5733	103	144	week	week	NOUN
dpc-5733	103	145	52	52	NUM
dpc-5733	103	146	:	:	PUNCT
dpc-5733	103	147	1.28	1.28	NUM
dpc-5733	103	148	;	;	PUNCT
dpc-5733	103	149	iqr	iqr	NOUN
dpc-5733	103	150	:	:	PUNCT
dpc-5733	103	151	0.8–2.1	0.8–2.1	NOUN
dpc-5733	103	152	;	;	PUNCT
dpc-5733	103	153	p=0.5759	p=0.5759	PROPN
dpc-5733	103	154	)	)	PUNCT
dpc-5733	103	155	.	.	PUNCT
dpc-5733	104	1	sr	sr	PROPN
dpc-5733	104	2	patient	patient	PROPN
dpc-5733	104	3	reached	reach	VERB
dpc-5733	104	4	a	a	DET
dpc-5733	104	5	significant	significant	ADJ
dpc-5733	104	6	reduction	reduction	NOUN
dpc-5733	104	7	in	in	ADP
dpc-5733	104	8	esr	esr	PROPN
dpc-5733	104	9	(	(	PUNCT
dpc-5733	104	10	t0	t0	NOUN
dpc-5733	104	11	:	:	PUNCT
dpc-5733	104	12	28	28	NUM
dpc-5733	104	13	;	;	PUNCT
dpc-5733	104	14	iqr	iqr	NOUN
dpc-5733	104	15	:	:	PUNCT
dpc-5733	104	16	14–39	14–39	NUM
dpc-5733	104	17	versus	versus	ADP
dpc-5733	104	18	week	week	NOUN
dpc-5733	104	19	52	52	NUM
dpc-5733	104	20	:	:	SYM
dpc-5733	104	21	19	19	NUM
dpc-5733	104	22	;	;	PUNCT
dpc-5733	104	23	iqr	iqr	NOUN
dpc-5733	104	24	:	:	PUNCT
dpc-5733	104	25	12–23	12–23	NUM
dpc-5733	104	26	;	;	PUNCT
dpc-5733	104	27	p<0.0001	p<0.0001	NOUN
dpc-5733	104	28	)	)	PUNCT
dpc-5733	104	29	,	,	PUNCT
dpc-5733	104	30	crp	crp	PROPN
dpc-5733	104	31	(	(	PUNCT
dpc-5733	104	32	t0	t0	NOUN
dpc-5733	104	33	:	:	PUNCT
dpc-5733	104	34	0.46	0.46	NUM
dpc-5733	104	35	;	;	PUNCT
dpc-5733	104	36	iqr	iqr	NOUN
dpc-5733	104	37	:	:	PUNCT
dpc-5733	104	38	0.31–0.52	0.31–0.52	NUM
dpc-5733	104	39	versus	versus	ADP
dpc-5733	104	40	week	week	NOUN
dpc-5733	104	41	52	52	NUM
dpc-5733	104	42	:	:	SYM
dpc-5733	104	43	0.27	0.27	NUM
dpc-5733	104	44	;	;	PUNCT
dpc-5733	104	45	iqr	iqr	NOUN
dpc-5733	104	46	:	:	PUNCT
dpc-5733	104	47	0.20–0.33	0.20–0.33	NUM
dpc-5733	104	48	;	;	PUNCT
dpc-5733	104	49	p<0.0001	p<0.0001	NOUN
dpc-5733	104	50	)	)	PUNCT
dpc-5733	104	51	,	,	PUNCT
dpc-5733	104	52	nlr	nlr	PROPN
dpc-5733	104	53	(	(	PUNCT
dpc-5733	104	54	t0	t0	PROPN
dpc-5733	104	55	:	:	PUNCT
dpc-5733	104	56	2.23	2.23	NUM
dpc-5733	104	57	;	;	PUNCT
dpc-5733	104	58	iqr	iqr	NOUN
dpc-5733	104	59	:	:	PUNCT
dpc-5733	104	60	1.83–2.97	1.83–2.97	NOUN
dpc-5733	104	61	versus	versus	ADP
dpc-5733	104	62	week	week	NOUN
dpc-5733	104	63	52	52	NUM
dpc-5733	104	64	:	:	PUNCT
dpc-5733	104	65	2.20	2.20	NUM
dpc-5733	104	66	;	;	PUNCT
dpc-5733	104	67	iqr	iqr	NOUN
dpc-5733	104	68	:	:	PUNCT
dpc-5733	104	69	1.78–2.54	1.78–2.54	NUM
dpc-5733	104	70	;	;	PUNCT
dpc-5733	104	71	p=0.0124	p=0.0124	NUM
dpc-5733	104	72	)	)	PUNCT
dpc-5733	104	73	,	,	PUNCT
dpc-5733	104	74	sii	sii	PROPN
dpc-5733	104	75	(	(	PUNCT
dpc-5733	104	76	t0	t0	NOUN
dpc-5733	104	77	:	:	PUNCT
dpc-5733	104	78	596.3	596.3	NUM
dpc-5733	104	79	;	;	PUNCT
dpc-5733	104	80	iqr	iqr	NOUN
dpc-5733	104	81	:	:	PUNCT
dpc-5733	104	82	452.3–898.3	452.3–898.3	NUM
dpc-5733	104	83	versus	versus	ADP
dpc-5733	104	84	week	week	NOUN
dpc-5733	104	85	figure	figure	NOUN
dpc-5733	104	86	2	2	NUM
dpc-5733	104	87	.	.	PUNCT
dpc-5733	104	88	efficacy	efficacy	NOUN
dpc-5733	104	89	of	of	ADP
dpc-5733	104	90	risankizumab	risankizumab	NOUN
dpc-5733	104	91	on	on	ADP
dpc-5733	104	92	pasi	pasi	NOUN
dpc-5733	104	93	score	score	NOUN
dpc-5733	104	94	over	over	ADP
dpc-5733	104	95	time	time	NOUN
dpc-5733	104	96	in	in	ADP
dpc-5733	104	97	lr	lr	X
dpc-5733	104	98	(	(	PUNCT
dpc-5733	104	99	a	a	NOUN
dpc-5733	104	100	)	)	PUNCT
dpc-5733	104	101	and	and	CCONJ
dpc-5733	104	102	sr	sr	PROPN
dpc-5733	104	103	(	(	PUNCT
dpc-5733	104	104	b	b	NOUN
dpc-5733	104	105	)	)	PUNCT
dpc-5733	104	106	patients	patient	NOUN
dpc-5733	104	107	.	.	PUNCT
dpc-5733	105	1	changes	change	NOUN
dpc-5733	105	2	in	in	ADP
dpc-5733	105	3	pasi	pasi	NOUN
dpc-5733	105	4	score	score	NOUN
dpc-5733	105	5	were	be	AUX
dpc-5733	105	6	significant	significant	ADJ
dpc-5733	105	7	as	as	ADV
dpc-5733	105	8	early	early	ADV
dpc-5733	105	9	as	as	ADP
dpc-5733	105	10	week	week	NOUN
dpc-5733	105	11	12	12	NUM
dpc-5733	105	12	of	of	ADP
dpc-5733	105	13	treatment	treatment	NOUN
dpc-5733	105	14	in	in	ADP
dpc-5733	105	15	both	both	CCONJ
dpc-5733	105	16	sr	sr	PROPN
dpc-5733	105	17	and	and	CCONJ
dpc-5733	105	18	lr	lr	PROPN
dpc-5733	105	19	subgroups	subgroup	NOUN
dpc-5733	105	20	;	;	PUNCT
dpc-5733	105	21	however	however	ADV
dpc-5733	105	22	,	,	PUNCT
dpc-5733	105	23	despite	despite	SCONJ
dpc-5733	105	24	the	the	DET
dpc-5733	105	25	fact	fact	NOUN
dpc-5733	105	26	that	that	SCONJ
dpc-5733	105	27	no	no	DET
dpc-5733	105	28	difference	difference	NOUN
dpc-5733	105	29	at	at	ADP
dpc-5733	105	30	baseline	baseline	NOUN
dpc-5733	105	31	was	be	AUX
dpc-5733	105	32	observed	observe	VERB
dpc-5733	105	33	in	in	ADP
dpc-5733	105	34	sr	sr	PROPN
dpc-5733	105	35	versus	versus	ADP
dpc-5733	105	36	lr	lr	NOUN
dpc-5733	105	37	patients	patient	NOUN
dpc-5733	105	38	(	(	PUNCT
dpc-5733	105	39	p	p	X
dpc-5733	105	40	>	>	X
dpc-5733	105	41	0.9999	0.9999	NUM
dpc-5733	105	42	)	)	PUNCT
dpc-5733	105	43	,	,	PUNCT
dpc-5733	105	44	at	at	ADP
dpc-5733	105	45	week	week	NOUN
dpc-5733	105	46	12	12	NUM
dpc-5733	105	47	lr	lr	NOUN
dpc-5733	105	48	patients	patient	NOUN
dpc-5733	105	49	had	have	VERB
dpc-5733	105	50	significantly	significantly	ADV
dpc-5733	105	51	higher	high	ADJ
dpc-5733	105	52	values	value	NOUN
dpc-5733	105	53	of	of	ADP
dpc-5733	105	54	pasi	pasi	NOUN
dpc-5733	105	55	(	(	PUNCT
dpc-5733	105	56	p<0.0001	p<0.0001	NOUN
dpc-5733	105	57	)	)	PUNCT
dpc-5733	105	58	,	,	PUNCT
dpc-5733	105	59	which	which	PRON
dpc-5733	105	60	turned	turn	VERB
dpc-5733	105	61	into	into	ADP
dpc-5733	105	62	similar	similar	ADJ
dpc-5733	105	63	scores	score	NOUN
dpc-5733	105	64	at	at	ADP
dpc-5733	105	65	week	week	NOUN
dpc-5733	105	66	24	24	NUM
dpc-5733	105	67	(	(	PUNCT
dpc-5733	105	68	sr	sr	PROPN
dpc-5733	105	69	versus	versus	ADP
dpc-5733	105	70	lr	lr	PROPN
dpc-5733	105	71	,	,	PUNCT
dpc-5733	105	72	p>0.9999	p>0.9999	PROPN
dpc-5733	105	73	)	)	PUNCT
dpc-5733	105	74	and	and	CCONJ
dpc-5733	105	75	at	at	ADP
dpc-5733	105	76	week	week	NOUN
dpc-5733	105	77	52	52	NUM
dpc-5733	105	78	(	(	PUNCT
dpc-5733	105	79	sr	sr	PROPN
dpc-5733	105	80	versus	versus	ADP
dpc-5733	105	81	lr	lr	PROPN
dpc-5733	105	82	,	,	PUNCT
dpc-5733	105	83	p>0.9999	p>0.9999	PROPN
dpc-5733	105	84	)	)	PUNCT
dpc-5733	105	85	(	(	PUNCT
dpc-5733	105	86	multiple	multiple	ADJ
dpc-5733	105	87	comparison	comparison	NOUN
dpc-5733	105	88	,	,	PUNCT
dpc-5733	105	89	kruskal	kruskal	PROPN
dpc-5733	105	90	wallis	wallis	PROPN
dpc-5733	105	91	test	test	PROPN
dpc-5733	105	92	with	with	ADP
dpc-5733	105	93	dunn	dunn	PROPN
dpc-5733	105	94	’s	’s	PART
dpc-5733	105	95	correction	correction	NOUN
dpc-5733	105	96	)	)	PUNCT
dpc-5733	105	97	.	.	PUNCT
dpc-5733	106	1	original	original	ADJ
dpc-5733	106	2	article	article	NOUN
dpc-5733	106	3	|	|	ADV
dpc-5733	106	4	dermatol	dermatol	ADJ
dpc-5733	106	5	pract	pract	NOUN
dpc-5733	106	6	concept	concept	NOUN
dpc-5733	106	7	.	.	PUNCT
dpc-5733	107	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	107	2	7	7	NUM
dpc-5733	107	3	in	in	ADP
dpc-5733	107	4	a	a	DET
dpc-5733	107	5	retrospective	retrospective	ADJ
dpc-5733	107	6	study	study	NOUN
dpc-5733	107	7	,	,	PUNCT
dpc-5733	107	8	anti	anti	ADJ
dpc-5733	107	9	-	-	ADJ
dpc-5733	107	10	il-17	il-17	ADJ
dpc-5733	107	11	agents	agent	NOUN
dpc-5733	107	12	(	(	PUNCT
dpc-5733	107	13	number	number	NOUN
dpc-5733	107	14	of	of	ADP
dpc-5733	107	15	patients	patient	NOUN
dpc-5733	107	16	,	,	PUNCT
dpc-5733	107	17	314	314	NUM
dpc-5733	107	18	)	)	PUNCT
dpc-5733	107	19	were	be	AUX
dpc-5733	107	20	more	more	ADV
dpc-5733	107	21	effective	effective	ADJ
dpc-5733	107	22	in	in	ADP
dpc-5733	107	23	reducing	reduce	VERB
dpc-5733	107	24	nlr	nlr	PROPN
dpc-5733	107	25	,	,	PUNCT
dpc-5733	107	26	plr	plr	NOUN
dpc-5733	107	27	,	,	PUNCT
dpc-5733	107	28	mlr	mlr	NOUN
dpc-5733	107	29	,	,	PUNCT
dpc-5733	107	30	and	and	CCONJ
dpc-5733	107	31	sii	sii	PROPN
dpc-5733	107	32	compared	compare	VERB
dpc-5733	107	33	to	to	ADP
dpc-5733	107	34	anti	anti	ADJ
dpc-5733	107	35	-	-	PROPN
dpc-5733	107	36	tnf	tnf	PROPN
dpc-5733	107	37	(	(	PUNCT
dpc-5733	107	38	n=49	n=49	NUM
dpc-5733	107	39	)	)	PUNCT
dpc-5733	107	40	and	and	CCONJ
dpc-5733	107	41	also	also	ADV
dpc-5733	107	42	to	to	ADP
dpc-5733	107	43	anti	anti	ADJ
dpc-5733	107	44	-	-	ADJ
dpc-5733	107	45	il-12/23+il-23	il-12/23+il-23	ADJ
dpc-5733	107	46	agents	agent	NOUN
dpc-5733	107	47	(	(	PUNCT
dpc-5733	107	48	n=72	n=72	NOUN
dpc-5733	107	49	)	)	PUNCT
dpc-5733	107	50	,	,	PUNCT
dpc-5733	107	51	which	which	PRON
dpc-5733	107	52	exerted	exert	VERB
dpc-5733	107	53	a	a	DET
dpc-5733	107	54	significant	significant	ADJ
dpc-5733	107	55	effect	effect	NOUN
dpc-5733	107	56	on	on	ADP
dpc-5733	107	57	nlr	nlr	PROPN
dpc-5733	107	58	and	and	CCONJ
dpc-5733	107	59	sii	sii	PROPN
dpc-5733	107	60	.	.	PUNCT
dpc-5733	108	1	however	however	ADV
dpc-5733	108	2	,	,	PUNCT
dpc-5733	108	3	no	no	DET
dpc-5733	108	4	subanalysis	subanalysis	NOUN
dpc-5733	108	5	of	of	ADP
dpc-5733	108	6	the	the	DET
dpc-5733	108	7	single	single	ADJ
dpc-5733	108	8	molecules	molecule	NOUN
dpc-5733	108	9	was	be	AUX
dpc-5733	108	10	performed	perform	VERB
dpc-5733	108	11	[	[	PUNCT
dpc-5733	108	12	39	39	NUM
dpc-5733	108	13	]	]	PUNCT
dpc-5733	108	14	.	.	PUNCT
dpc-5733	109	1	morariu	morariu	PROPN
dpc-5733	109	2	et	et	PROPN
dpc-5733	109	3	al	al	PROPN
dpc-5733	109	4	.	.	PUNCT
dpc-5733	110	1	[	[	X
dpc-5733	110	2	13	13	NUM
dpc-5733	110	3	]	]	PUNCT
dpc-5733	110	4	retrospectively	retrospectively	ADV
dpc-5733	110	5	looked	look	VERB
dpc-5733	110	6	at	at	ADP
dpc-5733	110	7	the	the	DET
dpc-5733	110	8	effects	effect	NOUN
dpc-5733	110	9	of	of	ADP
dpc-5733	110	10	anti	anti	ADJ
dpc-5733	110	11	-	-	ADJ
dpc-5733	110	12	tnf	tnf	ADJ
dpc-5733	110	13	(	(	PUNCT
dpc-5733	110	14	adalimumab	adalimumab	PROPN
dpc-5733	110	15	,	,	PUNCT
dpc-5733	110	16	n=22	n=22	PROPN
dpc-5733	110	17	;	;	PUNCT
dpc-5733	110	18	etanercept	etanercept	NOUN
dpc-5733	110	19	,	,	PUNCT
dpc-5733	110	20	n=18	n=18	ADV
dpc-5733	110	21	;	;	PUNCT
dpc-5733	110	22	infliximab	infliximab	NOUN
dpc-5733	110	23	,	,	PUNCT
dpc-5733	110	24	n=6	n=6	NOUN
dpc-5733	110	25	;	;	PUNCT
dpc-5733	110	26	certolizumab	certolizumab	NOUN
dpc-5733	110	27	;	;	PUNCT
dpc-5733	110	28	n=6	n=6	X
dpc-5733	110	29	)	)	PUNCT
dpc-5733	110	30	,	,	PUNCT
dpc-5733	110	31	anti	anti	ADJ
dpc-5733	110	32	-	-	ADJ
dpc-5733	110	33	il-17	il-17	ADJ
dpc-5733	110	34	(	(	PUNCT
dpc-5733	110	35	ixekizumab	ixekizumab	NOUN
dpc-5733	110	36	,	,	PUNCT
dpc-5733	110	37	n=61	n=61	NOUN
dpc-5733	110	38	;	;	PUNCT
dpc-5733	110	39	secukinumab	secukinumab	NOUN
dpc-5733	110	40	,	,	PUNCT
dpc-5733	110	41	n=41	n=41	PROPN
dpc-5733	110	42	)	)	PUNCT
dpc-5733	110	43	,	,	PUNCT
dpc-5733	110	44	anti	anti	ADJ
dpc-5733	110	45	-	-	ADJ
dpc-5733	110	46	il-23p19	il-23p19	ADJ
dpc-5733	110	47	(	(	PUNCT
dpc-5733	110	48	tildrakizumab	tildrakizumab	NOUN
dpc-5733	110	49	,	,	PUNCT
dpc-5733	110	50	n=11	n=11	NOUN
dpc-5733	110	51	;	;	PUNCT
dpc-5733	110	52	guselkumab	guselkumab	NOUN
dpc-5733	110	53	,	,	PUNCT
dpc-5733	110	54	n=22	n=22	PROPN
dpc-5733	110	55	;	;	PUNCT
dpc-5733	110	56	risankizumab	risankizumab	NOUN
dpc-5733	110	57	,	,	PUNCT
dpc-5733	110	58	n=44	n=44	PROPN
dpc-5733	110	59	)	)	PUNCT
dpc-5733	110	60	,	,	PUNCT
dpc-5733	110	61	and	and	CCONJ
dpc-5733	110	62	anti	anti	ADJ
dpc-5733	110	63	-	-	ADJ
dpc-5733	110	64	il-23p40	il-23p40	ADJ
dpc-5733	110	65	(	(	PUNCT
dpc-5733	110	66	ustekinumab	ustekinumab	NOUN
dpc-5733	110	67	,	,	PUNCT
dpc-5733	110	68	n=17	n=17	NOUN
dpc-5733	110	69	)	)	PUNCT
dpc-5733	110	70	biologics	biologic	NOUN
dpc-5733	110	71	.	.	PUNCT
dpc-5733	111	1	a	a	DET
dpc-5733	111	2	reduction	reduction	NOUN
dpc-5733	111	3	in	in	ADP
dpc-5733	111	4	nlr	nlr	PROPN
dpc-5733	111	5	,	,	PUNCT
dpc-5733	111	6	plr	plr	NOUN
dpc-5733	111	7	,	,	PUNCT
dpc-5733	111	8	derived	derive	VERB
dpc-5733	111	9	nlr	nlr	PROPN
dpc-5733	111	10	/	/	SYM
dpc-5733	111	11	dnlr	dnlr	PROPN
dpc-5733	111	12	,	,	PUNCT
dpc-5733	111	13	sii	sii	PROPN
dpc-5733	111	14	,	,	PUNCT
dpc-5733	111	15	siri	siri	NOUN
dpc-5733	111	16	,	,	PUNCT
dpc-5733	111	17	aisi	aisi	PROPN
dpc-5733	111	18	,	,	PUNCT
dpc-5733	111	19	mlr	mlr	PROPN
dpc-5733	111	20	,	,	PUNCT
dpc-5733	111	21	and	and	CCONJ
dpc-5733	111	22	platelet	platelet	NOUN
dpc-5733	111	23	-	-	PUNCT
dpc-5733	111	24	to	to	ADP
dpc-5733	111	25	-	-	PUNCT
dpc-5733	111	26	monocyte	monocyte	NOUN
dpc-5733	111	27	ratio	ratio	NOUN
dpc-5733	111	28	/	/	SYM
dpc-5733	111	29	pmr	pmr	PROPN
dpc-5733	111	30	was	be	AUX
dpc-5733	111	31	observed	observe	VERB
dpc-5733	111	32	at	at	ADP
dpc-5733	111	33	week	week	NOUN
dpc-5733	111	34	52	52	NUM
dpc-5733	111	35	,	,	PUNCT
dpc-5733	111	36	with	with	ADP
dpc-5733	111	37	differences	difference	NOUN
dpc-5733	111	38	between	between	ADP
dpc-5733	111	39	molecules	molecule	NOUN
dpc-5733	111	40	,	,	PUNCT
dpc-5733	111	41	but	but	CCONJ
dpc-5733	111	42	without	without	ADP
dpc-5733	111	43	class	class	NOUN
dpc-5733	111	44	effect	effect	NOUN
dpc-5733	111	45	.	.	PUNCT
dpc-5733	112	1	similar	similar	ADJ
dpc-5733	112	2	results	result	NOUN
dpc-5733	112	3	were	be	AUX
dpc-5733	112	4	shown	show	VERB
dpc-5733	112	5	by	by	ADP
dpc-5733	112	6	kulakli	kulakli	PROPN
dpc-5733	112	7	s	s	PART
dpc-5733	112	8	et	et	NOUN
dpc-5733	112	9	al	al	PROPN
dpc-5733	112	10	.	.	PUNCT
dpc-5733	113	1	[	[	X
dpc-5733	113	2	14	14	NUM
dpc-5733	113	3	]	]	PUNCT
dpc-5733	113	4	,	,	PUNCT
dpc-5733	113	5	while	while	SCONJ
dpc-5733	113	6	another	another	DET
dpc-5733	113	7	retrospective	retrospective	ADJ
dpc-5733	113	8	study	study	NOUN
dpc-5733	113	9	suggested	suggest	VERB
dpc-5733	113	10	that	that	SCONJ
dpc-5733	113	11	lower	low	ADJ
dpc-5733	113	12	baseline	baseline	NOUN
dpc-5733	113	13	levels	level	NOUN
dpc-5733	113	14	of	of	ADP
dpc-5733	113	15	nlr	nlr	PROPN
dpc-5733	113	16	could	could	AUX
dpc-5733	113	17	be	be	AUX
dpc-5733	113	18	predictive	predictive	ADJ
dpc-5733	113	19	of	of	ADP
dpc-5733	113	20	response	response	NOUN
dpc-5733	113	21	to	to	ADP
dpc-5733	113	22	anti	anti	ADJ
dpc-5733	113	23	-	-	ADJ
dpc-5733	113	24	tnf	tnf	ADJ
dpc-5733	113	25	agents	agent	NOUN
dpc-5733	113	26	[	[	X
dpc-5733	113	27	40	40	NUM
dpc-5733	113	28	]	]	PUNCT
dpc-5733	113	29	.	.	PUNCT
dpc-5733	114	1	a	a	DET
dpc-5733	114	2	retrospective	retrospective	ADJ
dpc-5733	114	3	analysis	analysis	NOUN
dpc-5733	114	4	[	[	X
dpc-5733	114	5	41	41	NUM
dpc-5733	114	6	]	]	PUNCT
dpc-5733	114	7	of	of	ADP
dpc-5733	114	8	the	the	DET
dpc-5733	114	9	voyage	voyage	NOUN
dpc-5733	114	10	i	i	PRON
dpc-5733	114	11	and	and	CCONJ
dpc-5733	114	12	ii	ii	PROPN
dpc-5733	114	13	and	and	CCONJ
dpc-5733	114	14	eclipse	eclipse	NOUN
dpc-5733	114	15	studies	study	NOUN
dpc-5733	114	16	showed	show	VERB
dpc-5733	114	17	that	that	SCONJ
dpc-5733	114	18	the	the	DET
dpc-5733	114	19	ability	ability	NOUN
dpc-5733	114	20	to	to	PART
dpc-5733	114	21	modulate	modulate	VERB
dpc-5733	114	22	nlr	nlr	PROPN
dpc-5733	114	23	,	,	PUNCT
dpc-5733	114	24	mlr	mlr	NOUN
dpc-5733	114	25	,	,	PUNCT
dpc-5733	114	26	and	and	CCONJ
dpc-5733	114	27	plr	plr	NOUN
dpc-5733	114	28	of	of	ADP
dpc-5733	114	29	biologic	biologic	ADJ
dpc-5733	114	30	agents	agent	NOUN
dpc-5733	114	31	such	such	ADJ
dpc-5733	114	32	as	as	ADP
dpc-5733	114	33	guselkumab	guselkumab	NOUN
dpc-5733	114	34	,	,	PUNCT
dpc-5733	114	35	secukinumab	secukinumab	NOUN
dpc-5733	114	36	,	,	PUNCT
dpc-5733	114	37	and	and	CCONJ
dpc-5733	114	38	adalimumab	adalimumab	NOUN
dpc-5733	114	39	was	be	AUX
dpc-5733	114	40	higher	high	ADJ
dpc-5733	114	41	compared	compare	VERB
dpc-5733	114	42	to	to	ADP
dpc-5733	114	43	placebo	placebo	NOUN
dpc-5733	114	44	-	-	PUNCT
dpc-5733	114	45	treated	treat	VERB
dpc-5733	114	46	patients	patient	NOUN
dpc-5733	114	47	during	during	ADP
dpc-5733	114	48	the	the	DET
dpc-5733	114	49	first	first	ADJ
dpc-5733	114	50	16	16	NUM
dpc-5733	114	51	weeks	week	NOUN
dpc-5733	114	52	of	of	ADP
dpc-5733	114	53	treatment	treatment	NOUN
dpc-5733	114	54	,	,	PUNCT
dpc-5733	114	55	while	while	SCONJ
dpc-5733	114	56	two	two	NUM
dpc-5733	114	57	other	other	ADJ
dpc-5733	114	58	studies	study	NOUN
dpc-5733	114	59	showed	show	VERB
dpc-5733	114	60	discording	discord	VERB
dpc-5733	114	61	results	result	NOUN
dpc-5733	114	62	on	on	ADP
dpc-5733	114	63	the	the	DET
dpc-5733	114	64	superiority	superiority	NOUN
dpc-5733	114	65	of	of	ADP
dpc-5733	114	66	anti	anti	ADJ
dpc-5733	114	67	-	-	ADJ
dpc-5733	114	68	il17	il17	PROPN
dpc-5733	114	69	versus	versus	ADP
dpc-5733	114	70	anti	anti	X
dpc-5733	114	71	il-23	il-23	NOUN
dpc-5733	114	72	agents	agent	NOUN
dpc-5733	114	73	in	in	ADP
dpc-5733	114	74	reducing	reduce	VERB
dpc-5733	114	75	systemic	systemic	ADJ
dpc-5733	114	76	inflammation	inflammation	NOUN
dpc-5733	114	77	[	[	X
dpc-5733	114	78	42,43	42,43	X
dpc-5733	114	79	]	]	X
dpc-5733	114	80	.	.	PUNCT
dpc-5733	115	1	this	this	DET
dpc-5733	115	2	study	study	NOUN
dpc-5733	115	3	offers	offer	VERB
dpc-5733	115	4	a	a	DET
dpc-5733	115	5	prospective	prospective	ADJ
dpc-5733	115	6	evaluation	evaluation	NOUN
dpc-5733	115	7	on	on	ADP
dpc-5733	115	8	hematologic	hematologic	NOUN
dpc-5733	115	9	indices	index	NOUN
dpc-5733	115	10	in	in	ADP
dpc-5733	115	11	psoriasis	psoriasis	NOUN
dpc-5733	115	12	,	,	PUNCT
dpc-5733	115	13	and	and	CCONJ
dpc-5733	115	14	it	it	PRON
dpc-5733	115	15	includes	include	VERB
dpc-5733	115	16	the	the	DET
dpc-5733	115	17	largest	large	ADJ
dpc-5733	115	18	population	population	NOUN
dpc-5733	115	19	of	of	ADP
dpc-5733	115	20	patients	patient	NOUN
dpc-5733	115	21	treated	treat	VERB
dpc-5733	115	22	with	with	ADP
dpc-5733	115	23	risankizumab	risankizumab	NOUN
dpc-5733	115	24	analyzed	analyze	VERB
dpc-5733	115	25	for	for	ADP
dpc-5733	115	26	blood	blood	NOUN
dpc-5733	115	27	cells	cell	NOUN
dpc-5733	115	28	and	and	CCONJ
dpc-5733	115	29	inflammatory	inflammatory	ADJ
dpc-5733	115	30	values	value	NOUN
dpc-5733	115	31	.	.	PUNCT
dpc-5733	116	1	the	the	DET
dpc-5733	116	2	results	result	NOUN
dpc-5733	116	3	of	of	ADP
dpc-5733	116	4	this	this	DET
dpc-5733	116	5	study	study	NOUN
dpc-5733	116	6	confirmed	confirm	VERB
dpc-5733	116	7	the	the	DET
dpc-5733	116	8	potential	potential	ADJ
dpc-5733	116	9	ability	ability	NOUN
dpc-5733	116	10	of	of	ADP
dpc-5733	116	11	risankizumab	risankizumab	NOUN
dpc-5733	116	12	to	to	PART
dpc-5733	116	13	reduce	reduce	VERB
dpc-5733	116	14	systemic	systemic	ADJ
dpc-5733	116	15	inflammation	inflammation	NOUN
dpc-5733	116	16	,	,	PUNCT
dpc-5733	116	17	lowering	lower	VERB
dpc-5733	116	18	esr	esr	PROPN
dpc-5733	116	19	,	,	PUNCT
dpc-5733	116	20	crp	crp	PROPN
dpc-5733	116	21	,	,	PUNCT
dpc-5733	116	22	nlr	nlr	PROPN
dpc-5733	116	23	,	,	PUNCT
dpc-5733	116	24	and	and	CCONJ
dpc-5733	116	25	sii	sii	PROPN
dpc-5733	116	26	overtime	overtime	NOUN
dpc-5733	116	27	.	.	PUNCT
dpc-5733	117	1	it	it	PRON
dpc-5733	117	2	also	also	ADV
dpc-5733	117	3	demonstrated	demonstrate	VERB
dpc-5733	117	4	the	the	DET
dpc-5733	117	5	effect	effect	NOUN
dpc-5733	117	6	of	of	ADP
dpc-5733	117	7	systemic	systemic	ADJ
dpc-5733	117	8	treatment	treatment	NOUN
dpc-5733	117	9	on	on	ADP
dpc-5733	117	10	piv	piv	NOUN
dpc-5733	117	11	in	in	ADP
dpc-5733	117	12	psoriasis	psoriasis	NOUN
dpc-5733	117	13	,	,	PUNCT
dpc-5733	117	14	which	which	PRON
dpc-5733	117	15	has	have	AUX
dpc-5733	117	16	been	be	AUX
dpc-5733	117	17	reported	report	VERB
dpc-5733	117	18	in	in	ADP
dpc-5733	117	19	other	other	ADJ
dpc-5733	117	20	cutaneous	cutaneous	ADJ
dpc-5733	117	21	diseases	disease	NOUN
dpc-5733	117	22	such	such	ADJ
dpc-5733	117	23	as	as	ADP
dpc-5733	117	24	hidradenitis	hidradenitis	PROPN
dpc-5733	117	25	suppurativa	suppurativa	NOUN
dpc-5733	117	26	[	[	X
dpc-5733	117	27	5,44–46	5,44–46	NUM
dpc-5733	117	28	]	]	X
dpc-5733	117	29	.	.	PUNCT
dpc-5733	118	1	another	another	DET
dpc-5733	118	2	new	new	ADJ
dpc-5733	118	3	finding	finding	NOUN
dpc-5733	118	4	of	of	ADP
dpc-5733	118	5	our	our	PRON
dpc-5733	118	6	study	study	NOUN
dpc-5733	118	7	is	be	AUX
dpc-5733	118	8	the	the	DET
dpc-5733	118	9	transient	transient	ADJ
dpc-5733	118	10	increase	increase	NOUN
dpc-5733	118	11	in	in	ADP
dpc-5733	118	12	eosinophils	eosinophil	NOUN
dpc-5733	118	13	during	during	ADP
dpc-5733	118	14	the	the	DET
dpc-5733	118	15	first	first	ADJ
dpc-5733	118	16	weeks	week	NOUN
dpc-5733	118	17	,	,	PUNCT
dpc-5733	118	18	and	and	CCONJ
dpc-5733	118	19	their	their	PRON
dpc-5733	118	20	progressive	progressive	ADJ
dpc-5733	118	21	restoration	restoration	NOUN
dpc-5733	118	22	to	to	ADP
dpc-5733	118	23	baseline	baseline	NOUN
dpc-5733	118	24	levels	level	NOUN
dpc-5733	118	25	;	;	PUNCT
dpc-5733	118	26	this	this	PRON
dpc-5733	118	27	is	be	AUX
dpc-5733	118	28	potentially	potentially	ADV
dpc-5733	118	29	relevant	relevant	ADJ
dpc-5733	118	30	,	,	PUNCT
dpc-5733	118	31	since	since	SCONJ
dpc-5733	118	32	the	the	DET
dpc-5733	118	33	relative	relative	ADJ
dpc-5733	118	34	risk	risk	NOUN
dpc-5733	118	35	of	of	ADP
dpc-5733	118	36	psoriasis	psoriasis	NOUN
dpc-5733	118	37	incidence	incidence	NOUN
dpc-5733	118	38	increases	increase	VERB
dpc-5733	118	39	with	with	ADP
dpc-5733	118	40	the	the	DET
dpc-5733	118	41	increase	increase	NOUN
dpc-5733	118	42	in	in	ADP
dpc-5733	118	43	neutrophils	neutrophil	NOUN
dpc-5733	118	44	,	,	PUNCT
dpc-5733	118	45	monocytes	monocyte	NOUN
dpc-5733	118	46	,	,	PUNCT
dpc-5733	118	47	and	and	CCONJ
dpc-5733	118	48	eosinophils	eosinophil	NOUN
dpc-5733	118	49	.	.	PUNCT
dpc-5733	119	1	eosinophils	eosinophil	NOUN
dpc-5733	119	2	can	can	AUX
dpc-5733	119	3	have	have	VERB
dpc-5733	119	4	a	a	DET
dpc-5733	119	5	potential	potential	ADJ
dpc-5733	119	6	impact	impact	NOUN
dpc-5733	119	7	on	on	ADP
dpc-5733	119	8	psoriasis	psoriasis	NOUN
dpc-5733	119	9	severity	severity	NOUN
dpc-5733	119	10	[	[	X
dpc-5733	119	11	15	15	NUM
dpc-5733	119	12	]	]	PUNCT
dpc-5733	119	13	.	.	PUNCT
dpc-5733	120	1	we	we	PRON
dpc-5733	120	2	have	have	AUX
dpc-5733	120	3	also	also	ADV
dpc-5733	120	4	shown	show	VERB
dpc-5733	120	5	that	that	SCONJ
dpc-5733	120	6	risankizumab	risankizumab	NOUN
dpc-5733	120	7	increases	increase	VERB
dpc-5733	120	8	peripheral	peripheral	ADJ
dpc-5733	120	9	basophils	basophil	NOUN
dpc-5733	120	10	,	,	PUNCT
dpc-5733	120	11	with	with	ADP
dpc-5733	120	12	special	special	ADJ
dpc-5733	120	13	regard	regard	NOUN
dpc-5733	120	14	to	to	ADP
dpc-5733	120	15	sr	sr	PROPN
dpc-5733	120	16	patients	patient	NOUN
dpc-5733	120	17	.	.	PUNCT
dpc-5733	121	1	recently	recently	ADV
dpc-5733	121	2	,	,	PUNCT
dpc-5733	121	3	zhang	zhang	PROPN
dpc-5733	121	4	et	et	PROPN
dpc-5733	121	5	al	al	PROPN
dpc-5733	121	6	.	.	PROPN
dpc-5733	121	7	showed	show	VERB
dpc-5733	121	8	that	that	SCONJ
dpc-5733	121	9	eosinophils	eosinophil	NOUN
dpc-5733	121	10	and	and	CCONJ
dpc-5733	121	11	basophils	basophil	NOUN
dpc-5733	121	12	positively	positively	ADV
dpc-5733	121	13	correlate	correlate	VERB
dpc-5733	121	14	to	to	ADP
dpc-5733	121	15	pasi	pasi	NOUN
dpc-5733	121	16	and	and	CCONJ
dpc-5733	121	17	that	that	SCONJ
dpc-5733	121	18	,	,	PUNCT
dpc-5733	121	19	although	although	SCONJ
dpc-5733	121	20	not	not	PART
dpc-5733	121	21	significantly	significantly	ADV
dpc-5733	121	22	,	,	PUNCT
dpc-5733	121	23	they	they	PRON
dpc-5733	121	24	increase	increase	VERB
dpc-5733	121	25	during	during	ADP
dpc-5733	121	26	treatment	treatment	NOUN
dpc-5733	121	27	[	[	X
dpc-5733	121	28	39	39	NUM
dpc-5733	121	29	]	]	PUNCT
dpc-5733	121	30	.	.	PUNCT
dpc-5733	122	1	we	we	PRON
dpc-5733	122	2	understand	understand	VERB
dpc-5733	122	3	that	that	SCONJ
dpc-5733	122	4	our	our	PRON
dpc-5733	122	5	results	result	NOUN
dpc-5733	122	6	need	need	VERB
dpc-5733	122	7	to	to	PART
dpc-5733	122	8	be	be	AUX
dpc-5733	122	9	implemented	implement	VERB
dpc-5733	122	10	and	and	CCONJ
dpc-5733	122	11	compared	compare	VERB
dpc-5733	122	12	with	with	ADP
dpc-5733	122	13	data	datum	NOUN
dpc-5733	122	14	on	on	ADP
dpc-5733	122	15	cutaneous	cutaneous	ADJ
dpc-5733	122	16	samples	sample	NOUN
dpc-5733	122	17	;	;	PUNCT
dpc-5733	122	18	however	however	ADV
dpc-5733	122	19	,	,	PUNCT
dpc-5733	122	20	due	due	ADP
dpc-5733	122	21	to	to	ADP
dpc-5733	122	22	the	the	DET
dpc-5733	122	23	very	very	ADV
dpc-5733	122	24	low	low	ADJ
dpc-5733	122	25	levels	level	NOUN
dpc-5733	122	26	of	of	ADP
dpc-5733	122	27	cutaneous	cutaneous	ADJ
dpc-5733	122	28	and	and	CCONJ
dpc-5733	122	29	peripheral	peripheral	ADJ
dpc-5733	122	30	basophils	basophil	NOUN
dpc-5733	122	31	,	,	PUNCT
dpc-5733	122	32	it	it	PRON
dpc-5733	122	33	may	may	AUX
dpc-5733	122	34	be	be	AUX
dpc-5733	122	35	difficult	difficult	ADJ
dpc-5733	122	36	to	to	PART
dpc-5733	122	37	dissect	dissect	VERB
dpc-5733	122	38	this	this	DET
dpc-5733	122	39	pathogenetic	pathogenetic	ADJ
dpc-5733	122	40	aspect	aspect	NOUN
dpc-5733	122	41	.	.	PUNCT
dpc-5733	123	1	indeed	indeed	ADV
dpc-5733	123	2	,	,	PUNCT
dpc-5733	123	3	a	a	DET
dpc-5733	123	4	next	next	ADJ
dpc-5733	123	5	step	step	NOUN
dpc-5733	123	6	could	could	AUX
dpc-5733	123	7	be	be	AUX
dpc-5733	123	8	to	to	PART
dpc-5733	123	9	prospectively	prospectively	ADV
dpc-5733	123	10	evaluate	evaluate	VERB
dpc-5733	123	11	52	52	NUM
dpc-5733	123	12	:	:	SYM
dpc-5733	123	13	10.13	10.13	NUM
dpc-5733	123	14	;	;	PUNCT
dpc-5733	123	15	iqr	iqr	NOUN
dpc-5733	123	16	:	:	PUNCT
dpc-5733	123	17	8.9	8.9	NUM
dpc-5733	123	18	-	-	SYM
dpc-5733	123	19	11.04	11.04	NUM
dpc-5733	123	20	;	;	PUNCT
dpc-5733	123	21	p=0.0001	p=0.0001	NOUN
dpc-5733	123	22	,	,	PUNCT
dpc-5733	123	23	reduction	reduction	NOUN
dpc-5733	123	24	)	)	PUNCT
dpc-5733	123	25	modified	modify	VERB
dpc-5733	123	26	overtime	overtime	NOUN
dpc-5733	123	27	.	.	PUNCT
dpc-5733	124	1	discussion	discussion	NOUN
dpc-5733	124	2	the	the	DET
dpc-5733	124	3	role	role	NOUN
dpc-5733	124	4	of	of	ADP
dpc-5733	124	5	cutaneous	cutaneous	ADJ
dpc-5733	124	6	and	and	CCONJ
dpc-5733	124	7	systemic	systemic	ADJ
dpc-5733	124	8	inflammation	inflammation	NOUN
dpc-5733	124	9	in	in	ADP
dpc-5733	124	10	psoriasis	psoriasis	NOUN
dpc-5733	124	11	has	have	AUX
dpc-5733	124	12	been	be	AUX
dpc-5733	124	13	extensively	extensively	ADV
dpc-5733	124	14	studied	study	VERB
dpc-5733	124	15	and	and	CCONJ
dpc-5733	124	16	demonstrated	demonstrate	VERB
dpc-5733	124	17	[	[	X
dpc-5733	124	18	15–17	15–17	NUM
dpc-5733	124	19	]	]	PUNCT
dpc-5733	124	20	.	.	PUNCT
dpc-5733	125	1	however	however	ADV
dpc-5733	125	2	,	,	PUNCT
dpc-5733	125	3	understanding	understand	VERB
dpc-5733	125	4	the	the	DET
dpc-5733	125	5	potential	potential	ADJ
dpc-5733	125	6	effect	effect	NOUN
dpc-5733	125	7	of	of	ADP
dpc-5733	125	8	systemic	systemic	ADJ
dpc-5733	125	9	treatment	treatment	NOUN
dpc-5733	125	10	at	at	ADP
dpc-5733	125	11	the	the	DET
dpc-5733	125	12	peripheral	peripheral	ADJ
dpc-5733	125	13	level	level	NOUN
dpc-5733	125	14	is	be	AUX
dpc-5733	125	15	still	still	ADV
dpc-5733	125	16	under	under	ADP
dpc-5733	125	17	investigation	investigation	NOUN
dpc-5733	125	18	.	.	PUNCT
dpc-5733	126	1	recently	recently	ADV
dpc-5733	126	2	,	,	PUNCT
dpc-5733	126	3	many	many	ADJ
dpc-5733	126	4	authors	author	NOUN
dpc-5733	126	5	have	have	AUX
dpc-5733	126	6	focused	focus	VERB
dpc-5733	126	7	on	on	ADP
dpc-5733	126	8	the	the	DET
dpc-5733	126	9	application	application	NOUN
dpc-5733	126	10	on	on	ADP
dpc-5733	126	11	simple	simple	ADJ
dpc-5733	126	12	indices	index	NOUN
dpc-5733	126	13	such	such	ADJ
dpc-5733	126	14	as	as	ADP
dpc-5733	126	15	the	the	DET
dpc-5733	126	16	ratio	ratio	NOUN
dpc-5733	126	17	between	between	ADP
dpc-5733	126	18	blood	blood	NOUN
dpc-5733	126	19	cells	cell	NOUN
dpc-5733	126	20	in	in	ADP
dpc-5733	126	21	order	order	NOUN
dpc-5733	126	22	to	to	PART
dpc-5733	126	23	identify	identify	VERB
dpc-5733	126	24	disease	disease	NOUN
dpc-5733	126	25	severity	severity	NOUN
dpc-5733	126	26	and	and	CCONJ
dpc-5733	126	27	activity	activity	NOUN
dpc-5733	126	28	markers	marker	NOUN
dpc-5733	126	29	in	in	ADP
dpc-5733	126	30	many	many	ADJ
dpc-5733	126	31	human	human	ADJ
dpc-5733	126	32	diseases	disease	NOUN
dpc-5733	126	33	,	,	PUNCT
dpc-5733	126	34	from	from	ADP
dpc-5733	126	35	cancer	cancer	NOUN
dpc-5733	126	36	to	to	ADP
dpc-5733	126	37	inflammatory	inflammatory	ADJ
dpc-5733	126	38	disorders	disorder	NOUN
dpc-5733	126	39	,	,	PUNCT
dpc-5733	126	40	including	include	VERB
dpc-5733	126	41	psoriasis	psoriasis	NOUN
dpc-5733	126	42	[	[	X
dpc-5733	126	43	5,12,18–22	5,12,18–22	NUM
dpc-5733	126	44	]	]	X
dpc-5733	126	45	.	.	PUNCT
dpc-5733	127	1	data	datum	NOUN
dpc-5733	127	2	in	in	ADP
dpc-5733	127	3	the	the	DET
dpc-5733	127	4	literature	literature	NOUN
dpc-5733	127	5	suggest	suggest	VERB
dpc-5733	127	6	that	that	SCONJ
dpc-5733	127	7	patients	patient	NOUN
dpc-5733	127	8	with	with	ADP
dpc-5733	127	9	cutaneous	cutaneous	ADJ
dpc-5733	127	10	psoriasis	psoriasis	NOUN
dpc-5733	127	11	and	and	CCONJ
dpc-5733	127	12	psa	psa	NOUN
dpc-5733	127	13	have	have	AUX
dpc-5733	127	14	significantly	significantly	ADV
dpc-5733	127	15	increased	increase	VERB
dpc-5733	127	16	nlr	nlr	PROPN
dpc-5733	127	17	,	,	PUNCT
dpc-5733	127	18	mlr	mlr	PROPN
dpc-5733	127	19	,	,	PUNCT
dpc-5733	127	20	plr	plr	NOUN
dpc-5733	127	21	,	,	PUNCT
dpc-5733	127	22	and	and	CCONJ
dpc-5733	127	23	sii	sii	PROPN
dpc-5733	127	24	compared	compare	VERB
dpc-5733	127	25	to	to	ADP
dpc-5733	127	26	controls	control	NOUN
dpc-5733	127	27	.	.	PUNCT
dpc-5733	128	1	moreover	moreover	ADV
dpc-5733	128	2	,	,	PUNCT
dpc-5733	128	3	nlr	nlr	PROPN
dpc-5733	128	4	and	and	CCONJ
dpc-5733	128	5	plr	plr	NOUN
dpc-5733	128	6	positively	positively	ADV
dpc-5733	128	7	correlate	correlate	VERB
dpc-5733	128	8	with	with	ADP
dpc-5733	128	9	the	the	DET
dpc-5733	128	10	mean	mean	ADJ
dpc-5733	128	11	pasi	pasi	NOUN
dpc-5733	128	12	scores	score	NOUN
dpc-5733	128	13	being	be	AUX
dpc-5733	128	14	significant	significant	ADJ
dpc-5733	128	15	indicators	indicator	NOUN
dpc-5733	128	16	of	of	ADP
dpc-5733	128	17	psoriasis	psoriasis	NOUN
dpc-5733	128	18	severity	severity	NOUN
dpc-5733	128	19	[	[	X
dpc-5733	128	20	11,12,23,24	11,12,23,24	NUM
dpc-5733	128	21	]	]	PUNCT
dpc-5733	128	22	.	.	PUNCT
dpc-5733	129	1	tiuca	tiuca	PROPN
dpc-5733	129	2	om	om	PROPN
dpc-5733	129	3	et	et	PROPN
dpc-5733	129	4	al.[25	al.[25	PROPN
dpc-5733	129	5	]	]	PUNCT
dpc-5733	129	6	suggested	suggest	VERB
dpc-5733	129	7	that	that	SCONJ
dpc-5733	129	8	patients	patient	NOUN
dpc-5733	129	9	with	with	ADP
dpc-5733	129	10	mild	mild	ADJ
dpc-5733	129	11	psoriasis	psoriasis	NOUN
dpc-5733	129	12	could	could	AUX
dpc-5733	129	13	be	be	AUX
dpc-5733	129	14	defined	define	VERB
dpc-5733	129	15	by	by	ADP
dpc-5733	129	16	wbc<6.25	wbc<6.25	PROPN
dpc-5733	129	17	,	,	PUNCT
dpc-5733	129	18	neutrophils	neutrophil	VERB
dpc-5733	129	19	<	<	X
dpc-5733	129	20	3.64	3.64	NUM
dpc-5733	129	21	,	,	PUNCT
dpc-5733	129	22	nlr	nlr	PROPN
dpc-5733	129	23	<	<	PROPN
dpc-5733	129	24	2.35	2.35	NUM
dpc-5733	129	25	,	,	PUNCT
dpc-5733	129	26	d	d	PROPN
dpc-5733	129	27	-	-	PUNCT
dpc-5733	129	28	nlr	nlr	NOUN
dpc-5733	129	29	<	<	PROPN
dpc-5733	129	30	1.49	1.49	NUM
dpc-5733	129	31	,	,	PUNCT
dpc-5733	129	32	and	and	CCONJ
dpc-5733	129	33	sii	sii	PROPN
dpc-5733	129	34	<	<	X
dpc-5733	129	35	408.8	408.8	NUM
dpc-5733	129	36	.	.	PUNCT
dpc-5733	130	1	in	in	ADP
dpc-5733	130	2	our	our	PRON
dpc-5733	130	3	opinion	opinion	NOUN
dpc-5733	130	4	,	,	PUNCT
dpc-5733	130	5	these	these	DET
dpc-5733	130	6	data	datum	NOUN
dpc-5733	130	7	need	need	VERB
dpc-5733	130	8	to	to	PART
dpc-5733	130	9	be	be	AUX
dpc-5733	130	10	carefully	carefully	ADV
dpc-5733	130	11	validated	validate	VERB
dpc-5733	130	12	and	and	CCONJ
dpc-5733	130	13	correlated	correlate	VERB
dpc-5733	130	14	to	to	ADP
dpc-5733	130	15	clinical	clinical	ADJ
dpc-5733	130	16	cutaneous	cutaneous	ADJ
dpc-5733	130	17	and	and	CCONJ
dpc-5733	130	18	general	general	ADJ
dpc-5733	130	19	features	feature	NOUN
dpc-5733	130	20	of	of	ADP
dpc-5733	130	21	each	each	DET
dpc-5733	130	22	patient	patient	NOUN
dpc-5733	130	23	.	.	PUNCT
dpc-5733	131	1	in	in	ADP
dpc-5733	131	2	our	our	PRON
dpc-5733	131	3	patients	patient	NOUN
dpc-5733	131	4	,	,	PUNCT
dpc-5733	131	5	no	no	DET
dpc-5733	131	6	correlation	correlation	NOUN
dpc-5733	131	7	was	be	AUX
dpc-5733	131	8	found	find	VERB
dpc-5733	131	9	between	between	ADP
dpc-5733	131	10	inflammatory	inflammatory	ADJ
dpc-5733	131	11	indices	index	NOUN
dpc-5733	131	12	and	and	CCONJ
dpc-5733	131	13	disease	disease	NOUN
dpc-5733	131	14	severity	severity	NOUN
dpc-5733	131	15	,	,	PUNCT
dpc-5733	131	16	with	with	ADP
dpc-5733	131	17	the	the	DET
dpc-5733	131	18	exception	exception	NOUN
dpc-5733	131	19	of	of	ADP
dpc-5733	131	20	patients	patient	NOUN
dpc-5733	131	21	that	that	PRON
dpc-5733	131	22	had	have	VERB
dpc-5733	131	23	a	a	DET
dpc-5733	131	24	lower	low	ADJ
dpc-5733	131	25	response	response	NOUN
dpc-5733	131	26	to	to	PART
dpc-5733	131	27	risankizumab	risankizumab	VERB
dpc-5733	131	28	.	.	PUNCT
dpc-5733	132	1	this	this	PRON
dpc-5733	132	2	fits	fit	VERB
dpc-5733	132	3	with	with	ADP
dpc-5733	132	4	the	the	DET
dpc-5733	132	5	concept	concept	NOUN
dpc-5733	132	6	that	that	SCONJ
dpc-5733	132	7	nlr	nlr	PROPN
dpc-5733	132	8	might	might	AUX
dpc-5733	132	9	serve	serve	VERB
dpc-5733	132	10	as	as	ADP
dpc-5733	132	11	marker	marker	NOUN
dpc-5733	132	12	of	of	ADP
dpc-5733	132	13	global	global	ADJ
dpc-5733	132	14	disease	disease	NOUN
dpc-5733	132	15	severity	severity	NOUN
dpc-5733	132	16	.	.	PUNCT
dpc-5733	133	1	indeed	indeed	ADV
dpc-5733	133	2	,	,	PUNCT
dpc-5733	133	3	lr	lr	PROPN
dpc-5733	133	4	patients	patient	NOUN
dpc-5733	133	5	had	have	VERB
dpc-5733	133	6	higher	high	ADJ
dpc-5733	133	7	nlr	nlr	PROPN
dpc-5733	133	8	levels	level	NOUN
dpc-5733	133	9	at	at	ADP
dpc-5733	133	10	week	week	NOUN
dpc-5733	133	11	52	52	NUM
dpc-5733	133	12	compared	compare	VERB
dpc-5733	133	13	to	to	ADP
dpc-5733	133	14	sr	sr	PROPN
dpc-5733	133	15	group	group	NOUN
dpc-5733	133	16	,	,	PUNCT
dpc-5733	133	17	and	and	CCONJ
dpc-5733	133	18	changes	change	NOUN
dpc-5733	133	19	in	in	ADP
dpc-5733	133	20	nlr	nlr	PROPN
dpc-5733	133	21	were	be	AUX
dpc-5733	133	22	correlated	correlate	VERB
dpc-5733	133	23	to	to	ADP
dpc-5733	133	24	changes	change	NOUN
dpc-5733	133	25	in	in	ADP
dpc-5733	133	26	pasi	pasi	NOUN
dpc-5733	133	27	score	score	NOUN
dpc-5733	133	28	.	.	PUNCT
dpc-5733	134	1	modulation	modulation	NOUN
dpc-5733	134	2	of	of	ADP
dpc-5733	134	3	inflammatory	inflammatory	ADJ
dpc-5733	134	4	indices	index	NOUN
dpc-5733	134	5	during	during	ADP
dpc-5733	134	6	systemic	systemic	ADJ
dpc-5733	134	7	and	and	CCONJ
dpc-5733	134	8	biologic	biologic	NOUN
dpc-5733	134	9	therapies	therapy	NOUN
dpc-5733	134	10	has	have	AUX
dpc-5733	134	11	been	be	AUX
dpc-5733	134	12	reported	report	VERB
dpc-5733	134	13	,	,	PUNCT
dpc-5733	134	14	suggesting	suggest	VERB
dpc-5733	134	15	that	that	SCONJ
dpc-5733	134	16	treatment	treatment	NOUN
dpc-5733	134	17	efficacy	efficacy	NOUN
dpc-5733	134	18	could	could	AUX
dpc-5733	134	19	impact	impact	VERB
dpc-5733	134	20	the	the	DET
dpc-5733	134	21	total	total	ADJ
dpc-5733	134	22	inflammatory	inflammatory	ADJ
dpc-5733	134	23	overload	overload	NOUN
dpc-5733	134	24	in	in	ADP
dpc-5733	134	25	patients	patient	NOUN
dpc-5733	134	26	who	who	PRON
dpc-5733	134	27	are	be	AUX
dpc-5733	134	28	at	at	ADP
dpc-5733	134	29	risk	risk	NOUN
dpc-5733	134	30	or	or	CCONJ
dpc-5733	134	31	are	be	AUX
dpc-5733	134	32	affected	affect	VERB
dpc-5733	134	33	with	with	ADP
dpc-5733	134	34	several	several	ADJ
dpc-5733	134	35	comorbidities	comorbiditie	NOUN
dpc-5733	134	36	such	such	ADJ
dpc-5733	134	37	as	as	ADP
dpc-5733	134	38	diabetes	diabetes	NOUN
dpc-5733	134	39	,	,	PUNCT
dpc-5733	134	40	dyslipidemia	dyslipidemia	NOUN
dpc-5733	134	41	,	,	PUNCT
dpc-5733	134	42	or	or	CCONJ
dpc-5733	134	43	hypertension	hypertension	NOUN
dpc-5733	134	44	.	.	PUNCT
dpc-5733	135	1	indeed	indeed	ADV
dpc-5733	135	2	,	,	PUNCT
dpc-5733	135	3	all	all	DET
dpc-5733	135	4	the	the	DET
dpc-5733	135	5	above	above	ADV
dpc-5733	135	6	mentioned	mention	VERB
dpc-5733	135	7	diseases	disease	NOUN
dpc-5733	135	8	have	have	AUX
dpc-5733	135	9	been	be	AUX
dpc-5733	135	10	linked	link	VERB
dpc-5733	135	11	to	to	ADP
dpc-5733	135	12	increases	increase	NOUN
dpc-5733	135	13	in	in	ADP
dpc-5733	135	14	such	such	ADJ
dpc-5733	135	15	parameters	parameter	NOUN
dpc-5733	135	16	[	[	X
dpc-5733	135	17	26–32	26–32	NUM
dpc-5733	135	18	]	]	PUNCT
dpc-5733	135	19	.	.	PUNCT
dpc-5733	136	1	risankizumab	risankizumab	PROPN
dpc-5733	136	2	is	be	AUX
dpc-5733	136	3	one	one	NUM
dpc-5733	136	4	of	of	ADP
dpc-5733	136	5	the	the	DET
dpc-5733	136	6	latest	late	ADJ
dpc-5733	136	7	molecules	molecule	NOUN
dpc-5733	136	8	introduced	introduce	VERB
dpc-5733	136	9	for	for	ADP
dpc-5733	136	10	psoriasis	psoriasis	NOUN
dpc-5733	136	11	and	and	CCONJ
dpc-5733	136	12	psa	psa	VERB
dpc-5733	136	13	,	,	PUNCT
dpc-5733	136	14	one	one	NUM
dpc-5733	136	15	of	of	ADP
dpc-5733	136	16	the	the	DET
dpc-5733	136	17	anti	anti	ADJ
dpc-5733	136	18	-	-	ADJ
dpc-5733	136	19	il-23p19	il-23p19	ADJ
dpc-5733	136	20	agents	agent	NOUN
dpc-5733	136	21	,	,	PUNCT
dpc-5733	136	22	which	which	PRON
dpc-5733	136	23	have	have	AUX
dpc-5733	136	24	been	be	AUX
dpc-5733	136	25	proposed	propose	VERB
dpc-5733	136	26	as	as	ADP
dpc-5733	136	27	having	have	VERB
dpc-5733	136	28	a	a	DET
dpc-5733	136	29	disease	disease	NOUN
dpc-5733	136	30	-	-	PUNCT
dpc-5733	136	31	modifying	modify	VERB
dpc-5733	136	32	effect	effect	NOUN
dpc-5733	136	33	[	[	X
dpc-5733	136	34	33–36	33–36	NUM
dpc-5733	136	35	]	]	PUNCT
dpc-5733	136	36	.	.	PUNCT
dpc-5733	137	1	understanding	understand	VERB
dpc-5733	137	2	the	the	DET
dpc-5733	137	3	ability	ability	NOUN
dpc-5733	137	4	of	of	ADP
dpc-5733	137	5	risankizumab	risankizumab	NOUN
dpc-5733	137	6	to	to	PART
dpc-5733	137	7	obtain	obtain	VERB
dpc-5733	137	8	general	general	ADJ
dpc-5733	137	9	anti	anti	ADJ
dpc-5733	137	10	-	-	ADJ
dpc-5733	137	11	inflammatory	inflammatory	ADJ
dpc-5733	137	12	effect	effect	NOUN
dpc-5733	137	13	could	could	AUX
dpc-5733	137	14	add	add	VERB
dpc-5733	137	15	relevant	relevant	ADJ
dpc-5733	137	16	information	information	NOUN
dpc-5733	137	17	for	for	ADP
dpc-5733	137	18	therapeutic	therapeutic	ADJ
dpc-5733	137	19	decision	decision	NOUN
dpc-5733	137	20	making	make	VERB
dpc-5733	137	21	and	and	CCONJ
dpc-5733	137	22	timing	timing	NOUN
dpc-5733	137	23	.	.	PUNCT
dpc-5733	138	1	indeed	indeed	ADV
dpc-5733	138	2	,	,	PUNCT
dpc-5733	138	3	it	it	PRON
dpc-5733	138	4	has	have	AUX
dpc-5733	138	5	been	be	AUX
dpc-5733	138	6	reported	report	VERB
dpc-5733	138	7	that	that	SCONJ
dpc-5733	138	8	mlr	mlr	NOUN
dpc-5733	138	9	,	,	PUNCT
dpc-5733	138	10	nmlr	nmlr	NOUN
dpc-5733	138	11	(	(	PUNCT
dpc-5733	138	12	neutrophils+monocytes)/lymphocytes	neutrophils+monocytes)/lymphocyte	NOUN
dpc-5733	138	13	)	)	PUNCT
dpc-5733	138	14	,	,	PUNCT
dpc-5733	138	15	and	and	CCONJ
dpc-5733	138	16	siri	siri	NOUN
dpc-5733	138	17	positively	positively	ADV
dpc-5733	138	18	correlate	correlate	VERB
dpc-5733	138	19	with	with	ADP
dpc-5733	138	20	mortality	mortality	NOUN
dpc-5733	138	21	in	in	ADP
dpc-5733	138	22	patients	patient	NOUN
dpc-5733	138	23	with	with	ADP
dpc-5733	138	24	psoriasis	psoriasis	NOUN
dpc-5733	138	25	[	[	X
dpc-5733	138	26	37	37	NUM
dpc-5733	138	27	]	]	PUNCT
dpc-5733	138	28	.	.	PUNCT
dpc-5733	139	1	albayrak	albayrak	PROPN
dpc-5733	139	2	h.	h.	PROPN
dpc-5733	140	1	[	[	X
dpc-5733	140	2	38	38	NUM
dpc-5733	140	3	]	]	PUNCT
dpc-5733	140	4	described	describe	VERB
dpc-5733	140	5	nlr	nlr	PROPN
dpc-5733	140	6	,	,	PUNCT
dpc-5733	140	7	mlr	mlr	PROPN
dpc-5733	140	8	,	,	PUNCT
dpc-5733	140	9	plr	plr	NOUN
dpc-5733	140	10	,	,	PUNCT
dpc-5733	140	11	sii	sii	PROPN
dpc-5733	140	12	,	,	PUNCT
dpc-5733	140	13	and	and	CCONJ
dpc-5733	140	14	neutrophil	neutrophil	NOUN
dpc-5733	140	15	-	-	PUNCT
dpc-5733	140	16	to	to	ADP
dpc-5733	140	17	-	-	PUNCT
dpc-5733	140	18	monocyte	monocyte	NOUN
dpc-5733	140	19	ratio	ratio	NOUN
dpc-5733	140	20	(	(	PUNCT
dpc-5733	140	21	nmr	nmr	NOUN
dpc-5733	140	22	)	)	PUNCT
dpc-5733	140	23	variation	variation	NOUN
dpc-5733	140	24	during	during	ADP
dpc-5733	140	25	methotrexate	methotrexate	NOUN
dpc-5733	140	26	,	,	PUNCT
dpc-5733	140	27	acitretin	acitretin	NOUN
dpc-5733	140	28	,	,	PUNCT
dpc-5733	140	29	and	and	CCONJ
dpc-5733	140	30	anti	anti	ADJ
dpc-5733	140	31	-	-	ADJ
dpc-5733	140	32	tnf	tnf	ADJ
dpc-5733	140	33	agents	agent	NOUN
dpc-5733	140	34	,	,	PUNCT
dpc-5733	140	35	suggesting	suggest	VERB
dpc-5733	140	36	that	that	SCONJ
dpc-5733	140	37	biologics	biologic	NOUN
dpc-5733	140	38	are	be	AUX
dpc-5733	140	39	more	more	ADV
dpc-5733	140	40	effective	effective	ADJ
dpc-5733	140	41	in	in	ADP
dpc-5733	140	42	reducing	reduce	VERB
dpc-5733	140	43	inflammation	inflammation	NOUN
dpc-5733	140	44	.	.	PUNCT
dpc-5733	140	45	8	8	NUM
dpc-5733	140	46	original	original	ADJ
dpc-5733	140	47	article	article	NOUN
dpc-5733	140	48	|	|	ADV
dpc-5733	140	49	dermatol	dermatol	ADJ
dpc-5733	140	50	pract	pract	NOUN
dpc-5733	140	51	concept	concept	NOUN
dpc-5733	140	52	.	.	PUNCT
dpc-5733	141	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	141	2	this	this	DET
dpc-5733	141	3	manuscript	manuscript	NOUN
dpc-5733	141	4	gave	give	VERB
dpc-5733	141	5	their	their	PRON
dpc-5733	141	6	written	write	VERB
dpc-5733	141	7	informed	inform	VERB
dpc-5733	141	8	consent	consent	NOUN
dpc-5733	141	9	to	to	ADP
dpc-5733	141	10	the	the	DET
dpc-5733	141	11	publication	publication	NOUN
dpc-5733	141	12	of	of	ADP
dpc-5733	141	13	their	their	PRON
dpc-5733	141	14	case	case	NOUN
dpc-5733	141	15	details	detail	NOUN
dpc-5733	141	16	.	.	PUNCT
dpc-5733	142	1	references	reference	NOUN
dpc-5733	142	2	1	1	NUM
dpc-5733	142	3	.	.	PUNCT
dpc-5733	142	4	guo	guo	PROPN
dpc-5733	142	5	l	l	PROPN
dpc-5733	142	6	,	,	PUNCT
dpc-5733	142	7	huang	huang	PROPN
dpc-5733	142	8	y	y	PROPN
dpc-5733	142	9	,	,	PUNCT
dpc-5733	142	10	he	he	PRON
dpc-5733	142	11	j	j	PROPN
dpc-5733	142	12	,	,	PUNCT
dpc-5733	142	13	li	li	PROPN
dpc-5733	142	14	d	d	PROPN
dpc-5733	142	15	,	,	PUNCT
dpc-5733	142	16	li	li	PROPN
dpc-5733	142	17	w	w	PROPN
dpc-5733	142	18	,	,	PUNCT
dpc-5733	142	19	xiao	xiao	PROPN
dpc-5733	142	20	h	h	PROPN
dpc-5733	142	21	,	,	PUNCT
dpc-5733	142	22	xu	xu	PROPN
dpc-5733	142	23	x	x	PROPN
dpc-5733	142	24	,	,	PUNCT
dpc-5733	142	25	zhang	zhang	PROPN
dpc-5733	142	26	y	y	PROPN
dpc-5733	142	27	,	,	PUNCT
dpc-5733	142	28	wang	wang	PROPN
dpc-5733	142	29	r.	r.	PROPN
dpc-5733	142	30	associations	associations	PROPN
dpc-5733	142	31	of	of	ADP
dpc-5733	142	32	lifestyle	lifestyle	NOUN
dpc-5733	142	33	characteristics	characteristic	NOUN
dpc-5733	142	34	with	with	ADP
dpc-5733	142	35	circulating	circulate	VERB
dpc-5733	142	36	immune	immune	ADJ
dpc-5733	142	37	markers	marker	NOUN
dpc-5733	142	38	in	in	ADP
dpc-5733	142	39	the	the	DET
dpc-5733	142	40	general	general	ADJ
dpc-5733	142	41	population	population	NOUN
dpc-5733	142	42	based	base	VERB
dpc-5733	142	43	on	on	ADP
dpc-5733	142	44	nhanes	nhane	NOUN
dpc-5733	142	45	1999	1999	NUM
dpc-5733	142	46	to	to	ADP
dpc-5733	142	47	2014	2014	NUM
dpc-5733	142	48	.	.	PUNCT
dpc-5733	143	1	sci	sci	PROPN
dpc-5733	143	2	rep	rep	PROPN
dpc-5733	143	3	.	.	PROPN
dpc-5733	143	4	2024	2024	NUM
dpc-5733	143	5	jun	jun	PROPN
dpc-5733	143	6	11;14(1):13444	11;14(1):13444	NUM
dpc-5733	143	7	.	.	PUNCT
dpc-5733	144	1	doi	doi	NOUN
dpc-5733	144	2	:	:	PUNCT
dpc-5733	144	3	10.1038	10.1038	NUM
dpc-5733	144	4	/s41598	/s41598	ADJ
dpc-5733	144	5	-	-	PUNCT
dpc-5733	144	6	024	024	NUM
dpc-5733	144	7	-	-	PUNCT
dpc-5733	144	8	63875	63875	NUM
dpc-5733	144	9	-	-	SYM
dpc-5733	144	10	2	2	NUM
dpc-5733	144	11	.	.	PUNCT
dpc-5733	144	12	pmid	pmid	NOUN
dpc-5733	144	13	:	:	PUNCT
dpc-5733	144	14	38862546	38862546	NUM
dpc-5733	144	15	.	.	PUNCT
dpc-5733	145	1	2	2	X
dpc-5733	145	2	.	.	X
dpc-5733	145	3	buonacera	buonacera	PROPN
dpc-5733	145	4	a	a	X
dpc-5733	145	5	,	,	PUNCT
dpc-5733	145	6	stancanelli	stancanelli	PROPN
dpc-5733	145	7	b	b	PROPN
dpc-5733	145	8	,	,	PUNCT
dpc-5733	145	9	colaci	colaci	PROPN
dpc-5733	145	10	m	m	PRON
dpc-5733	145	11	,	,	PUNCT
dpc-5733	145	12	malatino	malatino	PROPN
dpc-5733	145	13	l.	l.	PROPN
dpc-5733	145	14	neutrophil	neutrophil	PROPN
dpc-5733	145	15	to	to	ADP
dpc-5733	145	16	lymphocyte	lymphocyte	ADJ
dpc-5733	145	17	ratio	ratio	NOUN
dpc-5733	145	18	:	:	PUNCT
dpc-5733	145	19	an	an	DET
dpc-5733	145	20	emerging	emerge	VERB
dpc-5733	145	21	marker	marker	NOUN
dpc-5733	145	22	of	of	ADP
dpc-5733	145	23	the	the	DET
dpc-5733	145	24	relationships	relationship	NOUN
dpc-5733	145	25	between	between	ADP
dpc-5733	145	26	the	the	DET
dpc-5733	145	27	immune	immune	ADJ
dpc-5733	145	28	system	system	NOUN
dpc-5733	145	29	and	and	CCONJ
dpc-5733	145	30	diseases	disease	NOUN
dpc-5733	145	31	.	.	PUNCT
dpc-5733	146	1	int	int	PROPN
dpc-5733	146	2	j	j	PROPN
dpc-5733	146	3	mol	mol	ADP
dpc-5733	146	4	sci	sci	PROPN
dpc-5733	146	5	.	.	PROPN
dpc-5733	147	1	2022	2022	NUM
dpc-5733	147	2	mar	mar	PROPN
dpc-5733	147	3	26;23(7):3636	26;23(7):3636	PROPN
dpc-5733	147	4	.	.	PUNCT
dpc-5733	148	1	doi	doi	NOUN
dpc-5733	148	2	:	:	PUNCT
dpc-5733	148	3	10.3390	10.3390	NUM
dpc-5733	148	4	/	/	SYM
dpc-5733	148	5	ijms23073636	ijms23073636	PROPN
dpc-5733	148	6	.	.	PUNCT
dpc-5733	149	1	pmid	pmid	NOUN
dpc-5733	149	2	:	:	PUNCT
dpc-5733	149	3	35408994	35408994	NUM
dpc-5733	149	4	.	.	PUNCT
dpc-5733	150	1	3	3	X
dpc-5733	150	2	.	.	X
dpc-5733	151	1	islam	islam	PROPN
dpc-5733	151	2	mm	mm	PROPN
dpc-5733	151	3	,	,	PUNCT
dpc-5733	151	4	satici	satici	PROPN
dpc-5733	151	5	mo	mo	PROPN
dpc-5733	151	6	,	,	PUNCT
dpc-5733	151	7	eroglu	eroglu	PROPN
dpc-5733	151	8	se	se	X
dpc-5733	151	9	.	.	PUNCT
dpc-5733	152	1	unraveling	unravel	VERB
dpc-5733	152	2	the	the	DET
dpc-5733	152	3	clinical	clinical	ADJ
dpc-5733	152	4	significance	significance	NOUN
dpc-5733	152	5	and	and	CCONJ
dpc-5733	152	6	prognostic	prognostic	ADJ
dpc-5733	152	7	value	value	NOUN
dpc-5733	152	8	of	of	ADP
dpc-5733	152	9	the	the	DET
dpc-5733	152	10	neutrophil	neutrophil	NOUN
dpc-5733	152	11	-	-	PUNCT
dpc-5733	152	12	to	to	ADP
dpc-5733	152	13	-	-	PUNCT
dpc-5733	152	14	lymphocyte	lymphocyte	NOUN
dpc-5733	152	15	ratio	ratio	NOUN
dpc-5733	152	16	,	,	PUNCT
dpc-5733	152	17	platelet	platelet	NOUN
dpc-5733	152	18	-	-	PUNCT
dpc-5733	152	19	to	to	ADP
dpc-5733	152	20	-	-	PUNCT
dpc-5733	152	21	lymphocyte	lymphocyte	NOUN
dpc-5733	152	22	ratio	ratio	NOUN
dpc-5733	152	23	,	,	PUNCT
dpc-5733	152	24	systemic	systemic	ADJ
dpc-5733	152	25	immune	immune	NOUN
dpc-5733	152	26	-	-	PUNCT
dpc-5733	152	27	inflammation	inflammation	NOUN
dpc-5733	152	28	index	index	NOUN
dpc-5733	152	29	,	,	PUNCT
dpc-5733	152	30	systemic	systemic	ADJ
dpc-5733	152	31	inflammation	inflammation	ADJ
dpc-5733	152	32	response	response	NOUN
dpc-5733	152	33	index	index	NOUN
dpc-5733	152	34	,	,	PUNCT
dpc-5733	152	35	and	and	CCONJ
dpc-5733	152	36	delta	delta	PROPN
dpc-5733	152	37	neutrophil	neutrophil	PROPN
dpc-5733	152	38	index	index	PROPN
dpc-5733	152	39	:	:	PUNCT
dpc-5733	152	40	an	an	DET
dpc-5733	152	41	extensive	extensive	ADJ
dpc-5733	152	42	literature	literature	NOUN
dpc-5733	152	43	review	review	NOUN
dpc-5733	152	44	.	.	PUNCT
dpc-5733	153	1	turk	turk	PROPN
dpc-5733	153	2	j	j	PROPN
dpc-5733	153	3	emerg	emerg	PROPN
dpc-5733	153	4	med	med	PROPN
dpc-5733	153	5	.	.	PUNCT
dpc-5733	154	1	2024	2024	NUM
dpc-5733	154	2	jan	jan	PROPN
dpc-5733	154	3	8;24(1):8	8;24(1):8	NUM
dpc-5733	154	4	-	-	SYM
dpc-5733	154	5	19	19	NUM
dpc-5733	154	6	.	.	PUNCT
dpc-5733	154	7	doi	doi	NOUN
dpc-5733	154	8	:	:	PUNCT
dpc-5733	154	9	10.4103	10.4103	NUM
dpc-5733	154	10	/	/	SYM
dpc-5733	154	11	tjem.tjem_198_23	tjem.tjem_198_23	NOUN
dpc-5733	154	12	.	.	PUNCT
dpc-5733	155	1	pmid	pmid	NOUN
dpc-5733	155	2	:	:	PUNCT
dpc-5733	155	3	38343523	38343523	NUM
dpc-5733	155	4	.	.	PUNCT
dpc-5733	156	1	4	4	X
dpc-5733	156	2	.	.	X
dpc-5733	156	3	zahorec	zahorec	PROPN
dpc-5733	156	4	r.	r.	PROPN
dpc-5733	156	5	neutrophil	neutrophil	PROPN
dpc-5733	156	6	-	-	PUNCT
dpc-5733	156	7	to	to	ADP
dpc-5733	156	8	-	-	PUNCT
dpc-5733	156	9	lymphocyte	lymphocyte	NOUN
dpc-5733	156	10	ratio	ratio	NOUN
dpc-5733	156	11	,	,	PUNCT
dpc-5733	156	12	past	past	NOUN
dpc-5733	156	13	,	,	PUNCT
dpc-5733	156	14	present	present	ADJ
dpc-5733	156	15	and	and	CCONJ
dpc-5733	156	16	future	future	ADJ
dpc-5733	156	17	perspectives	perspective	NOUN
dpc-5733	156	18	.	.	PUNCT
dpc-5733	157	1	bratisl	bratisl	PROPN
dpc-5733	157	2	lek	lek	PROPN
dpc-5733	157	3	listy	listy	PROPN
dpc-5733	157	4	.	.	PUNCT
dpc-5733	158	1	2021;122(7):474	2021;122(7):474	NUM
dpc-5733	158	2	-	-	SYM
dpc-5733	158	3	488	488	NUM
dpc-5733	159	1	.	.	PUNCT
dpc-5733	159	2	doi	doi	NOUN
dpc-5733	159	3	:	:	PUNCT
dpc-5733	159	4	10.4149	10.4149	NUM
dpc-5733	159	5	/	/	SYM
dpc-5733	159	6	bll_2021_078	bll_2021_078	ADV
dpc-5733	159	7	.	.	PUNCT
dpc-5733	160	1	pmid	pmid	NOUN
dpc-5733	160	2	:	:	PUNCT
dpc-5733	160	3	34161115	34161115	NUM
dpc-5733	160	4	.	.	PUNCT
dpc-5733	161	1	5	5	X
dpc-5733	161	2	.	.	NOUN
dpc-5733	161	3	gambichler	gambichler	PROPN
dpc-5733	161	4	t	t	PROPN
dpc-5733	161	5	,	,	PUNCT
dpc-5733	161	6	hessam	hessam	PROPN
dpc-5733	161	7	s	s	PROPN
dpc-5733	161	8	,	,	PUNCT
dpc-5733	161	9	cramer	cramer	PROPN
dpc-5733	161	10	p	p	NOUN
dpc-5733	161	11	,	,	PUNCT
dpc-5733	161	12	abu	abu	PROPN
dpc-5733	161	13	rached	rache	VERB
dpc-5733	161	14	n	n	PROPN
dpc-5733	161	15	,	,	PUNCT
dpc-5733	161	16	bechara	bechara	PROPN
dpc-5733	162	1	fg	fg	PROPN
dpc-5733	162	2	.	.	PROPN
dpc-5733	162	3	complete	complete	ADJ
dpc-5733	162	4	blood	blood	NOUN
dpc-5733	162	5	collection	collection	NOUN
dpc-5733	162	6	-	-	PUNCT
dpc-5733	162	7	based	base	VERB
dpc-5733	162	8	systemic	systemic	ADJ
dpc-5733	162	9	inflammation	inflammation	NOUN
dpc-5733	162	10	biomarkers	biomarker	NOUN
dpc-5733	162	11	for	for	ADP
dpc-5733	162	12	patients	patient	NOUN
dpc-5733	162	13	with	with	ADP
dpc-5733	162	14	hidradenitis	hidradenitis	PROPN
dpc-5733	162	15	suppurativa	suppurativa	PROPN
dpc-5733	162	16	.	.	PUNCT
dpc-5733	163	1	j	j	PROPN
dpc-5733	163	2	eur	eur	PROPN
dpc-5733	163	3	acad	acad	PROPN
dpc-5733	163	4	dermatol	dermatol	NOUN
dpc-5733	163	5	venereol	venereol	NOUN
dpc-5733	163	6	.	.	PUNCT
dpc-5733	164	1	2022	2022	NUM
dpc-5733	164	2	sep;36(9):1593	sep;36(9):1593	PROPN
dpc-5733	164	3	-	-	PUNCT
dpc-5733	164	4	1596	1596	NUM
dpc-5733	164	5	.	.	PUNCT
dpc-5733	165	1	doi	doi	NOUN
dpc-5733	165	2	:	:	PUNCT
dpc-5733	165	3	10.1111	10.1111	NUM
dpc-5733	165	4	/	/	SYM
dpc-5733	165	5	jdv.18175	jdv.18175	PROPN
dpc-5733	165	6	.	.	PUNCT
dpc-5733	166	1	epub	epub	NOUN
dpc-5733	166	2	2022	2022	NUM
dpc-5733	166	3	may	may	AUX
dpc-5733	166	4	7	7	NUM
dpc-5733	166	5	.	.	PUNCT
dpc-5733	167	1	pmid	pmid	NOUN
dpc-5733	167	2	:	:	PUNCT
dpc-5733	167	3	35462426	35462426	NUM
dpc-5733	167	4	.	.	PUNCT
dpc-5733	168	1	6	6	NUM
dpc-5733	168	2	.	.	X
dpc-5733	168	3	li	li	PROPN
dpc-5733	168	4	w	w	PROPN
dpc-5733	168	5	,	,	PUNCT
dpc-5733	168	6	wang	wang	PROPN
dpc-5733	168	7	x	x	PROPN
dpc-5733	168	8	,	,	PUNCT
dpc-5733	168	9	diao	diao	PROPN
dpc-5733	168	10	h	h	PROPN
dpc-5733	168	11	,	,	PUNCT
dpc-5733	168	12	yang	yang	PROPN
dpc-5733	168	13	y	y	PROPN
dpc-5733	168	14	,	,	PUNCT
dpc-5733	168	15	ding	ding	NOUN
dpc-5733	168	16	l	l	PROPN
dpc-5733	168	17	,	,	PUNCT
dpc-5733	168	18	huan	huan	PROPN
dpc-5733	168	19	w	w	PROPN
dpc-5733	168	20	,	,	PUNCT
dpc-5733	168	21	chen	chen	PROPN
dpc-5733	168	22	y	y	PROPN
dpc-5733	168	23	,	,	PUNCT
dpc-5733	168	24	cui	cui	VERB
dpc-5733	168	25	w.	w.	PROPN
dpc-5733	168	26	systemic	systemic	PROPN
dpc-5733	168	27	immune	immune	ADJ
dpc-5733	168	28	inflammation	inflammation	NOUN
dpc-5733	168	29	index	index	NOUN
dpc-5733	168	30	with	with	ADP
dpc-5733	168	31	all	all	DET
dpc-5733	168	32	-	-	PUNCT
dpc-5733	168	33	cause	cause	NOUN
dpc-5733	168	34	and	and	CCONJ
dpc-5733	168	35	cause	cause	VERB
dpc-5733	168	36	specific	specific	ADJ
dpc-5733	168	37	mortality	mortality	NOUN
dpc-5733	168	38	:	:	PUNCT
dpc-5733	168	39	a	a	DET
dpc-5733	168	40	meta	meta	ADJ
dpc-5733	168	41	-	-	PUNCT
dpc-5733	168	42	analysis	analysis	NOUN
dpc-5733	168	43	.	.	PUNCT
dpc-5733	169	1	inflamm	inflamm	PROPN
dpc-5733	169	2	res	re	NOUN
dpc-5733	169	3	.	.	PUNCT
dpc-5733	170	1	2024	2024	NUM
dpc-5733	170	2	dec;73	dec;73	ADJ
dpc-5733	170	3	(	(	PUNCT
dpc-5733	170	4	12):2199	12):2199	NUM
dpc-5733	170	5	-	-	SYM
dpc-5733	170	6	2216	2216	NUM
dpc-5733	170	7	.	.	PUNCT
dpc-5733	171	1	doi	doi	NOUN
dpc-5733	171	2	:	:	PUNCT
dpc-5733	171	3	10.1007	10.1007	NUM
dpc-5733	171	4	/	/	SYM
dpc-5733	171	5	s00011	s00011	NUM
dpc-5733	171	6	-	-	PUNCT
dpc-5733	171	7	024	024	NUM
dpc-5733	171	8	-	-	PUNCT
dpc-5733	171	9	01959	01959	NUM
dpc-5733	171	10	-	-	SYM
dpc-5733	171	11	5	5	NUM
dpc-5733	171	12	.	.	PUNCT
dpc-5733	172	1	epub	epub	NOUN
dpc-5733	172	2	2024	2024	NUM
dpc-5733	172	3	oct	oct	PROPN
dpc-5733	172	4	14	14	NUM
dpc-5733	172	5	.	.	PUNCT
dpc-5733	173	1	pmid	pmid	NOUN
dpc-5733	173	2	:	:	PUNCT
dpc-5733	173	3	39400697	39400697	NUM
dpc-5733	173	4	.	.	PUNCT
dpc-5733	174	1	7	7	X
dpc-5733	174	2	.	.	X
dpc-5733	174	3	pang	pang	PROPN
dpc-5733	174	4	j	j	PROPN
dpc-5733	174	5	,	,	PUNCT
dpc-5733	174	6	ding	ding	NOUN
dpc-5733	174	7	n	n	CCONJ
dpc-5733	174	8	,	,	PUNCT
dpc-5733	174	9	yin	yin	PROPN
dpc-5733	174	10	n	n	CCONJ
dpc-5733	174	11	,	,	PUNCT
dpc-5733	174	12	xiao	xiao	PROPN
dpc-5733	174	13	z.	z.	PROPN
dpc-5733	174	14	systemic	systemic	ADJ
dpc-5733	174	15	immune	immune	PROPN
dpc-5733	174	16	-	-	PUNCT
dpc-5733	174	17	inflammation	inflammation	NOUN
dpc-5733	174	18	index	index	NOUN
dpc-5733	174	19	as	as	ADP
dpc-5733	174	20	a	a	DET
dpc-5733	174	21	prognostic	prognostic	ADJ
dpc-5733	174	22	marker	marker	NOUN
dpc-5733	174	23	in	in	ADP
dpc-5733	174	24	her2	her2	PROPN
dpc-5733	174	25	-	-	PUNCT
dpc-5733	174	26	positive	positive	ADJ
dpc-5733	174	27	breast	breast	NOUN
dpc-5733	174	28	cancer	cancer	NOUN
dpc-5733	174	29	patients	patient	NOUN
dpc-5733	174	30	undergoing	undergo	VERB
dpc-5733	174	31	trastuzumab	trastuzumab	NOUN
dpc-5733	174	32	therapy	therapy	NOUN
dpc-5733	174	33	.	.	PUNCT
dpc-5733	175	1	sci	sci	PROPN
dpc-5733	175	2	rep	rep	PROPN
dpc-5733	175	3	.	.	PROPN
dpc-5733	175	4	2024	2024	NUM
dpc-5733	175	5	mar	mar	PROPN
dpc-5733	175	6	19;14(1):6578	19;14(1):6578	NUM
dpc-5733	175	7	.	.	PUNCT
dpc-5733	176	1	doi	doi	NOUN
dpc-5733	176	2	:	:	PUNCT
dpc-5733	176	3	10.1038	10.1038	NUM
dpc-5733	176	4	/	/	SYM
dpc-5733	176	5	s41598	s41598	NOUN
dpc-5733	176	6	-	-	PUNCT
dpc-5733	176	7	024	024	NUM
dpc-5733	176	8	-	-	PUNCT
dpc-5733	176	9	57343	57343	NUM
dpc-5733	176	10	-	-	PUNCT
dpc-5733	176	11	0	0	NUM
dpc-5733	176	12	.	.	PUNCT
dpc-5733	177	1	pmid	pmid	NOUN
dpc-5733	177	2	:	:	PUNCT
dpc-5733	177	3	38503890	38503890	NUM
dpc-5733	177	4	.	.	PUNCT
dpc-5733	178	1	8	8	X
dpc-5733	178	2	.	.	X
dpc-5733	178	3	deng	deng	PROPN
dpc-5733	178	4	x	x	PROPN
dpc-5733	178	5	,	,	PUNCT
dpc-5733	178	6	liu	liu	PROPN
dpc-5733	178	7	d	d	PROPN
dpc-5733	178	8	,	,	PUNCT
dpc-5733	178	9	li	li	PROPN
dpc-5733	178	10	m	m	PROPN
dpc-5733	178	11	,	,	PUNCT
dpc-5733	178	12	he	he	PRON
dpc-5733	178	13	j	j	PROPN
dpc-5733	178	14	,	,	PUNCT
dpc-5733	178	15	fu	fu	PROPN
dpc-5733	178	16	y.	y.	PROPN
dpc-5733	178	17	association	association	PROPN
dpc-5733	178	18	between	between	ADP
dpc-5733	178	19	systemic	systemic	ADJ
dpc-5733	178	20	immune	immune	ADJ
dpc-5733	178	21	-	-	PUNCT
dpc-5733	178	22	inflammation	inflammation	NOUN
dpc-5733	178	23	index	index	NOUN
dpc-5733	178	24	and	and	CCONJ
dpc-5733	178	25	insulin	insulin	NOUN
dpc-5733	178	26	resistance	resistance	NOUN
dpc-5733	178	27	and	and	CCONJ
dpc-5733	178	28	mortality	mortality	NOUN
dpc-5733	178	29	.	.	PUNCT
dpc-5733	179	1	sci	sci	PROPN
dpc-5733	179	2	rep	rep	PROPN
dpc-5733	179	3	.	.	PROPN
dpc-5733	179	4	2024	2024	NUM
dpc-5733	179	5	jan	jan	PROPN
dpc-5733	179	6	23;14(1):2013	23;14(1):2013	NUM
dpc-5733	179	7	.	.	PUNCT
dpc-5733	179	8	doi	doi	NOUN
dpc-5733	179	9	:	:	PUNCT
dpc-5733	179	10	10.1038	10.1038	NUM
dpc-5733	179	11	/	/	SYM
dpc-5733	179	12	s41598	s41598	NOUN
dpc-5733	179	13	-	-	PUNCT
dpc-5733	179	14	024	024	NUM
dpc-5733	179	15	-51878	-51878	PROPN
dpc-5733	179	16	-	-	PUNCT
dpc-5733	179	17	y.	y.	PROPN
dpc-5733	179	18	pmid	pmid	PROPN
dpc-5733	179	19	:	:	PUNCT
dpc-5733	179	20	38263234	38263234	NUM
dpc-5733	179	21	.	.	PUNCT
dpc-5733	180	1	9	9	X
dpc-5733	180	2	.	.	X
dpc-5733	180	3	pérez	pérez	NOUN
dpc-5733	180	4	-	-	PUNCT
dpc-5733	180	5	martelo	martelo	PROPN
dpc-5733	180	6	m	m	PROPN
dpc-5733	180	7	,	,	PUNCT
dpc-5733	180	8	gonzález	gonzález	PROPN
dpc-5733	180	9	-	-	PUNCT
dpc-5733	180	10	garcía	garcía	PROPN
dpc-5733	180	11	a	a	PRON
dpc-5733	180	12	,	,	PUNCT
dpc-5733	180	13	vidal	vidal	NOUN
dpc-5733	180	14	-	-	PUNCT
dpc-5733	180	15	ínsua	ínsua	VERB
dpc-5733	180	16	y	y	PROPN
dpc-5733	180	17	,	,	PUNCT
dpc-5733	180	18	blanco	blanco	PROPN
dpc-5733	180	19	-	-	PUNCT
dpc-5733	180	20	freire	freire	PROPN
dpc-5733	180	21	c	c	NOUN
dpc-5733	180	22	,	,	PUNCT
dpc-5733	180	23	brozos	brozos	PROPN
dpc-5733	180	24	-	-	PUNCT
dpc-5733	180	25	vázquez	vázquez	NOUN
dpc-5733	180	26	em	em	PRON
dpc-5733	180	27	,	,	PUNCT
dpc-5733	180	28	abdulkader	abdulkader	PROPN
dpc-5733	180	29	-	-	PUNCT
dpc-5733	180	30	nallib	nallib	PROPN
dpc-5733	181	1	i	i	PROPN
dpc-5733	181	2	,	,	PUNCT
dpc-5733	181	3	álvarez	álvarez	PROPN
dpc-5733	181	4	-	-	PUNCT
dpc-5733	181	5	fernández	fernández	PROPN
dpc-5733	181	6	j	j	PROPN
dpc-5733	181	7	,	,	PUNCT
dpc-5733	181	8	lázare	lázare	PROPN
dpc-5733	181	9	-	-	PUNCT
dpc-5733	181	10	iglesias	iglesias	PROPN
dpc-5733	181	11	h	h	NOUN
dpc-5733	181	12	,	,	PUNCT
dpc-5733	181	13	garcía	garcía	ADJ
dpc-5733	181	14	-	-	PUNCT
dpc-5733	181	15	martínez	martínez	NOUN
dpc-5733	181	16	c	c	NOUN
dpc-5733	181	17	,	,	PUNCT
dpc-5733	181	18	betancor	betancor	NOUN
dpc-5733	181	19	yz	yz	PROPN
dpc-5733	181	20	,	,	PUNCT
dpc-5733	181	21	sánchez	sánchez	NOUN
dpc-5733	181	22	-	-	PUNCT
dpc-5733	181	23	ares	are	NOUN
dpc-5733	181	24	m	m	PROPN
dpc-5733	181	25	,	,	PUNCT
dpc-5733	181	26	tubío	tubío	PROPN
dpc-5733	181	27	jmc	jmc	PROPN
dpc-5733	181	28	,	,	PUNCT
dpc-5733	181	29	vázquez	vázquez	PROPN
dpc-5733	181	30	-	-	PUNCT
dpc-5733	181	31	rivera	rivera	NOUN
dpc-5733	181	32	f	f	NOUN
dpc-5733	181	33	,	,	PUNCT
dpc-5733	181	34	candamio	candamio	NOUN
dpc-5733	181	35	-	-	PUNCT
dpc-5733	181	36	folgar	folgar	NOUN
dpc-5733	181	37	s	s	NOUN
dpc-5733	181	38	,	,	PUNCT
dpc-5733	181	39	lópez	lópez	NOUN
dpc-5733	181	40	-	-	PUNCT
dpc-5733	181	41	lópez	lópez	NOUN
dpc-5733	181	42	r	r	NOUN
dpc-5733	181	43	,	,	PUNCT
dpc-5733	181	44	ruiz	ruiz	NOUN
dpc-5733	181	45	-	-	PUNCT
dpc-5733	181	46	bañobre	bañobre	NOUN
dpc-5733	181	47	j.	j.	PROPN
dpc-5733	181	48	clinical	clinical	PROPN
dpc-5733	181	49	significance	significance	NOUN
dpc-5733	181	50	of	of	ADP
dpc-5733	181	51	baseline	baseline	ADJ
dpc-5733	181	52	pan	pan	ADJ
dpc-5733	181	53	-	-	ADJ
dpc-5733	181	54	immune	immune	ADJ
dpc-5733	181	55	-	-	PUNCT
dpc-5733	181	56	inflammation	inflammation	NOUN
dpc-5733	181	57	value	value	NOUN
dpc-5733	181	58	and	and	CCONJ
dpc-5733	181	59	its	its	PRON
dpc-5733	181	60	dynamics	dynamic	NOUN
dpc-5733	181	61	in	in	ADP
dpc-5733	181	62	metastatic	metastatic	ADJ
dpc-5733	181	63	colorectal	colorectal	ADJ
dpc-5733	181	64	cancer	cancer	NOUN
dpc-5733	181	65	patients	patient	NOUN
dpc-5733	181	66	under	under	ADP
dpc-5733	181	67	first	first	ADJ
dpc-5733	181	68	-	-	PUNCT
dpc-5733	181	69	line	line	NOUN
dpc-5733	181	70	chemotherapy	chemotherapy	NOUN
dpc-5733	181	71	.	.	PUNCT
dpc-5733	182	1	sci	sci	PROPN
dpc-5733	182	2	rep	rep	PROPN
dpc-5733	182	3	.	.	PROPN
dpc-5733	182	4	2022	2022	NUM
dpc-5733	182	5	apr	apr	NOUN
dpc-5733	182	6	27;12(1):6893	27;12(1):6893	NUM
dpc-5733	182	7	.	.	PUNCT
dpc-5733	183	1	doi	doi	NOUN
dpc-5733	183	2	:	:	PUNCT
dpc-5733	183	3	10.1038	10.1038	NUM
dpc-5733	183	4	/s41598	/s41598	ADJ
dpc-5733	183	5	-	-	PUNCT
dpc-5733	183	6	022	022	PROPN
dpc-5733	183	7	-	-	PUNCT
dpc-5733	183	8	10884	10884	NUM
dpc-5733	183	9	-	-	SYM
dpc-5733	183	10	8	8	NUM
dpc-5733	183	11	.	.	PUNCT
dpc-5733	184	1	pmid	pmid	NOUN
dpc-5733	184	2	:	:	PUNCT
dpc-5733	184	3	35477740	35477740	NUM
dpc-5733	184	4	.	.	PUNCT
dpc-5733	185	1	10	10	NUM
dpc-5733	185	2	.	.	PUNCT
dpc-5733	185	3	fucà	fucà	VERB
dpc-5733	185	4	g	g	PROPN
dpc-5733	185	5	,	,	PUNCT
dpc-5733	185	6	guarini	guarini	PROPN
dpc-5733	185	7	v	v	NOUN
dpc-5733	185	8	,	,	PUNCT
dpc-5733	185	9	antoniotti	antoniotti	ADJ
dpc-5733	185	10	c	c	X
dpc-5733	185	11	,	,	PUNCT
dpc-5733	185	12	morano	morano	PROPN
dpc-5733	185	13	f	f	PROPN
dpc-5733	185	14	,	,	PUNCT
dpc-5733	185	15	moretto	moretto	PROPN
dpc-5733	185	16	r	r	PROPN
dpc-5733	185	17	,	,	PUNCT
dpc-5733	185	18	corallo	corallo	PROPN
dpc-5733	185	19	s	s	PROPN
dpc-5733	185	20	,	,	PUNCT
dpc-5733	185	21	marmorino	marmorino	PROPN
dpc-5733	185	22	f	f	PROPN
dpc-5733	185	23	,	,	PUNCT
dpc-5733	185	24	lonardi	lonardi	PROPN
dpc-5733	185	25	s	s	PROPN
dpc-5733	185	26	,	,	PUNCT
dpc-5733	185	27	rimassa	rimassa	ADJ
dpc-5733	185	28	l	l	NOUN
dpc-5733	185	29	,	,	PUNCT
dpc-5733	185	30	sartore	sartore	NOUN
dpc-5733	185	31	-	-	PUNCT
dpc-5733	185	32	bianchi	bianchi	NOUN
dpc-5733	185	33	a	a	NOUN
dpc-5733	185	34	,	,	PUNCT
dpc-5733	185	35	borelli	borelli	PROPN
dpc-5733	185	36	b	b	PROPN
dpc-5733	185	37	,	,	PUNCT
dpc-5733	185	38	tampellini	tampellini	PROPN
dpc-5733	185	39	m	m	PROPN
dpc-5733	185	40	,	,	PUNCT
dpc-5733	185	41	bustreo	bustreo	PROPN
dpc-5733	185	42	s	s	PROPN
dpc-5733	185	43	,	,	PUNCT
dpc-5733	185	44	claravezza	claravezza	NOUN
dpc-5733	185	45	m	m	PROPN
dpc-5733	185	46	,	,	PUNCT
dpc-5733	185	47	boccaccino	boccaccino	PROPN
dpc-5733	185	48	a	a	PRON
dpc-5733	185	49	,	,	PUNCT
dpc-5733	185	50	murialdo	murialdo	ADJ
dpc-5733	185	51	r	r	NOUN
dpc-5733	185	52	,	,	PUNCT
dpc-5733	185	53	zaniboni	zaniboni	NOUN
dpc-5733	185	54	a	a	PRON
dpc-5733	185	55	,	,	PUNCT
dpc-5733	185	56	tomasello	tomasello	VERB
dpc-5733	185	57	g	g	NOUN
dpc-5733	185	58	,	,	PUNCT
dpc-5733	185	59	loupakis	loupakis	PROPN
dpc-5733	185	60	f	f	PROPN
dpc-5733	185	61	,	,	PUNCT
dpc-5733	185	62	adamo	adamo	PROPN
dpc-5733	185	63	v	v	PROPN
dpc-5733	185	64	,	,	PUNCT
dpc-5733	185	65	tonini	tonini	PROPN
dpc-5733	185	66	g	g	PROPN
dpc-5733	185	67	,	,	PUNCT
dpc-5733	185	68	cortesi	cortesi	PROPN
dpc-5733	185	69	e	e	PROPN
dpc-5733	185	70	,	,	PUNCT
dpc-5733	185	71	de	de	X
dpc-5733	185	72	braud	braud	VERB
dpc-5733	185	73	f	f	NUM
dpc-5733	185	74	,	,	PUNCT
dpc-5733	185	75	cremolini	cremolini	PROPN
dpc-5733	185	76	c	c	PROPN
dpc-5733	185	77	,	,	PUNCT
dpc-5733	185	78	pietrantonio	pietrantonio	PROPN
dpc-5733	185	79	f.	f.	PROPN
dpc-5733	186	1	the	the	DET
dpc-5733	186	2	pan	pan	ADJ
dpc-5733	186	3	-	-	ADJ
dpc-5733	186	4	immune	immune	ADJ
dpc-5733	186	5	-	-	PUNCT
dpc-5733	186	6	inflammation	inflammation	NOUN
dpc-5733	186	7	value	value	NOUN
dpc-5733	186	8	is	be	AUX
dpc-5733	186	9	a	a	DET
dpc-5733	186	10	new	new	ADJ
dpc-5733	186	11	prognostic	prognostic	ADJ
dpc-5733	186	12	biomarker	biomarker	NOUN
dpc-5733	186	13	class	class	NOUN
dpc-5733	186	14	effect	effect	NOUN
dpc-5733	186	15	of	of	ADP
dpc-5733	186	16	hematologic	hematologic	NOUN
dpc-5733	186	17	markers	marker	NOUN
dpc-5733	186	18	,	,	PUNCT
dpc-5733	186	19	with	with	ADP
dpc-5733	186	20	a	a	DET
dpc-5733	186	21	direct	direct	ADJ
dpc-5733	186	22	comparison	comparison	NOUN
dpc-5733	186	23	between	between	ADP
dpc-5733	186	24	risankizumab	risankizumab	NOUN
dpc-5733	186	25	and	and	CCONJ
dpc-5733	186	26	other	other	ADJ
dpc-5733	186	27	anti	anti	ADJ
dpc-5733	186	28	-	-	ADJ
dpc-5733	186	29	il-23	il-23	ADJ
dpc-5733	186	30	agents	agent	NOUN
dpc-5733	186	31	and	and	CCONJ
dpc-5733	186	32	anti	anti	ADJ
dpc-5733	186	33	-	-	ADJ
dpc-5733	186	34	tnf	tnf	ADJ
dpc-5733	186	35	agents	agent	NOUN
dpc-5733	186	36	and	and	CCONJ
dpc-5733	186	37	il-17	il-17	ADV
dpc-5733	186	38	inhibitors	inhibitor	NOUN
dpc-5733	186	39	.	.	PUNCT
dpc-5733	187	1	an	an	DET
dpc-5733	187	2	increase	increase	NOUN
dpc-5733	187	3	in	in	ADP
dpc-5733	187	4	mpv	mpv	PROPN
dpc-5733	187	5	without	without	ADP
dpc-5733	187	6	a	a	DET
dpc-5733	187	7	significant	significant	ADJ
dpc-5733	187	8	impact	impact	NOUN
dpc-5733	187	9	on	on	ADP
dpc-5733	187	10	platelet	platelet	NOUN
dpc-5733	187	11	and	and	CCONJ
dpc-5733	187	12	plr	plr	NOUN
dpc-5733	187	13	in	in	ADP
dpc-5733	187	14	our	our	PRON
dpc-5733	187	15	patients	patient	NOUN
dpc-5733	187	16	needs	need	VERB
dpc-5733	187	17	to	to	PART
dpc-5733	187	18	be	be	AUX
dpc-5733	187	19	further	far	ADV
dpc-5733	187	20	assessed	assess	VERB
dpc-5733	187	21	,	,	PUNCT
dpc-5733	187	22	as	as	SCONJ
dpc-5733	187	23	data	datum	NOUN
dpc-5733	187	24	on	on	ADP
dpc-5733	187	25	baseline	baseline	PROPN
dpc-5733	187	26	mpv	mpv	PROPN
dpc-5733	187	27	levels	level	NOUN
dpc-5733	187	28	and	and	CCONJ
dpc-5733	187	29	their	their	PRON
dpc-5733	187	30	modulation	modulation	NOUN
dpc-5733	187	31	in	in	ADP
dpc-5733	187	32	psoriasis	psoriasis	NOUN
dpc-5733	187	33	and	and	CCONJ
dpc-5733	187	34	psa	psa	NOUN
dpc-5733	187	35	are	be	AUX
dpc-5733	187	36	conflicting	conflict	VERB
dpc-5733	187	37	[	[	X
dpc-5733	187	38	47–50	47–50	X
dpc-5733	187	39	]	]	X
dpc-5733	187	40	.	.	PUNCT
dpc-5733	188	1	in	in	ADP
dpc-5733	188	2	our	our	PRON
dpc-5733	188	3	study	study	NOUN
dpc-5733	188	4	,	,	PUNCT
dpc-5733	188	5	risankizumab	risankizumab	PROPN
dpc-5733	188	6	lowered	lower	VERB
dpc-5733	188	7	the	the	DET
dpc-5733	188	8	number	number	NOUN
dpc-5733	188	9	of	of	ADP
dpc-5733	188	10	neutrophils	neutrophil	NOUN
dpc-5733	188	11	,	,	PUNCT
dpc-5733	188	12	but	but	CCONJ
dpc-5733	188	13	also	also	ADV
dpc-5733	188	14	restored	restore	VERB
dpc-5733	188	15	them	they	PRON
dpc-5733	188	16	to	to	ADP
dpc-5733	188	17	the	the	DET
dpc-5733	188	18	baseline	baseline	ADJ
dpc-5733	188	19	difference	difference	NOUN
dpc-5733	188	20	in	in	ADP
dpc-5733	188	21	patients	patient	NOUN
dpc-5733	188	22	with	with	ADP
dpc-5733	188	23	initial	initial	ADJ
dpc-5733	188	24	slower	slow	ADJ
dpc-5733	188	25	response	response	NOUN
dpc-5733	188	26	.	.	PUNCT
dpc-5733	189	1	biologics	biologic	NOUN
dpc-5733	189	2	are	be	AUX
dpc-5733	189	3	known	know	VERB
dpc-5733	189	4	to	to	PART
dpc-5733	189	5	increase	increase	VERB
dpc-5733	189	6	the	the	DET
dpc-5733	189	7	risk	risk	NOUN
dpc-5733	189	8	of	of	ADP
dpc-5733	189	9	non	non	ADJ
dpc-5733	189	10	-	-	ADJ
dpc-5733	189	11	serious	serious	ADJ
dpc-5733	189	12	infections	infection	NOUN
dpc-5733	189	13	both	both	CCONJ
dpc-5733	189	14	in	in	ADP
dpc-5733	189	15	shortand	shortand	NOUN
dpc-5733	189	16	long	long	ADJ
dpc-5733	189	17	-	-	PUNCT
dpc-5733	189	18	term	term	NOUN
dpc-5733	189	19	treatment	treatment	NOUN
dpc-5733	189	20	.	.	PUNCT
dpc-5733	190	1	however	however	ADV
dpc-5733	190	2	,	,	PUNCT
dpc-5733	190	3	risankizumab	risankizumab	NOUN
dpc-5733	190	4	profile	profile	NOUN
dpc-5733	190	5	is	be	AUX
dpc-5733	190	6	very	very	ADV
dpc-5733	190	7	safe	safe	ADJ
dpc-5733	190	8	[	[	X
dpc-5733	190	9	33,51	33,51	NOUN
dpc-5733	190	10	]	]	X
dpc-5733	190	11	,	,	PUNCT
dpc-5733	190	12	and	and	CCONJ
dpc-5733	190	13	in	in	ADP
dpc-5733	190	14	our	our	PRON
dpc-5733	190	15	patients	patient	NOUN
dpc-5733	190	16	the	the	DET
dpc-5733	190	17	number	number	NOUN
dpc-5733	190	18	of	of	ADP
dpc-5733	190	19	neutrophils	neutrophil	NOUN
dpc-5733	190	20	was	be	AUX
dpc-5733	190	21	always	always	ADV
dpc-5733	190	22	within	within	ADP
dpc-5733	190	23	normal	normal	ADJ
dpc-5733	190	24	range	range	NOUN
dpc-5733	190	25	at	at	ADP
dpc-5733	190	26	each	each	DET
dpc-5733	190	27	time	time	NOUN
dpc-5733	190	28	point	point	NOUN
dpc-5733	190	29	,	,	PUNCT
dpc-5733	190	30	thus	thus	ADV
dpc-5733	190	31	suggesting	suggest	VERB
dpc-5733	190	32	overall	overall	ADJ
dpc-5733	190	33	rebalancing	rebalancing	NOUN
dpc-5733	190	34	of	of	ADP
dpc-5733	190	35	circulating	circulate	VERB
dpc-5733	190	36	and	and	CCONJ
dpc-5733	190	37	re	re	ADJ
dpc-5733	190	38	-	-	ADJ
dpc-5733	190	39	circulating	circulate	VERB
dpc-5733	190	40	cutaneous	cutaneous	ADJ
dpc-5733	190	41	wbcs	wbc	NOUN
dpc-5733	190	42	[	[	X
dpc-5733	190	43	52	52	NUM
dpc-5733	190	44	]	]	PUNCT
dpc-5733	190	45	.	.	PUNCT
dpc-5733	191	1	activated	activate	VERB
dpc-5733	191	2	neutrophils	neutrophil	NOUN
dpc-5733	191	3	and	and	CCONJ
dpc-5733	191	4	netosis	netosis	NOUN
dpc-5733	191	5	have	have	AUX
dpc-5733	191	6	been	be	AUX
dpc-5733	191	7	associated	associate	VERB
dpc-5733	191	8	with	with	ADP
dpc-5733	191	9	early	early	ADJ
dpc-5733	191	10	phases	phase	NOUN
dpc-5733	191	11	of	of	ADP
dpc-5733	191	12	psoriasis	psoriasis	NOUN
dpc-5733	191	13	development	development	NOUN
dpc-5733	191	14	;	;	PUNCT
dpc-5733	191	15	thus	thus	ADV
dpc-5733	191	16	,	,	PUNCT
dpc-5733	191	17	it	it	PRON
dpc-5733	191	18	is	be	AUX
dpc-5733	191	19	not	not	PART
dpc-5733	191	20	surprising	surprising	ADJ
dpc-5733	191	21	that	that	SCONJ
dpc-5733	191	22	higher	high	ADJ
dpc-5733	191	23	levels	level	NOUN
dpc-5733	191	24	of	of	ADP
dpc-5733	191	25	circulating	circulate	VERB
dpc-5733	191	26	cells	cell	NOUN
dpc-5733	191	27	could	could	AUX
dpc-5733	191	28	influence	influence	VERB
dpc-5733	191	29	therapeutic	therapeutic	ADJ
dpc-5733	191	30	response	response	NOUN
dpc-5733	191	31	,	,	PUNCT
dpc-5733	191	32	as	as	ADP
dpc-5733	191	33	in	in	ADP
dpc-5733	191	34	the	the	DET
dpc-5733	191	35	lr	lr	NOUN
dpc-5733	191	36	patients	patient	NOUN
dpc-5733	191	37	in	in	ADP
dpc-5733	191	38	our	our	PRON
dpc-5733	191	39	study	study	NOUN
dpc-5733	191	40	[	[	X
dpc-5733	191	41	53–55	53–55	NUM
dpc-5733	191	42	]	]	PUNCT
dpc-5733	191	43	.	.	PUNCT
dpc-5733	192	1	it	it	PRON
dpc-5733	192	2	is	be	AUX
dpc-5733	192	3	well	well	ADV
dpc-5733	192	4	known	know	VERB
dpc-5733	192	5	that	that	SCONJ
dpc-5733	192	6	bmi	bmi	NOUN
dpc-5733	192	7	represents	represent	VERB
dpc-5733	192	8	a	a	DET
dpc-5733	192	9	negative	negative	ADJ
dpc-5733	192	10	prognostic	prognostic	ADJ
dpc-5733	192	11	factor	factor	NOUN
dpc-5733	192	12	to	to	ADP
dpc-5733	192	13	therapeutic	therapeutic	ADJ
dpc-5733	192	14	success	success	NOUN
dpc-5733	192	15	[	[	X
dpc-5733	192	16	56–61	56–61	NUM
dpc-5733	192	17	]	]	PUNCT
dpc-5733	192	18	;	;	PUNCT
dpc-5733	192	19	of	of	ADP
dpc-5733	192	20	note	note	NOUN
dpc-5733	192	21	,	,	PUNCT
dpc-5733	192	22	some	some	DET
dpc-5733	192	23	authors	author	NOUN
dpc-5733	192	24	have	have	AUX
dpc-5733	192	25	highlighted	highlight	VERB
dpc-5733	192	26	that	that	SCONJ
dpc-5733	192	27	weight	weight	NOUN
dpc-5733	192	28	reduction	reduction	NOUN
dpc-5733	192	29	could	could	AUX
dpc-5733	192	30	reduce	reduce	VERB
dpc-5733	192	31	il-23	il-23	NOUN
dpc-5733	192	32	levels	level	NOUN
dpc-5733	192	33	[	[	X
dpc-5733	192	34	62	62	NUM
dpc-5733	192	35	]	]	PUNCT
dpc-5733	192	36	.	.	PUNCT
dpc-5733	193	1	indeed	indeed	ADV
dpc-5733	193	2	,	,	PUNCT
dpc-5733	193	3	we	we	PRON
dpc-5733	193	4	and	and	CCONJ
dpc-5733	193	5	others	other	NOUN
dpc-5733	193	6	have	have	AUX
dpc-5733	193	7	previously	previously	ADV
dpc-5733	193	8	shown	show	VERB
dpc-5733	193	9	that	that	SCONJ
dpc-5733	193	10	risankizumab	risankizumab	NOUN
dpc-5733	193	11	is	be	AUX
dpc-5733	193	12	effective	effective	ADJ
dpc-5733	193	13	regardless	regardless	ADV
dpc-5733	193	14	of	of	ADP
dpc-5733	193	15	baseline	baseline	NOUN
dpc-5733	193	16	bmi	bmi	NOUN
dpc-5733	193	17	.	.	PUNCT
dpc-5733	194	1	however	however	ADV
dpc-5733	194	2	,	,	PUNCT
dpc-5733	194	3	bmi	bmi	PROPN
dpc-5733	194	4	could	could	AUX
dpc-5733	194	5	affect	affect	VERB
dpc-5733	194	6	the	the	DET
dpc-5733	194	7	time	time	NOUN
dpc-5733	194	8	needed	need	VERB
dpc-5733	194	9	to	to	PART
dpc-5733	194	10	reach	reach	VERB
dpc-5733	194	11	the	the	DET
dpc-5733	194	12	result	result	NOUN
dpc-5733	194	13	within	within	ADP
dpc-5733	194	14	week	week	NOUN
dpc-5733	194	15	36	36	NUM
dpc-5733	194	16	,	,	PUNCT
dpc-5733	194	17	despite	despite	SCONJ
dpc-5733	194	18	the	the	DET
dpc-5733	194	19	fact	fact	NOUN
dpc-5733	194	20	that	that	SCONJ
dpc-5733	194	21	,	,	PUNCT
dpc-5733	194	22	in	in	ADP
dpc-5733	194	23	our	our	PRON
dpc-5733	194	24	patients	patient	NOUN
dpc-5733	194	25	,	,	PUNCT
dpc-5733	194	26	differences	difference	NOUN
dpc-5733	194	27	were	be	AUX
dpc-5733	194	28	resolved	resolve	VERB
dpc-5733	194	29	as	as	ADV
dpc-5733	194	30	soon	soon	ADV
dpc-5733	194	31	as	as	ADP
dpc-5733	194	32	week	week	NOUN
dpc-5733	194	33	24	24	NUM
dpc-5733	194	34	,	,	PUNCT
dpc-5733	194	35	and	and	CCONJ
dpc-5733	194	36	no	no	DET
dpc-5733	194	37	impact	impact	NOUN
dpc-5733	194	38	of	of	ADP
dpc-5733	194	39	bmi	bmi	NOUN
dpc-5733	194	40	was	be	AUX
dpc-5733	194	41	observed	observe	VERB
dpc-5733	194	42	in	in	ADP
dpc-5733	194	43	baseline	baseline	ADJ
dpc-5733	194	44	disease	disease	NOUN
dpc-5733	194	45	severity	severity	NOUN
dpc-5733	194	46	[	[	X
dpc-5733	194	47	63–65	63–65	NUM
dpc-5733	194	48	]	]	PUNCT
dpc-5733	194	49	.	.	PUNCT
dpc-5733	195	1	finally	finally	ADV
dpc-5733	195	2	,	,	PUNCT
dpc-5733	195	3	the	the	DET
dpc-5733	195	4	variation	variation	NOUN
dpc-5733	195	5	in	in	ADP
dpc-5733	195	6	pasi	pasi	NOUN
dpc-5733	195	7	score	score	NOUN
dpc-5733	195	8	significantly	significantly	ADV
dpc-5733	195	9	correlated	correlate	VERB
dpc-5733	195	10	to	to	ADP
dpc-5733	195	11	the	the	DET
dpc-5733	195	12	variation	variation	NOUN
dpc-5733	195	13	of	of	ADP
dpc-5733	195	14	nlr	nlr	PROPN
dpc-5733	195	15	,	,	PUNCT
dpc-5733	195	16	as	as	SCONJ
dpc-5733	195	17	reported	report	VERB
dpc-5733	195	18	by	by	ADP
dpc-5733	195	19	zhang	zhang	PROPN
dpc-5733	195	20	et	et	PROPN
dpc-5733	195	21	al	al	PROPN
dpc-5733	195	22	.	.	PUNCT
dpc-5733	196	1	[	[	X
dpc-5733	196	2	39	39	NUM
dpc-5733	196	3	]	]	PUNCT
dpc-5733	196	4	.	.	PUNCT
dpc-5733	197	1	conclusions	conclusion	NOUN
dpc-5733	197	2	risankizumab	risankizumab	VERB
dpc-5733	197	3	treatment	treatment	NOUN
dpc-5733	197	4	results	result	NOUN
dpc-5733	197	5	in	in	ADP
dpc-5733	197	6	progressive	progressive	ADJ
dpc-5733	197	7	modulation	modulation	NOUN
dpc-5733	197	8	of	of	ADP
dpc-5733	197	9	hematologic	hematologic	NOUN
dpc-5733	197	10	parameters	parameter	NOUN
dpc-5733	197	11	,	,	PUNCT
dpc-5733	197	12	with	with	ADP
dpc-5733	197	13	improvement	improvement	NOUN
dpc-5733	197	14	in	in	ADP
dpc-5733	197	15	general	general	ADJ
dpc-5733	197	16	systemic	systemic	ADJ
dpc-5733	197	17	inflammation	inflammation	NOUN
dpc-5733	197	18	.	.	PUNCT
dpc-5733	198	1	further	further	ADJ
dpc-5733	198	2	research	research	NOUN
dpc-5733	198	3	is	be	AUX
dpc-5733	198	4	needed	need	VERB
dpc-5733	198	5	to	to	PART
dpc-5733	198	6	understand	understand	VERB
dpc-5733	198	7	whether	whether	SCONJ
dpc-5733	198	8	this	this	DET
dpc-5733	198	9	modulation	modulation	NOUN
dpc-5733	198	10	relates	relate	VERB
dpc-5733	198	11	to	to	ADP
dpc-5733	198	12	cutaneous	cutaneous	ADJ
dpc-5733	198	13	amelioration	amelioration	NOUN
dpc-5733	198	14	and	and	CCONJ
dpc-5733	198	15	whether	whether	SCONJ
dpc-5733	198	16	the	the	DET
dpc-5733	198	17	exerted	exert	VERB
dpc-5733	198	18	anti	anti	ADJ
dpc-5733	198	19	-	-	ADJ
dpc-5733	198	20	inflammatory	inflammatory	ADJ
dpc-5733	198	21	effect	effect	NOUN
dpc-5733	198	22	lasts	last	VERB
dpc-5733	198	23	and	and	CCONJ
dpc-5733	198	24	contributes	contribute	VERB
dpc-5733	198	25	to	to	ADP
dpc-5733	198	26	disease	disease	NOUN
dpc-5733	198	27	modification	modification	NOUN
dpc-5733	198	28	,	,	PUNCT
dpc-5733	198	29	potentially	potentially	ADV
dpc-5733	198	30	offering	offer	VERB
dpc-5733	198	31	the	the	DET
dpc-5733	198	32	opportunity	opportunity	NOUN
dpc-5733	198	33	of	of	ADP
dpc-5733	198	34	treatment	treatment	NOUN
dpc-5733	198	35	discontinuation	discontinuation	NOUN
dpc-5733	198	36	or	or	CCONJ
dpc-5733	198	37	dose	dose	NOUN
dpc-5733	198	38	tapering	taper	VERB
dpc-5733	198	39	in	in	ADP
dpc-5733	198	40	patients	patient	NOUN
dpc-5733	198	41	with	with	ADP
dpc-5733	198	42	stable	stable	ADJ
dpc-5733	198	43	response	response	NOUN
dpc-5733	198	44	.	.	PUNCT
dpc-5733	199	1	ethics	ethic	NOUN
dpc-5733	199	2	approval	approval	NOUN
dpc-5733	199	3	:	:	PUNCT
dpc-5733	199	4	this	this	DET
dpc-5733	199	5	study	study	NOUN
dpc-5733	199	6	was	be	AUX
dpc-5733	199	7	performed	perform	VERB
dpc-5733	199	8	in	in	ADP
dpc-5733	199	9	line	line	NOUN
dpc-5733	199	10	with	with	ADP
dpc-5733	199	11	the	the	DET
dpc-5733	199	12	principles	principle	NOUN
dpc-5733	199	13	of	of	ADP
dpc-5733	199	14	the	the	DET
dpc-5733	199	15	declaration	declaration	NOUN
dpc-5733	199	16	of	of	ADP
dpc-5733	199	17	helsinki	helsinki	PROPN
dpc-5733	199	18	.	.	PUNCT
dpc-5733	200	1	approval	approval	NOUN
dpc-5733	200	2	was	be	AUX
dpc-5733	200	3	granted	grant	VERB
dpc-5733	200	4	by	by	ADP
dpc-5733	200	5	the	the	DET
dpc-5733	200	6	ethics	ethic	NOUN
dpc-5733	200	7	committee	committee	PROPN
dpc-5733	200	8	of	of	ADP
dpc-5733	200	9	azienda	azienda	PROPN
dpc-5733	200	10	usl	usl	PROPN
dpc-5733	200	11	toscana	toscana	PROPN
dpc-5733	200	12	centro	centro	X
dpc-5733	200	13	,	,	PUNCT
dpc-5733	200	14	firenze	firenze	PROPN
dpc-5733	200	15	(	(	PUNCT
dpc-5733	200	16	ceavc	ceavc	PROPN
dpc-5733	200	17	19799	19799	NUM
dpc-5733	200	18	)	)	PUNCT
dpc-5733	200	19	.	.	PUNCT
dpc-5733	201	1	ethics	ethic	NOUN
dpc-5733	201	2	statement	statement	NOUN
dpc-5733	201	3	:	:	PUNCT
dpc-5733	201	4	informed	inform	VERB
dpc-5733	201	5	consent	consent	NOUN
dpc-5733	201	6	was	be	AUX
dpc-5733	201	7	obtained	obtain	VERB
dpc-5733	201	8	from	from	ADP
dpc-5733	201	9	all	all	DET
dpc-5733	201	10	individual	individual	ADJ
dpc-5733	201	11	participants	participant	NOUN
dpc-5733	201	12	included	include	VERB
dpc-5733	201	13	in	in	ADP
dpc-5733	201	14	the	the	DET
dpc-5733	201	15	study	study	NOUN
dpc-5733	201	16	.	.	PUNCT
dpc-5733	202	1	the	the	DET
dpc-5733	202	2	patients	patient	NOUN
dpc-5733	202	3	in	in	ADP
dpc-5733	202	4	original	original	ADJ
dpc-5733	202	5	article	article	NOUN
dpc-5733	202	6	|	|	ADV
dpc-5733	202	7	dermatol	dermatol	ADJ
dpc-5733	202	8	pract	pract	NOUN
dpc-5733	202	9	concept	concept	NOUN
dpc-5733	202	10	.	.	PUNCT
dpc-5733	203	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	203	2	9	9	NUM
dpc-5733	203	3	doi	doi	NOUN
dpc-5733	203	4	:	:	PUNCT
dpc-5733	203	5	10.1007	10.1007	NUM
dpc-5733	203	6	/	/	SYM
dpc-5733	203	7	s10787	s10787	NOUN
dpc-5733	203	8	-	-	PUNCT
dpc-5733	203	9	024	024	NUM
dpc-5733	203	10	-	-	PUNCT
dpc-5733	203	11	01559	01559	NUM
dpc-5733	203	12	-	-	PUNCT
dpc-5733	203	13	z.	z.	PROPN
dpc-5733	203	14	epub	epub	PROPN
dpc-5733	203	15	2024	2024	NUM
dpc-5733	203	16	aug	aug	PROPN
dpc-5733	203	17	21	21	NUM
dpc-5733	203	18	.	.	PUNCT
dpc-5733	204	1	pmid	pmid	NOUN
dpc-5733	204	2	:	:	PUNCT
dpc-5733	204	3	39167310	39167310	NUM
dpc-5733	204	4	.	.	PUNCT
dpc-5733	205	1	22	22	NUM
dpc-5733	205	2	.	.	PUNCT
dpc-5733	206	1	aon	aon	PROPN
dpc-5733	206	2	m	m	PROPN
dpc-5733	206	3	,	,	PUNCT
dpc-5733	206	4	aoun	aoun	PROPN
dpc-5733	206	5	ah	ah	INTJ
dpc-5733	206	6	,	,	PUNCT
dpc-5733	206	7	alshami	alshami	NOUN
dpc-5733	206	8	a	a	PRON
dpc-5733	206	9	,	,	PUNCT
dpc-5733	206	10	alharbi	alharbi	NOUN
dpc-5733	206	11	a	a	PRON
dpc-5733	206	12	,	,	PUNCT
dpc-5733	206	13	alshammari	alshammari	ADJ
dpc-5733	206	14	f	f	NOUN
dpc-5733	206	15	,	,	PUNCT
dpc-5733	206	16	alnajjar	alnajjar	PROPN
dpc-5733	206	17	m	m	PROPN
dpc-5733	206	18	,	,	PUNCT
dpc-5733	206	19	almutawtah	almutawtah	PROPN
dpc-5733	206	20	a	a	PROPN
dpc-5733	206	21	,	,	PUNCT
dpc-5733	206	22	bin	bin	PROPN
dpc-5733	206	23	naji	naji	PROPN
dpc-5733	206	24	b	b	PROPN
dpc-5733	206	25	,	,	PUNCT
dpc-5733	206	26	alsaeed	alsaeed	VERB
dpc-5733	206	27	a	a	PRON
dpc-5733	206	28	,	,	PUNCT
dpc-5733	206	29	abdelwahab	abdelwahab	PROPN
dpc-5733	206	30	oa	oa	INTJ
dpc-5733	206	31	.	.	PROPN
dpc-5733	206	32	association	association	NOUN
dpc-5733	206	33	of	of	ADP
dpc-5733	206	34	the	the	DET
dpc-5733	206	35	systemic	systemic	ADJ
dpc-5733	206	36	immune	immune	ADJ
dpc-5733	206	37	inflammation	inflammation	NOUN
dpc-5733	206	38	index	index	NOUN
dpc-5733	206	39	(	(	PUNCT
dpc-5733	206	40	sii	sii	PROPN
dpc-5733	206	41	)	)	PUNCT
dpc-5733	206	42	and	and	CCONJ
dpc-5733	206	43	severity	severity	NOUN
dpc-5733	206	44	of	of	ADP
dpc-5733	206	45	diabetic	diabetic	ADJ
dpc-5733	206	46	ketoacidosis	ketoacidosis	NOUN
dpc-5733	206	47	in	in	ADP
dpc-5733	206	48	patients	patient	NOUN
dpc-5733	206	49	with	with	ADP
dpc-5733	206	50	type	type	NOUN
dpc-5733	206	51	1	1	NUM
dpc-5733	206	52	diabetes	diabetes	NOUN
dpc-5733	206	53	mellitus	mellitus	NOUN
dpc-5733	206	54	:	:	PUNCT
dpc-5733	206	55	a	a	DET
dpc-5733	206	56	retrospective	retrospective	ADJ
dpc-5733	206	57	cohort	cohort	NOUN
dpc-5733	206	58	study	study	NOUN
dpc-5733	206	59	.	.	PUNCT
dpc-5733	207	1	ann	ann	PROPN
dpc-5733	207	2	med	med	PROPN
dpc-5733	207	3	surg	surg	PROPN
dpc-5733	207	4	(	(	PUNCT
dpc-5733	207	5	lond	lond	PROPN
dpc-5733	207	6	)	)	PUNCT
dpc-5733	207	7	.	.	PUNCT
dpc-5733	208	1	2024	2024	NUM
dpc-5733	208	2	may	may	PROPN
dpc-5733	208	3	20;86(7):3865	20;86(7):3865	NUM
dpc-5733	208	4	-	-	SYM
dpc-5733	208	5	3872	3872	NUM
dpc-5733	208	6	.	.	PUNCT
dpc-5733	209	1	doi	doi	NOUN
dpc-5733	209	2	:	:	PUNCT
dpc-5733	209	3	10.1097	10.1097	NUM
dpc-5733	209	4	/ms9.0000000000002185	/ms9.0000000000002185	PUNCT
dpc-5733	209	5	.	.	PUNCT
dpc-5733	210	1	pmid	pmid	NOUN
dpc-5733	210	2	:	:	PUNCT
dpc-5733	210	3	3898921	3898921	NUM
dpc-5733	210	4	.	.	PUNCT
dpc-5733	211	1	23	23	NUM
dpc-5733	211	2	.	.	PUNCT
dpc-5733	212	1	yorulmaz	yorulmaz	INTJ
dpc-5733	212	2	a	a	PRON
dpc-5733	212	3	,	,	PUNCT
dpc-5733	212	4	hayran	hayran	NOUN
dpc-5733	212	5	y	y	PROPN
dpc-5733	212	6	,	,	PUNCT
dpc-5733	212	7	akpinar	akpinar	NOUN
dpc-5733	212	8	u	u	PROPN
dpc-5733	212	9	,	,	PUNCT
dpc-5733	212	10	yalcin	yalcin	PROPN
dpc-5733	212	11	b.	b.	PROPN
dpc-5733	212	12	systemic	systemic	ADJ
dpc-5733	212	13	immune	immune	NOUN
dpc-5733	212	14	-	-	PUNCT
dpc-5733	212	15	inflammation	inflammation	NOUN
dpc-5733	212	16	index	index	NOUN
dpc-5733	212	17	(	(	PUNCT
dpc-5733	212	18	sii	sii	PROPN
dpc-5733	212	19	)	)	PUNCT
dpc-5733	212	20	predicts	predict	NOUN
dpc-5733	212	21	increased	increase	VERB
dpc-5733	212	22	severity	severity	NOUN
dpc-5733	212	23	in	in	ADP
dpc-5733	212	24	psoriasis	psoriasis	NOUN
dpc-5733	212	25	and	and	CCONJ
dpc-5733	212	26	psoriatic	psoriatic	ADJ
dpc-5733	212	27	arthritis	arthritis	NOUN
dpc-5733	212	28	.	.	PUNCT
dpc-5733	213	1	curr	curr	PROPN
dpc-5733	213	2	health	health	PROPN
dpc-5733	213	3	sci	sci	PROPN
dpc-5733	213	4	j.	j.	PROPN
dpc-5733	213	5	2020	2020	NUM
dpc-5733	213	6	oct	oct	PROPN
dpc-5733	213	7	-	-	PUNCT
dpc-5733	213	8	dec;46(4):352	dec;46(4):352	NOUN
dpc-5733	213	9	-	-	PUNCT
dpc-5733	213	10	357	357	NUM
dpc-5733	213	11	.	.	PUNCT
dpc-5733	213	12	doi	doi	NOUN
dpc-5733	213	13	:	:	PUNCT
dpc-5733	213	14	10.12865	10.12865	NUM
dpc-5733	213	15	/	/	SYM
dpc-5733	213	16	chsj.46.04.05	chsj.46.04.05	NOUN
dpc-5733	213	17	.	.	PUNCT
dpc-5733	214	1	epub	epub	NOUN
dpc-5733	214	2	2020	2020	NUM
dpc-5733	214	3	dec	dec	PROPN
dpc-5733	214	4	31	31	NUM
dpc-5733	214	5	.	.	PUNCT
dpc-5733	215	1	pmid	pmid	NOUN
dpc-5733	215	2	:	:	PUNCT
dpc-5733	215	3	33717509	33717509	NUM
dpc-5733	215	4	.	.	PUNCT
dpc-5733	216	1	24	24	NUM
dpc-5733	216	2	.	.	PUNCT
dpc-5733	217	1	kim	kim	PROPN
dpc-5733	217	2	ds	ds	PROPN
dpc-5733	217	3	,	,	PUNCT
dpc-5733	217	4	shin	shin	NOUN
dpc-5733	218	1	d	d	PROPN
dpc-5733	218	2	,	,	PUNCT
dpc-5733	218	3	lee	lee	PROPN
dpc-5733	218	4	ms	ms	PROPN
dpc-5733	218	5	,	,	PUNCT
dpc-5733	218	6	kim	kim	PROPN
dpc-5733	218	7	hj	hj	PROPN
dpc-5733	218	8	,	,	PUNCT
dpc-5733	218	9	kim	kim	PROPN
dpc-5733	218	10	dy	dy	PROPN
dpc-5733	218	11	,	,	PUNCT
dpc-5733	218	12	kim	kim	PROPN
dpc-5733	218	13	sm	sm	PROPN
dpc-5733	218	14	,	,	PUNCT
dpc-5733	218	15	lee	lee	PROPN
dpc-5733	218	16	mg	mg	PROPN
dpc-5733	218	17	.	.	PUNCT
dpc-5733	219	1	assessments	assessment	NOUN
dpc-5733	219	2	of	of	ADP
dpc-5733	219	3	neutrophil	neutrophil	NOUN
dpc-5733	219	4	to	to	ADP
dpc-5733	219	5	lymphocyte	lymphocyte	ADJ
dpc-5733	219	6	ratio	ratio	NOUN
dpc-5733	219	7	and	and	CCONJ
dpc-5733	219	8	platelet	platelet	NOUN
dpc-5733	219	9	to	to	ADP
dpc-5733	219	10	lymphocyte	lymphocyte	ADJ
dpc-5733	219	11	ratio	ratio	NOUN
dpc-5733	219	12	in	in	ADP
dpc-5733	219	13	korean	korean	ADJ
dpc-5733	219	14	patients	patient	NOUN
dpc-5733	219	15	with	with	ADP
dpc-5733	219	16	psoriasis	psoriasis	NOUN
dpc-5733	219	17	vulgaris	vulgaris	NOUN
dpc-5733	219	18	and	and	CCONJ
dpc-5733	219	19	psoriatic	psoriatic	ADJ
dpc-5733	219	20	arthritis	arthritis	NOUN
dpc-5733	219	21	.	.	PUNCT
dpc-5733	220	1	j	j	PROPN
dpc-5733	220	2	dermatol	dermatol	NOUN
dpc-5733	220	3	.	.	PUNCT
dpc-5733	221	1	2016	2016	NUM
dpc-5733	221	2	mar;43(3):305	mar;43(3):305	ADV
dpc-5733	221	3	-	-	PUNCT
dpc-5733	221	4	10	10	NUM
dpc-5733	221	5	.	.	PUNCT
dpc-5733	222	1	doi	doi	NOUN
dpc-5733	222	2	:	:	PUNCT
dpc-5733	222	3	10.1111/1346	10.1111/1346	NUM
dpc-5733	222	4	-	-	SYM
dpc-5733	222	5	8138.13061	8138.13061	NUM
dpc-5733	222	6	.	.	PUNCT
dpc-5733	223	1	epub	epub	PROPN
dpc-5733	223	2	2015	2015	NUM
dpc-5733	223	3	aug	aug	PROPN
dpc-5733	223	4	18	18	NUM
dpc-5733	223	5	.	.	PUNCT
dpc-5733	224	1	pmid	pmid	NOUN
dpc-5733	224	2	:	:	PUNCT
dpc-5733	224	3	26381893	26381893	NUM
dpc-5733	224	4	.	.	PUNCT
dpc-5733	225	1	25	25	NUM
dpc-5733	225	2	.	.	X
dpc-5733	225	3	tiucă	tiucă	PROPN
dpc-5733	225	4	om	om	PROPN
dpc-5733	225	5	,	,	PUNCT
dpc-5733	225	6	morariu	morariu	PROPN
dpc-5733	225	7	sh	sh	PROPN
dpc-5733	225	8	,	,	PUNCT
dpc-5733	225	9	mariean	mariean	PROPN
dpc-5733	225	10	cr	cr	PROPN
dpc-5733	225	11	,	,	PUNCT
dpc-5733	225	12	tiucă	tiucă	PROPN
dpc-5733	225	13	ra	ra	PROPN
dpc-5733	225	14	,	,	PUNCT
dpc-5733	225	15	nicolescu	nicolescu	PROPN
dpc-5733	225	16	ac	ac	PROPN
dpc-5733	225	17	,	,	PUNCT
dpc-5733	225	18	cotoi	cotoi	PROPN
dpc-5733	225	19	os	os	PROPN
dpc-5733	225	20	.	.	PUNCT
dpc-5733	226	1	impact	impact	NOUN
dpc-5733	226	2	of	of	ADP
dpc-5733	226	3	blood	blood	NOUN
dpc-5733	226	4	-	-	PUNCT
dpc-5733	226	5	count	count	NOUN
dpc-5733	226	6	-	-	PUNCT
dpc-5733	226	7	derived	derive	VERB
dpc-5733	226	8	inflammatory	inflammatory	ADJ
dpc-5733	226	9	markers	marker	NOUN
dpc-5733	226	10	in	in	ADP
dpc-5733	226	11	psoriatic	psoriatic	ADJ
dpc-5733	226	12	disease	disease	NOUN
dpc-5733	226	13	progression	progression	NOUN
dpc-5733	226	14	.	.	PUNCT
dpc-5733	227	1	life	life	NOUN
dpc-5733	227	2	(	(	PUNCT
dpc-5733	227	3	basel	basel	PROPN
dpc-5733	227	4	)	)	PUNCT
dpc-5733	227	5	.	.	PUNCT
dpc-5733	228	1	2024	2024	NUM
dpc-5733	228	2	jan	jan	PROPN
dpc-5733	228	3	12;14(1):114	12;14(1):114	PROPN
dpc-5733	228	4	.	.	PUNCT
dpc-5733	229	1	doi	doi	NOUN
dpc-5733	229	2	:	:	PUNCT
dpc-5733	229	3	10.3390	10.3390	NUM
dpc-5733	229	4	/	/	SYM
dpc-5733	229	5	life14010114	life14010114	PROPN
dpc-5733	229	6	.	.	PUNCT
dpc-5733	230	1	pmid	pmid	NOUN
dpc-5733	230	2	:	:	PUNCT
dpc-5733	230	3	38255729	38255729	NUM
dpc-5733	230	4	.	.	PUNCT
dpc-5733	231	1	26	26	NUM
dpc-5733	231	2	.	.	PUNCT
dpc-5733	232	1	joseph	joseph	PROPN
dpc-5733	232	2	j	j	PROPN
dpc-5733	232	3	,	,	PUNCT
dpc-5733	232	4	truong	truong	PROPN
dpc-5733	232	5	k	k	PROPN
dpc-5733	232	6	,	,	PUNCT
dpc-5733	232	7	lo	lo	PROPN
dpc-5733	232	8	sn	sn	PROPN
dpc-5733	232	9	,	,	PUNCT
dpc-5733	232	10	foo	foo	PROPN
dpc-5733	232	11	f	f	PROPN
dpc-5733	232	12	,	,	PUNCT
dpc-5733	232	13	zaman	zaman	PROPN
dpc-5733	232	14	s	s	PART
dpc-5733	232	15	,	,	PUNCT
dpc-5733	232	16	chow	chow	X
dpc-5733	232	17	ck	ck	PROPN
dpc-5733	232	18	,	,	PUNCT
dpc-5733	232	19	smith	smith	PROPN
dpc-5733	232	20	a.	a.	NOUN
dpc-5733	232	21	impact	impact	NOUN
dpc-5733	232	22	of	of	ADP
dpc-5733	232	23	biologic	biologic	NOUN
dpc-5733	232	24	therapy	therapy	NOUN
dpc-5733	232	25	on	on	ADP
dpc-5733	232	26	key	key	ADJ
dpc-5733	232	27	cardiovascular	cardiovascular	ADJ
dpc-5733	232	28	risk	risk	NOUN
dpc-5733	232	29	parameters	parameter	NOUN
dpc-5733	232	30	in	in	ADP
dpc-5733	232	31	a	a	DET
dpc-5733	232	32	psoriatic	psoriatic	ADJ
dpc-5733	232	33	cohort	cohort	NOUN
dpc-5733	232	34	-	-	PUNCT
dpc-5733	232	35	a	a	DET
dpc-5733	232	36	retrospective	retrospective	ADJ
dpc-5733	232	37	review	review	NOUN
dpc-5733	232	38	.	.	PUNCT
dpc-5733	233	1	dermatol	dermatol	NOUN
dpc-5733	233	2	ther	ther	ADV
dpc-5733	233	3	(	(	PUNCT
dpc-5733	233	4	heidelb	heidelb	NOUN
dpc-5733	233	5	)	)	PUNCT
dpc-5733	233	6	.	.	PUNCT
dpc-5733	234	1	2024	2024	NUM
dpc-5733	234	2	may;14(5):1337	may;14(5):1337	PROPN
dpc-5733	234	3	-	-	PUNCT
dpc-5733	234	4	1348	1348	NUM
dpc-5733	234	5	.	.	PUNCT
dpc-5733	235	1	doi	doi	NOUN
dpc-5733	235	2	:	:	PUNCT
dpc-5733	235	3	10.1007	10.1007	NUM
dpc-5733	235	4	/	/	SYM
dpc-5733	235	5	s13555	s13555	PROPN
dpc-5733	235	6	-024	-024	PROPN
dpc-5733	235	7	-	-	PUNCT
dpc-5733	235	8	01154	01154	NUM
dpc-5733	235	9	-	-	SYM
dpc-5733	235	10	8	8	NUM
dpc-5733	235	11	.	.	PUNCT
dpc-5733	236	1	epub	epub	NOUN
dpc-5733	236	2	2024	2024	NUM
dpc-5733	236	3	apr	apr	NOUN
dpc-5733	236	4	25	25	NUM
dpc-5733	236	5	.	.	PUNCT
dpc-5733	237	1	pmid	pmid	NOUN
dpc-5733	237	2	:	:	PUNCT
dpc-5733	237	3	38664362	38664362	NUM
dpc-5733	237	4	.	.	PUNCT
dpc-5733	238	1	27	27	NUM
dpc-5733	238	2	.	.	PUNCT
dpc-5733	239	1	li	li	PROPN
dpc-5733	239	2	j	j	PROPN
dpc-5733	239	3	,	,	PUNCT
dpc-5733	239	4	wang	wang	PROPN
dpc-5733	239	5	x	x	PROPN
dpc-5733	239	6	,	,	PUNCT
dpc-5733	239	7	jia	jia	PROPN
dpc-5733	239	8	w	w	PROPN
dpc-5733	239	9	,	,	PUNCT
dpc-5733	239	10	wang	wang	PROPN
dpc-5733	239	11	k	k	PROPN
dpc-5733	239	12	,	,	PUNCT
dpc-5733	239	13	wang	wang	PROPN
dpc-5733	239	14	w	w	PROPN
dpc-5733	239	15	,	,	PUNCT
dpc-5733	239	16	diao	diao	PROPN
dpc-5733	239	17	w	w	PROPN
dpc-5733	239	18	,	,	PUNCT
dpc-5733	239	19	ou	ou	PROPN
dpc-5733	239	20	f	f	PROPN
dpc-5733	239	21	,	,	PUNCT
dpc-5733	239	22	ma	ma	PROPN
dpc-5733	239	23	j	j	PROPN
dpc-5733	239	24	,	,	PUNCT
dpc-5733	239	25	yang	yang	PROPN
dpc-5733	239	26	y.	y.	PROPN
dpc-5733	239	27	association	association	PROPN
dpc-5733	239	28	of	of	ADP
dpc-5733	239	29	the	the	DET
dpc-5733	239	30	systemic	systemic	ADJ
dpc-5733	239	31	immuno	immuno	ADJ
dpc-5733	239	32	-	-	PUNCT
dpc-5733	239	33	inflammation	inflammation	NOUN
dpc-5733	239	34	index	index	NOUN
dpc-5733	239	35	,	,	PUNCT
dpc-5733	239	36	neutrophil	neutrophil	NOUN
dpc-5733	239	37	-	-	PUNCT
dpc-5733	239	38	to	to	ADP
dpc-5733	239	39	-	-	PUNCT
dpc-5733	239	40	lymphocyte	lymphocyte	NOUN
dpc-5733	239	41	ratio	ratio	NOUN
dpc-5733	239	42	,	,	PUNCT
dpc-5733	239	43	and	and	CCONJ
dpc-5733	239	44	platelet	platelet	NOUN
dpc-5733	239	45	-	-	PUNCT
dpc-5733	239	46	to	to	ADP
dpc-5733	239	47	-	-	PUNCT
dpc-5733	239	48	lymphocyte	lymphocyte	ADJ
dpc-5733	239	49	ratio	ratio	NOUN
dpc-5733	239	50	with	with	ADP
dpc-5733	239	51	diabetic	diabetic	ADJ
dpc-5733	239	52	microvascular	microvascular	ADJ
dpc-5733	239	53	complications	complication	NOUN
dpc-5733	239	54	.	.	PUNCT
dpc-5733	240	1	front	front	ADJ
dpc-5733	240	2	endocrinol	endocrinol	NOUN
dpc-5733	240	3	(	(	PUNCT
dpc-5733	240	4	lausanne	lausanne	PROPN
dpc-5733	240	5	)	)	PUNCT
dpc-5733	240	6	.	.	PUNCT
dpc-5733	241	1	2024	2024	NUM
dpc-5733	241	2	apr	apr	NOUN
dpc-5733	241	3	10;15:1367376	10;15:1367376	NUM
dpc-5733	241	4	.	.	PUNCT
dpc-5733	242	1	doi	doi	NOUN
dpc-5733	242	2	:	:	PUNCT
dpc-5733	242	3	10.3389	10.3389	NUM
dpc-5733	242	4	/fendo.2024.1367376	/fendo.2024.1367376	PUNCT
dpc-5733	242	5	.	.	PUNCT
dpc-5733	243	1	pmid	pmid	NOUN
dpc-5733	243	2	:	:	PUNCT
dpc-5733	243	3	38660516	38660516	NUM
dpc-5733	243	4	.	.	PUNCT
dpc-5733	244	1	28	28	NUM
dpc-5733	244	2	.	.	PUNCT
dpc-5733	245	1	wang	wang	PROPN
dpc-5733	245	2	p	p	PROPN
dpc-5733	245	3	,	,	PUNCT
dpc-5733	245	4	guo	guo	PROPN
dpc-5733	245	5	x	x	X
dpc-5733	245	6	,	,	PUNCT
dpc-5733	245	7	zhou	zhou	PROPN
dpc-5733	245	8	y	y	PROPN
dpc-5733	245	9	,	,	PUNCT
dpc-5733	245	10	li	li	PROPN
dpc-5733	245	11	z	z	PROPN
dpc-5733	245	12	,	,	PUNCT
dpc-5733	245	13	yu	yu	PROPN
dpc-5733	245	14	s	s	PROPN
dpc-5733	245	15	,	,	PUNCT
dpc-5733	245	16	sun	sun	PROPN
dpc-5733	245	17	y	y	PROPN
dpc-5733	245	18	,	,	PUNCT
dpc-5733	245	19	hua	hua	PROPN
dpc-5733	245	20	y.	y.	PROPN
dpc-5733	245	21	monocyteto	monocyteto	PROPN
dpc-5733	245	22	-	-	PUNCT
dpc-5733	245	23	high	high	ADJ
dpc-5733	245	24	-	-	PUNCT
dpc-5733	245	25	density	density	NOUN
dpc-5733	245	26	lipoprotein	lipoprotein	ADJ
dpc-5733	245	27	ratio	ratio	NOUN
dpc-5733	245	28	and	and	CCONJ
dpc-5733	245	29	systemic	systemic	ADJ
dpc-5733	245	30	inflammation	inflammation	ADJ
dpc-5733	245	31	response	response	NOUN
dpc-5733	245	32	index	index	NOUN
dpc-5733	245	33	are	be	AUX
dpc-5733	245	34	associated	associate	VERB
dpc-5733	245	35	with	with	ADP
dpc-5733	245	36	the	the	DET
dpc-5733	245	37	risk	risk	NOUN
dpc-5733	245	38	of	of	ADP
dpc-5733	245	39	metabolic	metabolic	NOUN
dpc-5733	245	40	disorders	disorder	NOUN
dpc-5733	245	41	and	and	CCONJ
dpc-5733	245	42	cardiovascular	cardiovascular	ADJ
dpc-5733	245	43	diseases	disease	NOUN
dpc-5733	245	44	in	in	ADP
dpc-5733	245	45	general	general	ADJ
dpc-5733	245	46	rural	rural	ADJ
dpc-5733	245	47	population	population	NOUN
dpc-5733	245	48	.	.	PUNCT
dpc-5733	246	1	front	front	ADJ
dpc-5733	246	2	endocrinol	endocrinol	NOUN
dpc-5733	246	3	(	(	PUNCT
dpc-5733	246	4	lausanne	lausanne	PROPN
dpc-5733	246	5	)	)	PUNCT
dpc-5733	246	6	.	.	PUNCT
dpc-5733	247	1	2022	2022	NUM
dpc-5733	247	2	sep	sep	PROPN
dpc-5733	247	3	9;13:944991	9;13:944991	NUM
dpc-5733	247	4	.	.	PUNCT
dpc-5733	248	1	doi	doi	NOUN
dpc-5733	248	2	:	:	PUNCT
dpc-5733	248	3	10.3389	10.3389	NUM
dpc-5733	248	4	/fendo.2022.944991	/fendo.2022.944991	PUNCT
dpc-5733	248	5	.	.	PUNCT
dpc-5733	249	1	pmid	pmid	NOUN
dpc-5733	249	2	:	:	PUNCT
dpc-5733	249	3	36157453	36157453	NUM
dpc-5733	249	4	.	.	PUNCT
dpc-5733	250	1	29	29	NUM
dpc-5733	250	2	.	.	PUNCT
dpc-5733	251	1	meng	meng	PROPN
dpc-5733	251	2	x	x	PROPN
dpc-5733	251	3	,	,	PUNCT
dpc-5733	251	4	sun	sun	PROPN
dpc-5733	251	5	h	h	PROPN
dpc-5733	251	6	,	,	PUNCT
dpc-5733	251	7	tu	tu	PROPN
dpc-5733	251	8	x	x	PROPN
dpc-5733	251	9	,	,	PUNCT
dpc-5733	251	10	li	li	PROPN
dpc-5733	251	11	w.	w.	PROPN
dpc-5733	251	12	the	the	DET
dpc-5733	251	13	predictive	predictive	ADJ
dpc-5733	251	14	role	role	NOUN
dpc-5733	251	15	of	of	ADP
dpc-5733	251	16	hematological	hematological	ADJ
dpc-5733	251	17	parameters	parameter	NOUN
dpc-5733	251	18	in	in	ADP
dpc-5733	251	19	hypertension	hypertension	NOUN
dpc-5733	251	20	.	.	PUNCT
dpc-5733	252	1	angiology	angiology	NOUN
dpc-5733	252	2	.	.	PUNCT
dpc-5733	253	1	2024	2024	NUM
dpc-5733	253	2	sep;75(8	sep;75(8	NOUN
dpc-5733	253	3	):	):	PUNCT
dpc-5733	253	4	705	705	NUM
dpc-5733	253	5	-	-	SYM
dpc-5733	253	6	716	716	NUM
dpc-5733	253	7	.	.	PUNCT
dpc-5733	254	1	doi	doi	NOUN
dpc-5733	254	2	:	:	PUNCT
dpc-5733	254	3	10.1177/00033197231190423	10.1177/00033197231190423	NUM
dpc-5733	254	4	.	.	PUNCT
dpc-5733	254	5	epub	epub	PROPN
dpc-5733	254	6	2023	2023	NUM
dpc-5733	254	7	jul	jul	PROPN
dpc-5733	254	8	17	17	NUM
dpc-5733	254	9	.	.	PUNCT
dpc-5733	255	1	pmid	pmid	NOUN
dpc-5733	255	2	:	:	PUNCT
dpc-5733	255	3	37459606	37459606	NUM
dpc-5733	255	4	.	.	PUNCT
dpc-5733	256	1	30	30	NUM
dpc-5733	256	2	.	.	PUNCT
dpc-5733	257	1	aljuraiban	aljuraiban	PROPN
dpc-5733	257	2	gs	gs	PROPN
dpc-5733	257	3	,	,	PUNCT
dpc-5733	257	4	gibson	gibson	PROPN
dpc-5733	257	5	r	r	PROPN
dpc-5733	257	6	,	,	PUNCT
dpc-5733	257	7	oude	oude	VERB
dpc-5733	257	8	griep	griep	PROPN
dpc-5733	257	9	lm	lm	PROPN
dpc-5733	257	10	.	.	PUNCT
dpc-5733	257	11	associations	association	NOUN
dpc-5733	257	12	of	of	ADP
dpc-5733	257	13	systematic	systematic	ADJ
dpc-5733	257	14	inflammatory	inflammatory	ADJ
dpc-5733	257	15	markers	marker	NOUN
dpc-5733	257	16	with	with	ADP
dpc-5733	257	17	diet	diet	PROPN
dpc-5733	257	18	quality	quality	NOUN
dpc-5733	257	19	,	,	PUNCT
dpc-5733	257	20	blood	blood	NOUN
dpc-5733	257	21	pressure	pressure	NOUN
dpc-5733	257	22	,	,	PUNCT
dpc-5733	257	23	and	and	CCONJ
dpc-5733	257	24	obesity	obesity	NOUN
dpc-5733	257	25	in	in	ADP
dpc-5733	257	26	the	the	DET
dpc-5733	257	27	airwave	airwave	ADJ
dpc-5733	257	28	health	health	NOUN
dpc-5733	257	29	monitoring	monitoring	NOUN
dpc-5733	257	30	study	study	NOUN
dpc-5733	257	31	.	.	PUNCT
dpc-5733	258	1	j	j	PROPN
dpc-5733	258	2	inflamm	inflamm	PROPN
dpc-5733	258	3	res	re	NOUN
dpc-5733	258	4	.	.	PUNCT
dpc-5733	259	1	2024	2024	NUM
dpc-5733	259	2	may	may	AUX
dpc-5733	259	3	18;17:3129	18;17:3129	NUM
dpc-5733	259	4	-	-	SYM
dpc-5733	259	5	3141	3141	NUM
dpc-5733	259	6	.	.	PUNCT
dpc-5733	260	1	doi	doi	NOUN
dpc-5733	260	2	:	:	PUNCT
dpc-5733	260	3	10.2147	10.2147	NUM
dpc-5733	260	4	/	/	SYM
dpc-5733	260	5	jir	jir	PROPN
dpc-5733	260	6	.	.	PUNCT
dpc-5733	261	1	s459238	s459238	NOUN
dpc-5733	261	2	.	.	PUNCT
dpc-5733	262	1	pmid	pmid	NOUN
dpc-5733	262	2	:	:	PUNCT
dpc-5733	262	3	38784102	38784102	NUM
dpc-5733	262	4	.	.	PUNCT
dpc-5733	263	1	31	31	NUM
dpc-5733	263	2	.	.	PUNCT
dpc-5733	264	1	merola	merola	PROPN
dpc-5733	264	2	jf	jf	PROPN
dpc-5733	264	3	,	,	PUNCT
dpc-5733	264	4	mcinnes	mcinnes	PROPN
dpc-5733	264	5	ib	ib	PROPN
dpc-5733	264	6	,	,	PUNCT
dpc-5733	264	7	deodhar	deodhar	VERB
dpc-5733	264	8	aa	aa	PROPN
dpc-5733	264	9	,	,	PUNCT
dpc-5733	264	10	dey	dey	PROPN
dpc-5733	264	11	ak	ak	PROPN
dpc-5733	264	12	,	,	PUNCT
dpc-5733	264	13	adamstein	adamstein	PROPN
dpc-5733	264	14	nh	nh	PROPN
dpc-5733	264	15	,	,	PUNCT
dpc-5733	264	16	quebe	quebe	VERB
dpc-5733	264	17	-	-	PUNCT
dpc-5733	264	18	fehling	fehle	VERB
dpc-5733	264	19	e	e	NOUN
dpc-5733	264	20	,	,	PUNCT
dpc-5733	264	21	aassi	aassi	PROPN
dpc-5733	264	22	m	m	PROPN
dpc-5733	264	23	,	,	PUNCT
dpc-5733	264	24	peine	peine	PROPN
dpc-5733	264	25	m	m	PROPN
dpc-5733	264	26	,	,	PUNCT
dpc-5733	264	27	mehta	mehta	PROPN
dpc-5733	264	28	nn	nn	PROPN
dpc-5733	264	29	.	.	PROPN
dpc-5733	264	30	effect	effect	NOUN
dpc-5733	264	31	of	of	ADP
dpc-5733	264	32	secukinumab	secukinumab	NOUN
dpc-5733	264	33	on	on	ADP
dpc-5733	264	34	traditional	traditional	ADJ
dpc-5733	264	35	cardiovascular	cardiovascular	ADJ
dpc-5733	264	36	risk	risk	NOUN
dpc-5733	264	37	factors	factor	NOUN
dpc-5733	264	38	and	and	CCONJ
dpc-5733	264	39	inflammatory	inflammatory	ADJ
dpc-5733	264	40	biomarkers	biomarker	NOUN
dpc-5733	264	41	:	:	PUNCT
dpc-5733	264	42	post	post	VERB
dpc-5733	264	43	hoc	hoc	X
dpc-5733	264	44	analyses	analysis	NOUN
dpc-5733	264	45	of	of	ADP
dpc-5733	264	46	pooled	pool	VERB
dpc-5733	264	47	data	datum	NOUN
dpc-5733	264	48	across	across	ADP
dpc-5733	264	49	three	three	NUM
dpc-5733	264	50	indications	indication	NOUN
dpc-5733	264	51	.	.	PUNCT
dpc-5733	265	1	rheumatol	rheumatol	VERB
dpc-5733	265	2	ther	ther	ADV
dpc-5733	265	3	.	.	PUNCT
dpc-5733	266	1	2022	2022	NUM
dpc-5733	266	2	jun;9(3):935	jun;9(3):935	ADV
dpc-5733	266	3	-	-	PUNCT
dpc-5733	266	4	955	955	NUM
dpc-5733	266	5	.	.	PUNCT
dpc-5733	267	1	doi	doi	NOUN
dpc-5733	267	2	:	:	PUNCT
dpc-5733	267	3	10.1007	10.1007	NUM
dpc-5733	267	4	/	/	SYM
dpc-5733	267	5	s40744	s40744	NOUN
dpc-5733	267	6	-	-	PUNCT
dpc-5733	267	7	022	022	NUM
dpc-5733	267	8	-	-	PUNCT
dpc-5733	267	9	00434	00434	NUM
dpc-5733	267	10	-	-	PUNCT
dpc-5733	267	11	z.	z.	PROPN
dpc-5733	267	12	epub	epub	PROPN
dpc-5733	267	13	2022	2022	NUM
dpc-5733	267	14	mar	mar	PROPN
dpc-5733	267	15	19	19	NUM
dpc-5733	267	16	.	.	PUNCT
dpc-5733	268	1	pmid	pmid	NOUN
dpc-5733	268	2	:	:	PUNCT
dpc-5733	268	3	35305260	35305260	NUM
dpc-5733	268	4	.	.	PUNCT
dpc-5733	269	1	32	32	NUM
dpc-5733	269	2	.	.	PUNCT
dpc-5733	270	1	zhong	zhong	PROPN
dpc-5733	270	2	x	x	PROPN
dpc-5733	270	3	,	,	PUNCT
dpc-5733	270	4	huang	huang	PROPN
dpc-5733	270	5	d	d	PROPN
dpc-5733	270	6	,	,	PUNCT
dpc-5733	270	7	chen	chen	PROPN
dpc-5733	270	8	r	r	PROPN
dpc-5733	270	9	,	,	PUNCT
dpc-5733	270	10	yao	yao	PROPN
dpc-5733	270	11	l	l	NOUN
dpc-5733	270	12	,	,	PUNCT
dpc-5733	270	13	ma	ma	PROPN
dpc-5733	270	14	r	r	PROPN
dpc-5733	270	15	,	,	PUNCT
dpc-5733	270	16	yu	yu	PROPN
dpc-5733	270	17	y	y	PROPN
dpc-5733	270	18	,	,	PUNCT
dpc-5733	270	19	jiang	jiang	PROPN
dpc-5733	270	20	y	y	PROPN
dpc-5733	270	21	,	,	PUNCT
dpc-5733	270	22	kong	kong	PROPN
dpc-5733	270	23	l	l	PROPN
dpc-5733	270	24	,	,	PUNCT
dpc-5733	270	25	lu	lu	PROPN
dpc-5733	270	26	j	j	PROPN
dpc-5733	270	27	,	,	PUNCT
dpc-5733	270	28	li	li	PROPN
dpc-5733	270	29	y	y	PROPN
dpc-5733	270	30	,	,	PUNCT
dpc-5733	270	31	shi	shi	PROPN
dpc-5733	270	32	y.	y.	PROPN
dpc-5733	270	33	positive	positive	PROPN
dpc-5733	270	34	association	association	NOUN
dpc-5733	270	35	between	between	ADP
dpc-5733	270	36	insulin	insulin	NOUN
dpc-5733	270	37	resistance	resistance	NOUN
dpc-5733	270	38	and	and	CCONJ
dpc-5733	270	39	fatty	fatty	NOUN
dpc-5733	270	40	liver	liver	NOUN
dpc-5733	270	41	disease	disease	NOUN
dpc-5733	270	42	in	in	ADP
dpc-5733	270	43	psoriasis	psoriasis	NOUN
dpc-5733	270	44	:	:	PUNCT
dpc-5733	270	45	evidence	evidence	NOUN
dpc-5733	270	46	from	from	ADP
dpc-5733	270	47	a	a	PRON
dpc-5733	270	48	in	in	ADP
dpc-5733	270	49	metastatic	metastatic	ADJ
dpc-5733	270	50	colorectal	colorectal	ADJ
dpc-5733	270	51	cancer	cancer	NOUN
dpc-5733	270	52	:	:	PUNCT
dpc-5733	270	53	results	result	NOUN
dpc-5733	270	54	from	from	ADP
dpc-5733	270	55	a	a	DET
dpc-5733	270	56	pooled	pool	VERB
dpc-5733	270	57	-	-	PUNCT
dpc-5733	270	58	analysis	analysis	NOUN
dpc-5733	270	59	of	of	ADP
dpc-5733	270	60	the	the	DET
dpc-5733	270	61	valentino	valentino	NOUN
dpc-5733	270	62	and	and	CCONJ
dpc-5733	270	63	tribe	tribe	VERB
dpc-5733	270	64	first	first	ADJ
dpc-5733	270	65	-	-	PUNCT
dpc-5733	270	66	line	line	NOUN
dpc-5733	270	67	trials	trial	NOUN
dpc-5733	270	68	.	.	PUNCT
dpc-5733	271	1	br	br	PROPN
dpc-5733	271	2	j	j	PROPN
dpc-5733	271	3	cancer	cancer	NOUN
dpc-5733	271	4	.	.	PUNCT
dpc-5733	272	1	2020	2020	NUM
dpc-5733	272	2	aug;123(3):403	aug;123(3):403	NOUN
dpc-5733	272	3	-	-	PUNCT
dpc-5733	272	4	409	409	NUM
dpc-5733	272	5	.	.	PUNCT
dpc-5733	273	1	doi	doi	NOUN
dpc-5733	273	2	:	:	PUNCT
dpc-5733	273	3	10.1038	10.1038	NUM
dpc-5733	273	4	/	/	SYM
dpc-5733	273	5	s41416	s41416	NUM
dpc-5733	273	6	-	-	PUNCT
dpc-5733	273	7	020	020	NUM
dpc-5733	273	8	-	-	PUNCT
dpc-5733	273	9	0894	0894	NUM
dpc-5733	273	10	-	-	SYM
dpc-5733	273	11	7	7	NUM
dpc-5733	273	12	.	.	PUNCT
dpc-5733	274	1	epub	epub	NOUN
dpc-5733	274	2	2020	2020	NUM
dpc-5733	274	3	may	may	AUX
dpc-5733	274	4	19	19	NUM
dpc-5733	274	5	.	.	PUNCT
dpc-5733	275	1	pmid	pmid	NOUN
dpc-5733	275	2	:	:	PUNCT
dpc-5733	275	3	32424148	32424148	NUM
dpc-5733	275	4	11	11	NUM
dpc-5733	275	5	.	.	PUNCT
dpc-5733	276	1	ye	ye	PRON
dpc-5733	276	2	jh	jh	PROPN
dpc-5733	276	3	,	,	PUNCT
dpc-5733	276	4	zhang	zhang	PROPN
dpc-5733	276	5	y	y	PROPN
dpc-5733	276	6	,	,	PUNCT
dpc-5733	276	7	naidoo	naidoo	PROPN
dpc-5733	276	8	k	k	PROPN
dpc-5733	276	9	,	,	PUNCT
dpc-5733	276	10	ye	ye	PROPN
dpc-5733	276	11	s.	s.	PROPN
dpc-5733	276	12	neutrophil	neutrophil	PROPN
dpc-5733	276	13	-	-	PUNCT
dpc-5733	276	14	to	to	ADP
dpc-5733	276	15	-	-	PUNCT
dpc-5733	276	16	lymphocyte	lymphocyte	ADJ
dpc-5733	276	17	ratio	ratio	NOUN
dpc-5733	276	18	and	and	CCONJ
dpc-5733	276	19	platelet	platelet	NOUN
dpc-5733	276	20	-	-	PUNCT
dpc-5733	276	21	to	to	ADP
dpc-5733	276	22	-	-	PUNCT
dpc-5733	276	23	lymphocyte	lymphocyte	ADJ
dpc-5733	276	24	ratio	ratio	NOUN
dpc-5733	276	25	in	in	ADP
dpc-5733	276	26	psoriasis	psoriasis	NOUN
dpc-5733	276	27	:	:	PUNCT
dpc-5733	276	28	a	a	DET
dpc-5733	276	29	systematic	systematic	ADJ
dpc-5733	276	30	review	review	NOUN
dpc-5733	276	31	and	and	CCONJ
dpc-5733	276	32	meta	meta	ADJ
dpc-5733	276	33	-	-	PUNCT
dpc-5733	276	34	analysis	analysis	NOUN
dpc-5733	276	35	.	.	PUNCT
dpc-5733	277	1	arch	arch	ADJ
dpc-5733	277	2	dermatol	dermatol	NOUN
dpc-5733	277	3	res	re	NOUN
dpc-5733	277	4	.	.	PUNCT
dpc-5733	278	1	2024	2024	NUM
dpc-5733	278	2	feb	feb	PROPN
dpc-5733	278	3	8;316(3):85	8;316(3):85	PROPN
dpc-5733	278	4	.	.	PUNCT
dpc-5733	279	1	doi	doi	NOUN
dpc-5733	279	2	:	:	PUNCT
dpc-5733	279	3	10.1007	10.1007	NUM
dpc-5733	279	4	/	/	SYM
dpc-5733	279	5	s00403	s00403	NOUN
dpc-5733	279	6	-	-	PUNCT
dpc-5733	279	7	024	024	NUM
dpc-5733	279	8	-	-	PUNCT
dpc-5733	279	9	02823	02823	NUM
dpc-5733	279	10	-	-	PUNCT
dpc-5733	279	11	6	6	NUM
dpc-5733	279	12	.	.	PUNCT
dpc-5733	280	1	pmid	pmid	NOUN
dpc-5733	280	2	:	:	PUNCT
dpc-5733	280	3	38329632	38329632	NUM
dpc-5733	280	4	.	.	PUNCT
dpc-5733	281	1	12	12	NUM
dpc-5733	281	2	.	.	PUNCT
dpc-5733	282	1	liu	liu	PROPN
dpc-5733	282	2	yc	yc	PROPN
dpc-5733	282	3	,	,	PUNCT
dpc-5733	282	4	chuang	chuang	PROPN
dpc-5733	282	5	sh	sh	PROPN
dpc-5733	282	6	,	,	PUNCT
dpc-5733	282	7	chen	chen	PROPN
dpc-5733	282	8	yp	yp	PROPN
dpc-5733	282	9	,	,	PUNCT
dpc-5733	282	10	shih	shih	PROPN
dpc-5733	282	11	yh	yh	PROPN
dpc-5733	282	12	.	.	PROPN
dpc-5733	282	13	associations	association	NOUN
dpc-5733	282	14	of	of	ADP
dpc-5733	282	15	novel	novel	ADJ
dpc-5733	282	16	complete	complete	ADJ
dpc-5733	282	17	blood	blood	NOUN
dpc-5733	282	18	count	count	NOUN
dpc-5733	282	19	-	-	PUNCT
dpc-5733	282	20	derived	derive	VERB
dpc-5733	282	21	inflammatory	inflammatory	ADJ
dpc-5733	282	22	markers	marker	NOUN
dpc-5733	282	23	with	with	ADP
dpc-5733	282	24	psoriasis	psoriasis	NOUN
dpc-5733	282	25	:	:	PUNCT
dpc-5733	282	26	a	a	DET
dpc-5733	282	27	systematic	systematic	ADJ
dpc-5733	282	28	review	review	NOUN
dpc-5733	282	29	and	and	CCONJ
dpc-5733	282	30	meta	meta	ADJ
dpc-5733	282	31	-	-	PUNCT
dpc-5733	282	32	analysis	analysis	NOUN
dpc-5733	282	33	.	.	PUNCT
dpc-5733	283	1	arch	arch	ADJ
dpc-5733	283	2	dermatol	dermatol	NOUN
dpc-5733	283	3	res	re	NOUN
dpc-5733	283	4	.	.	PUNCT
dpc-5733	284	1	2024	2024	NUM
dpc-5733	284	2	may	may	AUX
dpc-5733	284	3	24;316(6):228	24;316(6):228	NUM
dpc-5733	284	4	.	.	PUNCT
dpc-5733	285	1	doi	doi	NOUN
dpc-5733	285	2	:	:	PUNCT
dpc-5733	285	3	10.1007	10.1007	NUM
dpc-5733	285	4	/	/	SYM
dpc-5733	285	5	s00403	s00403	NOUN
dpc-5733	285	6	-	-	PUNCT
dpc-5733	285	7	024	024	NUM
dpc-5733	285	8	-	-	PUNCT
dpc-5733	285	9	02994	02994	NUM
dpc-5733	285	10	-	-	SYM
dpc-5733	285	11	2	2	NUM
dpc-5733	285	12	.	.	PUNCT
dpc-5733	286	1	pmid	pmid	NOUN
dpc-5733	286	2	:	:	PUNCT
dpc-5733	286	3	38787437	38787437	NUM
dpc-5733	286	4	.	.	PUNCT
dpc-5733	287	1	13	13	NUM
dpc-5733	287	2	.	.	X
dpc-5733	287	3	morariu	morariu	PROPN
dpc-5733	287	4	sh	sh	PROPN
dpc-5733	287	5	,	,	PUNCT
dpc-5733	287	6	cotoi	cotoi	PROPN
dpc-5733	287	7	os	os	PROPN
dpc-5733	287	8	,	,	PUNCT
dpc-5733	287	9	tiucă	tiucă	ADV
dpc-5733	287	10	om	om	PROPN
dpc-5733	287	11	,	,	PUNCT
dpc-5733	287	12	baican	baican	NOUN
dpc-5733	287	13	a	a	PRON
dpc-5733	287	14	,	,	PUNCT
dpc-5733	287	15	gheucă	gheucă	PROPN
dpc-5733	287	16	-	-	PUNCT
dpc-5733	287	17	solovăstru	solovăstru	PROPN
dpc-5733	287	18	l	l	PROPN
dpc-5733	287	19	,	,	PUNCT
dpc-5733	287	20	decean	decean	ADJ
dpc-5733	287	21	h	h	NOUN
dpc-5733	287	22	,	,	PUNCT
dpc-5733	287	23	brihan	brihan	PROPN
dpc-5733	287	24	i	i	PROPN
dpc-5733	287	25	,	,	PUNCT
dpc-5733	287	26	silaghi	silaghi	PROPN
dpc-5733	287	27	k	k	PROPN
dpc-5733	287	28	,	,	PUNCT
dpc-5733	287	29	biro	biro	PROPN
dpc-5733	287	30	v	v	ADP
dpc-5733	287	31	,	,	PUNCT
dpc-5733	287	32	şerban	şerban	ADJ
dpc-5733	287	33	-	-	PUNCT
dpc-5733	287	34	pescar	pescar	NOUN
dpc-5733	287	35	d	d	PROPN
dpc-5733	287	36	,	,	PUNCT
dpc-5733	287	37	măgureanu	măgureanu	VERB
dpc-5733	287	38	i	i	PRON
dpc-5733	287	39	,	,	PUNCT
dpc-5733	287	40	ambros	ambros	PROPN
dpc-5733	287	41	m	m	PROPN
dpc-5733	287	42	,	,	PUNCT
dpc-5733	287	43	ilcuş	ilcuş	PROPN
dpc-5733	287	44	ri	ri	PROPN
dpc-5733	287	45	,	,	PUNCT
dpc-5733	287	46	prodan	prodan	PROPN
dpc-5733	287	47	l	l	PROPN
dpc-5733	287	48	,	,	PUNCT
dpc-5733	287	49	bălan	bălan	PROPN
dpc-5733	287	50	ab	ab	PROPN
dpc-5733	287	51	,	,	PUNCT
dpc-5733	287	52	husariu	husariu	PROPN
dpc-5733	287	53	m	m	PROPN
dpc-5733	287	54	,	,	PUNCT
dpc-5733	287	55	gugulus	gugulus	PROPN
dpc-5733	287	56	dl	dl	PROPN
dpc-5733	287	57	,	,	PUNCT
dpc-5733	287	58	stan	stan	PROPN
dpc-5733	287	59	ra	ra	PROPN
dpc-5733	287	60	,	,	PUNCT
dpc-5733	287	61	voiculescu	voiculescu	NOUN
dpc-5733	287	62	v	v	PROPN
dpc-5733	287	63	,	,	PUNCT
dpc-5733	287	64	nicolescu	nicolescu	PROPN
dpc-5733	287	65	ac	ac	PROPN
dpc-5733	287	66	.	.	PUNCT
dpc-5733	288	1	bloodcount	bloodcount	NOUN
dpc-5733	288	2	-	-	PUNCT
dpc-5733	288	3	derived	derive	VERB
dpc-5733	288	4	inflammatory	inflammatory	ADJ
dpc-5733	288	5	markers	marker	NOUN
dpc-5733	288	6	as	as	ADP
dpc-5733	288	7	predictors	predictor	NOUN
dpc-5733	288	8	of	of	ADP
dpc-5733	288	9	response	response	NOUN
dpc-5733	288	10	to	to	ADP
dpc-5733	288	11	biologics	biologic	NOUN
dpc-5733	288	12	and	and	CCONJ
dpc-5733	288	13	small	small	ADJ
dpc-5733	288	14	-	-	PUNCT
dpc-5733	288	15	molecule	molecule	NOUN
dpc-5733	288	16	inhibitors	inhibitor	NOUN
dpc-5733	288	17	in	in	ADP
dpc-5733	288	18	psoriasis	psoriasis	NOUN
dpc-5733	288	19	:	:	PUNCT
dpc-5733	288	20	a	a	DET
dpc-5733	288	21	multicenter	multicenter	ADJ
dpc-5733	288	22	study	study	NOUN
dpc-5733	288	23	.	.	PUNCT
dpc-5733	289	1	j	j	PROPN
dpc-5733	289	2	clin	clin	PROPN
dpc-5733	289	3	med	med	PROPN
dpc-5733	289	4	.	.	PUNCT
dpc-5733	290	1	2024	2024	NUM
dpc-5733	290	2	jul	jul	PROPN
dpc-5733	290	3	9;13(14):3992	9;13(14):3992	NUM
dpc-5733	290	4	.	.	PUNCT
dpc-5733	290	5	doi	doi	PROPN
dpc-5733	290	6	:	:	PUNCT
dpc-5733	290	7	10.3390	10.3390	NUM
dpc-5733	290	8	/jcm13143992	/jcm13143992	PUNCT
dpc-5733	290	9	.	.	PUNCT
dpc-5733	290	10	pmid	pmid	NOUN
dpc-5733	290	11	:	:	PUNCT
dpc-5733	290	12	39064032	39064032	NUM
dpc-5733	290	13	;	;	PUNCT
dpc-5733	290	14	pmcid	pmcid	PROPN
dpc-5733	290	15	:	:	PUNCT
dpc-5733	290	16	pmc11277525	pmc11277525	NOUN
dpc-5733	290	17	.	.	PUNCT
dpc-5733	291	1	14	14	NUM
dpc-5733	291	2	.	.	PUNCT
dpc-5733	292	1	kulakli	kulakli	PROPN
dpc-5733	292	2	s	s	PROPN
dpc-5733	292	3	,	,	PUNCT
dpc-5733	292	4	oguz	oguz	PROPN
dpc-5733	292	5	i	i	PROPN
dpc-5733	292	6	d	d	PROPN
dpc-5733	292	7	,	,	PUNCT
dpc-5733	292	8	aksan	aksan	PROPN
dpc-5733	292	9	b.	b.	PROPN
dpc-5733	292	10	could	could	AUX
dpc-5733	292	11	blood	blood	NOUN
dpc-5733	292	12	cell	cell	NOUN
dpc-5733	292	13	-	-	PUNCT
dpc-5733	292	14	based	base	VERB
dpc-5733	292	15	inflammatory	inflammatory	ADJ
dpc-5733	292	16	markers	marker	NOUN
dpc-5733	292	17	be	be	AUX
dpc-5733	292	18	used	use	VERB
dpc-5733	292	19	to	to	PART
dpc-5733	292	20	monitor	monitor	VERB
dpc-5733	292	21	response	response	NOUN
dpc-5733	292	22	to	to	ADP
dpc-5733	292	23	biologic	biologic	NOUN
dpc-5733	292	24	therapy	therapy	NOUN
dpc-5733	292	25	in	in	ADP
dpc-5733	292	26	psoriasis	psoriasis	NOUN
dpc-5733	292	27	?	?	PUNCT
dpc-5733	293	1	sisli	sisli	ADJ
dpc-5733	293	2	etfal	etfal	PROPN
dpc-5733	293	3	hastan	hastan	PROPN
dpc-5733	293	4	tip	tip	PROPN
dpc-5733	293	5	bul	bul	PROPN
dpc-5733	293	6	.	.	PUNCT
dpc-5733	294	1	2023	2023	NUM
dpc-5733	294	2	dec	dec	PROPN
dpc-5733	294	3	20;57(4):536	20;57(4):536	NUM
dpc-5733	294	4	-542	-542	PROPN
dpc-5733	294	5	.	.	PUNCT
dpc-5733	294	6	doi	doi	NOUN
dpc-5733	294	7	:	:	PUNCT
dpc-5733	294	8	10.14744	10.14744	NUM
dpc-5733	294	9	/	/	SYM
dpc-5733	294	10	semb.2023.43569	semb.2023.43569	NOUN
dpc-5733	294	11	.	.	PUNCT
dpc-5733	295	1	pmid	pmid	NOUN
dpc-5733	295	2	:	:	PUNCT
dpc-5733	295	3	38268655	38268655	NUM
dpc-5733	295	4	15	15	NUM
dpc-5733	295	5	.	.	PUNCT
dpc-5733	296	1	campanati	campanati	PROPN
dpc-5733	296	2	a	a	PROPN
dpc-5733	296	3	,	,	PUNCT
dpc-5733	296	4	marani	marani	PROPN
dpc-5733	296	5	a	a	PRON
dpc-5733	296	6	,	,	PUNCT
dpc-5733	296	7	martina	martina	PROPN
dpc-5733	296	8	e	e	PROPN
dpc-5733	296	9	,	,	PUNCT
dpc-5733	296	10	diotallevi	diotallevi	ADJ
dpc-5733	296	11	f	f	PROPN
dpc-5733	296	12	,	,	PUNCT
dpc-5733	296	13	radi	radi	NOUN
dpc-5733	296	14	g	g	NOUN
dpc-5733	296	15	,	,	PUNCT
dpc-5733	296	16	offidani	offidani	X
dpc-5733	296	17	a.	a.	NOUN
dpc-5733	296	18	psoriasis	psoriasis	NOUN
dpc-5733	296	19	as	as	ADP
dpc-5733	296	20	an	an	DET
dpc-5733	296	21	immune	immune	NOUN
dpc-5733	296	22	-	-	PUNCT
dpc-5733	296	23	mediated	mediate	VERB
dpc-5733	296	24	and	and	CCONJ
dpc-5733	296	25	inflammatory	inflammatory	ADJ
dpc-5733	296	26	systemic	systemic	ADJ
dpc-5733	296	27	disease	disease	NOUN
dpc-5733	296	28	:	:	PUNCT
dpc-5733	296	29	from	from	ADP
dpc-5733	296	30	pathophysiology	pathophysiology	NOUN
dpc-5733	296	31	to	to	PART
dpc-5733	296	32	novel	novel	VERB
dpc-5733	296	33	therapeutic	therapeutic	ADJ
dpc-5733	296	34	approaches	approach	NOUN
dpc-5733	296	35	.	.	PUNCT
dpc-5733	297	1	biomedicines	biomedicine	NOUN
dpc-5733	297	2	.	.	PUNCT
dpc-5733	298	1	2021	2021	NUM
dpc-5733	298	2	oct	oct	PROPN
dpc-5733	298	3	21;9(11):1511	21;9(11):1511	PROPN
dpc-5733	298	4	.	.	PUNCT
dpc-5733	299	1	doi	doi	NOUN
dpc-5733	299	2	:	:	PUNCT
dpc-5733	299	3	10.3390	10.3390	NUM
dpc-5733	299	4	/	/	SYM
dpc-5733	299	5	biomedicines9111511	biomedicines9111511	PROPN
dpc-5733	299	6	.	.	PUNCT
dpc-5733	300	1	pmid	pmid	NOUN
dpc-5733	300	2	:	:	PUNCT
dpc-5733	300	3	34829740	34829740	NUM
dpc-5733	300	4	;	;	PUNCT
dpc-5733	300	5	pmcid	pmcid	NOUN
dpc-5733	300	6	:	:	PUNCT
dpc-5733	300	7	pmc8615182	pmc8615182	NOUN
dpc-5733	300	8	.	.	PUNCT
dpc-5733	301	1	16	16	NUM
dpc-5733	301	2	.	.	PUNCT
dpc-5733	302	1	man	man	NOUN
dpc-5733	302	2	am	be	AUX
dpc-5733	302	3	,	,	PUNCT
dpc-5733	302	4	orăsan	orăsan	PROPN
dpc-5733	302	5	ms	ms	PROPN
dpc-5733	302	6	,	,	PUNCT
dpc-5733	302	7	hoteiuc	hoteiuc	NOUN
dpc-5733	302	8	oa	oa	PRON
dpc-5733	302	9	,	,	PUNCT
dpc-5733	302	10	olănescu	olănescu	NOUN
dpc-5733	302	11	-	-	PUNCT
dpc-5733	302	12	vaida	vaida	NOUN
dpc-5733	302	13	-	-	PUNCT
dpc-5733	302	14	voevod	voevod	PROPN
dpc-5733	302	15	mc	mc	PROPN
dpc-5733	302	16	,	,	PUNCT
dpc-5733	302	17	mocan	mocan	PROPN
dpc-5733	302	18	t.	t.	PROPN
dpc-5733	302	19	inflammation	inflammation	NOUN
dpc-5733	302	20	and	and	CCONJ
dpc-5733	302	21	psoriasis	psoriasis	NOUN
dpc-5733	302	22	:	:	PUNCT
dpc-5733	302	23	a	a	DET
dpc-5733	302	24	comprehensive	comprehensive	ADJ
dpc-5733	302	25	review	review	NOUN
dpc-5733	302	26	.	.	PUNCT
dpc-5733	303	1	int	int	PROPN
dpc-5733	303	2	j	j	PROPN
dpc-5733	303	3	mol	mol	ADP
dpc-5733	303	4	sci	sci	PROPN
dpc-5733	303	5	.	.	PROPN
dpc-5733	304	1	2023	2023	NUM
dpc-5733	304	2	nov	nov	NOUN
dpc-5733	304	3	8;24(22):16095	8;24(22):16095	NUM
dpc-5733	304	4	.	.	PUNCT
dpc-5733	304	5	doi	doi	NOUN
dpc-5733	304	6	:	:	PUNCT
dpc-5733	304	7	10.3390	10.3390	NUM
dpc-5733	304	8	/ijms242216095	/ijms242216095	PUNCT
dpc-5733	304	9	.	.	PUNCT
dpc-5733	305	1	pmid	pmid	NOUN
dpc-5733	305	2	:	:	PUNCT
dpc-5733	305	3	38003284	38003284	NUM
dpc-5733	305	4	.	.	PUNCT
dpc-5733	306	1	17	17	NUM
dpc-5733	306	2	.	.	PUNCT
dpc-5733	307	1	visser	visser	PROPN
dpc-5733	307	2	mje	mje	PROPN
dpc-5733	307	3	,	,	PUNCT
dpc-5733	307	4	venter	venter	PROPN
dpc-5733	307	5	c	c	PROPN
dpc-5733	307	6	,	,	PUNCT
dpc-5733	307	7	roberts	roberts	PROPN
dpc-5733	307	8	tj	tj	PROPN
dpc-5733	307	9	,	,	PUNCT
dpc-5733	307	10	tarr	tarr	VERB
dpc-5733	307	11	g	g	PROPN
dpc-5733	307	12	,	,	PUNCT
dpc-5733	307	13	pretorius	pretorius	PROPN
dpc-5733	307	14	e.	e.	PROPN
dpc-5733	307	15	psoriatic	psoriatic	PROPN
dpc-5733	307	16	disease	disease	NOUN
dpc-5733	307	17	is	be	AUX
dpc-5733	307	18	associated	associate	VERB
dpc-5733	307	19	with	with	ADP
dpc-5733	307	20	systemic	systemic	ADJ
dpc-5733	307	21	inflammation	inflammation	NOUN
dpc-5733	307	22	,	,	PUNCT
dpc-5733	307	23	endothelial	endothelial	ADJ
dpc-5733	307	24	activation	activation	NOUN
dpc-5733	307	25	,	,	PUNCT
dpc-5733	307	26	 	 	SPACE
dpc-5733	307	27	and	and	CCONJ
dpc-5733	307	28	altered	alter	VERB
dpc-5733	307	29	haemostatic	haemostatic	ADJ
dpc-5733	307	30	function	function	NOUN
dpc-5733	307	31	.	.	PUNCT
dpc-5733	308	1	sci	sci	PROPN
dpc-5733	308	2	rep	rep	PROPN
dpc-5733	308	3	.	.	PROPN
dpc-5733	308	4	2021	2021	NUM
dpc-5733	308	5	jun	jun	PROPN
dpc-5733	308	6	22;11(1):13043	22;11(1):13043	NUM
dpc-5733	308	7	.	.	PUNCT
dpc-5733	309	1	doi	doi	NOUN
dpc-5733	309	2	:	:	PUNCT
dpc-5733	309	3	10.1038	10.1038	NUM
dpc-5733	309	4	/	/	SYM
dpc-5733	309	5	s41598	s41598	NOUN
dpc-5733	309	6	-	-	PUNCT
dpc-5733	309	7	021	021	NUM
dpc-5733	309	8	-	-	PUNCT
dpc-5733	309	9	90684	90684	NUM
dpc-5733	309	10	-	-	PUNCT
dpc-5733	309	11	8	8	NUM
dpc-5733	309	12	.	.	PUNCT
dpc-5733	310	1	pmid	pmid	NOUN
dpc-5733	310	2	:	:	PUNCT
dpc-5733	310	3	34158537	34158537	NUM
dpc-5733	310	4	18	18	NUM
dpc-5733	310	5	.	.	PUNCT
dpc-5733	311	1	jin	jin	PROPN
dpc-5733	311	2	m	m	PROPN
dpc-5733	311	3	,	,	PUNCT
dpc-5733	311	4	yuan	yuan	PROPN
dpc-5733	311	5	s	s	PROPN
dpc-5733	311	6	,	,	PUNCT
dpc-5733	311	7	yuan	yuan	PROPN
dpc-5733	311	8	y	y	PROPN
dpc-5733	311	9	,	,	PUNCT
dpc-5733	311	10	yi	yi	PROPN
dpc-5733	311	11	l.	l.	PROPN
dpc-5733	311	12	prognostic	prognostic	PROPN
dpc-5733	311	13	and	and	CCONJ
dpc-5733	311	14	clinicopathological	clinicopathological	ADJ
dpc-5733	311	15	significance	significance	NOUN
dpc-5733	311	16	of	of	ADP
dpc-5733	311	17	the	the	DET
dpc-5733	311	18	systemic	systemic	ADJ
dpc-5733	311	19	immune	immune	ADJ
dpc-5733	311	20	-	-	PUNCT
dpc-5733	311	21	inflammation	inflammation	NOUN
dpc-5733	311	22	index	index	NOUN
dpc-5733	311	23	in	in	ADP
dpc-5733	311	24	patients	patient	NOUN
dpc-5733	311	25	with	with	ADP
dpc-5733	311	26	renal	renal	ADJ
dpc-5733	311	27	cell	cell	NOUN
dpc-5733	311	28	carcinoma	carcinoma	NOUN
dpc-5733	311	29	:	:	PUNCT
dpc-5733	311	30	a	a	DET
dpc-5733	311	31	meta	meta	ADJ
dpc-5733	311	32	-	-	PUNCT
dpc-5733	311	33	analysis	analysis	NOUN
dpc-5733	311	34	.	.	PUNCT
dpc-5733	312	1	front	front	ADJ
dpc-5733	312	2	oncol	oncol	ADJ
dpc-5733	312	3	.	.	PUNCT
dpc-5733	313	1	2021	2021	NUM
dpc-5733	313	2	dec	dec	PROPN
dpc-5733	313	3	7;11:735803	7;11:735803	NUM
dpc-5733	313	4	.	.	PUNCT
dpc-5733	314	1	doi	doi	NOUN
dpc-5733	314	2	:	:	PUNCT
dpc-5733	314	3	10.3389	10.3389	NUM
dpc-5733	314	4	/	/	SYM
dpc-5733	314	5	fonc.2021.735803	fonc.2021.735803	NOUN
dpc-5733	314	6	.	.	PUNCT
dpc-5733	315	1	pmid	pmid	NOUN
dpc-5733	315	2	:	:	PUNCT
dpc-5733	315	3	34950577	34950577	NUM
dpc-5733	315	4	.	.	PUNCT
dpc-5733	316	1	19	19	NUM
dpc-5733	316	2	.	.	PUNCT
dpc-5733	316	3	cai	cai	PROPN
dpc-5733	316	4	y	y	PROPN
dpc-5733	316	5	,	,	PUNCT
dpc-5733	316	6	zhao	zhao	PROPN
dpc-5733	316	7	l	l	PROPN
dpc-5733	316	8	,	,	PUNCT
dpc-5733	316	9	zhang	zhang	PROPN
dpc-5733	316	10	y	y	PROPN
dpc-5733	316	11	,	,	PUNCT
dpc-5733	316	12	luo	luo	PROPN
dpc-5733	316	13	d.	d.	PROPN
dpc-5733	316	14	association	association	PROPN
dpc-5733	316	15	between	between	ADP
dpc-5733	316	16	blood	blood	NOUN
dpc-5733	316	17	inflammatory	inflammatory	ADJ
dpc-5733	316	18	indicators	indicator	NOUN
dpc-5733	316	19	and	and	CCONJ
dpc-5733	316	20	prognosis	prognosis	NOUN
dpc-5733	316	21	of	of	ADP
dpc-5733	316	22	papillary	papillary	ADJ
dpc-5733	316	23	thyroid	thyroid	NOUN
dpc-5733	316	24	carcinoma	carcinoma	NOUN
dpc-5733	316	25	:	:	PUNCT
dpc-5733	316	26	a	a	DET
dpc-5733	316	27	narrative	narrative	NOUN
dpc-5733	316	28	review	review	NOUN
dpc-5733	316	29	.	.	PUNCT
dpc-5733	317	1	gland	gland	NOUN
dpc-5733	317	2	surg	surg	NOUN
dpc-5733	317	3	.	.	PUNCT
dpc-5733	318	1	2024	2024	NUM
dpc-5733	318	2	jun	jun	PROPN
dpc-5733	318	3	30;13(6):1088	30;13(6):1088	NUM
dpc-5733	318	4	-	-	PUNCT
dpc-5733	318	5	1096	1096	NUM
dpc-5733	318	6	.	.	PUNCT
dpc-5733	319	1	doi	doi	NOUN
dpc-5733	319	2	:	:	PUNCT
dpc-5733	319	3	10.21037	10.21037	NUM
dpc-5733	319	4	/	/	SYM
dpc-5733	319	5	gs-24	gs-24	NOUN
dpc-5733	319	6	-	-	PUNCT
dpc-5733	319	7	72	72	NUM
dpc-5733	319	8	.	.	PUNCT
dpc-5733	320	1	epub	epub	PROPN
dpc-5733	320	2	2024	2024	NUM
dpc-5733	320	3	jun	jun	PROPN
dpc-5733	320	4	25	25	NUM
dpc-5733	320	5	.	.	PUNCT
dpc-5733	321	1	pmid	pmid	NOUN
dpc-5733	321	2	:	:	PUNCT
dpc-5733	321	3	39015725	39015725	NUM
dpc-5733	321	4	.	.	PUNCT
dpc-5733	322	1	20	20	NUM
dpc-5733	322	2	.	.	PUNCT
dpc-5733	323	1	han	han	PROPN
dpc-5733	323	2	x	x	PROPN
dpc-5733	323	3	,	,	PUNCT
dpc-5733	323	4	liu	liu	PROPN
dpc-5733	323	5	s	s	PROPN
dpc-5733	323	6	,	,	PUNCT
dpc-5733	323	7	yang	yang	PROPN
dpc-5733	323	8	g	g	PROPN
dpc-5733	323	9	,	,	PUNCT
dpc-5733	323	10	hosseinifard	hosseinifard	PROPN
dpc-5733	323	11	h	h	PROPN
dpc-5733	323	12	,	,	PUNCT
dpc-5733	323	13	imani	imani	PROPN
dpc-5733	323	14	s	s	PROPN
dpc-5733	323	15	,	,	PUNCT
dpc-5733	323	16	yang	yang	PROPN
dpc-5733	323	17	l	l	PROPN
dpc-5733	323	18	,	,	PUNCT
dpc-5733	323	19	maghsoudloo	maghsoudloo	PROPN
dpc-5733	323	20	m	m	PROPN
dpc-5733	323	21	,	,	PUNCT
dpc-5733	323	22	fu	fu	PROPN
dpc-5733	323	23	s	s	PROPN
dpc-5733	323	24	,	,	PUNCT
dpc-5733	323	25	wen	wen	PROPN
dpc-5733	323	26	q	q	PROPN
dpc-5733	323	27	,	,	PUNCT
dpc-5733	323	28	liu	liu	PROPN
dpc-5733	323	29	q.	q.	PROPN
dpc-5733	323	30	prognostic	prognostic	PROPN
dpc-5733	323	31	value	value	NOUN
dpc-5733	323	32	of	of	ADP
dpc-5733	323	33	systemic	systemic	ADJ
dpc-5733	323	34	hemato	hemato	NOUN
dpc-5733	323	35	-	-	PUNCT
dpc-5733	323	36	immunological	immunological	ADJ
dpc-5733	323	37	indices	index	NOUN
dpc-5733	323	38	in	in	ADP
dpc-5733	323	39	uterine	uterine	ADJ
dpc-5733	323	40	cervical	cervical	ADJ
dpc-5733	323	41	cancer	cancer	NOUN
dpc-5733	323	42	:	:	PUNCT
dpc-5733	323	43	a	a	DET
dpc-5733	323	44	systemic	systemic	ADJ
dpc-5733	323	45	review	review	NOUN
dpc-5733	323	46	,	,	PUNCT
dpc-5733	323	47	meta	meta	ADJ
dpc-5733	323	48	-	-	PUNCT
dpc-5733	323	49	analysis	analysis	NOUN
dpc-5733	323	50	,	,	PUNCT
dpc-5733	323	51	and	and	CCONJ
dpc-5733	323	52	meta	meta	ADJ
dpc-5733	323	53	-	-	PUNCT
dpc-5733	323	54	regression	regression	NOUN
dpc-5733	323	55	of	of	ADP
dpc-5733	323	56	observational	observational	ADJ
dpc-5733	323	57	studies	study	NOUN
dpc-5733	323	58	.	.	PUNCT
dpc-5733	324	1	gynecol	gynecol	ADJ
dpc-5733	324	2	oncol	oncol	ADJ
dpc-5733	324	3	.	.	PUNCT
dpc-5733	325	1	2021	2021	NUM
dpc-5733	325	2	jan;160(1):351	jan;160(1):351	NOUN
dpc-5733	325	3	-	-	PUNCT
dpc-5733	325	4	360	360	NUM
dpc-5733	325	5	.	.	PUNCT
dpc-5733	326	1	doi	doi	NOUN
dpc-5733	326	2	:	:	PUNCT
dpc-5733	326	3	10.1016	10.1016	NUM
dpc-5733	326	4	/	/	SYM
dpc-5733	326	5	j.ygyno.2020.10.011	j.ygyno.2020.10.011	PROPN
dpc-5733	326	6	.	.	PUNCT
dpc-5733	327	1	epub	epub	PROPN
dpc-5733	327	2	2020	2020	NUM
dpc-5733	327	3	oct	oct	PROPN
dpc-5733	327	4	19	19	NUM
dpc-5733	327	5	.	.	PUNCT
dpc-5733	328	1	pmid	pmid	NOUN
dpc-5733	328	2	:	:	PUNCT
dpc-5733	328	3	33092868	33092868	NUM
dpc-5733	328	4	.	.	PUNCT
dpc-5733	329	1	21	21	NUM
dpc-5733	329	2	.	.	PUNCT
dpc-5733	330	1	chen	chen	PROPN
dpc-5733	330	2	x	x	PROPN
dpc-5733	330	3	,	,	PUNCT
dpc-5733	330	4	li	li	PROPN
dpc-5733	330	5	a	a	PROPN
dpc-5733	330	6	,	,	PUNCT
dpc-5733	330	7	ma	ma	PROPN
dpc-5733	330	8	q.	q.	PROPN
dpc-5733	330	9	neutrophil	neutrophil	PROPN
dpc-5733	330	10	-	-	PUNCT
dpc-5733	330	11	lymphocyte	lymphocyte	NOUN
dpc-5733	330	12	ratio	ratio	NOUN
dpc-5733	330	13	and	and	CCONJ
dpc-5733	330	14	systemic	systemic	ADJ
dpc-5733	330	15	immune	immune	ADJ
dpc-5733	330	16	-	-	PUNCT
dpc-5733	330	17	inflammation	inflammation	NOUN
dpc-5733	330	18	index	index	NOUN
dpc-5733	330	19	as	as	ADP
dpc-5733	330	20	predictors	predictor	NOUN
dpc-5733	330	21	of	of	ADP
dpc-5733	330	22	cardiovascular	cardiovascular	ADJ
dpc-5733	330	23	risk	risk	NOUN
dpc-5733	330	24	and	and	CCONJ
dpc-5733	330	25	mortality	mortality	NOUN
dpc-5733	330	26	in	in	ADP
dpc-5733	330	27	prediabetes	prediabete	NOUN
dpc-5733	330	28	and	and	CCONJ
dpc-5733	330	29	diabetes	diabetes	NOUN
dpc-5733	330	30	:	:	PUNCT
dpc-5733	330	31	a	a	DET
dpc-5733	330	32	population	population	NOUN
dpc-5733	330	33	-	-	PUNCT
dpc-5733	330	34	based	base	VERB
dpc-5733	330	35	study	study	NOUN
dpc-5733	330	36	.	.	PUNCT
dpc-5733	331	1	inflammopharmacology	inflammopharmacology	NOUN
dpc-5733	331	2	.	.	PUNCT
dpc-5733	332	1	2024	2024	NUM
dpc-5733	332	2	oct;32(5):3213	oct;32(5):3213	PROPN
dpc-5733	332	3	-	-	PUNCT
dpc-5733	332	4	3227	3227	NUM
dpc-5733	332	5	.	.	PUNCT
dpc-5733	333	1	10	10	NUM
dpc-5733	333	2	original	original	ADJ
dpc-5733	333	3	article	article	NOUN
dpc-5733	333	4	|	|	ADV
dpc-5733	333	5	dermatol	dermatol	ADJ
dpc-5733	333	6	pract	pract	NOUN
dpc-5733	333	7	concept	concept	NOUN
dpc-5733	333	8	.	.	PUNCT
dpc-5733	334	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	334	2	doi	doi	NOUN
dpc-5733	334	3	:	:	PUNCT
dpc-5733	334	4	10.1007	10.1007	NUM
dpc-5733	334	5	/	/	SYM
dpc-5733	334	6	s11845	s11845	VERB
dpc-5733	334	7	-	-	PUNCT
dpc-5733	334	8	025	025	NUM
dpc-5733	334	9	-	-	PUNCT
dpc-5733	334	10	03969	03969	NUM
dpc-5733	334	11	-	-	PUNCT
dpc-5733	334	12	6	6	NUM
dpc-5733	334	13	.	.	PUNCT
dpc-5733	335	1	epub	epub	NOUN
dpc-5733	335	2	2025	2025	NUM
dpc-5733	335	3	jun	jun	PROPN
dpc-5733	335	4	2	2	NUM
dpc-5733	335	5	.	.	PUNCT
dpc-5733	335	6	pmid	pmid	NOUN
dpc-5733	335	7	:	:	PUNCT
dpc-5733	335	8	40455345	40455345	NUM
dpc-5733	335	9	.	.	PUNCT
dpc-5733	336	1	43	43	NUM
dpc-5733	336	2	.	.	PUNCT
dpc-5733	336	3	demirel	demirel	PROPN
dpc-5733	336	4	öğüt	öğüt	PROPN
dpc-5733	336	5	n	n	CCONJ
dpc-5733	336	6	,	,	PUNCT
dpc-5733	336	7	ayanoğlu	ayanoğlu	PROPN
dpc-5733	336	8	ma	ma	PROPN
dpc-5733	336	9	,	,	PUNCT
dpc-5733	336	10	koç	koç	PROPN
dpc-5733	336	11	yıldırım	yıldırım	PROPN
dpc-5733	336	12	s	s	PROPN
dpc-5733	336	13	,	,	PUNCT
dpc-5733	336	14	erbağcı	erbağcı	VERB
dpc-5733	336	15	e	e	NOUN
dpc-5733	336	16	,	,	PUNCT
dpc-5733	336	17	ünal	ünal	PROPN
dpc-5733	336	18	s	s	PROPN
dpc-5733	336	19	,	,	PUNCT
dpc-5733	336	20	gökyayla	gökyayla	PROPN
dpc-5733	336	21	e.	e.	PROPN
dpc-5733	336	22	are	be	AUX
dpc-5733	336	23	il-17	il-17	ADP
dpc-5733	336	24	inhibitors	inhibitor	NOUN
dpc-5733	336	25	superior	superior	ADJ
dpc-5733	336	26	to	to	AUX
dpc-5733	336	27	il-23	il-23	VERB
dpc-5733	336	28	inhibitors	inhibitor	NOUN
dpc-5733	336	29	in	in	ADP
dpc-5733	336	30	reducing	reduce	VERB
dpc-5733	336	31	systemic	systemic	ADJ
dpc-5733	336	32	inflammation	inflammation	NOUN
dpc-5733	336	33	in	in	ADP
dpc-5733	336	34	moderate	moderate	ADJ
dpc-5733	336	35	-	-	PUNCT
dpc-5733	336	36	to	to	ADP
dpc-5733	336	37	-	-	PUNCT
dpc-5733	336	38	severe	severe	ADJ
dpc-5733	336	39	plaque	plaque	NOUN
dpc-5733	336	40	psoriasis	psoriasis	NOUN
dpc-5733	336	41	?	?	PUNCT
dpc-5733	337	1	a	a	DET
dpc-5733	337	2	retrospective	retrospective	ADJ
dpc-5733	337	3	cohort	cohort	NOUN
dpc-5733	337	4	study	study	NOUN
dpc-5733	337	5	.	.	PUNCT
dpc-5733	338	1	arch	arch	ADJ
dpc-5733	338	2	dermatol	dermatol	NOUN
dpc-5733	338	3	res	re	NOUN
dpc-5733	338	4	.	.	PUNCT
dpc-5733	339	1	2025	2025	NUM
dpc-5733	339	2	jan	jan	PROPN
dpc-5733	339	3	13;317(1):232	13;317(1):232	PROPN
dpc-5733	339	4	.	.	PUNCT
dpc-5733	340	1	doi	doi	NOUN
dpc-5733	340	2	:	:	PUNCT
dpc-5733	340	3	10.1007	10.1007	NUM
dpc-5733	340	4	/	/	SYM
dpc-5733	340	5	s00403	s00403	NOUN
dpc-5733	340	6	-	-	PUNCT
dpc-5733	340	7	024	024	NUM
dpc-5733	340	8	-	-	PUNCT
dpc-5733	340	9	03768	03768	NUM
dpc-5733	340	10	-	-	SYM
dpc-5733	340	11	6	6	NUM
dpc-5733	340	12	.	.	PUNCT
dpc-5733	341	1	pmid	pmid	NOUN
dpc-5733	341	2	:	:	PUNCT
dpc-5733	341	3	39804473	39804473	NUM
dpc-5733	341	4	.	.	PUNCT
dpc-5733	342	1	44	44	NUM
dpc-5733	342	2	.	.	PUNCT
dpc-5733	343	1	kaya	kaya	PROPN
dpc-5733	343	2	k	k	PROPN
dpc-5733	343	3	,	,	PUNCT
dpc-5733	343	4	gevher	gevher	PROPN
dpc-5733	343	5	ö.	ö.	NOUN
dpc-5733	343	6	effect	effect	NOUN
dpc-5733	343	7	of	of	ADP
dpc-5733	343	8	adalimumab	adalimumab	NOUN
dpc-5733	343	9	treatment	treatment	NOUN
dpc-5733	343	10	on	on	ADP
dpc-5733	343	11	inflammatory	inflammatory	ADJ
dpc-5733	343	12	and	and	CCONJ
dpc-5733	343	13	hematological	hematological	ADJ
dpc-5733	343	14	parameters	parameter	NOUN
dpc-5733	343	15	in	in	ADP
dpc-5733	343	16	patients	patient	NOUN
dpc-5733	343	17	with	with	ADP
dpc-5733	343	18	hidradenitis	hidradenitis	PROPN
dpc-5733	343	19	suppurativa	suppurativa	PROPN
dpc-5733	343	20	.	.	PUNCT
dpc-5733	344	1	cutan	cutan	PROPN
dpc-5733	344	2	ocul	ocul	PROPN
dpc-5733	344	3	toxicol	toxicol	PROPN
dpc-5733	344	4	.	.	PUNCT
dpc-5733	345	1	2024	2024	NUM
dpc-5733	345	2	dec;43(4):253	dec;43(4):253	NUM
dpc-5733	345	3	-	-	PUNCT
dpc-5733	345	4	257	257	NUM
dpc-5733	345	5	.	.	PUNCT
dpc-5733	346	1	doi	doi	NOUN
dpc-5733	346	2	:	:	PUNCT
dpc-5733	346	3	10.1080/15569527.2024.2387595	10.1080/15569527.2024.2387595	NUM
dpc-5733	346	4	.	.	PUNCT
dpc-5733	347	1	epub	epub	PROPN
dpc-5733	347	2	2024	2024	NUM
dpc-5733	347	3	aug	aug	PROPN
dpc-5733	347	4	11	11	NUM
dpc-5733	347	5	.	.	PUNCT
dpc-5733	348	1	pmid	pmid	NOUN
dpc-5733	348	2	:	:	PUNCT
dpc-5733	348	3	39102513	39102513	NUM
dpc-5733	348	4	.	.	PUNCT
dpc-5733	349	1	45	45	NUM
dpc-5733	349	2	.	.	PUNCT
dpc-5733	349	3	holgersen	holgersen	PROPN
dpc-5733	349	4	n	n	PROPN
dpc-5733	349	5	,	,	PUNCT
dpc-5733	349	6	nielsen	nielsen	PROPN
dpc-5733	349	7	vw	vw	PROPN
dpc-5733	349	8	,	,	PUNCT
dpc-5733	349	9	rosenø	rosenø	VERB
dpc-5733	349	10	nal	nal	PROPN
dpc-5733	349	11	,	,	PUNCT
dpc-5733	349	12	thyssen	thyssen	PROPN
dpc-5733	349	13	jp	jp	PROPN
dpc-5733	349	14	,	,	PUNCT
dpc-5733	349	15	egeberg	egeberg	PROPN
dpc-5733	349	16	a	a	PROPN
dpc-5733	349	17	,	,	PUNCT
dpc-5733	349	18	nielsen	nielsen	PROPN
dpc-5733	349	19	sh	sh	PROPN
dpc-5733	349	20	,	,	PUNCT
dpc-5733	349	21	ring	ring	NOUN
dpc-5733	349	22	hc	hc	PROPN
dpc-5733	349	23	,	,	PUNCT
dpc-5733	349	24	thomsen	thomsen	PROPN
dpc-5733	349	25	sf	sf	PROPN
dpc-5733	349	26	.	.	PUNCT
dpc-5733	350	1	biomarkers	biomarker	NOUN
dpc-5733	350	2	of	of	ADP
dpc-5733	350	3	systemic	systemic	ADJ
dpc-5733	350	4	inflammation	inflammation	NOUN
dpc-5733	350	5	are	be	AUX
dpc-5733	350	6	associated	associate	VERB
dpc-5733	350	7	with	with	ADP
dpc-5733	350	8	disease	disease	NOUN
dpc-5733	350	9	severity	severity	NOUN
dpc-5733	350	10	and	and	CCONJ
dpc-5733	350	11	metabolic	metabolic	NOUN
dpc-5733	350	12	syndrome	syndrome	NOUN
dpc-5733	350	13	in	in	ADP
dpc-5733	350	14	patients	patient	NOUN
dpc-5733	350	15	with	with	ADP
dpc-5733	350	16	hidradenitis	hidradenitis	PROPN
dpc-5733	350	17	suppurativa	suppurativa	PROPN
dpc-5733	350	18	.	.	PUNCT
dpc-5733	351	1	jaad	jaad	PROPN
dpc-5733	351	2	int	int	PROPN
dpc-5733	351	3	.	.	PUNCT
dpc-5733	352	1	2024	2024	NUM
dpc-5733	352	2	mar	mar	PROPN
dpc-5733	352	3	15;15:170	15;15:170	NUM
dpc-5733	352	4	-	-	PUNCT
dpc-5733	352	5	178	178	NUM
dpc-5733	352	6	.	.	PUNCT
dpc-5733	352	7	doi	doi	NOUN
dpc-5733	352	8	:	:	PUNCT
dpc-5733	352	9	10.1016	10.1016	NUM
dpc-5733	352	10	/	/	SYM
dpc-5733	352	11	j.jdin.2024.03.002	j.jdin.2024.03.002	PROPN
dpc-5733	352	12	.	.	PUNCT
dpc-5733	353	1	pmid	pmid	NOUN
dpc-5733	353	2	:	:	PUNCT
dpc-5733	353	3	38638915	38638915	NUM
dpc-5733	353	4	.	.	PUNCT
dpc-5733	354	1	46	46	NUM
dpc-5733	354	2	.	.	PUNCT
dpc-5733	355	1	öksüm	öksüm	PROPN
dpc-5733	355	2	solak	solak	ADJ
dpc-5733	355	3	e	e	PROPN
dpc-5733	355	4	,	,	PUNCT
dpc-5733	355	5	baran	baran	NOUN
dpc-5733	355	6	ketencioglu	ketencioglu	PROPN
dpc-5733	355	7	b	b	PROPN
dpc-5733	355	8	,	,	PUNCT
dpc-5733	355	9	cinar	cinar	PROPN
dpc-5733	355	10	sl	sl	NOUN
dpc-5733	355	11	,	,	PUNCT
dpc-5733	355	12	kartal	kartal	PROPN
dpc-5733	355	13	d	d	PROPN
dpc-5733	355	14	,	,	PUNCT
dpc-5733	355	15	borlu	borlu	VERB
dpc-5733	355	16	m.	m.	NOUN
dpc-5733	355	17	the	the	DET
dpc-5733	355	18	role	role	NOUN
dpc-5733	355	19	of	of	ADP
dpc-5733	355	20	new	new	ADJ
dpc-5733	355	21	inflammatory	inflammatory	ADJ
dpc-5733	355	22	markers	marker	NOUN
dpc-5733	355	23	in	in	ADP
dpc-5733	355	24	determining	determine	VERB
dpc-5733	355	25	disease	disease	NOUN
dpc-5733	355	26	activation	activation	NOUN
dpc-5733	355	27	and	and	CCONJ
dpc-5733	355	28	severity	severity	NOUN
dpc-5733	355	29	in	in	ADP
dpc-5733	355	30	patients	patient	NOUN
dpc-5733	355	31	with	with	ADP
dpc-5733	355	32	hidradenitis	hidradenitis	PROPN
dpc-5733	355	33	suppurativa	suppurativa	PROPN
dpc-5733	355	34	.	.	PROPN
dpc-5733	356	1	int	int	PROPN
dpc-5733	356	2	j	j	PROPN
dpc-5733	356	3	dermatol	dermatol	NOUN
dpc-5733	356	4	.	.	PUNCT
dpc-5733	357	1	2023	2023	NUM
dpc-5733	357	2	aug;62(8):1076	aug;62(8):1076	PROPN
dpc-5733	357	3	-	-	PUNCT
dpc-5733	357	4	1081	1081	NUM
dpc-5733	357	5	.	.	PUNCT
dpc-5733	358	1	doi	doi	NOUN
dpc-5733	358	2	:	:	PUNCT
dpc-5733	358	3	10.1111	10.1111	NUM
dpc-5733	358	4	/ijd.16744	/ijd.16744	NOUN
dpc-5733	358	5	.	.	PUNCT
dpc-5733	359	1	epub	epub	PROPN
dpc-5733	359	2	2023	2023	NUM
dpc-5733	359	3	jun	jun	PROPN
dpc-5733	359	4	12	12	NUM
dpc-5733	359	5	.	.	PUNCT
dpc-5733	360	1	pmid	pmid	NOUN
dpc-5733	360	2	:	:	PUNCT
dpc-5733	360	3	37306156	37306156	NUM
dpc-5733	360	4	.	.	PUNCT
dpc-5733	361	1	47	47	NUM
dpc-5733	361	2	.	.	PUNCT
dpc-5733	362	1	asahina	asahina	PROPN
dpc-5733	362	2	a	a	PROPN
dpc-5733	362	3	,	,	PUNCT
dpc-5733	362	4	kubo	kubo	PROPN
dpc-5733	362	5	n	n	CCONJ
dpc-5733	362	6	,	,	PUNCT
dpc-5733	362	7	umezawa	umezawa	PROPN
dpc-5733	362	8	y	y	PROPN
dpc-5733	362	9	,	,	PUNCT
dpc-5733	362	10	honda	honda	NOUN
dpc-5733	362	11	h	h	PROPN
dpc-5733	362	12	,	,	PUNCT
dpc-5733	362	13	yanaba	yanaba	PROPN
dpc-5733	362	14	k	k	PROPN
dpc-5733	362	15	,	,	PUNCT
dpc-5733	362	16	nakagawa	nakagawa	PROPN
dpc-5733	362	17	h.	h.	PROPN
dpc-5733	362	18	neutrophil	neutrophil	PROPN
dpc-5733	362	19	-	-	PUNCT
dpc-5733	362	20	lymphocyte	lymphocyte	NOUN
dpc-5733	362	21	ratio	ratio	NOUN
dpc-5733	362	22	,	,	PUNCT
dpc-5733	362	23	platelet	platelet	ADJ
dpc-5733	362	24	-	-	PUNCT
dpc-5733	362	25	lymphocyte	lymphocyte	NOUN
dpc-5733	362	26	ratio	ratio	NOUN
dpc-5733	362	27	and	and	CCONJ
dpc-5733	362	28	mean	mean	VERB
dpc-5733	362	29	platelet	platelet	NOUN
dpc-5733	362	30	volume	volume	NOUN
dpc-5733	362	31	in	in	ADP
dpc-5733	362	32	japanese	japanese	ADJ
dpc-5733	362	33	patients	patient	NOUN
dpc-5733	362	34	with	with	ADP
dpc-5733	362	35	psoriasis	psoriasis	NOUN
dpc-5733	362	36	and	and	CCONJ
dpc-5733	362	37	psoriatic	psoriatic	ADJ
dpc-5733	362	38	arthritis	arthritis	NOUN
dpc-5733	362	39	:	:	PUNCT
dpc-5733	362	40	response	response	NOUN
dpc-5733	362	41	to	to	ADP
dpc-5733	362	42	therapy	therapy	NOUN
dpc-5733	362	43	with	with	ADP
dpc-5733	362	44	biologics	biologic	NOUN
dpc-5733	362	45	.	.	PUNCT
dpc-5733	363	1	j	j	PROPN
dpc-5733	363	2	dermatol	dermatol	NOUN
dpc-5733	363	3	.	.	PUNCT
dpc-5733	364	1	2017	2017	NUM
dpc-5733	364	2	oct;44(10):1112	oct;44(10):1112	X
dpc-5733	364	3	-	-	PUNCT
dpc-5733	364	4	1121	1121	NUM
dpc-5733	364	5	.	.	PUNCT
dpc-5733	365	1	doi	doi	NOUN
dpc-5733	365	2	:	:	PUNCT
dpc-5733	365	3	10.1111/1346	10.1111/1346	NUM
dpc-5733	365	4	-8138.13875	-8138.13875	NOUN
dpc-5733	365	5	.	.	PUNCT
dpc-5733	366	1	epub	epub	PROPN
dpc-5733	366	2	2017	2017	NUM
dpc-5733	366	3	may	may	PROPN
dpc-5733	366	4	11	11	NUM
dpc-5733	366	5	.	.	PUNCT
dpc-5733	367	1	pmid	pmid	NOUN
dpc-5733	367	2	:	:	PUNCT
dpc-5733	367	3	28493493	28493493	NUM
dpc-5733	367	4	.	.	PUNCT
dpc-5733	368	1	48	48	NUM
dpc-5733	368	2	.	.	PUNCT
dpc-5733	369	1	kim	kim	PROPN
dpc-5733	369	2	ds	ds	PROPN
dpc-5733	369	3	,	,	PUNCT
dpc-5733	369	4	lee	lee	PROPN
dpc-5733	369	5	j	j	PROPN
dpc-5733	369	6	,	,	PUNCT
dpc-5733	369	7	kim	kim	PROPN
dpc-5733	369	8	sh	sh	PROPN
dpc-5733	369	9	,	,	PUNCT
dpc-5733	369	10	kim	kim	PROPN
dpc-5733	369	11	sm	sm	PROPN
dpc-5733	369	12	,	,	PUNCT
dpc-5733	369	13	lee	lee	PROPN
dpc-5733	369	14	mg	mg	PROPN
dpc-5733	369	15	.	.	PUNCT
dpc-5733	370	1	mean	mean	VERB
dpc-5733	370	2	platelet	platelet	NOUN
dpc-5733	370	3	volume	volume	NOUN
dpc-5733	370	4	is	be	AUX
dpc-5733	370	5	elevated	elevate	VERB
dpc-5733	370	6	in	in	ADP
dpc-5733	370	7	patients	patient	NOUN
dpc-5733	370	8	with	with	ADP
dpc-5733	370	9	psoriasis	psoriasis	NOUN
dpc-5733	370	10	vulgaris	vulgaris	NOUN
dpc-5733	370	11	.	.	PUNCT
dpc-5733	371	1	yonsei	yonsei	PROPN
dpc-5733	371	2	med	med	PROPN
dpc-5733	371	3	j.	j.	PROPN
dpc-5733	371	4	2015	2015	NUM
dpc-5733	371	5	may;56(3):712	may;56(3):712	NOUN
dpc-5733	371	6	-	-	PUNCT
dpc-5733	371	7	8	8	NUM
dpc-5733	371	8	.	.	PUNCT
dpc-5733	371	9	doi	doi	NOUN
dpc-5733	371	10	:	:	PUNCT
dpc-5733	371	11	10.3349	10.3349	NUM
dpc-5733	371	12	/	/	SYM
dpc-5733	371	13	ymj.2015.56.3.712	ymj.2015.56.3.712	PROPN
dpc-5733	371	14	.	.	PUNCT
dpc-5733	372	1	pmid	pmid	NOUN
dpc-5733	372	2	:	:	PUNCT
dpc-5733	372	3	25837177	25837177	NUM
dpc-5733	372	4	.	.	PUNCT
dpc-5733	373	1	49	49	NUM
dpc-5733	373	2	.	.	PUNCT
dpc-5733	374	1	ataseven	ataseven	PROPN
dpc-5733	374	2	a	a	PRON
dpc-5733	374	3	,	,	PUNCT
dpc-5733	374	4	temiz	temiz	PROPN
dpc-5733	374	5	sa	sa	PROPN
dpc-5733	374	6	,	,	PUNCT
dpc-5733	374	7	eren	eren	PROPN
dpc-5733	374	8	g	g	PROPN
dpc-5733	374	9	,	,	PUNCT
dpc-5733	374	10	özer	özer	NOUN
dpc-5733	374	11	i̇	i̇	NOUN
dpc-5733	374	12	,	,	PUNCT
dpc-5733	374	13	dursun	dursun	NOUN
dpc-5733	374	14	r.	r.	PROPN
dpc-5733	374	15	comparison	comparison	NOUN
dpc-5733	374	16	of	of	ADP
dpc-5733	374	17	anti	anti	ADJ
dpc-5733	374	18	-	-	PROPN
dpc-5733	374	19	tnf	tnf	ADJ
dpc-5733	374	20	and	and	CCONJ
dpc-5733	374	21	il	il	PROPN
dpc-5733	374	22	-	-	PUNCT
dpc-5733	374	23	inhibitors	inhibitor	NOUN
dpc-5733	374	24	treatments	treatment	NOUN
dpc-5733	374	25	in	in	ADP
dpc-5733	374	26	patients	patient	NOUN
dpc-5733	374	27	with	with	ADP
dpc-5733	374	28	psoriasis	psoriasis	NOUN
dpc-5733	374	29	in	in	ADP
dpc-5733	374	30	terms	term	NOUN
dpc-5733	374	31	of	of	ADP
dpc-5733	374	32	response	response	NOUN
dpc-5733	374	33	to	to	ADP
dpc-5733	374	34	routine	routine	ADJ
dpc-5733	374	35	laboratory	laboratory	NOUN
dpc-5733	374	36	parameter	parameter	NOUN
dpc-5733	374	37	dynamics	dynamic	NOUN
dpc-5733	374	38	.	.	PUNCT
dpc-5733	375	1	j	j	PROPN
dpc-5733	375	2	dermatolog	dermatolog	PROPN
dpc-5733	375	3	treat	treat	NOUN
dpc-5733	375	4	.	.	PUNCT
dpc-5733	376	1	2022	2022	NUM
dpc-5733	376	2	mar;33(2):1091	mar;33(2):1091	NOUN
dpc-5733	376	3	-	-	NOUN
dpc-5733	376	4	1096	1096	NUM
dpc-5733	376	5	.	.	PUNCT
dpc-5733	377	1	doi	doi	NOUN
dpc-5733	377	2	:	:	PUNCT
dpc-5733	377	3	10.1080/09546634.2020.1801975	10.1080/09546634.2020.1801975	NUM
dpc-5733	377	4	.	.	PUNCT
dpc-5733	378	1	epub	epub	PROPN
dpc-5733	378	2	2020	2020	NUM
dpc-5733	378	3	aug	aug	PROPN
dpc-5733	378	4	4	4	NUM
dpc-5733	378	5	.	.	PUNCT
dpc-5733	378	6	pmid	pmid	NOUN
dpc-5733	378	7	:	:	PUNCT
dpc-5733	378	8	32713225	32713225	NUM
dpc-5733	378	9	.	.	PUNCT
dpc-5733	379	1	50	50	NUM
dpc-5733	379	2	.	.	PUNCT
dpc-5733	380	1	an	an	DET
dpc-5733	380	2	i	i	PROPN
dpc-5733	380	3	,	,	PUNCT
dpc-5733	380	4	ucmak	ucmak	PROPN
dpc-5733	380	5	d	d	PROPN
dpc-5733	380	6	,	,	PUNCT
dpc-5733	380	7	ozturk	ozturk	NOUN
dpc-5733	380	8	m.	m.	NOUN
dpc-5733	380	9	the	the	DET
dpc-5733	380	10	effect	effect	NOUN
dpc-5733	380	11	of	of	ADP
dpc-5733	380	12	biological	biological	ADJ
dpc-5733	380	13	agent	agent	NOUN
dpc-5733	380	14	treatment	treatment	NOUN
dpc-5733	380	15	on	on	ADP
dpc-5733	380	16	neutrophil	neutrophil	ADJ
dpc-5733	380	17	-	-	PUNCT
dpc-5733	380	18	to	to	ADP
dpc-5733	380	19	-	-	PUNCT
dpc-5733	380	20	lymphocyte	lymphocyte	NOUN
dpc-5733	380	21	ratio	ratio	NOUN
dpc-5733	380	22	,	,	PUNCT
dpc-5733	380	23	platelet	platelet	NOUN
dpc-5733	380	24	-	-	PUNCT
dpc-5733	380	25	to	to	ADP
dpc-5733	380	26	-	-	PUNCT
dpc-5733	380	27	lymphocyte	lymphocyte	NOUN
dpc-5733	380	28	ratio	ratio	NOUN
dpc-5733	380	29	,	,	PUNCT
dpc-5733	380	30	mean	mean	VERB
dpc-5733	380	31	platelet	platelet	NOUN
dpc-5733	380	32	volume	volume	NOUN
dpc-5733	380	33	,	,	PUNCT
dpc-5733	380	34	and	and	CCONJ
dpc-5733	380	35	c	c	X
dpc-5733	380	36	-	-	ADJ
dpc-5733	380	37	reactive	reactive	ADJ
dpc-5733	380	38	protein	protein	NOUN
dpc-5733	380	39	in	in	ADP
dpc-5733	380	40	psoriasis	psoriasis	NOUN
dpc-5733	380	41	patients	patient	NOUN
dpc-5733	380	42	.	.	PUNCT
dpc-5733	381	1	postepy	postepy	ADJ
dpc-5733	381	2	dermatol	dermatol	NOUN
dpc-5733	381	3	alergol	alergol	NOUN
dpc-5733	381	4	.	.	PUNCT
dpc-5733	382	1	2020	2020	NUM
dpc-5733	382	2	apr;37(2	apr;37(2	SYM
dpc-5733	382	3	):	):	PUNCT
dpc-5733	382	4	202	202	NUM
dpc-5733	382	5	-	-	SYM
dpc-5733	382	6	206	206	NUM
dpc-5733	382	7	.	.	PUNCT
dpc-5733	383	1	doi	doi	NOUN
dpc-5733	383	2	:	:	PUNCT
dpc-5733	383	3	10.5114	10.5114	NUM
dpc-5733	383	4	/	/	SYM
dpc-5733	383	5	ada.2020.94838	ada.2020.94838	NOUN
dpc-5733	383	6	.	.	PUNCT
dpc-5733	384	1	epub	epub	NOUN
dpc-5733	384	2	2020	2020	NUM
dpc-5733	384	3	may	may	AUX
dpc-5733	384	4	5	5	NUM
dpc-5733	384	5	.	.	PUNCT
dpc-5733	385	1	pmid	pmid	NOUN
dpc-5733	385	2	:	:	PUNCT
dpc-5733	385	3	32489355	32489355	NUM
dpc-5733	385	4	;	;	PUNCT
dpc-5733	385	5	pmcid	pmcid	ADJ
dpc-5733	385	6	:	:	PUNCT
dpc-5733	385	7	pmc7262800	pmc7262800	NOUN
dpc-5733	385	8	.	.	PUNCT
dpc-5733	386	1	51	51	NUM
dpc-5733	386	2	.	.	PUNCT
dpc-5733	386	3	alexis	alexis	PROPN
dpc-5733	386	4	af	af	PROPN
dpc-5733	386	5	,	,	PUNCT
dpc-5733	386	6	gooderham	gooderham	PROPN
dpc-5733	386	7	m	m	PROPN
dpc-5733	386	8	,	,	PUNCT
dpc-5733	386	9	kwatra	kwatra	PROPN
dpc-5733	386	10	sg	sg	PROPN
dpc-5733	386	11	,	,	PUNCT
dpc-5733	386	12	amin	amin	PROPN
dpc-5733	386	13	a	a	PROPN
dpc-5733	386	14	,	,	PUNCT
dpc-5733	386	15	taylor	taylor	PROPN
dpc-5733	386	16	s	s	PROPN
dpc-5733	386	17	,	,	PUNCT
dpc-5733	386	18	espaillat	espaillat	ADJ
dpc-5733	386	19	r	r	NOUN
dpc-5733	386	20	,	,	PUNCT
dpc-5733	386	21	rettig	rettig	PROPN
dpc-5733	386	22	t	t	PROPN
dpc-5733	386	23	,	,	PUNCT
dpc-5733	386	24	wu	wu	PROPN
dpc-5733	386	25	t	t	PROPN
dpc-5733	386	26	,	,	PUNCT
dpc-5733	386	27	shi	shi	PROPN
dpc-5733	386	28	l	l	PROPN
dpc-5733	386	29	,	,	PUNCT
dpc-5733	386	30	kaldas	kaldas	PROPN
dpc-5733	386	31	mi	mi	PROPN
dpc-5733	386	32	,	,	PUNCT
dpc-5733	386	33	dilley	dilley	PROPN
dpc-5733	386	34	dm	dm	PROPN
dpc-5733	386	35	,	,	PUNCT
dpc-5733	386	36	sinvhal	sinvhal	ADJ
dpc-5733	386	37	r	r	NOUN
dpc-5733	386	38	,	,	PUNCT
dpc-5733	386	39	nduaka	nduaka	ADV
dpc-5733	386	40	c	c	X
dpc-5733	386	41	,	,	PUNCT
dpc-5733	386	42	lockshin	lockshin	PROPN
dpc-5733	386	43	b.	b.	PROPN
dpc-5733	386	44	a	a	DET
dpc-5733	386	45	descriptive	descriptive	ADJ
dpc-5733	386	46	,	,	PUNCT
dpc-5733	386	47	post	post	ADJ
dpc-5733	386	48	 	 	SPACE
dpc-5733	386	49	hoc	hoc	X
dpc-5733	386	50	analysis	analysis	NOUN
dpc-5733	386	51	of	of	ADP
dpc-5733	386	52	efficacy	efficacy	NOUN
dpc-5733	386	53	and	and	CCONJ
dpc-5733	386	54	safety	safety	NOUN
dpc-5733	386	55	of	of	ADP
dpc-5733	386	56	risankizumab	risankizumab	NOUN
dpc-5733	386	57	in	in	ADP
dpc-5733	386	58	diverse	diverse	ADJ
dpc-5733	386	59	racial	racial	ADJ
dpc-5733	386	60	and	and	CCONJ
dpc-5733	386	61	ethnic	ethnic	ADJ
dpc-5733	386	62	patient	patient	NOUN
dpc-5733	386	63	populations	population	NOUN
dpc-5733	386	64	with	with	ADP
dpc-5733	386	65	moderate	moderate	ADJ
dpc-5733	386	66	-	-	PUNCT
dpc-5733	386	67	to	to	ADP
dpc-5733	386	68	-	-	PUNCT
dpc-5733	386	69	severe	severe	ADJ
dpc-5733	386	70	psoriasis	psoriasis	NOUN
dpc-5733	386	71	.	.	PUNCT
dpc-5733	387	1	dermatol	dermatol	NOUN
dpc-5733	387	2	ther	ther	ADV
dpc-5733	387	3	(	(	PUNCT
dpc-5733	387	4	heidelb	heidelb	NOUN
dpc-5733	387	5	)	)	PUNCT
dpc-5733	387	6	.	.	PUNCT
dpc-5733	388	1	2024	2024	NUM
dpc-5733	388	2	oct;14(10):2877	oct;14(10):2877	NOUN
dpc-5733	388	3	-	-	PUNCT
dpc-5733	388	4	2887	2887	NUM
dpc-5733	388	5	.	.	PUNCT
dpc-5733	389	1	doi	doi	NOUN
dpc-5733	389	2	:	:	PUNCT
dpc-5733	389	3	10.1007	10.1007	NUM
dpc-5733	389	4	/	/	SYM
dpc-5733	389	5	s13555	s13555	PROPN
dpc-5733	389	6	-	-	PUNCT
dpc-5733	389	7	024	024	NUM
dpc-5733	389	8	-	-	PUNCT
dpc-5733	389	9	01268	01268	NUM
dpc-5733	389	10	-	-	PUNCT
dpc-5733	389	11	z.	z.	PROPN
dpc-5733	389	12	epub	epub	PROPN
dpc-5733	389	13	2024	2024	NUM
dpc-5733	389	14	oct	oct	PROPN
dpc-5733	389	15	2	2	NUM
dpc-5733	389	16	.	.	PUNCT
dpc-5733	390	1	pmid	pmid	NOUN
dpc-5733	390	2	:	:	PUNCT
dpc-5733	390	3	39358667	39358667	NUM
dpc-5733	390	4	;	;	PUNCT
dpc-5733	390	5	pmcid	pmcid	NOUN
dpc-5733	390	6	:	:	PUNCT
dpc-5733	390	7	pmc11480268	pmc11480268	NOUN
dpc-5733	390	8	.	.	PUNCT
dpc-5733	391	1	52	52	NUM
dpc-5733	391	2	.	.	PUNCT
dpc-5733	392	1	okada	okada	PROPN
dpc-5733	392	2	y	y	PROPN
dpc-5733	392	3	,	,	PUNCT
dpc-5733	392	4	kajiyama	kajiyama	PROPN
dpc-5733	392	5	k	k	PROPN
dpc-5733	392	6	,	,	PUNCT
dpc-5733	392	7	ishiguro	ishiguro	PROPN
dpc-5733	392	8	c	c	PROPN
dpc-5733	392	9	,	,	PUNCT
dpc-5733	392	10	nonaka	nonaka	PROPN
dpc-5733	392	11	t	t	PROPN
dpc-5733	392	12	,	,	PUNCT
dpc-5733	392	13	komaki	komaki	PROPN
dpc-5733	392	14	t	t	PROPN
dpc-5733	392	15	,	,	PUNCT
dpc-5733	392	16	kuga	kuga	PROPN
dpc-5733	392	17	w	w	PROPN
dpc-5733	392	18	,	,	PUNCT
dpc-5733	392	19	komiyama	komiyama	PROPN
dpc-5733	392	20	n	n	CCONJ
dpc-5733	392	21	,	,	PUNCT
dpc-5733	392	22	iguchi	iguchi	PROPN
dpc-5733	392	23	t	t	PROPN
dpc-5733	392	24	,	,	PUNCT
dpc-5733	392	25	horiuchi	horiuchi	PROPN
dpc-5733	392	26	n	n	PROPN
dpc-5733	392	27	,	,	PUNCT
dpc-5733	392	28	uyama	uyama	ADJ
dpc-5733	392	29	y.	y.	NOUN
dpc-5733	392	30	risk	risk	NOUN
dpc-5733	392	31	of	of	ADP
dpc-5733	392	32	neutropenia	neutropenia	NOUN
dpc-5733	392	33	in	in	ADP
dpc-5733	392	34	psoriasis	psoriasis	NOUN
dpc-5733	392	35	patients	patient	NOUN
dpc-5733	392	36	prescribed	prescribe	VERB
dpc-5733	392	37	anti	anti	ADJ
dpc-5733	392	38	-	-	ADJ
dpc-5733	392	39	il-23	il-23	ADJ
dpc-5733	392	40	antibody	antibody	NOUN
dpc-5733	392	41	in	in	ADP
dpc-5733	392	42	comparison	comparison	NOUN
dpc-5733	392	43	with	with	ADP
dpc-5733	392	44	anti	anti	ADJ
dpc-5733	392	45	-	-	ADJ
dpc-5733	392	46	il-17	il-17	ADV
dpc-5733	392	47	antibody	antibody	NOUN
dpc-5733	392	48	or	or	CCONJ
dpc-5733	392	49	adalimumab	adalimumab	NOUN
dpc-5733	392	50	based	base	VERB
dpc-5733	392	51	on	on	ADP
dpc-5733	392	52	real	real	ADJ
dpc-5733	392	53	-	-	PUNCT
dpc-5733	392	54	world	world	NOUN
dpc-5733	392	55	data	datum	NOUN
dpc-5733	392	56	from	from	ADP
dpc-5733	392	57	the	the	DET
dpc-5733	392	58	mid	mid	ADJ
dpc-5733	392	59	-	-	ADJ
dpc-5733	392	60	net	net	ADJ
dpc-5733	392	61	®	®	NOUN
dpc-5733	392	62	  	  	SPACE
dpc-5733	392	63	in	in	ADP
dpc-5733	392	64	japan	japan	PROPN
dpc-5733	392	65	.	.	PUNCT
dpc-5733	393	1	j	j	PROPN
dpc-5733	393	2	dermatolog	dermatolog	PROPN
dpc-5733	393	3	treat	treat	NOUN
dpc-5733	393	4	.	.	PUNCT
dpc-5733	394	1	2024	2024	NUM
dpc-5733	394	2	dec;35(1):2373826	dec;35(1):2373826	NOUN
dpc-5733	394	3	.	.	PUNCT
dpc-5733	395	1	doi	doi	PROPN
dpc-5733	395	2	:	:	PUNCT
dpc-5733	395	3	10.1080/09546634.2024.2373826	10.1080/09546634.2024.2373826	NUM
dpc-5733	395	4	.	.	PUNCT
dpc-5733	396	1	epub	epub	PROPN
dpc-5733	396	2	2024	2024	NUM
dpc-5733	396	3	jul	jul	PROPN
dpc-5733	396	4	4	4	NUM
dpc-5733	396	5	.	.	PUNCT
dpc-5733	397	1	pmid	pmid	NOUN
dpc-5733	397	2	:	:	PUNCT
dpc-5733	397	3	38964751	38964751	NUM
dpc-5733	397	4	.	.	PUNCT
dpc-5733	398	1	cross	cross	ADJ
dpc-5733	398	2	-	-	ADJ
dpc-5733	398	3	sectional	sectional	ADJ
dpc-5733	398	4	study	study	NOUN
dpc-5733	398	5	.	.	PUNCT
dpc-5733	399	1	front	front	ADJ
dpc-5733	399	2	immunol	immunol	NOUN
dpc-5733	399	3	.	.	PUNCT
dpc-5733	400	1	2024	2024	NUM
dpc-5733	400	2	apr	apr	NOUN
dpc-5733	400	3	23;15:1388967	23;15:1388967	NUM
dpc-5733	400	4	.	.	PUNCT
dpc-5733	401	1	doi	doi	NOUN
dpc-5733	401	2	:	:	PUNCT
dpc-5733	401	3	10.3389	10.3389	NUM
dpc-5733	401	4	/	/	SYM
dpc-5733	401	5	fimmu.2024.1388967	fimmu.2024.1388967	NOUN
dpc-5733	401	6	.	.	PUNCT
dpc-5733	402	1	pmid	pmid	NOUN
dpc-5733	402	2	:	:	PUNCT
dpc-5733	402	3	38715604	38715604	NUM
dpc-5733	402	4	.	.	PUNCT
dpc-5733	403	1	33	33	NUM
dpc-5733	403	2	.	.	PUNCT
dpc-5733	404	1	gordon	gordon	PROPN
dpc-5733	404	2	kb	kb	PROPN
dpc-5733	404	3	,	,	PUNCT
dpc-5733	404	4	blauvelt	blauvelt	VERB
dpc-5733	404	5	a	a	DET
dpc-5733	404	6	,	,	PUNCT
dpc-5733	404	7	bachelez	bachelez	PROPN
dpc-5733	404	8	h	h	NOUN
dpc-5733	404	9	,	,	PUNCT
dpc-5733	404	10	coates	coates	PROPN
dpc-5733	404	11	lc	lc	PROPN
dpc-5733	404	12	,	,	PUNCT
dpc-5733	404	13	van	van	PROPN
dpc-5733	404	14	den	den	PROPN
dpc-5733	404	15	bosch	bosch	PROPN
dpc-5733	404	16	fe	fe	PROPN
dpc-5733	404	17	,	,	PUNCT
dpc-5733	404	18	kaplan	kaplan	PROPN
dpc-5733	404	19	b	b	PROPN
dpc-5733	404	20	,	,	PUNCT
dpc-5733	404	21	koetse	koetse	PROPN
dpc-5733	404	22	w	w	PROPN
dpc-5733	404	23	,	,	PUNCT
dpc-5733	404	24	ashley	ashley	PROPN
dpc-5733	404	25	dg	dg	PROPN
dpc-5733	404	26	,	,	PUNCT
dpc-5733	404	27	lippe	lippe	PROPN
dpc-5733	404	28	r	r	PROPN
dpc-5733	404	29	,	,	PUNCT
dpc-5733	404	30	sinvhal	sinvhal	ADJ
dpc-5733	404	31	r	r	NOUN
dpc-5733	404	32	,	,	PUNCT
dpc-5733	404	33	papp	papp	PROPN
dpc-5733	404	34	ka	ka	PROPN
dpc-5733	404	35	.	.	PROPN
dpc-5733	404	36	long	long	ADJ
dpc-5733	404	37	-	-	PUNCT
dpc-5733	404	38	term	term	NOUN
dpc-5733	404	39	safety	safety	NOUN
dpc-5733	404	40	of	of	ADP
dpc-5733	404	41	risankizumab	risankizumab	NOUN
dpc-5733	404	42	in	in	ADP
dpc-5733	404	43	patients	patient	NOUN
dpc-5733	404	44	with	with	ADP
dpc-5733	404	45	psoriatic	psoriatic	ADJ
dpc-5733	404	46	disease	disease	NOUN
dpc-5733	404	47	:	:	PUNCT
dpc-5733	404	48	a	a	DET
dpc-5733	404	49	comprehensive	comprehensive	ADJ
dpc-5733	404	50	analysis	analysis	NOUN
dpc-5733	404	51	from	from	ADP
dpc-5733	404	52	clinical	clinical	ADJ
dpc-5733	404	53	trials	trial	NOUN
dpc-5733	404	54	.	.	PUNCT
dpc-5733	405	1	dermatol	dermatol	NOUN
dpc-5733	405	2	ther	ther	ADV
dpc-5733	405	3	(	(	PUNCT
dpc-5733	405	4	heidelb	heidelb	NOUN
dpc-5733	405	5	)	)	PUNCT
dpc-5733	405	6	.	.	PUNCT
dpc-5733	406	1	2024	2024	NUM
dpc-5733	406	2	sep;14(9):2523	sep;14(9):2523	NOUN
dpc-5733	406	3	-	-	PUNCT
dpc-5733	406	4	2538	2538	NUM
dpc-5733	406	5	.	.	PUNCT
dpc-5733	407	1	doi	doi	NOUN
dpc-5733	407	2	:	:	PUNCT
dpc-5733	407	3	10.1007	10.1007	NUM
dpc-5733	407	4	/s13555	/s13555	NUM
dpc-5733	407	5	-	-	PUNCT
dpc-5733	407	6	024	024	NUM
dpc-5733	407	7	-	-	PUNCT
dpc-5733	407	8	01238	01238	NUM
dpc-5733	407	9	-	-	SYM
dpc-5733	407	10	5	5	NUM
dpc-5733	407	11	.	.	PUNCT
dpc-5733	408	1	epub	epub	NOUN
dpc-5733	408	2	2024	2024	NUM
dpc-5733	408	3	aug	aug	PROPN
dpc-5733	408	4	17	17	NUM
dpc-5733	408	5	.	.	PUNCT
dpc-5733	409	1	pmid	pmid	NOUN
dpc-5733	409	2	:	:	PUNCT
dpc-5733	409	3	39153059	39153059	NUM
dpc-5733	409	4	.	.	PUNCT
dpc-5733	410	1	34	34	NUM
dpc-5733	410	2	.	.	PUNCT
dpc-5733	411	1	gordon	gordon	PROPN
dpc-5733	411	2	kb	kb	PROPN
dpc-5733	411	3	,	,	PUNCT
dpc-5733	411	4	strober	strober	ADV
dpc-5733	411	5	b	b	NUM
dpc-5733	411	6	,	,	PUNCT
dpc-5733	411	7	lebwohl	lebwohl	PROPN
dpc-5733	411	8	m	m	PROPN
dpc-5733	411	9	,	,	PUNCT
dpc-5733	411	10	augustin	augustin	PROPN
dpc-5733	411	11	m	m	PROPN
dpc-5733	411	12	,	,	PUNCT
dpc-5733	411	13	blauvelt	blauvelt	VERB
dpc-5733	411	14	a	a	PRON
dpc-5733	411	15	,	,	PUNCT
dpc-5733	411	16	poulin	poulin	PROPN
dpc-5733	411	17	y	y	PROPN
dpc-5733	411	18	,	,	PUNCT
dpc-5733	411	19	papp	papp	PROPN
dpc-5733	411	20	ka	ka	PROPN
dpc-5733	411	21	,	,	PUNCT
dpc-5733	411	22	sofen	sofen	PROPN
dpc-5733	411	23	h	h	PROPN
dpc-5733	411	24	,	,	PUNCT
dpc-5733	411	25	puig	puig	PROPN
dpc-5733	411	26	l	l	NOUN
dpc-5733	411	27	,	,	PUNCT
dpc-5733	411	28	foley	foley	PROPN
dpc-5733	411	29	p	p	X
dpc-5733	411	30	,	,	PUNCT
dpc-5733	411	31	ohtsuki	ohtsuki	PROPN
dpc-5733	411	32	m	m	PROPN
dpc-5733	411	33	,	,	PUNCT
dpc-5733	411	34	flack	flack	NOUN
dpc-5733	411	35	m	m	PROPN
dpc-5733	411	36	,	,	PUNCT
dpc-5733	411	37	geng	geng	PROPN
dpc-5733	411	38	z	z	PROPN
dpc-5733	411	39	,	,	PUNCT
dpc-5733	411	40	gu	gu	PROPN
dpc-5733	411	41	y	y	PROPN
dpc-5733	411	42	,	,	PUNCT
dpc-5733	411	43	valdes	valde	VERB
dpc-5733	411	44	jm	jm	PROPN
dpc-5733	411	45	,	,	PUNCT
dpc-5733	411	46	thompson	thompson	PROPN
dpc-5733	411	47	ehz	ehz	PROPN
dpc-5733	411	48	,	,	PUNCT
dpc-5733	411	49	bachelez	bachelez	PROPN
dpc-5733	411	50	h.	h.	PROPN
dpc-5733	411	51	efficacy	efficacy	PROPN
dpc-5733	411	52	and	and	CCONJ
dpc-5733	411	53	safety	safety	NOUN
dpc-5733	411	54	of	of	ADP
dpc-5733	411	55	risankizumab	risankizumab	NOUN
dpc-5733	411	56	in	in	ADP
dpc-5733	411	57	moderate	moderate	ADJ
dpc-5733	411	58	-	-	PUNCT
dpc-5733	411	59	to	to	ADP
dpc-5733	411	60	-	-	PUNCT
dpc-5733	411	61	severe	severe	ADJ
dpc-5733	411	62	plaque	plaque	NOUN
dpc-5733	411	63	psoriasis	psoriasis	NOUN
dpc-5733	411	64	(	(	PUNCT
dpc-5733	411	65	ultimma-1	ultimma-1	NUM
dpc-5733	411	66	and	and	CCONJ
dpc-5733	411	67	ultimma-2	ultimma-2	NUM
dpc-5733	411	68	):	):	PUNCT
dpc-5733	411	69	results	result	NOUN
dpc-5733	411	70	from	from	ADP
dpc-5733	411	71	two	two	NUM
dpc-5733	411	72	double	double	ADJ
dpc-5733	411	73	-	-	PUNCT
dpc-5733	411	74	blind	blind	ADJ
dpc-5733	411	75	,	,	PUNCT
dpc-5733	411	76	randomised	randomise	VERB
dpc-5733	411	77	,	,	PUNCT
dpc-5733	411	78	placebo	placebo	NOUN
dpc-5733	411	79	-	-	PUNCT
dpc-5733	411	80	controlled	control	VERB
dpc-5733	411	81	and	and	CCONJ
dpc-5733	411	82	ustekinumab	ustekinumab	NOUN
dpc-5733	411	83	-	-	PUNCT
dpc-5733	411	84	controlled	control	VERB
dpc-5733	411	85	phase	phase	NOUN
dpc-5733	411	86	3	3	NUM
dpc-5733	411	87	trials	trial	NOUN
dpc-5733	411	88	.	.	PUNCT
dpc-5733	412	1	lancet	lancet	NOUN
dpc-5733	412	2	.	.	PUNCT
dpc-5733	413	1	2018	2018	NUM
dpc-5733	413	2	aug	aug	PROPN
dpc-5733	413	3	25;392(10148):650	25;392(10148):650	NUM
dpc-5733	413	4	-	-	SYM
dpc-5733	413	5	661	661	NUM
dpc-5733	413	6	.	.	PUNCT
dpc-5733	414	1	doi	doi	NOUN
dpc-5733	414	2	:	:	PUNCT
dpc-5733	414	3	10.1016	10.1016	NUM
dpc-5733	414	4	/	/	SYM
dpc-5733	414	5	s0140	s0140	PROPN
dpc-5733	414	6	-	-	PUNCT
dpc-5733	414	7	6736(18)31713	6736(18)31713	NUM
dpc-5733	414	8	-	-	PUNCT
dpc-5733	414	9	6	6	NUM
dpc-5733	414	10	.	.	PUNCT
dpc-5733	415	1	epub	epub	PROPN
dpc-5733	415	2	2018	2018	NUM
dpc-5733	415	3	aug	aug	PROPN
dpc-5733	415	4	7	7	NUM
dpc-5733	415	5	.	.	PUNCT
dpc-5733	416	1	pmid	pmid	NOUN
dpc-5733	416	2	:	:	PUNCT
dpc-5733	416	3	30097359	30097359	NUM
dpc-5733	416	4	.	.	PUNCT
dpc-5733	417	1	35	35	NUM
dpc-5733	417	2	.	.	PUNCT
dpc-5733	418	1	strober	strober	PROPN
dpc-5733	418	2	b	b	NUM
dpc-5733	418	3	,	,	PUNCT
dpc-5733	418	4	bachelez	bachelez	PROPN
dpc-5733	418	5	h	h	PROPN
dpc-5733	418	6	,	,	PUNCT
dpc-5733	418	7	crowley	crowley	PROPN
dpc-5733	418	8	j	j	PROPN
dpc-5733	418	9	,	,	PUNCT
dpc-5733	418	10	elewski	elewski	PROPN
dpc-5733	418	11	be	be	VERB
dpc-5733	418	12	,	,	PUNCT
dpc-5733	418	13	gooderham	gooderham	PROPN
dpc-5733	418	14	m	m	PROPN
dpc-5733	418	15	,	,	PUNCT
dpc-5733	418	16	menter	menter	X
dpc-5733	418	17	a	a	PRON
dpc-5733	418	18	,	,	PUNCT
dpc-5733	418	19	strohal	strohal	ADJ
dpc-5733	418	20	r	r	NOUN
dpc-5733	418	21	,	,	PUNCT
dpc-5733	418	22	chen	chen	PROPN
dpc-5733	418	23	mm	mm	PROPN
dpc-5733	418	24	,	,	PUNCT
dpc-5733	418	25	wu	wu	PROPN
dpc-5733	418	26	t	t	PROPN
dpc-5733	418	27	,	,	PUNCT
dpc-5733	418	28	zhan	zhan	PROPN
dpc-5733	418	29	t	t	PROPN
dpc-5733	418	30	,	,	PUNCT
dpc-5733	418	31	photowala	photowala	ADJ
dpc-5733	418	32	h	h	NOUN
dpc-5733	418	33	,	,	PUNCT
dpc-5733	418	34	armstrong	armstrong	PROPN
dpc-5733	418	35	a.	a.	PROPN
dpc-5733	418	36	efficacy	efficacy	PROPN
dpc-5733	418	37	of	of	ADP
dpc-5733	418	38	long	long	ADJ
dpc-5733	418	39	-	-	PUNCT
dpc-5733	418	40	term	term	NOUN
dpc-5733	418	41	risankizumab	risankizumab	NOUN
dpc-5733	418	42	treatment	treatment	NOUN
dpc-5733	418	43	for	for	ADP
dpc-5733	418	44	moderate	moderate	ADJ
dpc-5733	418	45	-	-	PUNCT
dpc-5733	418	46	to	to	ADP
dpc-5733	418	47	-	-	PUNCT
dpc-5733	418	48	severe	severe	ADJ
dpc-5733	418	49	plaque	plaque	NOUN
dpc-5733	418	50	psoriasis	psoriasis	NOUN
dpc-5733	418	51	:	:	PUNCT
dpc-5733	418	52	subgroup	subgroup	NOUN
dpc-5733	418	53	analyses	analysis	NOUN
dpc-5733	418	54	by	by	ADP
dpc-5733	418	55	baseline	baseline	NOUN
dpc-5733	418	56	characteristics	characteristic	NOUN
dpc-5733	418	57	and	and	CCONJ
dpc-5733	418	58	psoriatic	psoriatic	ADJ
dpc-5733	418	59	disease	disease	NOUN
dpc-5733	418	60	manifestations	manifestation	NOUN
dpc-5733	418	61	through	through	ADP
dpc-5733	418	62	256	256	NUM
dpc-5733	418	63	  	  	SPACE
dpc-5733	418	64	weeks	week	NOUN
dpc-5733	418	65	(	(	PUNCT
dpc-5733	418	66	limmitless	limmitless	NOUN
dpc-5733	418	67	trial	trial	NOUN
dpc-5733	418	68	)	)	PUNCT
dpc-5733	418	69	.	.	PUNCT
dpc-5733	419	1	j	j	PROPN
dpc-5733	419	2	eur	eur	PROPN
dpc-5733	419	3	acad	acad	PROPN
dpc-5733	419	4	dermatol	dermatol	NOUN
dpc-5733	419	5	venereol	venereol	NOUN
dpc-5733	419	6	.	.	PUNCT
dpc-5733	420	1	2024	2024	NUM
dpc-5733	420	2	may;38(5):864	may;38(5):864	NUM
dpc-5733	420	3	-	-	PUNCT
dpc-5733	420	4	872	872	PROPN
dpc-5733	420	5	.	.	PUNCT
dpc-5733	421	1	doi	doi	NOUN
dpc-5733	421	2	:	:	PUNCT
dpc-5733	421	3	10.1111	10.1111	NUM
dpc-5733	421	4	/	/	SYM
dpc-5733	421	5	jdv.19748	jdv.19748	PROPN
dpc-5733	421	6	.	.	PUNCT
dpc-5733	421	7	epub	epub	PROPN
dpc-5733	421	8	2024	2024	NUM
dpc-5733	421	9	jan	jan	PROPN
dpc-5733	421	10	5	5	NUM
dpc-5733	421	11	.	.	PUNCT
dpc-5733	422	1	pmid	pmid	NOUN
dpc-5733	422	2	:	:	PUNCT
dpc-5733	422	3	38179809	38179809	NUM
dpc-5733	422	4	.	.	PUNCT
dpc-5733	423	1	36	36	NUM
dpc-5733	423	2	.	.	PUNCT
dpc-5733	424	1	bellinato	bellinato	PROPN
dpc-5733	424	2	f	f	PROPN
dpc-5733	424	3	,	,	PUNCT
dpc-5733	424	4	chiricozzi	chiricozzi	VERB
dpc-5733	424	5	a	a	ADV
dpc-5733	424	6	,	,	PUNCT
dpc-5733	424	7	piaserico	piaserico	NOUN
dpc-5733	424	8	s	s	PART
dpc-5733	424	9	,	,	PUNCT
dpc-5733	424	10	targher	targher	ADV
dpc-5733	424	11	g	g	NOUN
dpc-5733	424	12	,	,	PUNCT
dpc-5733	424	13	gisondi	gisondi	NOUN
dpc-5733	424	14	p.	p.	NOUN
dpc-5733	424	15	could	could	AUX
dpc-5733	424	16	targeted	target	VERB
dpc-5733	424	17	pharmacotherapies	pharmacotherapie	NOUN
dpc-5733	424	18	exert	exert	VERB
dpc-5733	424	19	a	a	DET
dpc-5733	424	20	"	"	PUNCT
dpc-5733	424	21	disease	disease	NOUN
dpc-5733	424	22	modification	modification	NOUN
dpc-5733	424	23	effect	effect	NOUN
dpc-5733	424	24	"	"	PUNCT
dpc-5733	424	25	in	in	ADP
dpc-5733	424	26	patients	patient	NOUN
dpc-5733	424	27	with	with	ADP
dpc-5733	424	28	chronic	chronic	ADJ
dpc-5733	424	29	plaque	plaque	NOUN
dpc-5733	424	30	psoriasis	psoriasis	NOUN
dpc-5733	424	31	?	?	PUNCT
dpc-5733	425	1	int	int	PROPN
dpc-5733	425	2	j	j	PROPN
dpc-5733	425	3	mol	mol	ADP
dpc-5733	425	4	sci	sci	PROPN
dpc-5733	425	5	.	.	PROPN
dpc-5733	425	6	2022	2022	NUM
dpc-5733	425	7	oct	oct	PROPN
dpc-5733	425	8	25;23(21):12849	25;23(21):12849	NUM
dpc-5733	425	9	.	.	PUNCT
dpc-5733	426	1	doi	doi	NOUN
dpc-5733	426	2	:	:	PUNCT
dpc-5733	426	3	10.3390	10.3390	NUM
dpc-5733	426	4	/	/	SYM
dpc-5733	426	5	ijms232112849	ijms232112849	PROPN
dpc-5733	426	6	.	.	PUNCT
dpc-5733	427	1	pmid	pmid	NOUN
dpc-5733	427	2	:	:	PUNCT
dpc-5733	427	3	36361639	36361639	NUM
dpc-5733	427	4	.	.	PUNCT
dpc-5733	428	1	37	37	NUM
dpc-5733	428	2	.	.	PUNCT
dpc-5733	429	1	zhao	zhao	PROPN
dpc-5733	429	2	y	y	PROPN
dpc-5733	429	3	,	,	PUNCT
dpc-5733	429	4	yang	yang	PROPN
dpc-5733	429	5	xt	xt	PROPN
dpc-5733	429	6	,	,	PUNCT
dpc-5733	429	7	bai	bai	PROPN
dpc-5733	429	8	yp	yp	PROPN
dpc-5733	429	9	,	,	PUNCT
dpc-5733	429	10	li	li	PROPN
dpc-5733	429	11	lf	lf	PROPN
dpc-5733	429	12	.	.	PROPN
dpc-5733	429	13	association	association	PROPN
dpc-5733	429	14	of	of	ADP
dpc-5733	429	15	complete	complete	ADJ
dpc-5733	429	16	blood	blood	NOUN
dpc-5733	429	17	cell	cell	NOUN
dpc-5733	429	18	count	count	NOUN
dpc-5733	429	19	-	-	PUNCT
dpc-5733	429	20	derived	derive	VERB
dpc-5733	429	21	inflammatory	inflammatory	ADJ
dpc-5733	429	22	biomarkers	biomarker	NOUN
dpc-5733	429	23	with	with	ADP
dpc-5733	429	24	psoriasis	psoriasis	NOUN
dpc-5733	429	25	and	and	CCONJ
dpc-5733	429	26	mortality	mortality	NOUN
dpc-5733	429	27	.	.	PUNCT
dpc-5733	430	1	clin	clin	PROPN
dpc-5733	430	2	cosmet	cosmet	PROPN
dpc-5733	430	3	investig	investig	NOUN
dpc-5733	430	4	dermatol	dermatol	NOUN
dpc-5733	430	5	.	.	PUNCT
dpc-5733	431	1	2023	2023	NUM
dpc-5733	431	2	nov	nov	NOUN
dpc-5733	431	3	13;16:3267	13;16:3267	NUM
dpc-5733	431	4	-	-	SYM
dpc-5733	431	5	3278	3278	NUM
dpc-5733	431	6	.	.	PUNCT
dpc-5733	432	1	doi	doi	NOUN
dpc-5733	432	2	:	:	PUNCT
dpc-5733	432	3	10.2147	10.2147	NUM
dpc-5733	432	4	/	/	SYM
dpc-5733	432	5	ccid.s437936	ccid.s437936	PROPN
dpc-5733	432	6	.	.	PUNCT
dpc-5733	433	1	pmid	pmid	NOUN
dpc-5733	433	2	:	:	PUNCT
dpc-5733	433	3	38021430	38021430	NUM
dpc-5733	433	4	.	.	PUNCT
dpc-5733	434	1	38	38	NUM
dpc-5733	434	2	.	.	PUNCT
dpc-5733	435	1	albayrak	albayrak	PROPN
dpc-5733	435	2	h.	h.	PROPN
dpc-5733	435	3	neutrophil	neutrophil	PROPN
dpc-5733	435	4	-	-	PUNCT
dpc-5733	435	5	to	to	ADP
dpc-5733	435	6	-	-	PUNCT
dpc-5733	435	7	lymphocyte	lymphocyte	NOUN
dpc-5733	435	8	ratio	ratio	NOUN
dpc-5733	435	9	,	,	PUNCT
dpc-5733	435	10	neutrophil	neutrophil	NOUN
dpc-5733	435	11	-	-	PUNCT
dpc-5733	435	12	to	to	NOUN
dpc-5733	435	13	monocyte	monocyte	NOUN
dpc-5733	435	14	ratio	ratio	NOUN
dpc-5733	435	15	,	,	PUNCT
dpc-5733	435	16	platelet	platelet	NOUN
dpc-5733	435	17	-	-	PUNCT
dpc-5733	435	18	to	to	ADP
dpc-5733	435	19	-	-	PUNCT
dpc-5733	435	20	lymphocyte	lymphocyte	NOUN
dpc-5733	435	21	ratio	ratio	NOUN
dpc-5733	435	22	,	,	PUNCT
dpc-5733	435	23	and	and	CCONJ
dpc-5733	435	24	systemic	systemic	ADJ
dpc-5733	435	25	immune	immune	ADJ
dpc-5733	435	26	-	-	PUNCT
dpc-5733	435	27	inflammation	inflammation	NOUN
dpc-5733	435	28	index	index	NOUN
dpc-5733	435	29	in	in	ADP
dpc-5733	435	30	psoriasis	psoriasis	NOUN
dpc-5733	435	31	patients	patient	NOUN
dpc-5733	435	32	:	:	PUNCT
dpc-5733	435	33	response	response	NOUN
dpc-5733	435	34	to	to	ADP
dpc-5733	435	35	treatment	treatment	NOUN
dpc-5733	435	36	with	with	ADP
dpc-5733	435	37	biological	biological	ADJ
dpc-5733	435	38	drugs	drug	NOUN
dpc-5733	435	39	.	.	PUNCT
dpc-5733	436	1	j	j	PROPN
dpc-5733	436	2	clin	clin	PROPN
dpc-5733	436	3	med	med	PROPN
dpc-5733	436	4	.	.	PUNCT
dpc-5733	437	1	2023	2023	NUM
dpc-5733	437	2	aug	aug	PROPN
dpc-5733	437	3	22;12(17):5452	22;12(17):5452	NUM
dpc-5733	437	4	.	.	PUNCT
dpc-5733	438	1	doi	doi	NOUN
dpc-5733	438	2	:	:	PUNCT
dpc-5733	438	3	10.3390	10.3390	NUM
dpc-5733	438	4	/	/	SYM
dpc-5733	438	5	jcm12175452	jcm12175452	NOUN
dpc-5733	438	6	.	.	PUNCT
dpc-5733	439	1	pmid	pmid	NOUN
dpc-5733	439	2	:	:	PUNCT
dpc-5733	439	3	37685519	37685519	NUM
dpc-5733	439	4	.	.	PUNCT
dpc-5733	440	1	39	39	NUM
dpc-5733	440	2	.	.	PUNCT
dpc-5733	441	1	zhang	zhang	PROPN
dpc-5733	441	2	y	y	PROPN
dpc-5733	441	3	,	,	PUNCT
dpc-5733	441	4	qian	qian	PROPN
dpc-5733	441	5	h	h	PROPN
dpc-5733	441	6	,	,	PUNCT
dpc-5733	441	7	kuang	kuang	PROPN
dpc-5733	441	8	yh	yh	PROPN
dpc-5733	441	9	,	,	PUNCT
dpc-5733	441	10	wang	wang	PROPN
dpc-5733	441	11	y	y	PROPN
dpc-5733	441	12	,	,	PUNCT
dpc-5733	441	13	chen	chen	PROPN
dpc-5733	441	14	wq	wq	PROPN
dpc-5733	441	15	,	,	PUNCT
dpc-5733	441	16	zhu	zhu	PROPN
dpc-5733	441	17	w.	w.	PROPN
dpc-5733	441	18	evaluation	evaluation	NOUN
dpc-5733	441	19	of	of	ADP
dpc-5733	441	20	the	the	DET
dpc-5733	441	21	inflammatory	inflammatory	ADJ
dpc-5733	441	22	parameters	parameter	NOUN
dpc-5733	441	23	as	as	ADP
dpc-5733	441	24	potential	potential	ADJ
dpc-5733	441	25	biomarkers	biomarker	NOUN
dpc-5733	441	26	of	of	ADP
dpc-5733	441	27	systemic	systemic	ADJ
dpc-5733	441	28	inflammation	inflammation	ADJ
dpc-5733	441	29	extent	extent	NOUN
dpc-5733	441	30	and	and	CCONJ
dpc-5733	441	31	the	the	DET
dpc-5733	441	32	disease	disease	NOUN
dpc-5733	441	33	severity	severity	NOUN
dpc-5733	441	34	in	in	ADP
dpc-5733	441	35	psoriasis	psoriasis	NOUN
dpc-5733	441	36	patients	patient	NOUN
dpc-5733	441	37	.	.	PUNCT
dpc-5733	442	1	arch	arch	ADJ
dpc-5733	442	2	dermatol	dermatol	NOUN
dpc-5733	442	3	res	re	NOUN
dpc-5733	442	4	.	.	PUNCT
dpc-5733	443	1	2024	2024	NUM
dpc-5733	443	2	may	may	PROPN
dpc-5733	443	3	24;316(6):229	24;316(6):229	NUM
dpc-5733	443	4	.	.	PUNCT
dpc-5733	444	1	doi	doi	NOUN
dpc-5733	444	2	:	:	PUNCT
dpc-5733	444	3	10.1007	10.1007	NUM
dpc-5733	444	4	/	/	SYM
dpc-5733	444	5	s00403	s00403	NOUN
dpc-5733	444	6	-	-	PUNCT
dpc-5733	444	7	024	024	NUM
dpc-5733	444	8	-	-	PUNCT
dpc-5733	444	9	02972	02972	NUM
dpc-5733	444	10	-	-	SYM
dpc-5733	444	11	8	8	NUM
dpc-5733	444	12	.	.	PUNCT
dpc-5733	445	1	pmid	pmid	NOUN
dpc-5733	445	2	:	:	PUNCT
dpc-5733	445	3	38787405	38787405	NUM
dpc-5733	445	4	.	.	PUNCT
dpc-5733	446	1	40	40	NUM
dpc-5733	446	2	.	.	PUNCT
dpc-5733	447	1	andersen	andersen	PROPN
dpc-5733	447	2	csb	csb	PROPN
dpc-5733	447	3	,	,	PUNCT
dpc-5733	447	4	kvist	kvist	NOUN
dpc-5733	447	5	-	-	PUNCT
dpc-5733	447	6	hansen	hansen	PROPN
dpc-5733	447	7	a	a	PROPN
dpc-5733	447	8	,	,	PUNCT
dpc-5733	447	9	siewertsen	siewertsen	NOUN
dpc-5733	447	10	m	m	NOUN
dpc-5733	447	11	,	,	PUNCT
dpc-5733	447	12	enevold	enevold	PROPN
dpc-5733	447	13	c	c	PROPN
dpc-5733	447	14	,	,	PUNCT
dpc-5733	447	15	hansen	hansen	PROPN
dpc-5733	447	16	pr	pr	PROPN
dpc-5733	447	17	,	,	PUNCT
dpc-5733	447	18	kaur	kaur	PROPN
dpc-5733	447	19	-	-	PUNCT
dpc-5733	447	20	knudsen	knudsen	PROPN
dpc-5733	447	21	d	d	PROPN
dpc-5733	447	22	,	,	PUNCT
dpc-5733	447	23	zachariae	zachariae	PROPN
dpc-5733	447	24	c	c	PROPN
dpc-5733	447	25	,	,	PUNCT
dpc-5733	447	26	nielsen	nielsen	PROPN
dpc-5733	447	27	ch	ch	PROPN
dpc-5733	447	28	,	,	PUNCT
dpc-5733	447	29	loft	loft	PROPN
dpc-5733	447	30	n	n	CCONJ
dpc-5733	447	31	,	,	PUNCT
dpc-5733	447	32	skov	skov	PROPN
dpc-5733	447	33	l.	l.	PROPN
dpc-5733	447	34	blood	blood	NOUN
dpc-5733	447	35	cell	cell	NOUN
dpc-5733	447	36	biomarkers	biomarker	NOUN
dpc-5733	447	37	of	of	ADP
dpc-5733	447	38	inflammation	inflammation	NOUN
dpc-5733	447	39	and	and	CCONJ
dpc-5733	447	40	cytokine	cytokine	ADJ
dpc-5733	447	41	levels	level	NOUN
dpc-5733	447	42	as	as	ADP
dpc-5733	447	43	predictors	predictor	NOUN
dpc-5733	447	44	of	of	ADP
dpc-5733	447	45	response	response	NOUN
dpc-5733	447	46	to	to	ADP
dpc-5733	447	47	biologics	biologic	NOUN
dpc-5733	447	48	in	in	ADP
dpc-5733	447	49	patients	patient	NOUN
dpc-5733	447	50	with	with	ADP
dpc-5733	447	51	psoriasis	psoriasis	NOUN
dpc-5733	447	52	.	.	PUNCT
dpc-5733	448	1	int	int	PROPN
dpc-5733	448	2	j	j	PROPN
dpc-5733	448	3	mol	mol	ADP
dpc-5733	448	4	sci	sci	PROPN
dpc-5733	448	5	.	.	PROPN
dpc-5733	449	1	2023	2023	NUM
dpc-5733	449	2	mar	mar	PROPN
dpc-5733	449	3	24;24(7):6111	24;24(7):6111	NUM
dpc-5733	449	4	.	.	PUNCT
dpc-5733	450	1	doi	doi	NOUN
dpc-5733	450	2	:	:	PUNCT
dpc-5733	450	3	10.3390	10.3390	NUM
dpc-5733	450	4	/ijms24076111	/ijms24076111	NUM
dpc-5733	450	5	.	.	PUNCT
dpc-5733	451	1	pmid	pmid	NOUN
dpc-5733	451	2	:	:	PUNCT
dpc-5733	451	3	37047086	37047086	NUM
dpc-5733	451	4	.	.	PUNCT
dpc-5733	452	1	41	41	NUM
dpc-5733	452	2	.	.	PUNCT
dpc-5733	453	1	kearney	kearney	PROPN
dpc-5733	453	2	n	n	PROPN
dpc-5733	453	3	,	,	PUNCT
dpc-5733	453	4	gorecki	gorecki	NOUN
dpc-5733	453	5	p	p	NOUN
dpc-5733	453	6	,	,	PUNCT
dpc-5733	453	7	acciarri	acciarri	PROPN
dpc-5733	453	8	l	l	NOUN
dpc-5733	453	9	,	,	PUNCT
dpc-5733	453	10	buyze	buyze	PROPN
dpc-5733	453	11	j	j	NOUN
dpc-5733	453	12	,	,	PUNCT
dpc-5733	453	13	akawung	akawung	PROPN
dpc-5733	453	14	a	a	PROPN
dpc-5733	453	15	,	,	PUNCT
dpc-5733	453	16	merola	merola	PROPN
dpc-5733	453	17	jf	jf	PROPN
dpc-5733	453	18	,	,	PUNCT
dpc-5733	453	19	kirby	kirby	PROPN
dpc-5733	453	20	b.	b.	PROPN
dpc-5733	453	21	treatment	treatment	NOUN
dpc-5733	453	22	of	of	ADP
dpc-5733	453	23	plaque	plaque	NOUN
dpc-5733	453	24	psoriasis	psoriasis	NOUN
dpc-5733	453	25	with	with	ADP
dpc-5733	453	26	guselkumab	guselkumab	NOUN
dpc-5733	453	27	reduces	reduce	VERB
dpc-5733	453	28	systemic	systemic	ADJ
dpc-5733	453	29	inflammatory	inflammatory	ADJ
dpc-5733	453	30	burden	burden	NOUN
dpc-5733	453	31	as	as	SCONJ
dpc-5733	453	32	measured	measure	VERB
dpc-5733	453	33	by	by	ADP
dpc-5733	453	34	neutrophil	neutrophil	ADJ
dpc-5733	453	35	/	/	SYM
dpc-5733	453	36	lymphocyte	lymphocyte	ADJ
dpc-5733	453	37	ratio	ratio	NOUN
dpc-5733	453	38	,	,	PUNCT
dpc-5733	453	39	platelet	platelet	NOUN
dpc-5733	453	40	/	/	SYM
dpc-5733	453	41	lymphocyte	lymphocyte	ADJ
dpc-5733	453	42	ratio	ratio	NOUN
dpc-5733	453	43	,	,	PUNCT
dpc-5733	453	44	and	and	CCONJ
dpc-5733	453	45	monocyte	monocyte	ADJ
dpc-5733	453	46	/	/	SYM
dpc-5733	453	47	lymphocyte	lymphocyte	ADJ
dpc-5733	453	48	ratio	ratio	NOUN
dpc-5733	453	49	:	:	PUNCT
dpc-5733	453	50	a	a	DET
dpc-5733	453	51	post	post	X
dpc-5733	453	52	hoc	hoc	X
dpc-5733	453	53	analysis	analysis	NOUN
dpc-5733	453	54	of	of	ADP
dpc-5733	453	55	three	three	NUM
dpc-5733	453	56	randomised	randomised	ADJ
dpc-5733	453	57	clinical	clinical	ADJ
dpc-5733	453	58	trials	trial	NOUN
dpc-5733	453	59	.	.	PUNCT
dpc-5733	454	1	dermatology	dermatology	NOUN
dpc-5733	454	2	.	.	PUNCT
dpc-5733	455	1	2025;241(3):272	2025;241(3):272	NUM
dpc-5733	455	2	-	-	SYM
dpc-5733	455	3	286	286	NUM
dpc-5733	455	4	.	.	PUNCT
dpc-5733	456	1	doi	doi	NOUN
dpc-5733	456	2	:	:	PUNCT
dpc-5733	456	3	10.1159/000545148	10.1159/000545148	NUM
dpc-5733	456	4	.	.	PUNCT
dpc-5733	457	1	epub	epub	NOUN
dpc-5733	457	2	2025	2025	NUM
dpc-5733	457	3	apr	apr	NOUN
dpc-5733	457	4	10	10	NUM
dpc-5733	457	5	.	.	PUNCT
dpc-5733	458	1	pmid	pmid	NOUN
dpc-5733	458	2	:	:	PUNCT
dpc-5733	458	3	40209685	40209685	NUM
dpc-5733	458	4	.	.	PUNCT
dpc-5733	459	1	42	42	NUM
dpc-5733	459	2	.	.	PUNCT
dpc-5733	460	1	çelik	çelik	PROPN
dpc-5733	460	2	ms	ms	PROPN
dpc-5733	460	3	,	,	PUNCT
dpc-5733	460	4	aktaş	aktaş	PROPN
dpc-5733	460	5	h.	h.	PROPN
dpc-5733	460	6	the	the	DET
dpc-5733	460	7	effect	effect	NOUN
dpc-5733	460	8	of	of	ADP
dpc-5733	460	9	il-17	il-17	NUM
dpc-5733	460	10	and	and	CCONJ
dpc-5733	460	11	il-23	il-23	VERB
dpc-5733	460	12	ınhibitors	ınhibitor	NOUN
dpc-5733	460	13	on	on	ADP
dpc-5733	460	14	hematological	hematological	ADJ
dpc-5733	460	15	ınflammatory	ınflammatory	NOUN
dpc-5733	460	16	parameters	parameter	NOUN
dpc-5733	460	17	in	in	ADP
dpc-5733	460	18	patients	patient	NOUN
dpc-5733	460	19	with	with	ADP
dpc-5733	460	20	psoriasis	psoriasis	NOUN
dpc-5733	460	21	vulgaris	vulgaris	NOUN
dpc-5733	460	22	.	.	PUNCT
dpc-5733	461	1	ir	ir	PROPN
dpc-5733	461	2	j	j	PROPN
dpc-5733	461	3	med	med	PROPN
dpc-5733	461	4	sci	sci	PROPN
dpc-5733	461	5	.	.	PROPN
dpc-5733	461	6	2025	2025	NUM
dpc-5733	461	7	aug;194(4):1329	aug;194(4):1329	PROPN
dpc-5733	461	8	-	-	SYM
dpc-5733	461	9	1334	1334	NUM
dpc-5733	461	10	.	.	PUNCT
dpc-5733	462	1	original	original	ADJ
dpc-5733	462	2	article	article	NOUN
dpc-5733	462	3	|	|	ADV
dpc-5733	462	4	dermatol	dermatol	ADJ
dpc-5733	462	5	pract	pract	NOUN
dpc-5733	462	6	concept	concept	NOUN
dpc-5733	462	7	.	.	PUNCT
dpc-5733	463	1	2025;15(4):5733	2025;15(4):5733	NUM
dpc-5733	463	2	11	11	NUM
dpc-5733	463	3	types	type	NOUN
dpc-5733	463	4	to	to	PART
dpc-5733	463	5	biologic	biologic	NOUN
dpc-5733	463	6	therapies	therapy	NOUN
dpc-5733	463	7	in	in	ADP
dpc-5733	463	8	patients	patient	NOUN
dpc-5733	463	9	with	with	ADP
dpc-5733	463	10	moderate	moderate	ADJ
dpc-5733	463	11	-	-	PUNCT
dpc-5733	463	12	to	to	ADP
dpc-5733	463	13	-	-	PUNCT
dpc-5733	463	14	severe	severe	ADJ
dpc-5733	463	15	plaque	plaque	NOUN
dpc-5733	463	16	psoriasis	psoriasis	NOUN
dpc-5733	463	17	from	from	ADP
dpc-5733	463	18	two	two	NUM
dpc-5733	463	19	randomized	randomized	ADJ
dpc-5733	463	20	clinical	clinical	ADJ
dpc-5733	463	21	trials	trial	NOUN
dpc-5733	463	22	.	.	PUNCT
dpc-5733	464	1	dermatol	dermatol	NOUN
dpc-5733	464	2	ther	ther	ADV
dpc-5733	464	3	(	(	PUNCT
dpc-5733	464	4	heidelb	heidelb	NOUN
dpc-5733	464	5	)	)	PUNCT
dpc-5733	464	6	.	.	PUNCT
dpc-5733	465	1	2024	2024	NUM
dpc-5733	465	2	mar;14(3):745	mar;14(3):745	NOUN
dpc-5733	465	3	-	-	PUNCT
dpc-5733	465	4	758	758	NUM
dpc-5733	465	5	.	.	PUNCT
dpc-5733	466	1	doi	doi	NOUN
dpc-5733	466	2	:	:	PUNCT
dpc-5733	466	3	10.1007	10.1007	NUM
dpc-5733	466	4	/s13555	/s13555	NUM
dpc-5733	466	5	-	-	PUNCT
dpc-5733	466	6	024	024	NUM
dpc-5733	466	7	-	-	PUNCT
dpc-5733	466	8	01123	01123	NUM
dpc-5733	466	9	-	-	SYM
dpc-5733	466	10	1	1	NUM
dpc-5733	466	11	.	.	PUNCT
dpc-5733	467	1	epub	epub	NOUN
dpc-5733	467	2	2024	2024	NUM
dpc-5733	467	3	mar	mar	PROPN
dpc-5733	467	4	15	15	NUM
dpc-5733	467	5	.	.	PUNCT
dpc-5733	468	1	pmid	pmid	NOUN
dpc-5733	468	2	:	:	PUNCT
dpc-5733	468	3	38485863	38485863	NUM
dpc-5733	468	4	;	;	PUNCT
dpc-5733	468	5	pmcid	pmcid	ADJ
dpc-5733	468	6	:	:	PUNCT
dpc-5733	468	7	pmc10965842	pmc10965842	NOUN
dpc-5733	468	8	.	.	PUNCT
dpc-5733	469	1	61	61	NUM
dpc-5733	469	2	.	.	PUNCT
dpc-5733	470	1	torres	torres	PROPN
dpc-5733	470	2	t	t	PROPN
dpc-5733	470	3	,	,	PUNCT
dpc-5733	470	4	puig	puig	PROPN
dpc-5733	470	5	l	l	NOUN
dpc-5733	470	6	,	,	PUNCT
dpc-5733	470	7	vender	vender	PROPN
dpc-5733	470	8	r	r	PROPN
dpc-5733	470	9	,	,	PUNCT
dpc-5733	470	10	yeung	yeung	PROPN
dpc-5733	470	11	j	j	PROPN
dpc-5733	470	12	,	,	PUNCT
dpc-5733	470	13	carrascosa	carrascosa	PROPN
dpc-5733	470	14	jm	jm	PROPN
dpc-5733	470	15	,	,	PUNCT
dpc-5733	470	16	piaserico	piaserico	PROPN
dpc-5733	470	17	s	s	PART
dpc-5733	470	18	,	,	PUNCT
dpc-5733	470	19	gisondi	gisondi	NOUN
dpc-5733	470	20	p	p	NOUN
dpc-5733	470	21	,	,	PUNCT
dpc-5733	470	22	lynde	lynde	PROPN
dpc-5733	470	23	c	c	PROPN
dpc-5733	470	24	,	,	PUNCT
dpc-5733	470	25	ferreira	ferreira	PROPN
dpc-5733	470	26	p	p	PROPN
dpc-5733	470	27	,	,	PUNCT
dpc-5733	470	28	bastos	bastos	PROPN
dpc-5733	470	29	pm	pm	NOUN
dpc-5733	470	30	,	,	PUNCT
dpc-5733	470	31	dauden	dauden	ADJ
dpc-5733	470	32	e	e	NOUN
dpc-5733	470	33	,	,	PUNCT
dpc-5733	470	34	leite	leite	PROPN
dpc-5733	470	35	l	l	PROPN
dpc-5733	470	36	,	,	PUNCT
dpc-5733	470	37	valerio	valerio	PROPN
dpc-5733	470	38	j	j	PROPN
dpc-5733	470	39	,	,	PUNCT
dpc-5733	470	40	del	del	PROPN
dpc-5733	470	41	alcázar	alcázar	PROPN
dpc-5733	470	42	-	-	PROPN
dpc-5733	470	43	viladomiu	viladomiu	PROPN
dpc-5733	470	44	e	e	PROPN
dpc-5733	470	45	,	,	PUNCT
dpc-5733	470	46	rull	rull	PROPN
dpc-5733	470	47	ev	ev	NOUN
dpc-5733	470	48	,	,	PUNCT
dpc-5733	470	49	llamas	llamas	PROPN
dpc-5733	470	50	-	-	PUNCT
dpc-5733	470	51	velasco	velasco	PROPN
dpc-5733	470	52	m	m	PROPN
dpc-5733	470	53	,	,	PUNCT
dpc-5733	470	54	pirro	pirro	PROPN
dpc-5733	470	55	f	f	PROPN
dpc-5733	470	56	,	,	PUNCT
dpc-5733	470	57	messina	messina	PROPN
dpc-5733	470	58	f	f	PROPN
dpc-5733	470	59	,	,	PUNCT
dpc-5733	470	60	bruni	bruni	PROPN
dpc-5733	470	61	m	m	PROPN
dpc-5733	470	62	,	,	PUNCT
dpc-5733	470	63	licata	licata	VERB
dpc-5733	470	64	g	g	PROPN
dpc-5733	470	65	,	,	PUNCT
dpc-5733	470	66	ricceri	ricceri	PROPN
dpc-5733	470	67	f	f	PROPN
dpc-5733	470	68	,	,	PUNCT
dpc-5733	470	69	nidegger	nidegger	PROPN
dpc-5733	470	70	a	a	X
dpc-5733	470	71	,	,	PUNCT
dpc-5733	470	72	hugo	hugo	PROPN
dpc-5733	470	73	j	j	PROPN
dpc-5733	470	74	,	,	PUNCT
dpc-5733	470	75	mufti	mufti	PROPN
dpc-5733	470	76	a	a	PROPN
dpc-5733	470	77	,	,	PUNCT
dpc-5733	470	78	daponte	daponte	NOUN
dpc-5733	470	79	ai	ai	PROPN
dpc-5733	470	80	,	,	PUNCT
dpc-5733	470	81	teixeira	teixeira	PROPN
dpc-5733	470	82	l	l	PROPN
dpc-5733	470	83	,	,	PUNCT
dpc-5733	470	84	balato	balato	VERB
dpc-5733	470	85	a	a	PRON
dpc-5733	470	86	,	,	PUNCT
dpc-5733	470	87	romanelli	romanelli	NOUN
dpc-5733	470	88	m	m	PROPN
dpc-5733	470	89	,	,	PUNCT
dpc-5733	471	1	prignano	prignano	PROPN
dpc-5733	471	2	f	f	PROPN
dpc-5733	471	3	,	,	PUNCT
dpc-5733	471	4	gkalpakiotis	gkalpakiotis	PROPN
dpc-5733	471	5	s	s	PROPN
dpc-5733	471	6	,	,	PUNCT
dpc-5733	471	7	conrad	conrad	PROPN
dpc-5733	471	8	c	c	PROPN
dpc-5733	471	9	,	,	PUNCT
dpc-5733	471	10	lazaridou	lazaridou	PROPN
dpc-5733	471	11	e	e	PROPN
dpc-5733	471	12	,	,	PUNCT
dpc-5733	471	13	rompoti	rompoti	PROPN
dpc-5733	471	14	n	n	CCONJ
dpc-5733	471	15	,	,	PUNCT
dpc-5733	471	16	papoutsaki	papoutsaki	PROPN
dpc-5733	471	17	m	m	PROPN
dpc-5733	471	18	,	,	PUNCT
dpc-5733	471	19	nogueira	nogueira	PROPN
dpc-5733	471	20	m	m	PROPN
dpc-5733	471	21	,	,	PUNCT
dpc-5733	471	22	chiricozzi	chiricozzi	PROPN
dpc-5733	471	23	a.	a.	NOUN
dpc-5733	471	24	drug	drug	PROPN
dpc-5733	471	25	survival	survival	NOUN
dpc-5733	471	26	of	of	ADP
dpc-5733	471	27	interleukin	interleukin	NOUN
dpc-5733	471	28	(	(	PUNCT
dpc-5733	471	29	il)-17	il)-17	PROPN
dpc-5733	471	30	and	and	CCONJ
dpc-5733	471	31	il-23	il-23	VERB
dpc-5733	471	32	inhibitors	inhibitor	NOUN
dpc-5733	471	33	for	for	ADP
dpc-5733	471	34	the	the	DET
dpc-5733	471	35	treatment	treatment	NOUN
dpc-5733	471	36	of	of	ADP
dpc-5733	471	37	psoriasis	psoriasis	NOUN
dpc-5733	471	38	:	:	PUNCT
dpc-5733	471	39	a	a	DET
dpc-5733	471	40	retrospective	retrospective	ADJ
dpc-5733	471	41	multi	multi	ADJ
dpc-5733	471	42	-	-	NOUN
dpc-5733	471	43	country	country	NOUN
dpc-5733	471	44	,	,	PUNCT
dpc-5733	471	45	multicentric	multicentric	ADJ
dpc-5733	471	46	cohort	cohort	NOUN
dpc-5733	471	47	study	study	NOUN
dpc-5733	471	48	.	.	PUNCT
dpc-5733	472	1	am	be	AUX
dpc-5733	472	2	j	j	PROPN
dpc-5733	472	3	clin	clin	PROPN
dpc-5733	472	4	dermatol	dermatol	NOUN
dpc-5733	472	5	.	.	PUNCT
dpc-5733	473	1	2022	2022	NUM
dpc-5733	473	2	nov;23(6):891	nov;23(6):891	NUM
dpc-5733	473	3	-	-	PUNCT
dpc-5733	473	4	904	904	NUM
dpc-5733	473	5	.	.	PUNCT
dpc-5733	474	1	doi	doi	NOUN
dpc-5733	474	2	:	:	PUNCT
dpc-5733	474	3	10.1007	10.1007	NUM
dpc-5733	474	4	/s40257	/s40257	NOUN
dpc-5733	474	5	-	-	PUNCT
dpc-5733	474	6	022	022	NUM
dpc-5733	474	7	-	-	PUNCT
dpc-5733	474	8	00722	00722	NUM
dpc-5733	474	9	-	-	PUNCT
dpc-5733	474	10	y.	y.	NOUN
dpc-5733	474	11	epub	epub	PROPN
dpc-5733	474	12	2022	2022	NUM
dpc-5733	474	13	aug	aug	PROPN
dpc-5733	474	14	17	17	NUM
dpc-5733	474	15	.	.	PUNCT
dpc-5733	475	1	pmid	pmid	NOUN
dpc-5733	475	2	:	:	PUNCT
dpc-5733	475	3	35976568	35976568	NUM
dpc-5733	475	4	.	.	PUNCT
dpc-5733	476	1	62	62	NUM
dpc-5733	476	2	.	.	PUNCT
dpc-5733	477	1	landgren	landgren	PROPN
dpc-5733	477	2	aj	aj	PROPN
dpc-5733	477	3	,	,	PUNCT
dpc-5733	477	4	jonsson	jonsson	PROPN
dpc-5733	477	5	ca	ca	PROPN
dpc-5733	477	6	,	,	PUNCT
dpc-5733	477	7	bilberg	bilberg	PROPN
dpc-5733	477	8	a	a	PRON
dpc-5733	477	9	,	,	PUNCT
dpc-5733	477	10	eliasson	eliasson	NOUN
dpc-5733	477	11	b	b	NOUN
dpc-5733	477	12	,	,	PUNCT
dpc-5733	477	13	torres	torre	VERB
dpc-5733	477	14	l	l	NOUN
dpc-5733	477	15	,	,	PUNCT
dpc-5733	477	16	dehlin	dehlin	PROPN
dpc-5733	477	17	m	m	PROPN
dpc-5733	477	18	,	,	PUNCT
dpc-5733	477	19	jacobsson	jacobsson	PROPN
dpc-5733	477	20	lth	lth	PROPN
dpc-5733	477	21	,	,	PUNCT
dpc-5733	477	22	gjertsson	gjertsson	NOUN
dpc-5733	477	23	i	i	PRON
dpc-5733	477	24	,	,	PUNCT
dpc-5733	477	25	larsson	larsson	PROPN
dpc-5733	478	1	i	i	PROPN
dpc-5733	478	2	,	,	PUNCT
dpc-5733	478	3	klingberg	klingberg	PROPN
dpc-5733	478	4	e.	e.	PROPN
dpc-5733	478	5	serum	serum	PROPN
dpc-5733	478	6	il-23	il-23	NOUN
dpc-5733	478	7	significantly	significantly	ADV
dpc-5733	478	8	decreased	decrease	VERB
dpc-5733	478	9	in	in	ADP
dpc-5733	478	10	obese	obese	ADJ
dpc-5733	478	11	patients	patient	NOUN
dpc-5733	478	12	with	with	ADP
dpc-5733	478	13	psoriatic	psoriatic	ADJ
dpc-5733	478	14	arthritis	arthritis	NOUN
dpc-5733	478	15	six	six	NUM
dpc-5733	478	16	months	month	NOUN
dpc-5733	478	17	after	after	ADP
dpc-5733	478	18	a	a	DET
dpc-5733	478	19	structured	structured	ADJ
dpc-5733	478	20	weight	weight	NOUN
dpc-5733	478	21	loss	loss	NOUN
dpc-5733	478	22	intervention	intervention	NOUN
dpc-5733	478	23	.	.	PUNCT
dpc-5733	479	1	arthritis	arthritis	NOUN
dpc-5733	479	2	res	re	NOUN
dpc-5733	479	3	ther	ther	ADV
dpc-5733	479	4	.	.	PUNCT
dpc-5733	480	1	2023	2023	NUM
dpc-5733	480	2	jul	jul	PROPN
dpc-5733	480	3	27;25(1):131	27;25(1):131	NUM
dpc-5733	480	4	.	.	PUNCT
dpc-5733	481	1	doi	doi	NOUN
dpc-5733	481	2	:	:	PUNCT
dpc-5733	481	3	10.1186	10.1186	NUM
dpc-5733	481	4	/	/	SYM
dpc-5733	481	5	s13075	s13075	NUM
dpc-5733	481	6	-	-	PUNCT
dpc-5733	481	7	023	023	NUM
dpc-5733	481	8	-	-	PUNCT
dpc-5733	481	9	03105	03105	NUM
dpc-5733	481	10	-	-	PUNCT
dpc-5733	481	11	8	8	NUM
dpc-5733	481	12	.	.	PUNCT
dpc-5733	482	1	pmid	pmid	NOUN
dpc-5733	482	2	:	:	PUNCT
dpc-5733	482	3	37501212	37501212	NUM
dpc-5733	482	4	;	;	PUNCT
dpc-5733	482	5	pmcid	pmcid	ADJ
dpc-5733	482	6	:	:	PUNCT
dpc-5733	482	7	pmc10373368	pmc10373368	NOUN
dpc-5733	482	8	.	.	PUNCT
dpc-5733	483	1	63	63	NUM
dpc-5733	483	2	.	.	PUNCT
dpc-5733	484	1	dragotto	dragotto	PROPN
dpc-5733	484	2	m	m	PROPN
dpc-5733	484	3	,	,	PUNCT
dpc-5733	484	4	capalbo	capalbo	NOUN
dpc-5733	484	5	e	e	NOUN
dpc-5733	484	6	,	,	PUNCT
dpc-5733	484	7	cartocci	cartocci	VERB
dpc-5733	484	8	a	a	PRON
dpc-5733	484	9	,	,	PUNCT
dpc-5733	484	10	manzo	manzo	PROPN
dpc-5733	484	11	margiotta	margiotta	PROPN
dpc-5733	484	12	f	f	PROPN
dpc-5733	484	13	,	,	PUNCT
dpc-5733	484	14	michelucci	michelucci	VERB
dpc-5733	484	15	a	a	PRON
dpc-5733	484	16	,	,	PUNCT
dpc-5733	484	17	rosi	rosi	PROPN
dpc-5733	484	18	e	e	PROPN
dpc-5733	484	19	,	,	PUNCT
dpc-5733	484	20	ricceri	ricceri	PROPN
dpc-5733	484	21	f	f	PROPN
dpc-5733	484	22	,	,	PUNCT
dpc-5733	484	23	simoni	simoni	PROPN
dpc-5733	484	24	b	b	PROPN
dpc-5733	484	25	,	,	PUNCT
dpc-5733	484	26	savarese	savarese	PROPN
dpc-5733	484	27	i	i	PRON
dpc-5733	484	28	,	,	PUNCT
dpc-5733	484	29	milanesi	milanesi	NOUN
dpc-5733	484	30	n	n	CCONJ
dpc-5733	484	31	,	,	PUNCT
dpc-5733	484	32	rossari	rossari	PROPN
dpc-5733	484	33	s	s	PROPN
dpc-5733	484	34	,	,	PUNCT
dpc-5733	484	35	magnano	magnano	PROPN
dpc-5733	484	36	m	m	PROPN
dpc-5733	484	37	,	,	PUNCT
dpc-5733	484	38	romanelli	romanelli	PROPN
dpc-5733	484	39	m	m	PROPN
dpc-5733	484	40	,	,	PUNCT
dpc-5733	484	41	rubegni	rubegni	VERB
dpc-5733	484	42	p	p	NOUN
dpc-5733	484	43	,	,	PUNCT
dpc-5733	484	44	prignano	prignano	ADJ
dpc-5733	484	45	f	f	PROPN
dpc-5733	484	46	,	,	PUNCT
dpc-5733	484	47	di	di	PROPN
dpc-5733	484	48	cesare	cesare	PROPN
dpc-5733	484	49	a	a	PROPN
dpc-5733	484	50	,	,	PUNCT
dpc-5733	484	51	panduri	panduri	PROPN
dpc-5733	484	52	s	s	PROPN
dpc-5733	484	53	,	,	PUNCT
dpc-5733	484	54	pescitelli	pescitelli	PROPN
dpc-5733	484	55	l	l	PROPN
dpc-5733	484	56	,	,	PUNCT
dpc-5733	484	57	trovato	trovato	PROPN
dpc-5733	484	58	e.	e.	PROPN
dpc-5733	484	59	real	real	ADJ
dpc-5733	484	60	-	-	PUNCT
dpc-5733	484	61	life	life	NOUN
dpc-5733	484	62	effectiveness	effectiveness	NOUN
dpc-5733	484	63	of	of	ADP
dpc-5733	484	64	risankizumab	risankizumab	NOUN
dpc-5733	484	65	according	accord	VERB
dpc-5733	484	66	to	to	ADP
dpc-5733	484	67	body	body	NOUN
dpc-5733	484	68	mass	mass	PROPN
dpc-5733	484	69	index	index	NOUN
dpc-5733	484	70	:	:	PUNCT
dpc-5733	484	71	results	result	NOUN
dpc-5733	484	72	of	of	ADP
dpc-5733	484	73	an	an	DET
dpc-5733	484	74	italian	italian	ADJ
dpc-5733	484	75	multicentre	multicentre	NOUN
dpc-5733	484	76	retrospective	retrospective	ADJ
dpc-5733	484	77	study	study	NOUN
dpc-5733	484	78	.	.	PUNCT
dpc-5733	485	1	j	j	PROPN
dpc-5733	485	2	eur	eur	PROPN
dpc-5733	485	3	acad	acad	PROPN
dpc-5733	485	4	dermatol	dermatol	NOUN
dpc-5733	485	5	venereol	venereol	NOUN
dpc-5733	485	6	.	.	PUNCT
dpc-5733	486	1	2023	2023	NUM
dpc-5733	486	2	apr	apr	NOUN
dpc-5733	486	3	16	16	NUM
dpc-5733	486	4	.	.	PUNCT
dpc-5733	487	1	doi	doi	NOUN
dpc-5733	487	2	:	:	PUNCT
dpc-5733	487	3	10.1111	10.1111	NUM
dpc-5733	487	4	/	/	SYM
dpc-5733	487	5	jdv.19117	jdv.19117	PROPN
dpc-5733	487	6	.	.	PUNCT
dpc-5733	488	1	epub	epub	NOUN
dpc-5733	488	2	ahead	ahead	ADV
dpc-5733	488	3	of	of	ADP
dpc-5733	488	4	print	print	NOUN
dpc-5733	488	5	.	.	PUNCT
dpc-5733	489	1	pmid	pmid	NOUN
dpc-5733	489	2	:	:	PUNCT
dpc-5733	489	3	37062048	37062048	NUM
dpc-5733	489	4	.	.	PUNCT
dpc-5733	490	1	64	64	NUM
dpc-5733	490	2	.	.	PUNCT
dpc-5733	491	1	ricceri	ricceri	PROPN
dpc-5733	491	2	f	f	PROPN
dpc-5733	491	3	,	,	PUNCT
dpc-5733	491	4	chiricozzi	chiricozzi	VERB
dpc-5733	491	5	a	a	NOUN
dpc-5733	491	6	,	,	PUNCT
dpc-5733	491	7	peris	peris	PROPN
dpc-5733	491	8	k	k	PROPN
dpc-5733	491	9	,	,	PUNCT
dpc-5733	491	10	prignano	prignano	PROPN
dpc-5733	491	11	f.	f.	PROPN
dpc-5733	491	12	successful	successful	ADJ
dpc-5733	491	13	use	use	NOUN
dpc-5733	491	14	of	of	ADP
dpc-5733	491	15	anti	anti	ADJ
dpc-5733	491	16	-	-	ADJ
dpc-5733	491	17	il-23	il-23	ADJ
dpc-5733	491	18	molecules	molecule	NOUN
dpc-5733	491	19	in	in	ADP
dpc-5733	491	20	overweight	overweight	NOUN
dpc-5733	491	21	-	-	PUNCT
dpc-5733	491	22	to	to	ADP
dpc-5733	491	23	-	-	PUNCT
dpc-5733	491	24	obese	obese	ADJ
dpc-5733	491	25	psoriatic	psoriatic	ADJ
dpc-5733	491	26	patients	patient	NOUN
dpc-5733	491	27	:	:	PUNCT
dpc-5733	491	28	a	a	DET
dpc-5733	491	29	multicentric	multicentric	ADJ
dpc-5733	491	30	retrospective	retrospective	ADJ
dpc-5733	491	31	study	study	NOUN
dpc-5733	491	32	.	.	PUNCT
dpc-5733	492	1	dermatol	dermatol	NOUN
dpc-5733	492	2	ther	ther	ADV
dpc-5733	492	3	.	.	PUNCT
dpc-5733	493	1	2022	2022	NUM
dpc-5733	493	2	nov;35(11):e15793	nov;35(11):e15793	NOUN
dpc-5733	493	3	.	.	PUNCT
dpc-5733	494	1	doi	doi	NOUN
dpc-5733	494	2	:	:	PUNCT
dpc-5733	494	3	10.1111	10.1111	NUM
dpc-5733	494	4	/	/	SYM
dpc-5733	494	5	dth.15793	dth.15793	NUM
dpc-5733	494	6	.	.	PUNCT
dpc-5733	495	1	epub	epub	NOUN
dpc-5733	495	2	2022	2022	NUM
dpc-5733	495	3	sep	sep	PROPN
dpc-5733	495	4	9	9	NUM
dpc-5733	495	5	.	.	PUNCT
dpc-5733	496	1	pmid	pmid	NOUN
dpc-5733	496	2	:	:	PUNCT
dpc-5733	496	3	36038527	36038527	NUM
dpc-5733	496	4	.	.	PUNCT
dpc-5733	497	1	65	65	NUM
dpc-5733	497	2	.	.	PUNCT
dpc-5733	498	1	crowley	crowley	PROPN
dpc-5733	498	2	jj	jj	PROPN
dpc-5733	498	3	,	,	PUNCT
dpc-5733	498	4	langley	langley	PROPN
dpc-5733	498	5	rg	rg	PROPN
dpc-5733	498	6	,	,	PUNCT
dpc-5733	498	7	gordon	gordon	PROPN
dpc-5733	498	8	kb	kb	PROPN
dpc-5733	498	9	,	,	PUNCT
dpc-5733	498	10	pinter	pinter	VERB
dpc-5733	498	11	a	a	PRON
dpc-5733	498	12	,	,	PUNCT
dpc-5733	498	13	ferris	ferris	PROPN
dpc-5733	498	14	lk	lk	PROPN
dpc-5733	498	15	,	,	PUNCT
dpc-5733	498	16	rubant	rubant	PROPN
dpc-5733	498	17	s	s	PROPN
dpc-5733	498	18	,	,	PUNCT
dpc-5733	498	19	photowala	photowala	ADJ
dpc-5733	498	20	h	h	NOUN
dpc-5733	498	21	,	,	PUNCT
dpc-5733	498	22	xue	xue	PROPN
dpc-5733	498	23	z	z	PROPN
dpc-5733	498	24	,	,	PUNCT
dpc-5733	498	25	wu	wu	PROPN
dpc-5733	498	26	t	t	PROPN
dpc-5733	498	27	,	,	PUNCT
dpc-5733	498	28	zhan	zhan	PROPN
dpc-5733	498	29	t	t	PROPN
dpc-5733	498	30	,	,	PUNCT
dpc-5733	498	31	beeck	beeck	PROPN
dpc-5733	498	32	s	s	PROPN
dpc-5733	498	33	,	,	PUNCT
dpc-5733	498	34	shah	shah	PROPN
dpc-5733	498	35	m	m	PROPN
dpc-5733	498	36	,	,	PUNCT
dpc-5733	498	37	warren	warren	PROPN
dpc-5733	498	38	rb	rb	PROPN
dpc-5733	498	39	.	.	PUNCT
dpc-5733	498	40	efficacy	efficacy	NOUN
dpc-5733	498	41	of	of	ADP
dpc-5733	498	42	risankizumab	risankizumab	PROPN
dpc-5733	498	43	versus	versus	ADP
dpc-5733	498	44	secukinumab	secukinumab	NOUN
dpc-5733	498	45	in	in	ADP
dpc-5733	498	46	patients	patient	NOUN
dpc-5733	498	47	with	with	ADP
dpc-5733	498	48	moderate	moderate	ADJ
dpc-5733	498	49	-	-	PUNCT
dpc-5733	498	50	to	to	ADP
dpc-5733	498	51	-	-	PUNCT
dpc-5733	498	52	severe	severe	ADJ
dpc-5733	498	53	psoriasis	psoriasis	NOUN
dpc-5733	498	54	:	:	PUNCT
dpc-5733	498	55	subgroup	subgroup	NOUN
dpc-5733	498	56	analysis	analysis	NOUN
dpc-5733	498	57	from	from	ADP
dpc-5733	498	58	the	the	DET
dpc-5733	498	59	immerge	immerge	ADJ
dpc-5733	498	60	study	study	NOUN
dpc-5733	498	61	.	.	PUNCT
dpc-5733	499	1	dermatol	dermatol	NOUN
dpc-5733	499	2	ther	ther	ADV
dpc-5733	499	3	(	(	PUNCT
dpc-5733	499	4	heidelb	heidelb	NOUN
dpc-5733	499	5	)	)	PUNCT
dpc-5733	499	6	.	.	PUNCT
dpc-5733	500	1	2022	2022	NUM
dpc-5733	500	2	feb;12(2):561	feb;12(2):561	NUM
dpc-5733	500	3	-	-	PUNCT
dpc-5733	500	4	575	575	NUM
dpc-5733	500	5	.	.	PUNCT
dpc-5733	501	1	doi	doi	NOUN
dpc-5733	501	2	:	:	PUNCT
dpc-5733	501	3	10.1007	10.1007	NUM
dpc-5733	501	4	/	/	SYM
dpc-5733	501	5	s13555	s13555	PROPN
dpc-5733	501	6	-	-	PUNCT
dpc-5733	501	7	021	021	NUM
dpc-5733	501	8	-	-	PUNCT
dpc-5733	501	9	00679	00679	NUM
dpc-5733	501	10	-	-	SYM
dpc-5733	501	11	6	6	NUM
dpc-5733	501	12	.	.	PUNCT
dpc-5733	502	1	epub	epub	NOUN
dpc-5733	502	2	2022	2022	NUM
dpc-5733	502	3	jan	jan	PROPN
dpc-5733	502	4	20	20	NUM
dpc-5733	502	5	.	.	PUNCT
dpc-5733	503	1	pmid	pmid	NOUN
dpc-5733	503	2	:	:	PUNCT
dpc-5733	503	3	35050485	35050485	NUM
dpc-5733	503	4	.	.	PUNCT
dpc-5733	504	1	53	53	NUM
dpc-5733	504	2	.	.	PUNCT
dpc-5733	505	1	rodriguez	rodriguez	NOUN
dpc-5733	505	2	-	-	PUNCT
dpc-5733	505	3	rosales	rosales	PROPN
dpc-5733	505	4	ya	ya	PROPN
dpc-5733	505	5	,	,	PUNCT
dpc-5733	505	6	langereis	langereis	PROPN
dpc-5733	505	7	jd	jd	PROPN
dpc-5733	505	8	,	,	PUNCT
dpc-5733	505	9	gorris	gorris	PROPN
dpc-5733	505	10	maj	maj	PROPN
dpc-5733	505	11	,	,	PUNCT
dpc-5733	505	12	van	van	PROPN
dpc-5733	505	13	den	den	PROPN
dpc-5733	505	14	reek	reek	PROPN
dpc-5733	505	15	jmpa	jmpa	PROPN
dpc-5733	505	16	,	,	PUNCT
dpc-5733	505	17	fasse	fasse	X
dpc-5733	505	18	e	e	PROPN
dpc-5733	505	19	,	,	PUNCT
dpc-5733	505	20	netea	netea	NOUN
dpc-5733	505	21	mg	mg	PROPN
dpc-5733	505	22	,	,	PUNCT
dpc-5733	505	23	de	de	PROPN
dpc-5733	505	24	vries	vries	PROPN
dpc-5733	505	25	ijm	ijm	PROPN
dpc-5733	505	26	,	,	PUNCT
dpc-5733	505	27	gomez	gomez	PROPN
dpc-5733	505	28	-	-	PUNCT
dpc-5733	505	29	muñoz	muñoz	PROPN
dpc-5733	505	30	l	l	PROPN
dpc-5733	505	31	,	,	PUNCT
dpc-5733	505	32	van	van	PROPN
dpc-5733	505	33	cranenbroek	cranenbroek	PROPN
dpc-5733	505	34	b	b	PROPN
dpc-5733	505	35	,	,	PUNCT
dpc-5733	505	36	körber	körber	PROPN
dpc-5733	505	37	a	a	NOUN
dpc-5733	505	38	,	,	PUNCT
dpc-5733	505	39	sondermann	sondermann	PROPN
dpc-5733	505	40	w	w	PROPN
dpc-5733	505	41	,	,	PUNCT
dpc-5733	505	42	joosten	joosten	VERB
dpc-5733	505	43	i	i	PRON
dpc-5733	505	44	,	,	PUNCT
dpc-5733	505	45	de	de	PROPN
dpc-5733	505	46	jong	jong	PROPN
dpc-5733	505	47	emgj	emgj	PROPN
dpc-5733	505	48	,	,	PUNCT
dpc-5733	505	49	koenen	koenen	NOUN
dpc-5733	505	50	hjpm	hjpm	NOUN
dpc-5733	505	51	.	.	PUNCT
dpc-5733	506	1	immunomodulatory	immunomodulatory	ADJ
dpc-5733	506	2	aged	aged	ADJ
dpc-5733	506	3	neutrophils	neutrophil	NOUN
dpc-5733	506	4	are	be	AUX
dpc-5733	506	5	augmented	augment	VERB
dpc-5733	506	6	in	in	ADP
dpc-5733	506	7	blood	blood	NOUN
dpc-5733	506	8	and	and	CCONJ
dpc-5733	506	9	skin	skin	NOUN
dpc-5733	506	10	of	of	ADP
dpc-5733	506	11	psoriasis	psoriasis	NOUN
dpc-5733	506	12	patients	patient	NOUN
dpc-5733	506	13	.	.	PUNCT
dpc-5733	507	1	j	j	PROPN
dpc-5733	507	2	allergy	allergy	PROPN
dpc-5733	507	3	clin	clin	PROPN
dpc-5733	507	4	immunol	immunol	PROPN
dpc-5733	507	5	.	.	PUNCT
dpc-5733	508	1	2021	2021	NUM
dpc-5733	508	2	oct;148(4):1030	oct;148(4):1030	NUM
dpc-5733	508	3	-	-	SYM
dpc-5733	508	4	1040	1040	NUM
dpc-5733	508	5	.	.	PUNCT
dpc-5733	509	1	doi	doi	NOUN
dpc-5733	509	2	:	:	PUNCT
dpc-5733	509	3	10.1016	10.1016	NUM
dpc-5733	509	4	/	/	SYM
dpc-5733	509	5	j	j	PROPN
dpc-5733	509	6	.jaci.2021.02.041	.jaci.2021.02.041	PUNCT
dpc-5733	509	7	.	.	PUNCT
dpc-5733	510	1	epub	epub	NOUN
dpc-5733	510	2	2021	2021	NUM
dpc-5733	510	3	mar	mar	PROPN
dpc-5733	510	4	19	19	NUM
dpc-5733	510	5	.	.	PUNCT
dpc-5733	511	1	pmid	pmid	NOUN
dpc-5733	511	2	:	:	PUNCT
dpc-5733	511	3	33745888	33745888	NUM
dpc-5733	511	4	.	.	PUNCT
dpc-5733	512	1	54	54	NUM
dpc-5733	512	2	.	.	PUNCT
dpc-5733	513	1	zhang	zhang	PROPN
dpc-5733	513	2	j	j	PROPN
dpc-5733	513	3	,	,	PUNCT
dpc-5733	513	4	feng	feng	PROPN
dpc-5733	513	5	y	y	PROPN
dpc-5733	513	6	,	,	PUNCT
dpc-5733	513	7	shi	shi	PROPN
dpc-5733	513	8	d.	d.	PROPN
dpc-5733	513	9	netosis	netosis	PROPN
dpc-5733	513	10	of	of	ADP
dpc-5733	513	11	psoriasis	psoriasis	NOUN
dpc-5733	513	12	:	:	PUNCT
dpc-5733	513	13	a	a	DET
dpc-5733	513	14	critical	critical	ADJ
dpc-5733	513	15	step	step	NOUN
dpc-5733	513	16	in	in	ADP
dpc-5733	513	17	amplifying	amplify	VERB
dpc-5733	513	18	the	the	DET
dpc-5733	513	19	inflammatory	inflammatory	ADJ
dpc-5733	513	20	response	response	NOUN
dpc-5733	513	21	.	.	PUNCT
dpc-5733	514	1	front	front	ADJ
dpc-5733	514	2	immunol	immunol	NOUN
dpc-5733	514	3	.	.	PUNCT
dpc-5733	515	1	2024	2024	NUM
dpc-5733	515	2	aug	aug	PROPN
dpc-5733	515	3	1;15:1374934	1;15:1374934	NUM
dpc-5733	515	4	.	.	PUNCT
dpc-5733	516	1	doi	doi	NOUN
dpc-5733	516	2	:	:	PUNCT
dpc-5733	516	3	10.3389	10.3389	NUM
dpc-5733	516	4	/	/	SYM
dpc-5733	516	5	fimmu.2024.1374934	fimmu.2024.1374934	NOUN
dpc-5733	516	6	.	.	PUNCT
dpc-5733	517	1	pmid	pmid	NOUN
dpc-5733	517	2	:	:	PUNCT
dpc-5733	517	3	39148738	39148738	NUM
dpc-5733	517	4	.	.	PUNCT
dpc-5733	518	1	55	55	NUM
dpc-5733	518	2	.	.	PUNCT
dpc-5733	519	1	lambert	lambert	PROPN
dpc-5733	519	2	s	s	PROPN
dpc-5733	519	3	,	,	PUNCT
dpc-5733	519	4	hambro	hambro	PROPN
dpc-5733	519	5	ca	ca	PROPN
dpc-5733	519	6	,	,	PUNCT
dpc-5733	519	7	johnston	johnston	PROPN
dpc-5733	519	8	a	a	PROPN
dpc-5733	519	9	,	,	PUNCT
dpc-5733	519	10	stuart	stuart	PROPN
dpc-5733	519	11	pe	pe	PROPN
dpc-5733	519	12	,	,	PUNCT
dpc-5733	519	13	tsoi	tsoi	PROPN
dpc-5733	519	14	lc	lc	PROPN
dpc-5733	519	15	,	,	PUNCT
dpc-5733	519	16	nair	nair	NOUN
dpc-5733	519	17	rp	rp	PROPN
dpc-5733	519	18	,	,	PUNCT
dpc-5733	519	19	elder	elder	NOUN
dpc-5733	519	20	jt	jt	PROPN
dpc-5733	519	21	.	.	PUNCT
dpc-5733	520	1	neutrophil	neutrophil	ADP
dpc-5733	520	2	extracellular	extracellular	ADJ
dpc-5733	520	3	traps	trap	NOUN
dpc-5733	520	4	induce	induce	VERB
dpc-5733	520	5	human	human	ADJ
dpc-5733	520	6	  	  	SPACE
dpc-5733	520	7	th17	th17	PROPN
dpc-5733	520	8	cells	cell	NOUN
dpc-5733	520	9	:	:	PUNCT
dpc-5733	520	10	effect	effect	NOUN
dpc-5733	520	11	of	of	ADP
dpc-5733	520	12	psoriasis	psoriasis	NOUN
dpc-5733	520	13	-	-	PUNCT
dpc-5733	520	14	associated	associate	VERB
dpc-5733	520	15	traf3ip2	traf3ip2	PRON
dpc-5733	520	16	genotype	genotype	NOUN
dpc-5733	520	17	.	.	PUNCT
dpc-5733	521	1	j	j	NOUN
dpc-5733	521	2	  	  	SPACE
dpc-5733	521	3	invest	invest	VERB
dpc-5733	521	4	dermatol	dermatol	NOUN
dpc-5733	521	5	.	.	PUNCT
dpc-5733	522	1	2019	2019	NUM
dpc-5733	522	2	jun;139(6):1245	jun;139(6):1245	NOUN
dpc-5733	522	3	-	-	SYM
dpc-5733	522	4	1253	1253	NUM
dpc-5733	522	5	.	.	PUNCT
dpc-5733	523	1	doi	doi	NOUN
dpc-5733	523	2	:	:	PUNCT
dpc-5733	523	3	10.1016	10.1016	NUM
dpc-5733	523	4	/	/	SYM
dpc-5733	523	5	j	j	PROPN
dpc-5733	523	6	.jid.2018.11.021	.jid.2018.11.021	PROPN
dpc-5733	523	7	.	.	PUNCT
dpc-5733	524	1	epub	epub	PROPN
dpc-5733	524	2	2018	2018	NUM
dpc-5733	524	3	dec	dec	PROPN
dpc-5733	524	4	5	5	NUM
dpc-5733	524	5	.	.	PUNCT
dpc-5733	525	1	pmid	pmid	NOUN
dpc-5733	525	2	:	:	PUNCT
dpc-5733	525	3	30528823	30528823	NUM
dpc-5733	525	4	.	.	PUNCT
dpc-5733	526	1	56	56	NUM
dpc-5733	526	2	.	.	PUNCT
dpc-5733	527	1	hjort	hjort	NOUN
dpc-5733	527	2	g	g	PROPN
dpc-5733	527	3	,	,	PUNCT
dpc-5733	527	4	schwarz	schwarz	PROPN
dpc-5733	527	5	cw	cw	NOUN
dpc-5733	527	6	,	,	PUNCT
dpc-5733	527	7	skov	skov	PROPN
dpc-5733	527	8	l	l	NOUN
dpc-5733	527	9	,	,	PUNCT
dpc-5733	527	10	loft	loft	PROPN
dpc-5733	527	11	n.	n.	PROPN
dpc-5733	527	12	clinical	clinical	ADJ
dpc-5733	527	13	characteristics	characteristic	NOUN
dpc-5733	527	14	associated	associate	VERB
dpc-5733	527	15	with	with	ADP
dpc-5733	527	16	response	response	NOUN
dpc-5733	527	17	to	to	ADP
dpc-5733	527	18	biologics	biologic	NOUN
dpc-5733	527	19	in	in	ADP
dpc-5733	527	20	the	the	DET
dpc-5733	527	21	treatment	treatment	NOUN
dpc-5733	527	22	of	of	ADP
dpc-5733	527	23	psoriasis	psoriasis	NOUN
dpc-5733	527	24	:	:	PUNCT
dpc-5733	527	25	a	a	DET
dpc-5733	527	26	meta	meta	ADJ
dpc-5733	527	27	-	-	PUNCT
dpc-5733	527	28	analysis	analysis	NOUN
dpc-5733	527	29	.	.	PUNCT
dpc-5733	528	1	jama	jama	PROPN
dpc-5733	528	2	dermatol	dermatol	NOUN
dpc-5733	528	3	.	.	PUNCT
dpc-5733	529	1	2024	2024	NUM
dpc-5733	529	2	aug	aug	PROPN
dpc-5733	529	3	1;160(8	1;160(8	NUM
dpc-5733	529	4	):	):	PUNCT
dpc-5733	529	5	830	830	NUM
dpc-5733	529	6	-	-	SYM
dpc-5733	529	7	837	837	NUM
dpc-5733	529	8	.	.	PUNCT
dpc-5733	530	1	doi	doi	NOUN
dpc-5733	530	2	:	:	PUNCT
dpc-5733	530	3	10.1001	10.1001	NUM
dpc-5733	530	4	/	/	SYM
dpc-5733	530	5	jamadermatol.2024.1677	jamadermatol.2024.1677	PROPN
dpc-5733	530	6	.	.	PUNCT
dpc-5733	531	1	erratum	erratum	PROPN
dpc-5733	531	2	in	in	ADP
dpc-5733	531	3	:	:	PUNCT
dpc-5733	531	4	jama	jama	X
dpc-5733	531	5	dermatol	dermatol	NOUN
dpc-5733	531	6	.	.	PUNCT
dpc-5733	532	1	2024	2024	NUM
dpc-5733	532	2	nov	nov	NOUN
dpc-5733	532	3	1;160(11):1257	1;160(11):1257	PROPN
dpc-5733	532	4	.	.	PUNCT
dpc-5733	533	1	doi	doi	NOUN
dpc-5733	533	2	:	:	PUNCT
dpc-5733	533	3	10.1001	10.1001	NUM
dpc-5733	533	4	/jamadermatol.2024.4301	/jamadermatol.2024.4301	NOUN
dpc-5733	533	5	.	.	PUNCT
dpc-5733	534	1	pmid	pmid	NOUN
dpc-5733	534	2	:	:	PUNCT
dpc-5733	534	3	38888917	38888917	NUM
dpc-5733	534	4	.	.	PUNCT
dpc-5733	535	1	57	57	NUM
dpc-5733	535	2	.	.	X
dpc-5733	535	3	schwarz	schwarz	PROPN
dpc-5733	535	4	cw	cw	PROPN
dpc-5733	535	5	,	,	PUNCT
dpc-5733	535	6	loft	loft	PROPN
dpc-5733	535	7	n	n	PROPN
dpc-5733	535	8	,	,	PUNCT
dpc-5733	535	9	rasmussen	rasmussen	PROPN
dpc-5733	535	10	mk	mk	PROPN
dpc-5733	535	11	,	,	PUNCT
dpc-5733	535	12	nissen	nissen	PROPN
dpc-5733	535	13	cv	cv	PROPN
dpc-5733	535	14	,	,	PUNCT
dpc-5733	535	15	dam	dam	PROPN
dpc-5733	535	16	tn	tn	PROPN
dpc-5733	535	17	,	,	PUNCT
dpc-5733	535	18	ajgeiy	ajgeiy	PROPN
dpc-5733	535	19	kk	kk	PROPN
dpc-5733	535	20	,	,	PUNCT
dpc-5733	535	21	egeberg	egeberg	PROPN
dpc-5733	535	22	a	a	PROPN
dpc-5733	535	23	,	,	PUNCT
dpc-5733	535	24	skov	skov	NOUN
dpc-5733	535	25	l.	l.	NOUN
dpc-5733	535	26	predictors	predictor	NOUN
dpc-5733	535	27	of	of	ADP
dpc-5733	535	28	response	response	NOUN
dpc-5733	535	29	to	to	ADP
dpc-5733	535	30	biologics	biologic	NOUN
dpc-5733	535	31	in	in	ADP
dpc-5733	535	32	patients	patient	NOUN
dpc-5733	535	33	with	with	ADP
dpc-5733	535	34	moderate	moderate	ADJ
dpc-5733	535	35	-	-	PUNCT
dpc-5733	535	36	to	to	ADP
dpc-5733	535	37	-	-	PUNCT
dpc-5733	535	38	severe	severe	ADJ
dpc-5733	535	39	psoriasis	psoriasis	NOUN
dpc-5733	535	40	:	:	PUNCT
dpc-5733	535	41	a	a	DET
dpc-5733	535	42	danish	danish	ADJ
dpc-5733	535	43	nationwide	nationwide	ADJ
dpc-5733	535	44	cohort	cohort	NOUN
dpc-5733	535	45	study	study	NOUN
dpc-5733	535	46	.	.	PUNCT
dpc-5733	536	1	acta	acta	PROPN
dpc-5733	536	2	derm	derm	PROPN
dpc-5733	536	3	venereol	venereol	NOUN
dpc-5733	536	4	.	.	PUNCT
dpc-5733	537	1	2021	2021	NUM
dpc-5733	537	2	oct	oct	PROPN
dpc-5733	537	3	26;101(10):adv00579	26;101(10):adv00579	PROPN
dpc-5733	537	4	.	.	PUNCT
dpc-5733	538	1	doi	doi	NOUN
dpc-5733	538	2	:	:	PUNCT
dpc-5733	538	3	10.2340	10.2340	NUM
dpc-5733	538	4	/	/	SYM
dpc-5733	538	5	actadv.v101.351	actadv.v101.351	NOUN
dpc-5733	538	6	.	.	PUNCT
dpc-5733	539	1	pmid	pmid	NOUN
dpc-5733	539	2	:	:	PUNCT
dpc-5733	539	3	34642768	34642768	NUM
dpc-5733	539	4	.	.	PUNCT
dpc-5733	540	1	58	58	NUM
dpc-5733	540	2	.	.	PUNCT
dpc-5733	541	1	warren	warren	PROPN
dpc-5733	541	2	rb	rb	PROPN
dpc-5733	541	3	,	,	PUNCT
dpc-5733	541	4	marsden	marsden	PROPN
dpc-5733	541	5	a	a	X
dpc-5733	541	6	,	,	PUNCT
dpc-5733	541	7	tomenson	tomenson	NOUN
dpc-5733	541	8	b	b	PROPN
dpc-5733	541	9	,	,	PUNCT
dpc-5733	541	10	mason	mason	PROPN
dpc-5733	541	11	kj	kj	PROPN
dpc-5733	541	12	,	,	PUNCT
dpc-5733	541	13	soliman	soliman	NOUN
dpc-5733	541	14	mm	mm	PROPN
dpc-5733	541	15	,	,	PUNCT
dpc-5733	541	16	burden	burden	NOUN
dpc-5733	541	17	ad	ad	NOUN
dpc-5733	541	18	,	,	PUNCT
dpc-5733	541	19	reynolds	reynolds	PROPN
dpc-5733	541	20	nj	nj	PROPN
dpc-5733	541	21	,	,	PUNCT
dpc-5733	541	22	stocken	stocken	VERB
dpc-5733	541	23	d	d	PROPN
dpc-5733	541	24	,	,	PUNCT
dpc-5733	541	25	emsley	emsley	PROPN
dpc-5733	541	26	r	r	PROPN
dpc-5733	541	27	,	,	PUNCT
dpc-5733	541	28	griffiths	griffiths	PROPN
dpc-5733	541	29	cem	cem	PROPN
dpc-5733	541	30	,	,	PUNCT
dpc-5733	541	31	smith	smith	PROPN
dpc-5733	541	32	c	c	PROPN
dpc-5733	541	33	;	;	PUNCT
dpc-5733	541	34	psort	psort	NOUN
dpc-5733	541	35	consortium	consortium	NOUN
dpc-5733	541	36	and	and	CCONJ
dpc-5733	541	37	on	on	ADP
dpc-5733	541	38	behalf	behalf	NOUN
dpc-5733	541	39	of	of	ADP
dpc-5733	541	40	the	the	DET
dpc-5733	541	41	badbir	badbir	PROPN
dpc-5733	541	42	study	study	NOUN
dpc-5733	541	43	group	group	NOUN
dpc-5733	541	44	.	.	PUNCT
dpc-5733	542	1	identifying	identify	VERB
dpc-5733	542	2	demographic	demographic	ADJ
dpc-5733	542	3	,	,	PUNCT
dpc-5733	542	4	social	social	ADJ
dpc-5733	542	5	and	and	CCONJ
dpc-5733	542	6	clinical	clinical	ADJ
dpc-5733	542	7	predictors	predictor	NOUN
dpc-5733	542	8	of	of	ADP
dpc-5733	542	9	biologic	biologic	NOUN
dpc-5733	542	10	therapy	therapy	NOUN
dpc-5733	542	11	effectiveness	effectiveness	NOUN
dpc-5733	542	12	in	in	ADP
dpc-5733	542	13	psoriasis	psoriasis	NOUN
dpc-5733	542	14	:	:	PUNCT
dpc-5733	542	15	a	a	DET
dpc-5733	542	16	multicentre	multicentre	ADJ
dpc-5733	542	17	longitudinal	longitudinal	ADJ
dpc-5733	542	18	cohort	cohort	NOUN
dpc-5733	542	19	study	study	NOUN
dpc-5733	542	20	.	.	PUNCT
dpc-5733	543	1	br	br	PROPN
dpc-5733	543	2	j	j	PROPN
dpc-5733	543	3	dermatol	dermatol	NOUN
dpc-5733	543	4	.	.	PUNCT
dpc-5733	544	1	2019	2019	NUM
dpc-5733	544	2	may;180(5):1069	may;180(5):1069	NOUN
dpc-5733	544	3	-	-	SYM
dpc-5733	544	4	1076	1076	NUM
dpc-5733	544	5	.	.	PUNCT
dpc-5733	545	1	doi	doi	NOUN
dpc-5733	545	2	:	:	PUNCT
dpc-5733	545	3	10.1111	10.1111	NUM
dpc-5733	545	4	/	/	SYM
dpc-5733	545	5	bjd.16776	bjd.16776	PROPN
dpc-5733	545	6	.	.	PUNCT
dpc-5733	546	1	epub	epub	PROPN
dpc-5733	546	2	2018	2018	NUM
dpc-5733	546	3	aug	aug	PROPN
dpc-5733	546	4	28	28	NUM
dpc-5733	546	5	.	.	PUNCT
dpc-5733	547	1	pmid	pmid	NOUN
dpc-5733	547	2	:	:	PUNCT
dpc-5733	547	3	30155885	30155885	NUM
dpc-5733	547	4	;	;	PUNCT
dpc-5733	547	5	pmcid	pmcid	ADJ
dpc-5733	547	6	:	:	PUNCT
dpc-5733	547	7	pmc6519065	pmc6519065	NOUN
dpc-5733	547	8	.	.	PUNCT
dpc-5733	548	1	59	59	NUM
dpc-5733	548	2	.	.	PUNCT
dpc-5733	549	1	huang	huang	PROPN
dpc-5733	549	2	d	d	PROPN
dpc-5733	549	3	,	,	PUNCT
dpc-5733	549	4	zhong	zhong	PROPN
dpc-5733	549	5	x	x	PROPN
dpc-5733	549	6	,	,	PUNCT
dpc-5733	549	7	jiang	jiang	PROPN
dpc-5733	549	8	y	y	PROPN
dpc-5733	549	9	,	,	PUNCT
dpc-5733	549	10	kong	kong	PROPN
dpc-5733	549	11	l	l	PROPN
dpc-5733	549	12	,	,	PUNCT
dpc-5733	549	13	ma	ma	PROPN
dpc-5733	549	14	r	r	PROPN
dpc-5733	549	15	,	,	PUNCT
dpc-5733	549	16	lu	lu	PROPN
dpc-5733	549	17	j	j	PROPN
dpc-5733	549	18	,	,	PUNCT
dpc-5733	549	19	li	li	PROPN
dpc-5733	549	20	y	y	PROPN
dpc-5733	549	21	,	,	PUNCT
dpc-5733	549	22	shi	shi	PROPN
dpc-5733	549	23	y.	y.	PROPN
dpc-5733	549	24	insulin	insulin	PROPN
dpc-5733	549	25	resistance	resistance	NOUN
dpc-5733	549	26	impairs	impair	VERB
dpc-5733	549	27	biologic	biologic	ADJ
dpc-5733	549	28	agent	agent	NOUN
dpc-5733	549	29	response	response	NOUN
dpc-5733	549	30	in	in	ADP
dpc-5733	549	31	moderate	moderate	ADJ
dpc-5733	549	32	-	-	PUNCT
dpc-5733	549	33	to	to	ADP
dpc-5733	549	34	-	-	PUNCT
dpc-5733	549	35	severe	severe	ADJ
dpc-5733	549	36	plaque	plaque	NOUN
dpc-5733	549	37	psoriasis	psoriasis	NOUN
dpc-5733	549	38	:	:	PUNCT
dpc-5733	549	39	insights	insight	NOUN
dpc-5733	549	40	from	from	ADP
dpc-5733	549	41	a	a	DET
dpc-5733	549	42	prospective	prospective	ADJ
dpc-5733	549	43	cohort	cohort	NOUN
dpc-5733	549	44	study	study	NOUN
dpc-5733	549	45	in	in	ADP
dpc-5733	549	46	china	china	PROPN
dpc-5733	549	47	.	.	PUNCT
dpc-5733	550	1	br	br	PROPN
dpc-5733	550	2	j	j	PROPN
dpc-5733	550	3	dermatol	dermatol	NOUN
dpc-5733	550	4	.	.	PUNCT
dpc-5733	551	1	2024	2024	NUM
dpc-5733	551	2	sep	sep	PROPN
dpc-5733	551	3	18;191(4):616623	18;191(4):616623	NUM
dpc-5733	551	4	.	.	PUNCT
dpc-5733	552	1	doi	doi	NOUN
dpc-5733	552	2	:	:	PUNCT
dpc-5733	552	3	10.1093	10.1093	NUM
dpc-5733	552	4	/	/	SYM
dpc-5733	552	5	bjd	bjd	PROPN
dpc-5733	552	6	/	/	SYM
dpc-5733	552	7	ljae147	ljae147	PROPN
dpc-5733	552	8	.	.	PUNCT
dpc-5733	553	1	pmid	pmid	NOUN
dpc-5733	553	2	:	:	PUNCT
dpc-5733	553	3	38634691	38634691	NUM
dpc-5733	553	4	.	.	PUNCT
dpc-5733	554	1	60	60	NUM
dpc-5733	554	2	.	.	PUNCT
dpc-5733	555	1	egeberg	egeberg	PROPN
dpc-5733	555	2	a	a	PROPN
dpc-5733	555	3	,	,	PUNCT
dpc-5733	555	4	conrad	conrad	PROPN
dpc-5733	555	5	c	c	PROPN
dpc-5733	555	6	,	,	PUNCT
dpc-5733	555	7	gorecki	gorecki	NOUN
dpc-5733	555	8	p	p	NOUN
dpc-5733	555	9	,	,	PUNCT
dpc-5733	555	10	wegner	wegner	PROPN
dpc-5733	555	11	s	s	PROPN
dpc-5733	555	12	,	,	PUNCT
dpc-5733	555	13	buyze	buyze	ADJ
dpc-5733	555	14	j	j	NOUN
dpc-5733	555	15	,	,	PUNCT
dpc-5733	555	16	acciarri	acciarri	PROPN
dpc-5733	555	17	l	l	PROPN
dpc-5733	555	18	,	,	PUNCT
dpc-5733	555	19	thaçi	thaçi	PROPN
dpc-5733	555	20	d.	d.	PROPN
dpc-5733	555	21	response	response	NOUN
dpc-5733	555	22	types	type	NOUN
dpc-5733	555	23	and	and	CCONJ
dpc-5733	555	24	factors	factor	NOUN
dpc-5733	555	25	associated	associate	VERB
dpc-5733	555	26	with	with	ADP
dpc-5733	555	27	response	response	NOUN